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Abstract 
 
α-Diazocarbonyl compounds are widely used in organic chemistry as versatile carbene 
precursors which enable concise synthesis towards complex asymmetric molecules. 
Due to their intrinsic highly energetic nature, flow technology can be applied to ensure 
safer, scalable and efficient protocols. Other modern enabling tools such as Design of 
Experiment (DoE) and online analysis, provide great advantages to achieve faster 
analysis and optimisations of chemical transformations.  
In the first part of this work, α-diazocarbonyl compounds have been used in the 
enantioselective synthesis of novel trans-indolines.1 
 
The synthesis of the diazo precursors, previously investigated in batch, was translated 
into a flow system and optimised following a DoE-approach. Moreover, highly Lewis 
acidic boranes were found to enable related α-diazocarbonyl compounds to undergo a 
metal-free transfer/rearrangement cascade reaction towards asymmetric benzofuran-
3H-ones.2 
 
The focus in the final part of this work was on the development of a faster analytical 
method for an accelerated optimisation of stereoselective reactions. The reactions were 
performed in a continuous flow electrochemical reactor directly coupled to a 2D‐HPLC 
for immediate online analysis, which allowed a fast screening of reaction conditions using 
DoE.3 
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CHAPTER 1: Introduction 
1.1 α-Diazocarbonyl Compounds in Organic Synthesis 
Diazo compounds are a class of neutral organic reagents presenting a terminal 
dinitrogen moiety (Scheme 1.1).  
 
Scheme 1.1: Diazo compound 1 as precursor for carbene species 2. 
The highly energetic carbon-nitrogen bond can be cleaved, releasing molecular nitrogen 
N2 and generating the reactive carbene species 2. For this reason, since their discovery 
in 1858 by Peter Griess,1 diazo compounds are widely used in organic chemistry as 
versatile building blocks. However, due to their intrinsic reactivity, diazo intermediates 
are also highly toxic and explosive.2 Several explosions due to diazomethane have been 
reported as result of its fast decomposition at higher temperatures or in contact with 
scratched glassware.3 This high reactivity has limited their applications especially in 
industrial setting. 
Diazo compounds can be classified into three groups according to the electronic 
properties of their substituents (Figure 1.1).4 
 
Figure 1.1: Diazo compounds classified according to the electronic properties of the substituents: 
EWG = carbonyl, sulfonyl, cyano, nitro, phosphonate group; EDG = aryl, heteroaryl, vinyl group. 
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Early works in the area of diazo chemistry focused on the first class of diazo compounds 
bearing one (“acceptor”) or two (“acceptor/acceptor”) electron-withdrawing groups 
(EWG) such as dicarbonyl diazo or α-diazo ester. These electrophilic molecules 
generate highly reactive carbene intermediates that found applications in a wide range 
of transformations from cyclopropanation5 to X–H insertion (X = C, O, N) 6 and generation 
of ylides.7 However, due to the high electrophilic nature of the carbon atom and the 
inability of the EWG to stabilise the carbene centre, this class of compounds is 
characterised by low selectivity especially in intermolecular insertions, therefore they are 
mainly used for intramolecular processes. Subsequently, Davies and co-workers 
explored how proximal electron-donating groups (EDG), such as aryl or vinyl moieties, 
provide more stable carbene precursors (Class II). For this reason, and due to their 
slightly attenuated reactivity, “donor/acceptor” diazo compounds can be engaged in 
more selective intermolecular reactions.8 While these first two classes have received 
more attention, just a few examples have been reported using the third class of diazo 
compounds. The “donor/donor” carbene precursors have been known for many years 
but their electron-rich character makes their isolation problematic and an in situ 
generation is often required.4a,9 Furthermore, these types of diazo compounds are 
reported to be highly explosive and they are subjected to a fast dimerisation which limits 
their applicability (Scheme 1.2). 
 
Scheme 1.2: Dimerisation of “donor/acceptor” and “donor/donor” diazo compounds. 
This work of thesis mainly focuses on the synthesis and reactivity of donor/acceptor 
diazo compounds such as 6, that are generally preferred over diazoalkane intermediates 
because of their higher stability (Scheme 1.3). The additional resonance structure 6III 
presents a negative charge located on the more electronegative oxygen atom which 
stabilises the dipole of the diazo functional group. On the contrary, when the negative 
and the positive charge are located next to each other as in diazomethane (7), the loss 
of N2 is thermodynamically favoured and therefore the compound is less stable.  
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Scheme 1.3: Resonance structures for α-diazocarbonyl compound 6 and diazomethane (7). 
The thermal properties of diazo compounds are the reason why large-scale syntheses 
are still scarce, despite the advantages on selectivity of “donor/donor” carbene and the 
increased stability of “donor/acceptor” carbenes. Nevertheless, in the last two decades, 
continuous flow chemistry has proven to be a safer alternative for the synthesis of diazo 
compounds. As discussed later in this chapter, due to the better control of the 
temperature and the possibility to generate in situ highly energetic diazo precursors, flow 
chemistry enables “safer” protocols for the synthesis of diazo compounds, even in 
large-scale reactions.10,11 
1.1.1 Synthesis of α-Diazocarbonyl Compounds 
Diazocarbonyl compounds are widely used as valuable intermediate in organic chemistry 
and some diazo-containing compounds such as the kinamycins and Lomaiviticin A were 
also isolated from natural products (Figure 1.2).12 
 
Figure 1.2: Examples of natural products containing the diazo moiety. 
The broad use of diazocarboyl compounds relies on well-established and efficient 
synthetic methods depicted in Scheme 1.4: diazotisation of amino acids (a), 
diazo-transfer reactions (b), dehydrogenation of hydrazones (c), modification of azides 
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(d), acylation of diazoalkanes (e), substitution/cross-coupling (f) and substituent 
modification (g).13 
 
Scheme 1.4: Classic routes to α-diazocarbonyl compounds (6): a) diazotisation of amino acids; 
b) diazo-transfer reactions; c) dehydrogenation of hydrazones; d) modification of azides; 
e) acylation of diazoalkanes; f) substitution/cross-coupling; g) substituent modification. 
The first reported approach toward diazo compounds dates back to 1883, with the 
pioneering work of Curtius on the diazotisation of amino acids as a way of preparing ethyl 
diazoacetate (EDA, 11) from ethyl glycine ester (10) hydrochloride (Scheme 1.5).14 
Nowadays, this reaction is mainly used for the synthesis of diazonium salts15 and 
azides,16 while the introduction of a diazo moiety via diazotisation is less common. 
 
Scheme 1.5: First reported synthesis of ethyl α-diazoacetate 11 via diazotisation of amino 
acid 10.14 
In 1910, Dimroth reported the reaction between the malonic ester amide (12) and phenyl 
azide (13) to give diazomalonic ester (16) via triazole intermediate 15 (Scheme 1.6).17 A 
few years later Curtius and Klavehn prepared methyl diazo-N-tosylamide 20 from 
dimethyl malonate 17 using p-toluenesulfonyl azide 18a and suggesting 19 as 
intermediate.18 However, these reactions remained unacknowledged until 1964 when 
Regitz, inspired by the above-mentioned works, investigated the reaction between the 
sulfonyl azide 18a and the ketone anthrone (22) in pyridine/ethanol and isolated the 
corresponding diazocarbonyl 23 and tosylsulfonamide 21 as the side product.19 This 
base-promoted transfer of a diazo group from a sulfonyl azide reagent onto an activated 
Micol Santi Introduction  
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methyl or methylene group carries the name of Regitz diazo-transfer, in honour of the 
German chemist who first explained the mechanism in 1964.20 
 
Scheme 1.6: First examples of diazo-transfer reactions. 
According to the general mechanism, the diazo group is transferred from a diazo-transfer 
reagent 18, which is generally a sulfonyl azide, to the desired substrate bearing an 
activated methylene moiety such as the 1,3-dicarbonyl 24 under basic conditions 
(Scheme 1.7). 
 
Scheme 1.7: General mechanism of the α-diazo-transfer between the 1,3-dicarbonyl 24 and a 
sulfonyl azide 18. 
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The activated substrates 24 bearing one or more EWG can be deprotonated in the 
α-position by a relatively weak base such as triethylamine (TEA), diethylamine or pyridine 
forming the enolate 25. This reacts with the sulfonyl azide 18 generating the triazene 26 
that decomposes into the α-diazo-β-dicarbonyl compound 27 and releases sulfonamide 
21 as the side product. When less acidic methylene moieties are present, as in 
“donor/acceptor” precursors, it is necessary to use a slightly stronger base. For instance, 
α-aryl carbonyl substrates react better with 1,8-diazabicyclo[5.4.0]-undec-7-ene (DBU)21 
than with TEA, and for α-aryl amides stronger bases, such as LiHMDS 22 and LDA,23 are 
typically used. However, even with strong bases, the diazo-transfer does not occur at 
the α-position of simple cyclic and acyclic ketones bearing no additional EWG in 
β-position. To overcome this problem, Regitz and co-workers developed a deformylative 
diazo-transfer reaction using pre-functionalised substrates (Scheme 1.8).24 The ketone 
28 is activated via a Claisen-type condensation with ethyl formate (29) generating 30a. 
The activated methylene group is able to undergo a 1,3-dicarbonyl cycloaddition in the 
presence of tosyl azide 18a and TEA to form the triazole 31. Next, the intermediate 31 
decomposes to the α-diazoketone 6 releasing N-formylamide 32 as the side product. 
 
Scheme 1.8: Deformylative diazo-transfer approach.24 
Several modifications have been made to improve the efficiency of this reaction. For 
example, Danheiser and co-workers reported a two-step process using 
2,2,2-trifluoroethyl trifluoroacetate (33) for the formation of the activated 30b from an 
in situ generated lithium enolate for high-yielding synthesis of diazoketones 6 
(Scheme 1.9).25 Alternatively, Taber et al. reported an efficient benzoylation for the 
preparation of α-diazo esters 36, which avoids the use of strong bases and cryogenic 
conditions.26 In this case, the α-benzoyl intermediate 30c is achieved via a titanium 
chloride-mediated benzoylation followed by a milder diazo-transfer reaction which 
affords the diazo compound 36 from a base-sensitive precursor 34. 
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Scheme 1.9: Modification of the Regitz deformylative diazo-transfer approach. 
The main drawback of the diazo-transfer approach is the potential hazards associated 
with the azides used as diazo-transfer reagents (Figure 1.3). The first sulfonyl azides to 
be used for this purpose were p-toluenesulfonyl azide (18a, TsN3)20a and mesyl azide 
(18b).27 After stability studies, p-dodecylbenzenesulfonyl azide (18c, p-DBSA)28 and 
2,4,6-triisopropylbenzenesulfonyl azide (18d, trisyl azide)29 were proposed later as safer 
alternatives.30 Nowadays, the most commonly used diazo-transfer reagents are 
p-acetamidobenzenesulfonyl azide (18e, p-ABSA)31 and 4-nitrobenzenesulfonyl azide 
(18f, p-NBSA).32 Additional sulfonyl reagents are imidazole-1-sulfonyl azide salt 18h,33 
ionic liquid sulfonyl azides,34 as well as polystyrene-supported benzensulfonyl azide.35 
 
Figure 1.3: Sulfonyl azides commonly used as diazo-transfer reagents 18. 
Moreover, a sulfonyl-azide-free procedure has been recently reported where the 
diazo-transfer reagent is generated in situ using a mixture of sodium azide and 
m-carboxybenzenesulfonyl chloride 37 (Scheme 1.10).36 Nevertheless, considering also 
the hazards linked to sodium azide, particular attention has to be taken when handling 
these reagents. Furthermore, some azides may be labelled as “safer” due to their less 
explosive nature but they can still be equally as toxic and shock-sensitive. 
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Scheme 1.10: ‘Sulfonyl-Azide-Free’ aqueous-phase diazo-transfer reaction.36 
A common but mechanistically different way to prepare donor/acceptor and donor/donor 
diazo compounds is the dehydrogenation of hydrazones 38 (Scheme 1.11).37 This 
procedure can be carried out on a simple hydrazone such as 38a, using stoichiometric 
quantities of different oxidants such as Pb(OAc)4,37a Ag2O37b or more environmentally 
friendly “activated” DMSO38 and MnO2.39  
 
Scheme 1.11: Dehydrogenation of hydrazones 38a and tosylhydrazones 38b to generate 6. 
The more air stable tosylhydrazones 38b can be also used to obtain diazo compounds 
in situ in the presence of a base via Bamford-Stevens type reaction.9c,40 Generally, the 
performances are drastically improved when the oxidation occurs under continuous flow 
conditions,10 as the reactive diazo intermediate is generated in situ and immediately used 
in a further transformation.  
Over the last decade the direct conversion of azides 39 into the corresponding diazo 
moiety via triazene fragmentation has emerged as a new and efficient procedure to 
generate α-diazocarbonyl compounds (Scheme 1.12).41 This convenient approach, 
which has recently found its application in the synthesis of natural product such as 
aperidine,22 was reported for the first time by Myers and Raines in 2009.41 Myers et al. 
designed the phosphine 40 in order to trap 41 into an acyl triazenenophosphonium salt 
such as 42, which would then lead to acyl triazene 43 upon aqueous work-up. The 
following fragmentation of 43 under basic conditions (NaHCO3 or DBU) affords the 
desired diazo compound 6 and the amide 44 as side product.  
Micol Santi Introduction  
9 
 
Scheme 1.12: Phosphine-mediated azide conversion into diazo compounds.41 
A convenient way towards terminal α-diazo compounds 46 is the acylation of 
diazomethane (7) with acyl halides 45 (Scheme 1.13). It is worth mentioning that some 
terminal α-diazocarbonyl compounds13b are stable enough to be subjected to further 
transformations such as substituent modifications42 or cross-coupling reactions.43 This 
method provides access to various diazo compounds that are difficult to synthesise 
otherwise. 
 
Scheme 1.13: Generation of terminal α-diazo compounds 46a and 46b. 
In conclusion, the research of novel synthetic pathways towards α-diazocarbonyl 
compounds remains a hot topic in organic chemistry. During the last two decades several 
new reagents and procedures have been developed and enabling technologies, such as 
flow chemistry, provide valuable tools to successfully improve both efficiency and safety 
on the preparation of these versatile intermediates.10,13a 
1.1.2 Reactivity of α-Diazocarbonyl Compounds 
The intrinsic reactivity of α-diazocarbonyl compounds driven by the release of N2, makes 
them valuable precursors in organic synthesis. When exposed to heat, Brønsted acids, 
Lewis acids or catalytic amounts of transition metals, α-diazocarbonyl compounds react 
by generating useful intermediates such as free carbenes, carbenoids, enolates, ylides 
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or diazonium salts, which find application in various transformations: 
Wolff-rearrangement (a),44 cyclopropanations (b),45 C–X insertions (c),6 Buchner reaction 
(d)46 and ylide formation (e) (Scheme 1.14).13a,47 
 
Scheme 1.14: General application of α-diazocarbonyl compounds 6: a) Wolff-rearrangement, b) 
cyclopropanations, c) C–X insertion, d) Buchner reaction, e) ylide formation. 
Among all, the most exploited reactivity of α-diazo compounds involves carbene and 
carbenoid-mediated reactions. Carbene species are neutral compounds characterised 
by a bivalent carbon having only six valence electrons (R1R2C:) and presenting three sp2 
hybridized orbitals and one p orbital. They are typically classified into singlet carbenes 
and triplet carbenes, depending on the localisation of the electrons (Figure 1.4).48 Singlet 
carbenes have spin-paired electrons in the nonbonding sp2 hybridized orbital while the 
p orbital is empty, and they show a bond angle of 100–110°. Differently, the triplet 
carbenes present a wider bond angle (130–150°) as result of the minor repulsion due to 
unpaired electrons. One of the electrons is located in the sp2 hybridized orbital and the 
other in the higher energy p orbital. All carbenes can theoretically exist in both forms, 
however, most of them are more stable as triplets, unless they bear highly electron-
donating substituents capable of interacting with the empty p orbital stabilising the singlet 
state. 
 
Figure 1.4: Example of carbenes species. 
Due to their highly reactive nature, carbenes are mainly generated in situ through 
photolysis, thermal or transition metal-catalysed elimination processes, starting from 
precursors such as diazo compounds. When a carbene species is stabilised by a 
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transition metal it is referred to as a “carbenoid”. The carbenoids present a complex 
between the carbon bearing the lone pair and the metal, therefore the carbon structure 
is more like a tetravalent carbon rather than the typical bivalent carbon of a free 
carbene. Nevertheless, carbenes and carbenoids share similar reactivity to the point that 
in literature there are little distinctions and both terms are typically used as synonyms. 
A famous reaction involving carbene precursors is the Wolff-rearrangement, where a 
α-diazocarbonyl compound undergoes 1,2-migration to form a ketene 47 upon nitrogen 
loss (Scheme 1.15).44 When the migration happens on a ring as starting material, the 
process leads to a ring contracted product.49 The ketene intermediate 47 can undergoes 
nucleophilic attack or [2+2] cycloaddition depending on the substrate available. When 
the ketene 47 is attacked by a nucleophile (NuH), the homologue carbonyl 48 is formed. 
This homologation reaction, named Arndt-Eistert homologation,50 is still used nowadays 
to synthesise carboxylic acids or derivatives such as β-amino acids.51 Whereas in the 
presence of olefins, ketones or imines 49, the ketenes 47 follow a cycloaddition pathway 
leading to four-membered rings such as 50. 
 
Scheme 1.15: Wolff-rearrangement to ketene 47 that undergoes a) nucleophilic attack, or b) [2+2] 
cycloaddition with olefins, ketones or imines 49. 
A recent example for the enantioselective generation of trans-configured β-lactams via 
Wolff-rearrangement enabled by flow chemistry, was reported by Ley and co-workers 
(Scheme 1.16).52 In this work a flow-microwave reactor was used to prepare primary 
ketenes 52 from 2-diazoketenes 46 under controlled reaction conditions. The ketene 52 
reacts in situ with imines 51 in a [2+2] Staudinger cycloaddition affording β-lactams 53 
and 54 in moderate to good yield, preferentially with trans-configuration. The 
stereochemical outcome of the [2+2] Staudinger cycloaddition is likely to be influenced 
by the size of the substituent at the nitrogen atom of imines 51 (R2) or at the carbon atom 
(R3). 
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Scheme 1.16: Microwave-assisted Wolff-Staudinger strategy with formation of β-lactams.52 
Another common application of α-diazo compounds is the cyclopropanation53 of olefins. 
Considering the frequency of chiral cyclopropanes as structural motifs in pharmaceutical 
compounds,54 the interest towards cyclopropanations is strong in medicinal chemistry.55 
During this reaction, a highly strained three-membered ring is formed by photochemically 
or thermally induced nitrogen loss from pyrazoline 5456 or by transition-metal catalysed 
decomposition of diazo compounds (Scheme 1.17).53 
 
Scheme 1.17: Cyclopropanations using diazo compounds by a) photochemical or thermal 
denitrogenation of pyrazoline 54 or b) transition metal catalysis. 
The process can occur with good stereochemical control by using chiral catalysts57 or 
auxiliary directing groups,58 and can be adapted from batch to flow mode.59  
Furthermore, when the involved π-electrons belong to an aromatic ring, the cyclopropane 
causes a ring expansion to cycloheptatrienes 60 (Scheme 1.18).60 In this two-step 
reaction, also known as the Büchner ring expansion, an aromatic ring 58 reacts with 
α-diazocarbonyl compound 6 generating a bicyclo[4.1.0]heptadiene derivative 59. This 
undergoes a pericyclic ring expansion to generate a 7-membered ring 60. However, the 
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equilibrium is shifted towards the bicycle 59 and not the 7-membered ring 60, when the 
diazo compound 6 bears an EDG as substituent.61 
 
Scheme 1.18: General scheme for Büchner ring expansion reaction. 
The carbenoids are also used for their ability to form other reactive intermediates such 
as oxonium, sulfur, nitrogen and carbonyl ylides upon treatment with Lewis bases 
(Scheme 1.19).62 In the presence of ethers, sulfides, amines or carbonyl compounds, the 
carbenoid 61 acts as Lewis acid generating a Lewis adduct. Once generated, the latter 
can either remain as a metal-stabilised ylide 62 or it can dissociate from the metal forming 
a “free ylide” 63. These intermediates are highly unstable and quickly undergo further 
inter- or intramolecular reactions including sigmatropic rearrangements,63 dipolar 
cycloadditions64 and 1,2-rearrangments.65 
 
Scheme 1.19: General mechanism for ylides formation from α-diazocarbonyl compounds. 
1.1.2.1 Diazo Compounds and Carbene-mediated C–X Insertions 
Carbene-mediated C–X insertions from diazo compounds were reported for the first time 
in 1956 as an “indiscriminate” insertion of a diazomethane into n-pentane to form 
n-hexane, 2-methylpentane and 3-methylpentane in a 3:2.1 ratio.66 Although thermally 
or photochemically generated carbenes showed unselective insertions, later work 
conducted by Taber and co-workers reported highly regio- and stereoselective 
intramolecular C–H insertions towards five-membered rings when the carbene was 
generated by transition metal catalysis.67 Among all transition metals, copper68 and 
 Introduction Micol Santi 
14 
rhodium69 were reported to efficiently catalyse this class of transformations. Especially, 
the dirhodium catalysts bearing carboxylate and carboxamide ligands emerged as the 
most efficient catalysts for chemo- and regioselective intra- and intermolecular 
insertions. 
The reaction mechanism was proposed by Doyle et al. in 199369 and later confirmed by 
Nakamura and co-workers in 2002 (Scheme 1.20).70  
 
Scheme 1.20: Mechanistic proposals for C–H insertion. 
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According to the Doyle proposal, the CI–C and CI–H bond formation between 64 and 65 
bearing the carbene carbon CI occurs as the metal dissociates passing via the transition 
state 66. In this transition state, the different bond formations and cleavages happen at 
the same time but not necessarily with the same rate. Later, Taber et al. proposed 69 as 
alternative transition state in which a hydrogen atom is transferred from the C–H bond to 
the metal synchronous with the C–C bond formation. Product 70 is then released and 
the rhodium catalyst is regenerated.71 Eventually, density functional theory (DFT) 
calculations performed by Nakamura et al. in 2002 indicated a concerted but 
non-synchronous process70 as previously proposed by Doyle. Once the catalyst 71 
reacts with the diazo substrate 1, a molecule of N2 is released and the stabilised 
carbenoid 73 is formed allowing C–H insertions, among other chemical transformations. 
The carboxylate ligand acts as anchor for the dimer conferring a better stabilisation due 
to the presence of the nearby second rhodium atom. Moreover, the electron donation 
from one rhodium atom to the other assists the C–C bond formation and the catalyst 
regeneration. Nakamura et al. confirmed the additional stabilisation given by the 
dirhodium catalyst 71 by calculating a much lower activation energy for the C–H insertion 
with dirhodium(II) carboxylates catalyst (5.7 kcal/mol) compared to copper 
(15.6 kcal/mol) and ruthenium-carbenoids (27.6 kcal/mol).70 The presence of electron-
withdrawing substituents on the carbenoids, together with the presence of a positively 
charge rhodium atom, enhances the electrophilicity of the carbon centre CI, hence the 
reactivity towards C–H insertion is increased. 
Intuitively, when chiral ligands are used, it is possible to control diastereo- and 
enantioselectivity, thus, a big effort has been invested in the design of the most efficient 
ligands for each transformation. Both Doyle69 and Padwa72 independently reported that 
the nature of the ligands affects the regio- and chemoselectivity of the C–H insertion 
reactions. Generally, the presence of an EWG increases the reactivity to the detriment 
of the selectivity, while sterically hindered ligands and/or carbene substituents have a 
stronger influence on the stereoselectivity. In the late 90s, Davies et al. developed the 
chiral dirhodium(II) tetraprolinate catalyst Rh2(DOSP)4 71a and reported the first highly 
regioselective intermolecular C–H insertions of tetrahydrofuran (THF) in the 
donor/acceptor diazo compound 76 (Scheme 1.21).73 Moreover, the Rh2(DOSP)4 
catalyst 71a was found to suppress the side dimerisation reaction (see Scheme 1.2), 
affording exclusively the desired insertion product 77 in good to excellent yields  
(48–80%), with moderate stereoselectivity (up to 69% ee), preferentially as syn-isomer.  
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Scheme 1.21: First example of a stereoselective intermolecular C–H insertion.73 
Since then, the Davies group reported several successful X–H insertions catalysed by 
72a with excellent regiospecificity of the insertions occurring in the α-position to 
nitrogen74 or oxygen atoms75 as well as in the benzylic position.76 These afforded highly 
asymmetric products typically obtained via Mannich reaction, aldol condensation, 
Michael addition or Claisen rearrangement. Moreover, the Davies group expanded the 
library of carboxylated dirhodium catalysts to achieve site-selective and stereoselective 
inter-functionalisation of non-activated C–H bond into primary,77 secondary,78 and tertiary 
carbon atoms,79 later applied to total syntheses of biologically active compounds.80 
Simultaneously with Davies et al., Hashimoto et al.81 and McKervey et al.82 independently 
reported the first example of asymmetric intramolecular C–H insertion catalysed by chiral 
dirhodium(II) carboxylate catalysts such as 71b (Scheme 1.22). 
 
Scheme 1.22: Selected example of stereoselective intramolecular C–H insertions.81 
Doyle then designed a series of chiral dirhodium(II) carboximidate catalysts such as 
Rh2(5S-MEPY)4 71c that catalysed highly stereoselective cyclisations providing valuable 
lactones such as γ-lactone 82 in 62% yield and 91% ee (Scheme 1.23).83 
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Scheme 1.23: Selected example of stereoselective intramolecular C–H insertions.83 
Besides C–H insertion, also N–H84 and O–H85 insertions have been widely investigated 
by using amines, carboxylic acids, alcohols and water. Moreover, when hydrogen 
halides, sulfur or silicon-based acids are involved, it is possible to insert a bond between 
an hydrogen atom and an halogen,86 a sulfur87 or a silicon atom.88 Additionally, a small 
selection of X–Y insertion reactions have been reported, in which neither X nor Y is a 
hydrogen atom, which takes the name of α,α-substitutions. For instance, when 
diazocarbonyls are treated with molecular halogens89 or with (dichloroiodo)benzene,90 
α,α-dihalogenated products are formed. More recently, the range of metal catalysed 
insertions into C–C single bonds have also been included within the scope of X–Y 
insertions.91  
On the other hand, the carbene-functionalisation of an aromatic system has sometimes 
been misleadingly included within the “C–H insertion” classification, although it would be 
more appropriate to define them as “aromatic substitution”. In this case, the electrophilic 
addition of a carbene/carbenoid into an electron-rich aromatic ring generates a 
zwitterionic intermediate followed by proton transfer to restore the aromaticity.92 
Nevertheless, metal-promoted X–H and X–Y insertions of diazocarbonyl compounds 
represent a vast part of the applications involving diazo compounds and are still one of 
the main areas of modern organic research.  
1.1.2.2 α-Diazocarbonyl Compounds and Organoboron Compounds 
In all the above mentioned reactions, the diazo compounds are exploited for their 
electrophilic properties in order to achieve a chemical transformation. However, they 
possess an ambiphilic nature and can also act as nucleophiles. Moreover, some diazo 
compounds are usually stable enough to undergo further modifications without losing the 
diazo moiety, such as generating anionic nucleophiles such as 83 when treated with a 
base (Scheme 1.24).43c The anion 83 can then react further with carbonyl or imines such 
as 84 forming β-hydroxy or β-amino α-diazocarbonyl compounds 85. 
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Scheme 1.24: General mechanism for diazo nucleophile addition. 
One of the resonance structures of the diazo compound 46II presents a negative partial 
charge on the carbene atom, therefore 46 can be seen as neutral nucleophile and it can 
react with electron-deficient atoms such as boron atoms.93 The first example of a reaction 
between α-diazocarbonyl compounds such as diazopropanone 86 and trialkylboranes 
87 was reported by Hooz and Linke in 1968 (Scheme 1.25).94 In this 1,2-group transfer, 
one of the alkyl groups migrates from the borane to the diazo compound forming 
products such as 88. 
 
Scheme 1.25: First example of reactivity between diazocarbonyl compound 86 and borane 87. 
Later, Hooz and co-workers expanded the range of this metal-free 1,2-alkyl transfer to 
diazoketone94 to diazoaldehydes,95 diazonitrile,96 and EDA,96 however with a narrow 
scope limited by steric hindrance of the boranes. According to the proposed mechanism 
depicted in Scheme 1.26, the diazo compound 86 reacts with the borane 87 to form a 
tetracoordinated boron intermediate 89. Subsequently, one of the boron-substituents 
(-R) migrates to the carbon atom with nitrogen gas expulsion to generate the 
intermediate 90, which is in tautomeric equilibrium with its enolate form 91. 97 Finally, the 
reaction with an electrophile or hydrolysis of the boron enolate 91 affords the 
α-functionalised product 88. 
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Scheme 1.26: Proposed reaction mechanism of the 1,2-alkyl transfer from trialkylboranes 87 to 
α-diazocarbonyl compounds 86. 
Intuitively, different electrophiles could be trapped by the boron enolate 91. From their 
pioneering work (see Scheme 1.25), Hooz and co-workers, followed by other research 
groups, started investigating the reactivity of enolate intermediates 91 with various 
reagents from inorganic bases to other electrophilic species (Scheme 1.27). Firstly, the 
simple hydrolysis of the boron-adducts 91 affords the α-functionalised esters or ketones 
such as 88 without the need for metal-catalysis. When D2O is used to hydrolyse 91, the 
α-deuterated carbonyl 92 is afforded in quantitative yields.98 Compared to the classic 
acid- or base-promoted protocols, this is a unique way to form exclusively the 
α-monodeuterated carbonyl compound 92. Similarly, α-monohalogenated carbonyl 
compounds 93 are generated in good yield as sole products when the boron enolate 91 
is treated with N-halosuccinimide (NXS).99 The enolate 91 can be transformed in situ into 
a lithium enolate upon treatment with n-BuLi, which can further react with alkyl halides 
or other alkylating agents such as benzyl bromide, allyl bromide and dimethyl sulfate 
generating α,α-disubstituted carbonyls such 94.100 Moreover, Hooz et al. were able to 
trap the boron enolate as the corresponding trimethylsilyl ether 96 by using 
N-(trimethylsilyl)-imidazole (95).101 Furthermore, imines and Eschenmoser’s salt 97 can 
be used as electrophiles to quench the boron enolate 91 affording amine products 98 
typical of a Mannich reaction, in both high regio- and stereoselectivity.102 In an analogous 
manner, Mukaiyama et al.103 and later Hooz and co-workers104 developed a three-
component reaction with aldehydes and ketones, respectively, providing condensation 
products 100 in good yields and stereoselectivity.105 This multicomponent strategy was 
then adopted by Miranda et al. for the synthesis of 1,3-diketones and β-ketoesters, which 
are valuable intermediates for the generation of pyrazole moieties.106 The enol borane 
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91 was also reported to react with nitriles in a cycloaddition into boroxazines, which are 
easily hydrolysed to α-functionalised 1,3-diketones 101.107 
 
Scheme 1.27: General scheme of the reactivity of boron enolate 91 with various reagents. 
Although the versatile reactivity of boron enolates shows great utility in organic synthesis, 
it is generally limited due to the steric hindrance of the trialkylborane 87 (Figure 1.5). 
Further improvements were achieved by Levy et al. by using more reactive 
dialkylchloroboranes108 102 or vinyl- and aryldichloroboranes109 103 while 
alkyldichloroboranes afforded only moderate yields. 
 
Figure 1.5: Different boranes commonly used for the α-functionalisation of carbonyls. 
Nevertheless, these reagents are typically sensitive to moisture and less available, thus 
further studies have been made to investigate the reactivity of different organoboranes 
such as boronic acids 104 or boroxines 105 towards the 1,2-aryl transfer reaction. For 
instance, Barluenga and co-workers110 used more stable and less toxic boronic acids 
104 and tosylhydrazones to afford coupling products similar to 88. Alternatively, Wang 
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et al. used boroxines 105, prepared from corresponding boronic acids, to functionalise 
α-diazocarbonyl compounds.111 
Other organoboranes that are receiving particular attention in organic synthesis as Lewis 
acids are represented by triarylboranes 106a–h (Figure 1.6). In particular, tris(penta-
fluorophenyl)borane B(C6F5)3 106d has been applied to catalyse several metal-free 
transformations such as cyclisation,112 hydrogenation113 or hydrosilylation reactions114 
and group migrations.115 Moreover, the recent works by Stephan et al.116 Oestreich et 
al.117 and Melen et al.118 showed how tris[3,5-bis(trifluoromethyl)-phenyl]borane (BArF3, 
106h), tris(3,4,5-trifluorophenyl)borane 106e and tris(2,4,6-trifluorophenyl)borane 106g 
can be efficiently employed in metal-free hydroborations, with higher reactivity compared 
to 106d. A recent example was published by the Melen group, in which a catalytic 
hydroboration protocol was developed using 106e and microwave irradiation in order to 
expand the substrate scope of hydroboration to alkynes.118b 
 
Figure 1.6: Example of aryl boranes applied in organic synthesis. 
Regarding the reaction between 106 and α-diazocarbonyl compounds, Stephan et al. 
observed that, when ethyl 2-diazopropionate 107 was treated with triphenylborane 106a, 
the boron enolates 108a–b were formed as a mixture of E/Z isomers (Scheme 1.28).119 
The fluorinated 108b was found to react further with a second equivalent of 107 and, 
after a second aryl migration, 109 was formed.  
 
Scheme 1.28: Example of double 1,2-aryl migration from 106b to 2-diazopropanoate 107.119 
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Moreover, 106d was also recently reported to promote several C–X functionalisations 
into diazocarbonyl compounds, by activating molecules such as water alcohols or 
azides.120 
To conclude, the reaction between α-diazocarbonyl compounds and organoboranes 
offers an efficient and metal-free method towards novel C–C bond formation. 
Nevertheless, the reaction between triarylboranes and α-diazocarbonyl compounds 
remains still under-represented.102a,106 Since more Lewis acidic compounds, such as 
polyfluorinated triarylboranes, showed an increased reactivity, they were investigated in 
metal-free aryl migration towards α-functionalisation of esters, as discussed in more 
detail in chapter 3. 
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1.2 General Introduction on Enabling Technologies 
The term “enabling technology” defines an invention or innovation that is applied to 
improve performances and capabilities of a process.121 Therefore, the concept of 
“enabling technologies” has a broad meaning which includes all kinds of fields, from the 
invention of farming tools of the classical era122 to the introduction of smartphones and 
computers in the modern era. In chemistry, it indicates those branches such as flow 
chemistry,123 mechanochemistry,124 electrochemistry,125 photochemistry126 and 
microwave-assisted reactions,127 that are slowly changing the way chemical 
transformations are performed. More recently, within the wider concept of “enabling 
technology” have been included the 3D-printing,128 automated systems,129 machine-
learning algorithms for self-optimising systems130 as well as statistical software for 
Design-of-Experiment (DoE).131 These technologies, not only have allowed modern 
chemists to achieve different reactivities from “classic” methods and discover unknown 
reactions,132 but also helped making synthetic-protocols and industrial plants safer and 
more sustainable, cutting down costs and waste.133  
In the second part of this chapter the basics of flow chemistry and DoE are introduced, 
as flow chemistry was used to improve synthetic protocols and process optimisations 
were performed following a DoE-approach. A glossary of terminology regarding the most 
relevant terms about DoE can be found in Appendix A.  
1.2.1 Flow Chemistry 
In the last two decades continuous flow chemistry has rapidly thriven in both the 
academic and industrial sector due to its numerous advantages such as better mixing, 
heat and mass transfer and easier automation.123 When a flow system is used to perform 
a chemical transformation, the reaction is conducted in a continuous stream. The 
reagents are pumped throughout chemically resistant channels of different shapes and 
dimension in which they meet, mix and react. The product is then collected from the 
outlet and its yield is strictly influenced by the residence time (t), that is the time the 
reagents spent in the reactor. The latter depends on the reactor volume (V) and the flow 
rate (Q), two parameters controlled by the operator (Equation 1). 
𝑅𝑒𝑠𝑖𝑑𝑒𝑛𝑐𝑒 𝑇𝑖𝑚𝑒 (𝑡) = 𝑅𝑒𝑎𝑐𝑡𝑜𝑟 𝑉𝑜𝑙𝑢𝑚𝑒𝐹𝑙𝑜𝑤 𝑅𝑎𝑡𝑒 =   𝑉𝑄  
Equation 1 
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In order to have a higher residence time and to achieve better conversions, the reagents 
need to be pumped more slowly and/or a different reactor should be used. Nevertheless, 
it must be kept in mind that each design, as well as tubing size, has a different influence 
on the flow regime of the system and so on its mixing properties. For instance, a 
monophasic system in which two miscible liquids A and B are flowing in parallel without 
interruption follows a “laminar flow” regime and the mixing is achieved by diffusion and 
is defined as “passive mixing” (Figure 1.7a).123a 
          
Figure 1.7: Schematic diagram showing mixing in laminar flow and turbulent flow regimes. 
When the mixing happens randomly in both time and space due to inner mixers, tube 
lengths or rough surfaces, we talk about “turbulent flow” (Figure 1.7b). The Reynolds 
number (Re) is a dimensionless coefficient that can predict whether specific conditions 
will lead to a laminar or a turbulent flow (Equation 2). 
𝑅𝑒𝑦𝑛𝑜𝑙𝑑𝑠 𝑛𝑢𝑚𝑏𝑒𝑟 (𝑅𝑒) = 𝑢 ∗ 𝐿𝜈  
Equation 2 
It indicates the ratio between inertial forces (fluid velocity u (m•s−1), characteristic length 
L (m)) and viscous forces (kinematic viscosity ν (m2•s−1)). For fluids flowing in pipes the 
Re is commonly defined as: 
𝑅𝑒 = 𝑄 ∗ 𝐷𝜈 ∗ 𝐴  
Equation 3 
where Q is the flow rate (m3•s−1), D the internal diameter of the pipe (m), v the kinematic 
viscosity (m2•s−1) and A the cross-sectional area (m2).123a Typically, for laboratory flow 
equipment, the tubes have an internal diameter (ID) equal to or below 1 mm, therefore 
the flow regime falls in the region of microfluidics. In other words, the fluids operate at 
Reagent A 
Reagent B 
Reagent A 
Reagent B 
a) Laminar flow b) Turbulent flow 
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Re below 250 with laminar flow. The number of flow regimes increases when multiphasic 
systems are involved. For example, for gas-liquid transformations bubble, slug or annular 
flow can be observed depending on flow rate, whilst for solid-liquid mixtures the packed 
bed, fluidised bed or mixed bed are mainly used (Figure 1.8).123a 
 
Figure 1.8: Examples of flow regimes for a) gas-liquid mixtures and b) solid-liquid mixtures.  
The flow technology has allowed chemists to reach a remarkable control over reaction 
parameters, such as temperature and mixing, that influence a reaction outcome, 
enhancing efficiency, reliability of the chemical processes as well as enabling new 
reactions.132 Due to the high surface to volume ratio of micro-devices and flow reactors, 
the mass and heat exchange is more efficient, increasing performances and allowing 
exothermic reactions to be performed in a safer manner.123g The highly controlled 
generation of reactive species, together with their fast consumption in a continuous 
stream, avoids dangerous accumulations improving the safety profile of some reactions 
processes and allowing safer scale-ups.134 
Another huge advantage of continuous flow systems is their practicability in monitoring 
in situ the ongoing reactions, and their easy automation. Generally, when optimising a 
chemical reaction it is common practise to collect a sample and perform an “offline” 
analysis via GC-MS, LC-MS or NMR spectroscopy after work-up but with the advent of 
flow technologies there has been a remarkable improvement in developing “inline” and 
“online” monitoring techniques for a much faster optimisation. The difference between 
“online” and “inline” analysis, as introduced by Browne et al. and Cronin et al.,135 lies in 
the different way the flow stream is sampled. The term “inline analysis” describes a 
system in which the whole flow stream is continuously monitored. For instance, IR and 
UV as well as flow-NMR kit are composed by an inline flow cell, thus are considered 
a)  b) 
bubble flow 
slug flow 
annular flow 
packed bed fluidised bed mixed bed 
 Introduction Micol Santi 
26 
“inline” devices. Whereas monitoring systems such as MS or HPLC, that use injection 
devices such as switching valves to isolate fractions of the flow stream, are considered 
“online” analysis.135 
A big drawback of flow chemistry systems is the presence of solids, such as precipitate 
formed during the reaction or during the inline work-up. This can cause a blockage that 
could lead to too high pressures, leakages and may damage the system. Another 
drawback of using flow chemistry is the need for the appropriate equipment that must be 
purchased or designed and 3D-printed ad hoc for the purpose and can be costly.123a 
However, the benefits of flow chemistry often outweigh the disadvantages. The 
increased safety profile offered by flow systems is one of the most important 
characteristics, as sensitive and/or toxic intermediates can be generated in situ in smaller 
amounts avoiding dangerous accumulation of highly reactive compounds, and they can 
further react in the system without coming into contact with the operator. 
For this reason, there has been significant interest in the application of flow technology 
to the generation and use of diazo compounds at both laboratory and industrial scales.136 
One of the first large-scale flow system for the synthesis of diazomethane (7) in situ was 
reported by Proctor and Warr in 2002 (Scheme 1.29).137 This continuous 
preparation/consumption of diazomethane (7) from Diazald® (110) in a mixture of DMSO 
and water allowed to safely produce the α-diazoketone 112, which is an intermediate of 
the HIV protease inhibitor nelfinavir mesylate, in a gram-scale multi-step synthesis. 
 
Scheme 1.29: In situ generation of diazomethane (7) for a large-scale multi-step process.137  
For a similar transformation, the group of Kim et al. designed a dual-channel micro-
reactor system in which two parallel channels are separated by a thin hydrophobic 
membrane of poly(dimethylsiloxane) (PDMS) that prevents the passage of KOH, 
aqueous medium and p-toluensulfonate (Scheme 1.30).138 In the first channel an 
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aqueous solution of Diazald® (110) is used to generate diazomethane 7 that then diffuses 
through the membrane into the second channel where it can react with the substrate.  
 
Scheme 1.30: Dual-channel micro reactor system for in situ generation, separation, and 
reactions of diazomethane.138 
 
Moreover, a few years later Kappe and co-workers and more recently Koolman and co-
workers further improved this protocol by applying the tube-in-tube technology to 
continuous multi-step synthesis of valuable α-halo ketones139 and cyclopropylboronic 
esters,140 respectively. The tube-in-tube technology consists of two concentric tubes 
separated from each other by a gas-permeable AF-2400 membrane. In this case, the 
diazomethane (7) is generated in the inner tube and diffuses through the gas-permeable 
membrane into the outer chamber where it reacts following a similar principle to the one 
showed in Scheme 1.30. More sophisticated systems such as the Vapourtec R-Series 
settings have also been applied to similar transformation increasing the productivity.141 
Besides increasing the safety of diazomethane-generation, flow chemistry guarantees 
access to highly valuable transient reactive intermediate such as donor/donor carbene 
precursors. In 2014, Ley and co-workers published the in situ generation of diazoalkanes 
114 using a pre-packed flow cartridge of MnO2 (Scheme 1.31). 142 
 
Scheme 1.31: Flow generation and reaction of donor/donor carbene precursors 114. BPR = back 
pressure regulator.142 
Since then, similar systems with pre-packed cartridges have been successfully applied 
to different transformations such as the functionalisation of boronic acids,142 
Cu-catalysed allene synthesis,143 Rh-catalysed transformations,144 cyclopropanations59 
and C-C couplings.145 The Ley research group has also recently reported the in situ 
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synthesis of unstable diazoalkanes using a continuous-flow photoreactor and inline 
IR analysis (Scheme 1.32).10a The photolysis of 1,3,4-oxadiazoline 115 is a well-
established method to access the “non-stabilised” diazoalkane 116.146 The novelty 
introduced by Ley and co-workers lies in the continuous-flow photoreactor that allows 
better control over the provided irradiation which ensures good yields, improved 
scalability and reproducibility. 
 
Scheme 1.32: Flow generation of non-stabilised diazo compound 116, from oxadiazolines 115 
as precursor. BPR = back pressure regulator.10a 
The preparation of donor and donor/acceptor carbene precursors has also been 
conducted in a flow setup. The first continuous flow synthesis of ethyl diazoacetate 
(EDA, 9) was reported by Rutjes and co-workers (Scheme 1.33).147 For this purpose, 
three streams were used: an aqueous buffer solution of glycine ethyl ester 8 (pH 3.5), 
dichloromethane to extract EDA (9) and an aqueous solution of sodium nitrite. The 
biphasic mixture is then pumped into a thermo-controlled glass-microreactor where the 
diazotisation occurs, then into a sector to facilitate the phase separation before the inline 
Flow-Liquid-Liquid-Extraction (FLLEx) module. 
 
Scheme 1.33: Continuous-flow generation of EDA 9.147 
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Our group has also made some contributions to this topic. Indeed, not long ago, Wirth 
and co-workers reported the multi-step synthesis of β-hydroxy-α-diazo compounds 119 
under flow conditions with the in situ generation of EDA (Scheme 1.34).43b In this setup, 
EDA is generated in the first microreactor within 6 minutes via diazotisation, 
subsequently a first solution of aldehyde 118 and a second solution of DBU are added 
to the main stream yielding the desired β-hydroxy-α-diazo esters 119 in moderate to 
excellent yield with no inline extraction needed. 
 
Scheme 1.34: Synthesis of β-hydroxy-α-diazo esters 119 under continuous-flow conditions.43b 
Moreover, with the aim of expanding the EDA addition to ketones and lactones, Wirth 
et al. developed also a temperature controlled flow system for the in situ generation of 
LDA using a Vapourtec E-series system (Scheme 1.35).43a The system was dried and 
kept under argon148 and was composed by three reactors (R) and three cooling coils (C). 
The base LDA was generated within 0.8 minutes in a first coil (R1), at room temperature 
then cooled to −78 °C for 1.3 minutes (C1) before meeting the cold stream of EDA (9) 
previously cooled for 2.6 minutes (C2) and finally mixed in R2 for 0.2 minutes to form 
lithium ethyldiazoacetate (120). This was then trapped using a pre-cooled solution of 
ketone 121 and the outlet was quenched with a cold (−78 °C) benzoic acid solution in 
THF to afford the desired diazo compound 122 in good yields (up to 70%). 
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Scheme 1.35: Continuous flow system for the in situ generation of LDA and lithium ethyl 
diazoacetate 120 for the synthesis of β-hydroxy-α-diazo esters 122. R = reactor; C = cooling 
coil.43a 
 
As previously mentioned, the Regitz diazo-transfer is one of the most common method 
to prepare α-diazocarbonyl compounds. Nevertheless, although being documented in 
batch, flow applications remain limited. Our group in 2015 reported a flow protocol for 
the synthesis of donor/acceptor diazo compounds with an inline IR spectroscopy analysis 
for a faster optimisation and inline work-up.149 This protocol was then successfully 
coupled to a batch intramolecular cyclopropanation to form 125, a key intermediate for 
the synthesis of Milnacipran (Scheme 1.36).150 A solution of allylic ester 123 and DBU in 
acetonitrile was mixed together with a solution of tosyl azide (18a) in acetonitrile to 
generate the allyl α-diazoester 124. An aqueous solution of NaNO2 was pumped after 
the reactor coil to quench the reaction then the product 124 was extracted in n-heptane 
and the phases were separated using an inline membrane separator. The organic stream 
was then dropped into a round-bottomed flask containing of 1 mol% Rh2(oct)4 affording 
125 in 33% overall yield (8.2 g/day). 
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Scheme 1.36: Continuous-flow system for the generation of 125, key intermediate of Milnacipran 
analogues via Regitz diazo-transfer reaction; oct =octanoate.150 
The Collins and Maguire research groups further improved this protocol including the 
sulfonyl azide synthesis into a continuous flow multi-step synthesis (Scheme 1.37).151 
The hazardous tosyl and mesyl azide (18a–b) were safely generated in situ from an 
aqueous solution of sodium azide and a solution of either tosyl or mesyl chloride in 
acetonitrile. Once generated, the sulfonyl azide 18 was mixed with a stream containing 
the carbonyl substrate 126 and the base to afford the desired diazo compound 128 upon 
inline quenching with sodium acetoacetonate (127). 
 
Scheme 1.37: Safe continuous-flow generation of tosyl azide 18a and mesyl azide 18b for Regitz 
diazo-transfer reaction.151 
More recently, Monbaliu et al. coupled the synthesis of tosyl azide 18a reported by 
Maguire et al. to the flow diazo-transfer step reported by Wirth et al. and added the 
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intermolecular C–H insertion to the multi-step continuous-flow synthesis of 
N-Boc-protected Ritalin 131 (Scheme 1.38).152 
 
Scheme 1.38: Continuous-flow synthesis of Ritalin 131; NMP = N-methyl-2-pyrrolidone.152 
At first, the tosyl azide (18a) was synthesised in situ from stable tetrabutylammonium 
azide and tosyl chloride, then mixed with methyl phenylacetoacetate (129) that 
underwent Regitz diazo-transfer under basic conditions. Subsequently, the diazo 
compound was extracted from the organic phase by using an inline phase separator and 
further combined with a stream containing the N-Boc piperidine 130 and dirhodium 
catalyst. The full telescopic strategy afforded the N-Boc protected Ritalin 131 in 19% 
overall yield with a 20 minutes of residence time including the inline separation. 
In summary, since the early 2000s flow technologies provided chemists with a set of 
tools to overcome challenges faced during synthetic processes from the handling of 
hazardous compounds to scale-ups, thus the interest for developing automated systems 
for organic synthesis is still strongly increasing in both academia and industry. 
1.2.2 Design of Experiment 
Although flow chemistry has proven to be ideal to enable reactivities and cut reaction 
times, it certainly does not come without disadvantages. Flow systems are typically 
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composed by many modules which increases the complexity of the system, by adding 
variables that can influence the reaction outcome. Moreover, despite being a precious 
tool for faster high-throughput-screenings (HTS), it creates a large amount of data in a 
short period of time that might be hard and time-consuming to analyse. Hence, to tackle 
the problem self-optimising reactors153 that combine the use of intelligent algorithms,154 
in/online devices and statistical software for Design-of-Experiment (DoE) have been 
developed. The concept of DoE was introduced for the first time by Ronald Fisher in 
1926 in “The Arrangement of Field Experiments” and few years later in “The Design of 
Experiments”155 and it has since been applied mainly in agriculture, physics and 
engineering process optimisation.156 
DoE uses a statistical approach that allows to screen many variables and to estimate the 
main effects with a minimum amount of experiments. Furthermore, it can identify 
interactions between two or more factors leading to an optimum that a traditional one-
factor-at-a-time (OFAT) approach could have missed.157 At first, chemists appeared to 
be reluctant on embracing this new approach over the classic OFAT, perhaps intimidated 
by the statistics and formulae, which makes the task look more complex than necessary. 
Although an understanding of the basics of statistical tests is encouraged to meaningfully 
apply a DoE, an in-depth knowledge of statistic and mathematical algorithms it is not 
required, given the several simplified software commercially available nowadays (Design 
Expert, MODDE, JMP). In 2001, Owen and co-workers published a step-by-step 
procedure which aimed to guide chemists through the best decision while optimising a 
reaction process using DoE.158 Later, T. Laird with his editorial on Org. Process Res. 
Dev. spurred academia to introduce DoE trainings in undergraduate courses and to 
embrace the DoE system more often to identify empirical relationships within a complex 
system of parameters.159 This resulted in a blossom of industrial applications and 
publications per year using DoE in the past two decades.160 Nowadays, DoE found 
several applications in chemistry from reaction optimisation161 to crystallisations,162 and 
HPLC method development.163 Furthermore, it finds large utility in industry, mainly drug 
discovery, by increasing the efficiency and minimising costs and materials, saving time 
and energy consumption in agreement with the twelve principle of green chemistry,164 as 
well as validating robustness testing to ensure quality before releasing an active 
pharmaceutical ingredient (API).165 
The classic OFAT-approach consists of varying one factor within a range of values whilst 
the rest of n-parameters are fixed. Once the best condition for this factor is found it is 
kept fixed and the same process is repeated for all n-parameters in order to find the 
“optimum” for each factor (Figure 1.9a). This traditional approach suffers from several 
drawbacks. Firstly, it investigates a relatively small fraction of chemical space and finds 
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only one of the possible “optimum” within the given chemical space, and it is not 
necessary the best one. Secondly, by keeping in consideration only the “best” run per 
each variable, this classic method does not gain information from the discarded 
experiments. Finally, it is unable to uncover interactions among factors and might 
confuse “noises” with an actual effect, unless a significant number of repeats are made. 
On the other hand, DoE is composed by a set of statistically organised experiments, all 
equally distributed within the desired chemical space, and all of the run are necessary in 
order to find the local “optimum” (Figure 1.9b). Due to this organisation, DoE can 
distinguish signals that an OFAT-approach might miss in the noise, but mostly it can 
identify two-factor interactions (2FI) that are not detected with the OFAT method. 
Moreover, it allows to investigate even bigger and more complex chemical spaces that 
are too time consuming to be investigated using a traditional approach. 
       
Figure 1.9: Comparison between OFAT-approach (a) and DoE-approach (b) to investigate the 
chemical space (x,y,z). 
One of the drawbacks of DoE is that a complex design requires a large set of experiments 
which need to be perform by the same operator under similar experimental conditions, 
therefore in a relatively short period of time to avoid errors (e.g. nuisance). However, 
highly automated systems and in/online analysis methods can be adopted to speed up 
the analysis. 
The first things to do when dealing with DoE is to learn using the right terminology 
(Appendix A). Once familiar with the basic terms, in order to conduct a successful DoE, 
it is important to follow a precise work-flow: 
1) Define the objective: it is vital to have a clear goal (e.g. screening or optimisation) 
in order to select the appropriate ranges and design. 
2) Define the factors, their levels and their ranges: to define the chemical space that 
is going to be studied. The factors can be numeric or categoric, continuous or 
discrete. 
a) b) 
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3) Define the responses: it is necessary to have a reliable, accurate and precise 
method to measure the reaction outcome (e.g. yield or conversion). 
4) Select the most appropriate experimental design: the choice depends on the 
prefixed objective. 
5) Generating the experimental matrix: a matrix of experiments is generated by the 
software once all the above information are included. The experiments are 
randomised in order to reduce nuisance errors. Moreover, it is important to 
include central point experiments to ensure reproducibility and to detect 
nonlinearity. 
6) Perform the experiments: ideally, the experiments should be performed under 
same experimental and analytical conditions in a randomised order and within a 
restricted time to reduce nuisance error. When randomisation is not possible due 
to hard-to-change (HTC) factors, the run can be “blocked”. 
7) Software analysis: the most appropriate mathematical transformation (or none) 
is selected by the operator upon values such as adjusted and predictive R-
squared terms and by evaluating the diagnostic plots. Next, the analysis of 
variance (ANOVA) is providing which terms are the most significant terms by 
looking at p-values < 0.05. Finally, the software creates a table of “optimal 
conditions” that satisfy the objectives together with a series of contour plots and 
3D-surface plots. When there is more than one response to optimise, it is possible 
to overlap all contour plots and highlight the “sweet spot” in which all 
requirements are satisfied. 
8) Confirming reactions: it is important to verify experimentally what is predicted by 
the model. 
There are many types of experimental models and the choice depends on the dimension 
of the chemical space that we are interested in, thus, it is usually a compromise between 
the number of variables to study and the number of experiments to perform in order to 
have meaningful results (Figure 1.10). Among all, the simplest two-level factorial designs 
are the most commonly used for screening (Figures 1.10a and 1.10b). As depicted in 
Figure 1.10b, the Fractional Factorial Design (FFD) uses fewer experiments to explore 
the same chemical space of the full factorial design (FD, Figure 1.10a), hence it has a 
lower resolution compared to a FD. The factorial designs are reported as lk, where l 
indicates the number of levels of each factor and k the number of factors. Similarly, a 
fractional factorial design can be reported as lk−p, where l indicates the number of levels, 
k the number of factors, and p the size of the fraction of the FD used. In a more technical 
term, p represents the number of generators of the FFD. For example, in case of studying 
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four factors, a range of values defined by two levels, a maximum and a minimum must 
be selected. In coded values, these levels are indicated as “+1” or simply “+” and “−1” or  
“−” for the highest and the lowest level, respectively. In this case, the full factorial design 
is expressed as 24, which represents the total number of 16 experiments required by the 
FD. Similarly, the factorial designs can be noted as 24−1, 24−2, 24−3 and the numbers of 
the required experiments are 8, 4 and 2, respectively. Thus, a higher number of 
generators (p) leads to a lower resolved FFD. The FD and FDD, as screening designs, 
are using linear models to identify main effects. For this reason, to identify the presence 
of any curvature, it is recommended to add central points, which are reported with the 
coding factor level of “0”. 
When a non-linear response is detected, more resolved designs are typically used for 
Response-Surface-Modelling (RSM) such as the Central Composite Face (CCF, Figure 
1.10c) or the Circumscribed Composite Design (CCD, Figure 1.10d). However, these 
designs are not recommended for a high number of factors as they require a very large 
number of experiments. Generally, a lower resolution design is conducted first to narrow 
down the number of factors. Once the number of significant parameters is reduced, a 
higher resolution design can be performed if needed. 
 
 
Figure 1.10: Example of models: a) Factorial Design (FD); b) Fractional Factorial Design (FFD); 
c) Centred Composite Face (CCF); d) Circumscribe Composite Design (CCD); The required 
experiments per each models are shown as dots: red = factorial points, yellow = central points; 
blue = axial points. 
To conclude, the DoE uses a statistical approach to conduct and analyse a set of 
experiments offering an efficient approach towards complex systems and chemical 
reactions optimisation. Nevertheless, it is worth mentioning that the statistical analysis is 
just a tool that aims to facilitate the analysis of the data and the process optimisation. It 
should not replace the common sense nor the scientific knowledge of the operator, who 
is responsible to decide whether what it is suggested by the model is chemically sensible 
or dangerous to perform.  
a) b) c) d) 
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CHAPTER 2: Synthesis of Novel trans-Dihydroindoles 
2.1 Introduction 
The 2,3-dihydroindole scaffold, also known as indoline, can be found as the main core 
in several biologically active compounds and natural products. For instance, naturally 
occurring alkaloids such as strychnine (132), physostigmine (133), oleracein (134), 
aspidospermidine (135) and vinblastine (136) as well as drug molecule such as the 
Angiotensin-Converting-Enzyme (ACE) inhibitor pentopril (137) (Figure 2.1), present the 
indoline framework and therefore represents a synthetically interesting target for organic 
and medicinal chemists.1 
 
Figure 2.1: Natural products and drug molecules containing the indoline framework. 
For this reason, there is an increasing interest in developing new pathways for the 
synthesis of optically active 2,3-dihydroindoles in both synthetic and pharmaceutical 
chemistry.2 There are currently two main approaches towards such scaffolds. The first, 
is based on the dearomatisation or functionalisation of indoles (Scheme 2.1),3 which can 
occur through hydrogenation of the double bond,4 base-promoted intramolecular 
oxidative coupling,5 or by exploiting the intrinsic reactivity of the indole ring towards 
electrophiles.6 However, it is necessary to introduce/prepare the indole core in advance.7 
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Scheme 2.1: Dearomatisation/functionalisation of indoles. 
The second major approach relies on the construction of the nitrogen-containing 
five-membered ring via C–C and/or C–N bond formation. For this purpose, there are 
several available strategies depending on which of the bonds a-d needs to be 
constructed (Figure 2.2). 
 
Figure 2.2: Overview of the most common retrosynthetic pathways for the de novo synthesis of 
the pyrrolidine ring. 
A well-established method to build the C–N bond a is the Pd-catalysed aryl amination.8 
As this approach does not directly introduce new stereogenic centres the chiral backbone 
must be introduced in advance. On the other hand, enantioselective transition metal-
catalysed C–H activation/aryl alkylations have been reported for the synthesis of bond b 
and offer the stereoselective generation of C3 and C2.9 Moreover, Cu-catalysed aryl and 
alkyl aminations10 as well as iodine(III)-mediated reactions,11 present cheaper and more 
sustainable alternatives for the formation of bonds a or d. Additionally, intramolecular 
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radical aryl aminations12 and aryl alkylations13 offer an efficient metal-free approach 
towards bonds a or b, although it is usually difficult to control the enantioselectivity. To 
overcome this disadvantage, metallo-radical catalysis (MRC) has been successfully 
applied especially for the formation of bond c (Scheme 2.2).14 
 
Scheme 2.2: Overview of most common strategies towards dihydroindoles. 
Other methods that have been successfully adopted to synthesise the indoline de novo 
include the 1,2-carboamination of dienes,15 intramolecular carbolithiation16 and 
intramolecular Michael addition.17 However, only a few of these reported procedures 
allow the direct enantio- and diastereoselective formation of C2 and C3 of the 
nitrogen-containing five-membered ring. In 2008, García Ruano et al. developed an 
asymmetric tandem reaction to synthesise disubstituted indolines starting from optically 
pure sulfoxides 138 (Scheme 2.3).18  
 
Scheme 2.3: Anionic-anionic asymmetric tandem reaction towards optically active indolines.  
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In the presence of lithium diisopropylamide (LDA), (S)-sulfinyl derivative 138 is 
deprotonated in the benzylic position and undergoes stereoselective nucleophilic 
addition to the activated imine 139 followed by an intramolecular nucleophilic aromatic 
substitution leading to chiral dihydroindoles 141 in good yields and excellent 
stereoselectivity (>98:2). 
Another efficient protocol for the construction of enantiopure indoline nuclei is the [3+2] 
cycloaddition between benzyne precursors 142 and α,β-unsaturated 
γ-aminobutyronitriles 144 (Scheme 2.4).19 In this case the TMS-aryl triflate 142 
undergoes a fluoride-induced 1,2-elimination forming the aryne intermediate 143 in situ, 
which then reacts with α,β-unsaturated γ-aminobutyronitriles 144 to afford 
2,3-dihydroindoles 145 in good yields and enantioselectivity. 
 
Scheme 2.4: Indoline 145 construction via [3+2] cycloaddition reactions between benzynes 143 
and α,β-unsaturated γ-aminobutyronitriles 144.  
Recently, Zhang et al. reported the Cu-catalysed enantioselective intramolecular 
borylative cyclisation of 2-vinylaryl imines derivatives 146 with B2(pin)2 which affords 
cis-2,3-dihydroindoles 148 bearing a Bpin moiety in excellent yields and selectivity 
without the need of a chiral starting material (Scheme 2.5).20 
 
Scheme 2.5: Cu-catalysed asymmetric synthesis of cis-2,3-dihydro-1H-indoles 148.  
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The in situ generated chiral copper catalyst promotes the Markovnikov addition to the 
vinyl moiety forming an organocuprate intermediate that is then trapped by the imine as 
described also by the Buchwald group in 2015.21 
Intuitively, the formation of this C–C bond (disconnection c, Scheme 2.2) can be 
accomplished by using carbene chemistry.22 However, there are only a very few 
procedures using carbene-precursors for the synthesis of nitrogen-containing 
five-membered rings.23 In the early 2000s Davies et al.24 and Saito and co-workers25 
independently optimised the enantioselective synthesis of dihydrobenzofurans 150 via 
intramolecular rhodium-catalysed C–H insertion using 1 mol% Rh2(S-DOSP)4 (71a) and 
Rh2(S-PTTL)4 (71d), respectively (Scheme 2.6). In both cases the cis-dihydrobenzofuran 
was the major isomer. When Rh2(S-DOSP)4 was used as catalyst, the desired products 
150a–b were obtained in good yield (up to 85%) and selectivity up to 95% de and 63% ee 
after 72 hours at −50 °C in n-hexane. When Rh2(S-PTTL)4 was used instead, the 
dihydrobenzofurans 150a–b were isolated in good yields and excellent stereocontrol (up 
to 98% de and 94% ee) within one hour at −78 °C in toluene. 
 
Scheme 2.6: Synthesis of cis-dihydrobenzofurans 150a–b via RhII-catalysed C–H insertion.  
Despite these encouraging results and the advantage of installing two stereocentres in 
one step, the use of α-diazocarbonyl compounds as precursors for the preparation of 
2,3-dihydroindoles has received limited attention. In this chapter, the development of a 
general synthesis for chiral 2,3-dihydro-1H-indoles via the metal-catalysed C–H insertion 
using diazo compounds as carbene precursors is presented (Scheme 2.7). 
 
Scheme 2.7: Retrosynthetic approach toward chiral 2,3-dihydro-1H-indoles.  
Some preliminary studies on the diazo-transfer optimisation, side product investigation 
and solvent screening for the C–H asymmetric insertion have already been reported by 
Dr. S. T. R. Müller in his PhD thesis work titled: “Diazo Compounds in Continuous Flow 
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Technology”.26 During the work of this thesis, further optimisation studies have been 
carried out and the scope of diazo precursors and of trans-indolines have been 
expanded. Moreover, due to the well-known toxicity of diazo compounds, the 
diazo-transfer reaction was translated into a flow system using a DoE-approach for 
preliminary screening and optimisation. Parts of the following results are published in 
Eur. J. Org. Chem. 2017, 1889–1893.  
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2.2 Results and Discussion 
In Scheme 2.8 an overview of the synthetic pathways discussed in this chapter is given. 
 
Scheme 2.8: Overview of the synthetic pathway developed to achieve indolines 154. 
Firstly, an efficient synthesis for the precursors 152 was developed. Secondly, attention 
was moved to the optimisation of the diazo-transfer and the optimal conditions were used 
to build a library of α-diazocarbonyl intermediates 153 in good yields. Moreover, the 
translation of the diazo-transfer reaction into a flow setup was realised using a fractional 
factorial design (FFD) to screen the several parameters such as temperature, 
equivalents of base and sulfonyl azide, time and concentration. 
Finally, the effects of solvent, dirhodium catalysts and temperature on the stereoselective 
cyclisation were studied to afford the desired trans-indoles 154 as major products in good 
yields and enantioselectivities. 
2.2.1 Synthesis of the Starting Materials 
The synthesis started with the esterification of the commercially available 2-nitrophenyl 
acetic acid (151) in the presence of acetyl chloride in methanol or propan-2-ol at room 
temperature to afford 155a and 155b in excellent yields within 16 hours (Scheme 2.9). 
 
Scheme 2.9: Esterification of 2-nitrophenyl acetic acid 151. 
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Although reducing a nitroaromatic groups is a common procedure in organic chemistry, 
achieving a chemoselective reduction of the nitro group in presence of an ester moiety 
seemed to be more challenging. Hence, the reduction of the nitro group to the aryl amine 
was attempted following various literature protocols (Table 2.1).27,28 
Table 2.1: Reaction conditions for the reduction of the nitro group in 155a-b. 
 
Entry Conditions Major Product R Yield (%) 
1 NaBH4, AlCl3, dry THF 
rt, 2 h
 
 
Me (157) 17a 
2 HCO2H, Pd/C, dry MeOH 
rt, 12 h 
 
Me (158) 69 
3 
H2 (1 atm), Pd/C, dry ROH 
rt, 12 h 
 
Me (156a) 99 
4 i-Pr (156b) 70 
aStarting material 155a recovered. 
The use of a NaBH4/AlCl3 mixture resulted in the reduction of the ester moiety of 155a 
leading to alcohol 157 in 17% with mainly starting material recovered (entry 1), despite 
being successfully employed for the large scale reduction of 2,4-dinitrophenyl 
compounds.27 The catalytic hydrogenation of 155a using Pd/C and formic acid led to the 
isolation of lactam 158 in 69% yield (entry 2). The formation of 158 indicated the 
successful reduction of the nitro to the amino group, but the acidic conditions may have 
activated the ester group toward intramolecular nucleophilic attack leading to the cyclised 
product. Finally, the desired arylamines 156a–b were obtained in good to excellent yields 
using H2 gas (1 atm) and 10% Pd/C as catalyst (entries 3,4) that are immediately 
tosylated in pyridine affording 159a and 159b to prevent their decomposition 
(Scheme 2.10). 
 
Scheme 2.10: Tosylation of aryl amines 156a–b. 
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Next, the further N-functionalisation of 159 was investigated. Treatment of 159a with a 
mixture of benzyl bromide and triethylamine in acetonitrile afforded the desired product 
152a in reasonable yields (Table 2.2). 
Table 2.2: Reaction conditions for the benzylation of 159a.  
. 
Entry 160 (equiv.) NEt3 (equiv.) Conditions 152a (%) 
1 2 2 48 h, rt 63 
2 2 2 48 h, 45 °C 57 
3 2 3 72 h, rt 73 
4 3 3 48 h, rt 77–82a 
5 3 3 24 h, rt 42 
General Procedure: Reactions performed on a 4–6 mmol scale in CH3CN; aRange 
of four repeats. 
A large excess of the reagents and long reaction times were necessary to obtain 152a 
in more than 60% yields (entry 1). Furthermore, increasing the temperature did not 
improve the reaction outcome (entry 2). Using more equivalents of triethylamine 
(3 equivalents) afforded 152a in 73% yield after three days. The reaction was pushed 
further by increasing the amount of benzyl bromide 160 to 3 equivalents, leading to the 
formation of 152a in 77–82% yield after 48 hours (entry 4). Reducing the reaction time 
to 24 hours led to lower yield of 152a (42%; entry 5). 
Different benzyl and alkyl halides 161 were used together with 159a–b under the above 
optimised conditions (Table 2.2, entry 4) to build a library of substrates. All investigated 
substituents were very well tolerated, and the desired precursors 152a–l were obtained 
in 62–82% yields (Scheme 2.11). When the methyl ester was replaced with an isopropyl 
ester, the corresponding benzylated product 152b was isolated in 62%. Highly electron-
donating groups as well as highly electron-withdrawing substituents in para-position 
showed good reactivity affording 152c, 152d and 152e in 75%, 55% and 71% yield, 
respectively.  
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Scheme 2.11: Preparation of precursors 152a–l. 
Also, substrate 152f and 152g moderate bearing electron-donating electrophiles in 
para- and meta-position were prepared in good yields (61% and 69%). A small electronic 
effect was noticed for the ortho-substituted derivatives 152h–j. The products carrying the 
2-phenyl (152h) and the 2-methyl (152i) group were afforded in higher yields (79–82%) 
than the 2-nitro derivative 152j (62%). Bulkier derivatives such as 2-phenyl (152h) or 
2-bromonaphthyl (152k) substituted precursor were also prepared in 79% and 77% yield, 
respectively. Non-benzylic electrophiles were investigated next. While (E)-(3-bromoprop-
1-en-1-yl)benzene gave 152l in 68% yield, and allyl bromide afforded 152o in 25% yield, 
no reaction was observed between 2-bromobutane nor 1-bromohexane and the starting 
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material 159a, therefore 152m and 152n were not formed. This is not surprising because 
both 2-bromobutane and 1-bromohexane are poorly reactive toward SN2 reactions. 
Alternatively, treatment of 159a with triphenylphosphine, diisopropyl azodicarboxylate 
(DIAD) and the corresponding alcohols 162 in a Mitsunobu reaction29 afforded 152m–o, 
in 68%, 64% and 85% yield, respectively (Scheme 2.12). 
 
Scheme 2.12: Synthesis of alkyl derivatives 145m–o via Mitsunobu reaction. 
While expanding the substrate scope to other protecting groups, the N-Boc substituted 
amine 159c was prepared using di-tert-butyl dicarbonate (Boc2O) and triethylamine in 
acetonitrile (Scheme 2.13).a  
 
Scheme 2.13: Alternative route using N-Boc-protective group. 
The following treatment of 159c with benzyl bromide and triethylamine at room 
temperature did not lead to the desired benzylated product 152p leaving 159c 
unchanged. Performing the reaction at a higher temperature (50 °C) led to the formation 
of a mixture of lactams 163 and 158 in 84% and 10% yield, respectively, hence was not 
further investigated. 
Once the diazo precursors were prepared in good yields, attention was focussed on the 
synthesis of the carbene-precursors, the key-intermediates of this synthetic pathway. 
 
a.  The synthesis of 159c was carried out by Dr. S.T.R Müller 
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2.2.2 Synthesis of α-Diazocarbonyl Precursors 
The Regitz diazo-transfer reaction30 was used to syntheses the α-diazocarbonyl 
substrates 153 (Scheme 2.14). As mentioned in chapter 1, this base-promoted transfer 
into activated methylene moieties is a convenient approach for the synthesis of donor-
acceptor and acceptor-acceptor carbene. The standard protocol for 1,3-dicarbonyl 
compounds relies on triethylamine as base and sulfonyl azides such as tosyl azide (18a) 
or the safer analogues p-acetamidobenzenesulfonyl azide (p-ABSA, 18e) and 
p-dodecylbenzenesulfonyl (18c) as diazo-transfer reagents. The sulfonyl azide reagent 
are easily synthesised by adding sodium azide to a solution of substituted-
sulfonylchloride in acetone and water,31 a protocol that can be easily scaled up in a flow 
system.32 
 
Scheme 2.14: General scheme for a classic Regitz diazo-transfer reaction. 
However, for compounds containing mono-activated methylene groups, triethylamine 
(pKa (CH3CN): 18.8)33 is not strong enough to deprotonate in α-position. Therefore, the 
slightly stronger 1,5-diazabicyclo[5.4.0]undec-7-ene (DBU, pKa(CH3CN): 24.3)33 can be 
used for the synthesis of α-aryl-α-diazocarbonyl compounds34 such as phenyl 
diazoacetate 165 (Scheme 2.15). In this case the desired α-diazo compound 165 was 
successfully isolated in 83% yield as orange oil after column chromatography. 
 
Scheme 2.15: Diazo-transfer reaction of phenylacetate 164. 
Unfortunately, when the same conditions were used for on the model substrate 152a, 
the desired product 153a was isolated only as minor product in 36% yield along with the 
corresponding azide 166 in 45% yield (Scheme 2.16). 
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Scheme 2.16: Diazo-transfer reaction of the model substrate 152a. 
A similar azido-transfer reaction was reported for the reaction of trifluoromethanesulfonyl 
azide (18g) and β-keto carbonyl compounds,35 and for the reaction of 18g or tosyl azide 
(18a) and cyclic imides,36 but received a limited attention due to its unpredictability. 
Optimisation screening and mechanistic investigations were carried out next, to explain 
the azide formation and, ideally, avoid or at least minimise its generation. 
2.2.2.1 Optimisation of the Diazo-transfer Reaction in Batch 
Preliminary results showed that when the reaction was performed with p-ABSA (18e) as 
a diazo-transfer reagent and DBU as a base in acetonitrile, the side product 166 was 
obtained as the major product (up to 46% yield) irrespective of the amount of base or 
18e (Table 2.3, entries 1–3). Less product (8%) was observed upon increasing either 
p-ABSA or DBU (entries 2 and 3) and no starting material was recovered, suggesting a 
decomposition of the desired diazo compound 153a or the formation of other products 
under those conditions. Performing the reaction in THF led to a higher conversion of the 
starting material 152a, however, a lower 153a/166 ratio was observed with the undesired 
product isolated in 62% yield (entry 4). The trend was reversed when the reaction time 
was significantly increased, and desired compound 153a was obtained in a moderate 
yield (46%) along with 29% of the azide 166 after 7 days (entry 5). A turning point was 
reached once p-ABSA (18e) was replaced by p-NBSA (18f) (entry 6). In accordance with 
the observation of Evans and co-workers for a similar reaction,36a when p-NBSA is used 
in combination with phosphate buffer as the quenching medium, an inverted 
chemoselectivity was observed and the desired diazo compound 153a was formed as 
the major product (53%) with only 14% of side product 166. 
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Table 2.3: Preliminary screening for the diazo-transfer reaction conditions on 152a. 
 
Entry Sulfonyl Azide Base Conditions 153a (%) 166 (%) 
1 p-ABSA (1.2) DBU (1.7) CH3CN, 24 h, rt 36 45 
2 p-ABSA (3) DBU (1.7) CH3CN, 24 h, rt 8 42 
3 p-ABSA (1.2) DBU (4) CH3CN, 24 h, rt 8 46 
4 p-ABSA (1.2) DBU (1.7) THF, 24 h, rt 20 62 
5 p-ABSA (1.2) DBU (1.7) CH3CN, 7 days, rt 46 29 
6a p-NBSA (2) DBU (2.5) CH3CN, 24 h, rt 53 14 
General Procedure: Reactions performed on a 0.25–1 mmol scale of 152a (0.5 M) and quenched 
with NH4Cl saturated aqueous solution (pH = 5). aQuenched with 0.1 M phosphate buffer (pH = 7). 
This sulfonyl azide dependent chemoselectivity can be explain by the different stabilities 
of the triazene intermediates 167a and 167b formed in situ during the reaction 
(Figure 2.3). This hypothesis was proved by performing two parallel NMR experiments, 
where the course of the reaction of 152a with p-ABSA (a) and p-NBSA (b) were 
monitored by 1H NMR spectroscopy over 5 days. The starting material 152a was fully 
converted into the intermediate 167b within 10 minutes in the case of p-NBSA, while it 
was still detected after 60 minutes when p-ABSA was used. Moreover, triazene 167b 
showed a faster decomposition compared to 167a with traces of the desired diazo 
compound 153a detected after 22 hours and formed slowly over time, while 167a proved 
to be more stable with no product formation after 3 days. The decomposition of 167 lead 
to the diazo compound 153a in accordance with the mechanism reported in literature.37 
To investigate the mechanism further, several attempts were made to isolate and 
characterise triazene 167b. The diazo intermediate 153a (0.24 mmol) was treated with 
1.1 equivalents of p-NBSA and 1.1 equivalents of DBU in acetonitrile for 10 minutes 
before the addition of ice-cold water and extraction in dichloromethane. The protonated 
form of 167b was obtained as a 1:2 mixture of rotamers (in agreement with the ratio 
observed in situ 1:1.7) together with a ~10% of unreacted starting material 152a and 
DBU. Unfortunately, the pH-sensitivity and thermolability of intermediate 167b made its 
isolation extremely difficult. Noteworthy, from the 1H NMR experiment, the side product 
166 was detected only in traces after one hour with no further formation during the 
reaction. It is intuitive that the competition between diazo compound 153a and azide 166 
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formation must come from a different behaviour of the triazenes 167a and 167b during 
their fragmentation. 
 
 
Figure 2.3: 1H NMR spectra (300 MHz, CD3CN) of in situ reaction monitoring of 152a (0.02 mmol 
scale) with DBU (2.5 equiv.) and a) p-ABSA (18e, 2 equiv.) or b) p-NBSA (18f, 2 equiv.). From 
the bottom: reaction mixture before DBU addition (t = 0), reaction mixture after 10 min, 1 h, 3 h 
and 72 h.  
Consequently, the attention moved to study the parameters that could impact the 
triazene cleavage: reaction time, temperature and quenching (Table 2.4). Longer 
reaction time (48 h) increased the yield of the desired product 153a up to 63% with only 
13% of azide 166 (entry 2). Additionally, a neutral phosphate buffer solution was 
preferred over acidic (NH4Cl) or basic solution (NaHCO3) as quenching medium, 
affording higher yields for 153a (63%) and better diazo/azide ratios (entries 2–4). 
Increasing the temperature to 45 °C over 12 or 24 hours did not show a significant 
influence on the reaction outcome (entries 5–7). When the reaction was performed at 
45 °C for 48 hours, the desired product was still obtained in a good yield (65%) but the 
formation of the side product was reduced to 5%, with 9% of recovered starting material 
t = 0 
t = 10 min 
t = 1 h 
t = 3 h 
t = 72 h 
167a 167b 
152a (NCH2) 
a) b) 153a (NCH2) 
152a (NCH2) 
152a (NCH2) 
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(entry 8). Similarly, at 65 °C only the desired diazo compound 153a was isolated (65%). 
In this case, the azide 166 was not observed, but 15% of starting material 152a was 
recovered (entry 9). Reactions performed at even higher temperatures (80 °C) were less 
selective with the formation of numerous decomposition products that lead to poor yields 
of 153a (up to 46%; entries 10–13). 
Table 2.4: Screening of conditions for the diazo-transfer reaction on 152a. 
 
Entry 18f (equiv.) Conditions Quenching 153a (%) 166 (%) 
1 2 24 h, rt pH 7 53 14 
2 2 48 h, rt pH 7 63 13 
3 2 48 h, rt pH 5 50 18 
4 2 48 h, rt pH 10 53 29 
5 2 24 h, 45 °C pH 7 51 11 
6 2 12 h, 45 °C pH 7 50 13 
7 4 24 h, 45 °C pH 7 43 10 
8a 2 48 h, 45 °C pH 7 65 5 
9a 2 24 h, 65 °C pH 7 63 0 
10a 2 12 h, 80 °C pH 7 27 0 
11a 4 12 h, 80 °C pH 7 46 0 
12a 2 24 h, 80 °C pH 7 40 0 
13 4 24 h, 80 °C pH 7 decomposition 
General Procedure: Reactions performed on a 0.17–0.25 mmol scale of 152a (0.5 M) in 
acetonitrile. aStarting material 152a was recovered. 
Generally, the reactions carried out at 45–65 °C were more selective with little/no azide 
166 formation. However, in contrast to previous reports in literature,38 lower conversions 
were observed and the unreacted starting material 152a was often recovered. Although 
the side reaction was prevented and the desired product was obtained in 63% after 
24 hours compared to 53% at room temperature, a partial decomposition of triazene 
intermediate 167b back to the starting material 152a seemed to be responsible for the 
lower conversions. Indeed, when the reaction mixture containing 167b in CD3CN was 
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heated to 45 °C for 24 hours, the characteristic peaks of 152a where observed by in situ 
1H NMR spectroscopy. Furthermore, the thermostability of the diazo compound 153a 
was investigated and a full decomposition was observed when exposed to 65 °C for more 
than 24 hours, which explains the lower yield obtained for the reaction at 80 °C. 
Therefore, 45 °C was chosen as the optimal temperature and a series of the diazo 
precursors 153a–n were prepared using the optimal conditions of Table 2.4, entry 8 
(Scheme 2.17). The reactions were followed by thin-layer chromatography (TLC) but the 
very similar Rf values for 152, 153 and 166 made it difficult to determine the progress of 
the reaction by TLC, therefore the reactions in most cases were carried out twice and 
stopped after 24 or 48 hours. The diazo precursors 153a–k were synthesised in good 
yields (51–79%) especially after 48 hours, showing that both EWG and EDG were well 
tolerated under the optimised conditions. The only exceptions were the nitro derivatives 
152e and 152j which gave complex mixtures of products even under milder conditions 
at room temperature, and the attempts to isolate traces of product 153e or 153j were not 
successful. The cinnamic derivative 152l and the allylic 152o required milder conditions, 
as the products were highly unstable. Using 1.2 equivalents of DBU and p-NBSA at room 
temperature for 24 hours resulted in only 42% of 153l, while 152o led to a complex 
mixture but no desired product was detected. The N-alkyl substituted diazo compounds 
153m and 153n were obtained in poor to moderate yields (28–41%) and were harder to 
purify from unreacted starting material and side products. Therefore, due to purification 
and or instability issues, 153l–m were formed and used for the following step without 
further purifications. 
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Scheme 2.17: Substrate scope of the diazo compounds 153a–n. aReactions performed at room 
temperature using 1.2 equiv. of DBU and 1.2 equiv. of p-NBSA (18f) for 24 h; bYield by 1H NMR. 
2.2.2.2 Optimisation of the Diazo-transfer Reaction in a Flow Setup 
Flow technologies have shown several advantages over batch techniques when it comes 
to handling reactive/unstable intermediates in situ. Thanks to the higher surface area to 
volume ratio in flow devices, both mass and heat are quickly and efficiently transferred 
avoiding prolonged exposure to higher temperature or harsh reagents.  
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From the 1H NMR experiments (pg. 61) it was apparent that the starting material 152a 
was fully converted into the triazene intermediate 167b within a few minutes when 
p-NBSA (18f) was used. This encouraged further study of the diazo-transfer reaction in 
a flow system to accelerate the fragmentation of the triazene intermediate. Moreover, 
examples of diazo-transfer reactions have already been successfully reported in 
continuous flow setups.39 
The first flow system was designed to mimic the addition of reagents performed in batch 
for a reliable comparison (Scheme 2.18). For this experiment a 0.1 M solution of 152a 
and 2 equivalents of p-NBSA (18f) in acetonitrile (2 mL) was prepared and loaded in a 
2 mL syringe (Feed A). A second solution with DBU in acetonitrile (2 mL, 0.25 M) was 
prepared and loaded into a second 2 mL syringe (Feed B). A syringe pump was equipped 
with the two syringes, which were connected to the reactor with a T-piece mixer. The 
reactor consisted of a 3 mL FEP coil (i.d. = 0.5 mm) and was divided in two sections. 
The first part (V1 = 1 mL) was left at room temperature to mimic the reaction mixture in 
batch during the DBU addition at room temperature and to ensure the conversion of 152a 
into 167b during t’. The second section (V2 = 2 mL) was kept at 65 °C using a water bath 
to favour the fragmentation of 167b into 153a avoiding the side reaction during t’’. The 
two solutions were pumped at 0.2 mL•min−1 through the coil where they were mixed and 
reacted. The solution was equilibrated for 30 minutes before being collected over 
15 minutes and quenched with a 0.1 M phosphate buffer solution (pH = 7). The desired 
diazo compound 153a was formed in 42% NMR yield along with 16% of side azide 166. 
 
Scheme 2.18: First flow setup for the generation of 153a; V1 = 1 mL; V2 = 2 mL; t’ = 5 min; 
t’’ = 10 min; the reaction was quenched with phosphate buffer (pH = 7) and the shown NMR yields 
were based on 1H NMR spectroscopic analysis using 1,3,5-trimethoxybenzene as the internal 
standard. aIsolated yield after column chromatography. 
When similar conditions were performed in batch, the DBU solution was added at room 
temperature over 5 minutes; then the solution was warmed up to 65 °C and stirred for 
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further 10 minutes before being quenched with a phosphate buffer solution (pH = 7). Also 
in this case, the desired compound 153a was formed in 47% NMR yield along with 18% 
NMR yield of 166. In both cases no complete consumption of the starting material was 
observed, with 152a still present after 15 minutes in 26% and 23% NMR yield under flow 
and batch conditions, respectively. Despite the fact that no complete consumption was 
observed, this experiment showed a promising starting point for further optimisation 
studies. 
Some modifications of the reaction setup were made to adjust the reaction conditions to 
flow synthesis requirements. Firstly, the sulfonyl azide 18f was not well soluble in a 
0.15 M solution of acetonitrile at room temperature together with 152a and tended to 
precipitate in the syringe over time. To overcome this problem, a solution of only p-NBSA 
(18f) was pumped separately and combined with a pre-mixed solution of 152a and DBU, 
similar to what was reported in the literature (Scheme 2.19).39 
 
Scheme 2.19: Modified flow system for the generation of diazo compounds 153a; BPR = 
back-pressure regulator. 
Moreover, as gas formation was observed during the reaction, a back-pressure regulator 
BPR (40 psi) was added at the end of the coil to pressurise the system. With the aim of 
finding the optimal conditions, a DoE-approach (see Chapter 1 and Appendix A for 
glossary) was used to identify the most significant parameters and 2-factor interactions 
(2FI; see Appendix A). Since a designed set of experiments is more likely to work 
efficiently when applied to a known system, some pilot studies were performed first to 
gain some experience with the reaction system and to choose the right ranges for each 
parameter (Table 2.5). For the experimental planning the reactor was simplified to a 
single sector as a 1 mL coil (i.d. = 0.5 mm). Lower concentrations (0.05 M) of 152a 
compromised the yield with no reaction after 10 minutes and only 14% of 153a after 
50 minutes (entries 1–2). On the other hand, when the solution had a concentration of 
0.5 M of 152a, an inconsistent flow rate was observed due to crystallisation of p-NBSA 
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in the syringe and in the coil (entry 12). Moreover, no reaction was observed when THF 
was used as solvent regardless of the concentration, reaction time and temperature 
(entries 3, 6, 7) and when p-tosyl azide (18a) was used instead of p-NBSA (18f), 166 
was formed as major product (entry 11). 
Table 2.5: Pilot studies for the diazo-transfer reaction in flow. 
Entry 152a (M) 
18 
(equiv.) 
DBU 
(equiv.) Solvent 
T 
(°C) 
t 
(min) 
152a 
(%)a 
153a 
(%)a 
166 
(%)a 
1 0.05 18f (1) 2 CH3CN 65 10 100 - - 
2 0.05 18f (1) 2 CH3CN 22 50 73 15 7 
3 0.05 18f (1) 2 THF 22 50 100 - - 
4 0.1 18f (1) 2.5 CH3CN 65 10 73 14 (12)b 5 
5 0.1 18f (1) 2 CH3CN 22 50 52 24 19 
6 0.1 18f (1) 2 THF 22 50 100 - - 
7 0.2 18f (1) 2 THF 65 10 100 - - 
8 0.2 18f (1) 1.5 CH3CN 65 10 56 25 15 
9c 0.2 18f (1) 1.5 CH3CN 65 10 53 25 10 
10 0.2 18f (3) 2.5 CH3CN 22 50 15 45 (40)b 20 
11 0.2 18a (2.5) 2 CH3CN 22 50 20 17 61 
12d 0.5 18f (2.5)  2.5 CH3CN 65 50 (8)b (51)b (12)b 
General Procedure: The reactions were performed using the flow system depicted in 
Scheme 2.19 with an overall flow rates of 0.1–0.02 mL•min−1 and quenched with a phosphate 
buffer solution (pH = 7). aYield measured by 1H NMR spectroscopy using 1,3,5-trimethoxy-
benzene as the internal standard; bIsolated yield; cReaction quenched with saturated aqueous 
NH4Cl solution (pH = 5); dInconsistent flow rate due to p-NBSA precipitate. 
With this information in hand the following two-levels fractional factorial design (FFD 25-1; 
see Appendix A) was designed with five numerical variables and three responses were 
registered (Table 2.6). The chosen parameters were: concentration of 152a (+1 = 0.1 M; 
−1 = 0.05 M), p-NBSA (+1 = 3 equivalents; −1 = 1 equivalent), DBU (+1 = 2.5 equivalents;  
−1 = 1.5 equivalents), temperature (+1 = 65 °C; −1 = 22 °C) and residence time 
(+1 = 50 minutes; −1 = 10 minutes); the responses (starting material residue (%), diazo 
compound formation (%) and azide formation (%)) were measured by 1H NMR 
spectroscopy using 1,3,5-trimethoxybenzene as the internal standard. The 
16 experiments were performed in a random order over three days to minimise nuisance, 
and three central points were measured to identify any curvature. The acquired data 
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were fitted into the model and the three responses were analysed separately using 
pareto charts and half-normal plots to select the most significant factors. 
Table 2.6: Matrix for the FFD 25-1 with results. Factor generator for E = A*B*C*D. 
  Factors Responses 
Std Run 
order 
A: 152a 
(M) 
B: T 
(°C) 
C: DBU 
(equiv.) 
D: p-NBSA 
(equiv.) 
E: t 
(min) 
152a 
(%)a 
153a 
(%)a 
166 
(%)a 
1 11 0.1 22 1.5 1 50 36 30 22 
2 7 0.2 22 1.5 1 10 39 33 17 
3 14 0.1 65 1.5 1 10 73 12 7 
4 4 0.2 65 1.5 1 50 53 25 13 
5 16 0.1 22 2.5 1 10 43 28 16 
6 19 0.2 22 2.5 1 50 42 30 18 
7 1 0.1 65 2.5 1 50 68 15 9 
8 13 0.2 65 2.5 1 10 53 24 14 
9 3 0.1 22 1.5 3 10 29 42 17 
10 5 0.2 22 1.5 3 50 13 45 21 
11 2 0.1 65 1.5 3 50 41 26 15 
12 12 0.2 65 1.5 3 10 45 35 10 
13 10 0.1 22 2.5 3 50 14 47 20 
14 17 0.2 22 2.5 3 10 22 40 22 
15 9 0.1 65 2.5 3 10 36 39 14 
16 8 0.2 65 2.5 3 50 39 32 16 
17 6 0.15 43.5 2 2 30 38 33 15 
18 18 0.15 43.5 2 2 30 42 27 19 
19 15 0.15 43.5 2 2 30 40 29 15 
General Procedure: All reactions were performed according to Scheme 2.19. aYields 
determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the internal standard. 
According to the chosen models, the concentration of 152a (A), the amount of base (C) 
and the residence time (E) were not significant, which means that their influence on the 
outcomes was not statistically relevant within the investigated chemical space. In 
contrast, the impact of the temperature (B) was significant for all three responses, 
especially for the consumption of the starting material 152a. In fact, a higher residue of 
152a was observed after performing the reactions at higher temperature, which resulted 
in lower yields for 153a and azide 166 (Figure 2.4). As previously discussed for the batch 
process (pg. 61–63), despite the better yield for 153a (65%) and a better diazo/azide 
ratio observed for a reaction performed at 45 °C, a small amount of starting material 152a 
was recovered, and the decomposition of the triazene intermediate 167a was suspected. 
Under flow conditions, due to the bigger surface area to volume ratio, the effect due to 
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the temperature was enhanced leading to a faster decomposition of the triazene 167a 
that would explain the high amount of the starting material recovered. However, the 
pareto chart for the second response showed that the formation of the desired product 
153a was promoted when a higher amount of p-NBSA was used. 
 
 
Figure 2.4: Pareto charts showing main effect for (from left to right) response R1 (starting material 
residue), R2 (diazo compound formation) and R3 (azide formation). A = 152a, B = Temperature, 
C = Base, D = p-NBSA, E = time; Orange = positive effect; Blue = negative effect. 
The three models were confirmed to be significant by the analysis of variance (ANOVA) 
with no significant curvature (see Appendix A for glossary). The models were then used 
to navigate the aforesaid chemical space to find optimal combinations of factors that, 
simultaneously, minimised the starting material residue and azide formation while 
maximising the formation of the desired diazo compound. The contour plots in Figure 2.5 
provide a visual representation of the responses when the concentration of 152a (A), the 
DBU equivalents (C) and the time (E) are kept fixed. By overlapping these contour plots, 
it is possible to better visualised the “sweet spot” (highlighted in yellow) in which all the 
R1: R2: 
R3: 
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criteria are satisfied. In particular, when a solution of 0.2 M of 152a and 2 equivalents of 
DBU are used with a 10 minutes residence time, the desired product 153a is formed in 
more than 40% NMR yield, the residue of 152a and azide formation are less than 25% 
and 20%, respectively. 
 
 
Figure 2.5: Contour plots for a) starting material residue, b) diazo and c) azide formation with 
152a = 0.2 M and DBU = 2 equiv. after 10 min; d) Overlay plot with highlighted “sweet spot” in 
yellow for the following criteria SM residue < 25%, diazo compound > 40% and azide <19 or 17%. 
Following that, the reaction mixture of a batch experiment was compared to the mixture 
obtained under flow conditions by crude 1H NMR before and after work-up. As previously 
discussed (see Table 2.4), the batch reaction took 24 hours before traces of diazo 153a 
were detected by 1H NMR spectroscopy, hence the greatest part of the triazene 
intermediate was cleaved during the work-up and the diazo/azide ratio depended on the 
quenching agent. On the contrary, the products 153a and 166 were partially formed 
already after 10 minutes in the flow system with no work-up. With this information in 
a) b) c) 
c) 
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hand, different internal diameters were modified next to investigate their influence on the 
mixing, and the equivalents of DBU were increased to improve the conversion of the 
starting material (Table 2.7). 
Table 2.7: Screening of reactor internal diameters, temperatures and equivalents of DBU. 
 
Entry ID (mm) DBU (equiv.) T (°C) time (min) 152aa 153aa 166a 
1 0.5 2 22 10 22 45 19 
2 0.5 4 22 10 12 53 (49)b 27 
3 1 2 22 10 20 42 32 
4 1 4 22 10 13 50 31 
5 1 5 22 10 12 50 35 
6 0.2 4 22 10 22 47 29 
7 0.5 4 45 10 19 48 25 
8 0.5 4 65 10 35 45 16 
9 0.5 4 22 50 13 54 28 
10 0.5 4 22 5 10 52 26 
General Procedure: The reactions were performed on 0.2 M of 152a in acetonitrile using 2.5 
equiv. of p-NBSA (18f); aDetermined by 1H NMR spectroscopy using 1,3,5-trimethoxy-
benzene as the internal stadard; bIsolated yield. 
No effect was found when the internal diameter was changed from 0.5 to 1.0 mm 
(entries 1 and 3), however, when more equivalents of DBU were used, better 
conversions were achieved (80% combined yield) and the desired diazo compound 153a 
was obtained in 53% and 50% NMR yield for 0.5 and 1.0 mm, respectively (entries 2 and 
4). A smaller internal diameter (0.2 mm) and further addition of base did not lead to any 
improvement (entries 5, 6). In addition, 153a was formed in 52%, 53% and 54% within 
5, 10 and 50 minutes, respectively (entries 2, 9, 10), showing the insignificance of the 
residence time t. Hence, the optimal condition to achieve the α-diazocarbonyl 
intermediate 153a in good yield were found using 4 equivalents of DBU, 0.5 mm of 
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internal diameter coil at room temperature (Table 2.7, entry 2). Subsequently, the 
Rh(II)-catalysed enantioselective cyclisation was investigated. 
2.2.3 Optimisation of the C–H Insertion Reaction 
The metal-catalysed C–H insertions of aryl diazo acetates have been widely 
investigated, especially for the synthesis of optically active heterocycles.40 Among all, 
chiral Rh(II)-catalysts such as Rh2(DOSP)4 71a, Rh2(PTTL)4, 71d and Rh2(PTAD)4 71e 
have stood out as the most efficient and selective catalysts (Figure 2.6). 
 
Figure 2.6: Chiral Rh(II)-catalysts most reported in the literature for asymmetric C–H insertions. 
Firstly, racemic mixtures were synthesised using Rh2(OAc)4 as catalyst to investigate the 
reactivity of substrate 153a–n. In presence of dirhodium tetraacetate catalyst in dry 
dichloromethane and under nitrogen atmosphere, the model diazo substrate 153a fully 
converted into the desired 2,3-dihydroindoles 154 in 92% yield as a 3:1 mixture of trans- 
and cis-isomers within 12 hours (Scheme 2.20). 
 
Scheme 2.20: Achiral intramolecular dirhodium-catalysed cyclisation of 153a. 
Generally, all α-diazo substrates 153a-n formed the desired indolines in quantitative yield 
with high d.r. toward the trans-isomer, except N-sec-butyl 153n and the N-allylic 
derivative 153o that did not show the desired reactivity. 
With the aim of optimising the stereoselectivity several solvents were screened.26 Among 
all, n-hexane at room temperature provided the best d.r. and ee for the trans-isomer 154 
when Rh2(R-DOSP)4 was used as chiral catalyst (Table 2.8). Indeed, when the 
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dodecylphenylsulfonylprolinate (DOSP) ligand was used at room temperature in 
n-hexane, the trans-154 was obtained as the major product in good yields (up to 82%) 
and enantiomeric excess (up to 86% ee), while no stereoselectivity was detected for the 
cis-154 (entries 2–5). Lower temperatures26 showed to drastically improve the d.r. 
(>20:1) albeit lower enantiomeric excesses were observed (entry 6).  
Table 2.8: Screening of conditions for the synthesis of trans- and cis-indoline 154. 
 
Entry Conditions R Yield (%)a d.r.b 
(S,S)-154 
ee%c 
(S,R)-154 
ee%c 
1 Rh2(OAc)4 1 mol%, CH2Cl2, rt C6H5 92 3:1 n.a. n.a. 
226 Rh2(R-DOSP)4 1 mol% 
n-hexane, rt C6H5 72 10:1 80 6 
326 Rh2(S-DOSP)4 1 mol% 
n-hexane, rt C6H5 64 9:1 76 0 
4 Rh2(R-DOSP)4 1 mol% THF, rt C6H5 35 5.9:1 38 n.d. 
5 Rh2(R-DOSP)4 0.5 mol% 
n-hexane, rt C6H5 82 11:1 86 0 
6 Rh2(R-DOSP)4 0.5 mol% 
n-hexane, 0 °C C6H5 80 >20:1 73 0 
7 Rh2(R-PTAD)4 1 mol% 
n-hexane, rt C6H5 20 1:1.1 59 40 
8 Rh2(S-PTTL)4 1 mol% 
n-hexane, rt C6H5 63 1:4.5 11 4 
9 Rh2(S-PTTL)4 1 mol% 
n-hexane, rt 4-Me-C6H5 70 1:1.9 62 10 
General Procedure: Reactions performed on a 1 mmol scale of 153. aCombined yield of trans- 
and cis-isomers; bDetermined by 1H NMR spectroscopy; cDetermined by chiral HPLC; n.a. = not 
applicable; n.d. = not determined. 
Subsequently, the attention moved to other popular rhodium catalysts bearing the 
N-phthalamido-1-adamantylacetate (PTAD, 71e) and the N-phthamido-1-tert-leucinate 
(PTTL, 71d) ligands. Differently from 71a, when 71e or 71d were used the cis-154 was 
the major product formed in agreement with previous reports on dihydrobenzofurans.25 
In particular, the Rh2(PTAD)4 catalyst 71e showed very poor diasteroselectivity and a 
medium enantioselectivity for both trans- and cis-154 with 59% ee and 40% ee, 
respectively (entry 7). Moreover, the PTAD-ligand seems to encourage the formation of 
unidentified side products and only 20% of dihydroindoles 154 were isolated. On the 
other hand, the Rh2(S-PTTL)4 catalyst 71d afforded the cis-154 in better yield (63%) and 
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better diasteroselectivity (1:4.5 trans/cis ratio). However, the interaction between the 
carbene precursor 153a and the PTTL ligand lead to a very poor selectivity for both 
trans- and cis-isomers (up to 11% ee; entry 8), while a moderate selectivity (62% ee) 
was detected when a different substrate (153f) was used (entry 9).  
In the light of these observations, the DOSP-ligand was preferred over PTAD and PTTL 
for the successful synthesis of trans-indolines in both good yields and enantioselectivity. 
The absolute configuration of the major enantiomer (2R,3R)-2-phenyl-1-tosylindoline-3-
carboxylate (154a) was confirmed by single crystal X-ray analysis of the product obtained 
after recrystallisation from n-hexane/2-propanol 1:1 v/v, using Rh2(S-DOSP)4 71a 
catalyst (Figure 2.7).26  
 
Figure 2.7: Crystal structure for (2R,3R)-2-phenyl-1-tosylindoline-3-carboxylate 154a. 
Subsequently, the optimal reaction conditions (Table 2.8, entry 5) were applied on 
various diazo precursors (153a–n) leading to the trans-products 154a–k in good yields 
and in good to excellent enantiomeric excesses (Scheme 2.21). The substitution of the 
methyl ester with a bulkier iso-propyl ester decreased the selectivity with 154b formed 
as a 2.2:1 diastereomeric ratio and 35% ee. Products 154c–f bearing electron-donating 
and electron-withdrawing groups in para-, meta- and ortho- were obtained in good yields 
(up to 92%) and good to excellent selectivity (up to 80% ee). The bulkier 2-phenyl 
substituted aryl diazo derivative 153g was slower to react, affording 154g in 73% yield 
after 24 hours in 80% ee, while the slightly less sterically hindered 153h–i formed  
154h–i in 86% and 48% yield and 61% and 75% ee, respectively, after 12 hours. Besides 
the benzylic-derivatives in 153a–i, also the cinnamyl and the n-hexyl groups were well-
tolerated under these conditions. The cinnamic-derivative showed the desired reactivity 
affording 154j in 53% yield after 24 hours despite of the presence of the double bond, 
although with poor enantioselectivity (33% ee). On the other hand, the n-hexyl substrate 
154k was formed in good yield (64%) and excellent diasteroselectivity (>20:1) with a 
moderate enantiomeric excess (48% ee) within 12 hours. 
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Scheme 2.21: Substrate scope of trans-dihydroindoles 154a–k. Combined yields of trans and 
cis-154 are shown; diasteromeric ratio (d.r.) was determined by 1H NMR spectroscopy and the 
enantiomeric excess (ee) was determined by HPLC. The absolute stereochemistries were 
assigned in analogy to 154a. 
Eventually, the C–H insertion was examined in flow with the aim to combine the 
generation and reaction of the carbene precursor into a single continuous-flow setup. 
Unfortunately, there was no reaction occurring under the investigated conditions 
(Table 2.9) which seem to be not appropriate for flow conditions. 
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Table 2.9: Flow setup for intramolecular C–H insertion. 
  
Entry Rh(II) catalyst Time (min) Yield (%) 
1 Rh2(OAc)4 1 mol% 20 no reaction 
2 Rh2(oct)4 1 mol% 40 traces 
3 Rh2(R-DOSP)4 1 mol% 40 no reaction 
4 Rh2(R-PTAD)4 1 mol% 40 traces 
The reaction in batch required 12–24 hours to occur completely, probably as result of 
the bulky tosyl group close to the C–H insertion site, making the translation into a flow 
system harder. Therefore, a synthesis for different N-substituted diazo compounds was 
initiated (Scheme 2.22). 2-Aminophenylacetate 156a was quantitatively converted to the 
imine 169 within 10–20 minutes in the presence of benzaldehyde (168) and MgSO4 
under neat reaction conditions. The Pt-catalysed reduction/methylation of 169 in the 
presence of formic acid and phenylsilane described by Zhu et al.,41 provided only the 
undesired lactone 163 as the major product. The desired product 171 was obtained by 
imine reduction to 170 followed by methylation. For a successful reduction, a 1:1 mixture 
of boric acid and NaBH442 was used to avoid ester hydrolysis observed when only NaBH4 
was used. The secondary amine 170 was then treated with methyl iodide and 
triethylamine in DMF to generate the N-methyl derivative 171, which was formed only in 
poor yield (only 16–21%) due to the competitive cyclisation to 163 (36–40% yield). 
Subsequently, 171 was treated with p-NBSA (2 equivalents) and DBU (2 equivalents) in 
acetonitrile at room temperature for 24 hours, but a complex mixture of unreacted 171, 
desired product 172 and the side product 173 was obtained. When the crude mixture 
was treated with Rh2(OAc)4 in dichloromethane the bright yellow solution turned pale 
green within 5 minutes and a gas evolution was observed. The 1H NMR spectroscopic 
analysis of the crude reaction mixture showed the disappearance of the diazo 
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precursor 172, but the afforded reaction mixture was complex, and no product could be 
isolated or identified.  
 
Scheme 2.22: Synthetic pathway to afford alternative N-methyl substituted indolines. 
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2.3 Conclusion and Outlook 
In conclusion, a novel and efficient stereoselective synthesis for trans-indolines from 
α-diazocarbonyl compounds using Rh(II)-catalysed intramolecular C–H insertions was 
developed. 
The library of carbene-precursors 153a–n was successfully synthesised in batch in 
moderate to very good yields via Regitz diazo-transfer. Furthermore, the reaction was 
translated in a flow system using a DOE-approach to optimise the synthesis of the model 
diazo intermediate 153a (up to 51% NMR yield). Moreover, a library of 11 new trans-
indolines 154a-k was built in good yields and with good to excellent selectivity.  
Further work can be done to expand the substrate scope in order to include substituents 
on the indoline aryl ring as well as investigating different N-protecting groups. Moreover, 
future work is focused on developing a continuous flow set-up for the diazo-transfer 
reaction and the asymmetric cyclisation combined with an online 2D-HPLC analytic 
system for a faster analysis of complex mixture of isomers. Indeed, the 2D-HPLC 
technique proved to speed up the analysis providing information about conversion, d.r. 
and ee within 40 min and it presents a convenient tool to quickly analyse asymmetric 
transformation in a short period of time (Figure 2.8). 
 
 
Figure 2.8: 2D-HPLC double chromatogram for the resolution of the indoline mixture 
(λ = 254 nm): first dimension silica column separates trans- from cis-isomer (blue line); second 
dimension YMC chiral column separates the enantiomers (red line). 
 
cis-148a 
trans-154a 
cis-154a 
Micol Santi Synthesis of trans-Dihydroindoles  
79 
References 
 
1 For selected examples see: a) J. D. Podoll, Y. Liu, L. Chang, S. Walls, W. Wang, X Wang, 
Proc. Natl. Acad. Sci. 2013, 110, 15573–15578; b) R. R. Poondra, N. N. Kumar, K. Bijian, M. 
Prakesch, V. Campagna-Slater, A. Reayi, P. T. Reddy, A. Choudhry, M. L. Barnes, D. M. 
Leek, M. Daroszewska, C. Lougheed, B. Xu, M. Schapira, M. A. Alaoui-Jamali, P. Arya, J. 
Comb. Chem. 2009, 11, 303–309; c) Z. Gan, P. T. Reddy, S. Quevillon, S. Couve-Bonnaire, 
P. Arya, Angew. Chem. Int. Ed. 2005, 44, 1366–1368. 
2  For recent reviews on indoline synthesis see: a) T.-B. Hua, C. Xiao, Q.-Q. Yang, J.-R. Chen, 
Chin. Chem. Lett. 2019, 31, 311–322; b) D. Liu, G. Zhao, L. Xiang, Eur. J. Org. Chem. 2010, 
3975–3984; c) S. Anas, H. B. Kagan, Tetrahedron: Asymmetry 2009, 20, 2193–2199. 
3  S. P. Roche, J.-J. Y. Tendoung, B. Treguier, Tetrahedron 2015, 71, 3549–3591.  
4  a) Y. Duan, L. Li, M.-W. Chen, C.-B. Yu, H.-J. Fan, Y.-G. Zhou, J. Am. Chem. Soc. 2014, 
136, 7688–7700; b) R. Kuwano, M. Kashiwabara, Org. Lett. 2006, 8, 2653–2655; c) R. 
Kuwano, K. Sato, T. Kurokawa, D. Karube, Y. Ito, J. Am. Chem. Soc. 2000, 122, 7614–7615.  
5 W. Zi, Z. Zuo, D. Ma, Acc. Chem. Res. 2015, 48, 702–711. 
6 a) K. Kubota, K. Hayama, H. Iwamoto, H. Ito, Angew. Chem. Int. Ed. 2015, 54, 8809–8813; 
b) A. Awata, T. Arai, Angew. Chem. Int. Ed. 2014, 53, 10462–10465; c) D. Zhang, H. Song, 
Y. Qin, Acc. Chem. Res. 2011, 44, 447–457. 
7 D. F. Taber, P. K. Tirunahari, Tetrahedron 2011, 67, 7195–7210. 
8 a) I. Bytschkov, H. Siebeneicher, S. Doye, Eur. J. Org. Chem. 2003, 15, 2888–2902; b) S. 
Wagaw, R. A. Rennels, S. L. Buchwald, J. Am. Chem. Soc. 1997, 119, 8451–8458; c) J. P. 
Wolfe, R. A. Rennels, S. L. Buchwald, Tetrahedron 1996, 52, 7525–7546; d) B. H. Yang, S. 
L. Buchwald, Org. Lett. 1999, 1, 35–38; d) J. F. Hartwig, Synlett 1997, 329–340; e) T.-S. Mei, 
D. Leow, H. Xiao, B. N. Laforteza, J.-Q. Yu, Org. Lett. 2013, 15, 3058–3061. 
9 For selected example see: a) Z.-Y. Li, H. H. Chaminda Lakmal, X. Qian, Z. Zhu, B. 
Donnadieu, S. J. McClain, X. Xu, X. Cui, J. Am. Chem. Soc. 2019, 141, 15730–15736; b) D. 
Katayev, M. Nakanishi, T. Bürgib, E. P. Kündig, Chem. Sci. 2012, 3, 1422–1425; c) M. 
Nakanishi, D. Katayev, C. Besnard, E. P. Kündig, Angew. Chem. Int. Ed. 2011, 50, 7438–
7441; d) A. B. Dounay, L. E. Overman, A. D. Wrobleski, J. Am. Chem. Soc. 2005, 127, 
10186–10187; e) A. M. Hyde, S. L. Buchwald, Angew. Chem. Int. Ed. 2008, 47, 177–180. 
10 a) F. Zhou, J. Guo, J. Liu, K. Ding, S. Yu, Q. Cai, J. Am. Chem. Soc. 2012, 134, 14326–
14329; b) J. J. Li, T. S. Mei, J. Q. Yu, Angew. Chem. Int. Ed. 2008, 47, 6452–6455; c) A. 
Minatti, S. L. Buchwald, Org. Lett. 2008, 10, 2721–2724. 
11 a) A. Correa, I. Tellitu, E. Dominguez, R. SanMartin, J. Org. Chem. 2006, 71, 8316–8319; b) 
L. Pouysegu, A.-V. Avenllan, S. Quideau, J. Org. Chem. 2002, 67, 3425–3436.  
12 a) R. Viswanathan, C. R. Smith, E. N. Prabhakaran, J. N. Johnston, J. Org. Chem. 2008, 73, 
3040–3046; b) J. Johnston, M. A. Plotkin, R. Viswanathan, E. N. Prabhakaran, Org. Lett. 
  Synthesis of trans-Dihydroindoles  Micol Santi 
80 
 
2001, 3, 1009–1011; c) R. Viswanathan, E. N. Prabhakaran, M. A. Plotkin, J. N. Johnston, 
J. Am. Chem. Soc. 2003, 125, 163–168. 
13  a) C. Leroi, D. Bertin, P. E. Dufils, D. Gigmes, S. Marque, P. Tordo, J. L. Couturier, O. 
Guerret, M. A. Ciufolini, Org. Lett. 2003, 5, 4943–4945; b) H. Fuwa, M. Sasaki, Org. Lett. 
2007, 9, 3347–3350. 
14 a) X. Wen, Y. Wang, X. P. Zhang, Chem. Sci. 2018, 9, 5082–5086; b) Y. Wang, X. Wen, X. 
Cui, X. P. Zhang, J. Am. Chem. Soc. 2018, 140, 4792–4796. 
15 a) R. C. Larock, N. Berrios-Peňa, K. Narayanan, J. Org. Chem. 1990, 55, 3447–3450; b) C. 
E. Houlden, C. D. Bailey, J. G. Ford, M. R. Gagne, G. C. Lloyd-Jones, K. I. Booker-Milburm, 
J. Am. Chem. Soc. 2008, 130, 10066–10067. 
16 a) G. S. Gil, U. M. Groth, J. Am. Chem. Soc. 2000, 122, 6789–6790; b) W. F. Bailey, M. J. 
Mealy, J. Am. Chem. Soc. 2000, 122, 6787–6788.  
17  a) J. Lee, K. M. Ko, S.-G. Kim, RSC Adv. 2017, 7, 56457 – 56462; b) R. Miyaji, K. Asano, S. 
Matsubara, Org. Lett. 2013, 15, 3658 – 3661.    
18  J. L. García Ruano, J. Alemán, S. Catalán, V. Marcos, S. Monteagudo, A. Parra, C. d. Pozo, 
S. Fustero, Angew. Chem. Int. Ed. 2008, 47, 7941–7944. 
19  a) T. Ikawa, Y. Sumii, S. Masuda, D. Wang, Y. Emi, A. Takagi, S. Akai, Synlett 2018, 29, 
530–536; b) R. D. Aher, G. M. Suryavanshi, A. Sudalai, J. Org. Chem. 2017, 82, 5940–5946; 
c) J.-X. Pian, L. He, G.-F. Du, H. Guo, B. Dai, J. Org. Chem. 2014, 79, 5820–5826; d) C. D. 
Gilmore, K. M. Allan, B. M. Stoltz, J. Am. Chem. Soc. 2008, 130, 1558–1559. 
20  a) G. Zhang, A. Cang, Y. Wang, Y. Li, G. Xu, Q. Zhang, T. Xiong, Q. Zhang, Org. Lett. 2018, 
20, 1798–1801; b) D. X. Li, J. Kim, J. W. Yang, J. Yun, Chem. Asian J. 2018, 13, 2365–2368. 
21  E. Ascic, S. L. Buchwald, J. Am. Chem. Soc. 2015, 137, 4666–4669. 
22  a) Y. Xia, D. Qiu, J. Wang, Chem. Rev. 2017, 117, 13810–13889. 
23  a) L. W. Souza, R. A. Squitieri, C. A. Dimirjian, B. M. Hodur, L.A. Nickerson, C. N. Penrod, 
J. Cordova, J. C. Fettinger, J. T. Shaw, Angew. Chem. Int. Ed. 2018, 57, 15213–15216; b) 
S. Lee, H.-J. Lim, K. Cha, G. A. Sulikowski, Tetrahedron 1997, 53, 16521–16532; c) H.-J. 
Lim, G. A. Sulikowski, J. Org. Chem. 1997, 60, 2326–2327; d) G. A. Sulikowski, S. Lee, 
Tetrahedron Lett. 1999, 40, 8035–8038. 
24 H. M. L. Davies, M. V. A. Grazini, E. Aouad, Org. Lett. 2001, 3, 1475–1477. 
25 H. Saito, H. Oishi, S. Kitagaki, S. Nakamura, M. Anada, S. Hashimoto, Org. Lett. 2002, 4, 
3887–3890.  
26  S. T. R. Müller Ph.D. Thesis 2015, Cardiff University, “Diazo Compounds in Continuous Flow 
Technology”. 
27  T. Tsung-Pei, US20120101224, 2012. 
28  G. D. Channe, G. Shankare, Indian J. Chem. 2000, 709–711. 
29  C.-J. Wallentin, J. D. Nguyen, P. Finkbeiner, C. R. J. Stephenson, J. Am. Chem. Soc. 2012, 
134, 8875–8884. 
30  a) M. Regitz, Angew. Chem. Int. Ed. Engl. 1967, 6, 733–749; b) M. Regitz, Synthesis 1972, 
351–373. 
Micol Santi Synthesis of trans-Dihydroindoles  
81 
 
31 D. Das, R. Samanta, Adv. Synth. Catal. 2018, 360, 379–384. 
32  R. M. O'Mahony, D. Lynch, H. L. D. Hayes, E. Ní Thuama, P. Donnellan, R. C. Jones, B. 
Glennon, S. G. Collins, A. R. Maguire, Eur. J. Org. Chem. 2017, 6533–6539.  
33  a) S. Tshepelevitsh, A. Kütt, M. Lõkov, I. Kaljurand, J. Saame, A. Heering, P. G. Plieger, R. 
Vianello, I. Leito, Eur. J. Org. Chem. 2019, 6735 – 6748; b) I. Kaljurand, A. Kütt, L. Sooväli, 
T. Rodima, V. Mäemets, I. Leito, I. A. Koppel, J. Org. Chem. 2005, 70, 1019–1028. 
34  a) S. Chuprakov, M. Rubin, V. Gevorgyan, J. Am. Chem. Soc. 2005, 127, 3714–3715; b) 
W.-J. Zhao, M. Yan, D. Huang, S.-J. Ji, Tetrahedron 2005, 61, 5585–5593. 
35  G. H. Hakimelahi, G. Just, Synth. Commun. 1980, 10, 429–435. 
36  a) D. A. Evans, T. C. Britton, J. A. Ellma, R. L. Dorow, J. Am. Chem. Soc. 1990, 112, 4011–
4030; b) D. A. Evans, T. C. Britton, J. Am. Chem. Soc. 1987, 109, 6881–6883. 
37 M. Regitz, Angew. Chem. Int. Ed. 1966, 5, 681–682. 
38  S. T. R. Müller, A. Murat, D. Maillos, P. Lesimple, P. Hellier, T. Wirth, Chem. Eur. J. 2015, 
21, 7016–7020. 
39 a) S. T. R. Müller, T. Wirth, ChemSusChem 2015, 8, 245–250; b) S. T. R. Müller, A. Murat, 
P. Hellier, T. Wirth, Org. Process Res. Chem. 2016, 20, 495–502; c) B. J. Deadman, R. M. 
O'Mahony, D. Lynch, D. C. Crowley, S. G. Collins, A. R. Maguire, Org. Biomol. Chem. 2016, 
14, 3423–3431. 
40 a) H. M. L. Davies, A. M. Walji, Modern Rhodium-Catalyzed Organic Reactions, Wiley-VCH, 
Weinheim, 2005, 301–340; b) T. Ye, M. A. McKervey, Chem. Rev. 1994, 94, 1091–1160; c) 
M. P. Doyle, M. A. McKervey, T. Ye, Modern Catalytic Methods for Organic Synthesis with 
Diazo Compouds: From Cyclopropanes to Ylides, Wiley, New York, 1998. 
41 L. Zhu, L.-S. Wang, B. Li, B. Fu, Catal. Sci. Technol. 2016, 6, 6172–6176. 
42 B.T. Cho, S. K. Kang, Tetrahedron 2005, 61, 5725–5734. 
    Micol Santi 
 
 
Micol Santi Synthesis of Fluorinated Benzofuranones  
83 
CHAPTER 3: Synthesis of Fluorinated Benzofuranones 
3.1 Introduction 
Fluorine-containing organic molecules have an important role in both medicinal and 
agrochemical chemistry due to the unique properties fluorine can provide to a molecule.1 
The presence of fluorine atoms has a biological importance: it can improve the metabolic 
stability of the molecule as well as its binding affinity to protein targets. Moreover, it can 
increase the lipophilicity, which results in a better permeability of the molecule through 
the biological membrane.2 Moreover, late stage 18F functionalisation provides access to 
useful radiolabel tracers that are widely used in Positron Emission Tomography (PET) 
imaging.3 Additionally, polyfluoroarenes play an important role in the electronics 
industries, as they find applications in electronic devices such as organic light-emitting 
diodes (OLEDs), organic thin film transistors (OFETs), photovoltaics and sensors.4 
Therefore, the research of new methods to install halogenated aryl groups represent a 
hot topic in organic chemistry.5 
Publications by Erker et al.6 as well as by Stephan et al.7 and the Melen group8 have 
shown that tris(pentafluorophenyl)borane B(C6F5)3 106d, mainly used as catalyst in 
metal-free cyclisations,9 hydrogenations,10 and hydrosilylation11 reactions, has the ability 
to undergo C6F5 group migration (Scheme 3.1). 
 
Scheme 3.1: Examples of metal-free fluoroaryl-migration using B(C6F5)3 (106d). 
However, most approaches have been limited to the use of B(C6F5)3 as part of a 
frustrated Lewis pair (FLP)10a and the migratory attitude of other aryl groups from boranes 
is much less studied. 
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As mentioned earlier (Chapter 1.1.2.2), α-diazocarbonyl compounds react with trialkyl- 
and triarylboranes to form boron enolate intermediates which then react with various 
electrophiles affording α-functionalised carbonyl compounds. In this chapter the 
metal-free α-aryl functionalisation of esters from α-diazocarbonyl precursors 179 in the 
presence of halogenated and non-halogenated triarylboranes 106 is presented 
(Scheme 3.2).12 The resulting α,α-diaryl esters 182, represent a valuable class of 
compounds due to their role as pharmacophores,13 and they can be typically achieved 
by rhodium-mediated functionalisation of diazo compounds in the presence of 
arylboronic acids 180 or arylsiloxanes 181.14 
 
Scheme 3.2: Previous protocols for the synthesis of α-aryl esters 182 from α-diazo esters 179 
catalysed by rhodium(I) or rhodium(II) (top); metal-free α-aryl functionalisation of esters from 
α-diazocarbonyl precursors 107 or 179 presented in this chapter (bottom). 
Nevertheless, the main focus of the chapter is the development of a metal-free synthesis 
towards fluorinated asymmetric benzofuran-2(3H)-ones 159 from 2-oxygen or 2-sulfur 
substituted aryl-α-diazo acetates 158 in the presence of fluorinated triarylboranes 108d 
and 108e (Scheme 3.3).  
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Scheme 3.3: Novel metal-free synthesis of benzofuran-2(3H)-ones 185 using triarylboranes 106d 
and 106e presented in this chapter. 
Benzofuran-2-(3H)-ones are oxygen-containing heterocycles which are present in many 
biologically active compounds such as (−)-fumimycin 186,15 rosmadial 187,16 yuccaol A 
18817 and abiesinol A 189 (Figure 3.1).18 Moreover, they are used as synthons for the 
synthesis of flavonoid-related aurones 19019 and sesquiterpenes such as aplysin 191.20 
 
Figure 3.1: Examples of natural products containing or synthesised from benzofuranones. 
The presence of a fully substituted quaternary carbon at the C-3 position is a key 
structural characteristic for such compounds and, to date, there are several protocols 
towards the asymmetric synthesis of 3,3-disubstituted benzofuranones 185 that follow 
two common retrosynthetic approaches (Scheme 3.4).21 One approach is based on the 
double functionalisation of benzofuranone scaffolds 192, promoted by organo- or 
metal-based catalysts,22 whereas the other approach relies on the de novo synthesis of 
the lactone framework from building blocks which bear a pre-functionalised C-3 position. 
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Scheme 3.4: Common retrosynthetic approaches towards 3,3-benzofuranones 185. 
For the de novo synthesis of the lactone core, metal-catalysed C–H activation/C–O bond 
formation,23 tandem Friedel-Crafts/lactonisation,24 Reppe-type cyclocarbonylation,25 and 
condensation of phenol derivatives26 have all been reported as successful strategies 
(Scheme 3.5). However, the protocols for the stereoselective synthesis of chiral lactones 
from achiral and acyclic starting materials are limited. 
 
Scheme 3.5: Overview of the most common strategies towards substituted benzofuranones. 
A recent example of the enantioselective synthesis of chiral benzofuranones relies on 
the palladium-catalysed C–H activation of 2,2-disubstituted phenylacetic acids 193. The 
activation is followed by C–O bond formation in the presence of a chiral ligand 194, which 
subsequently generates chiral benzofuranones 196 in good yields (up to 86%) and high 
enantioselectivities (up to 96% ee; Scheme 3.6).23a 
 
Scheme 3.6: Asymmetric Pd(II)-catalysed C–H activation/lactonisation of 2,2-disubstitutedphenyl 
acetic acid 193. 
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In 2018, Bella and co-workers26b developed a stereoselective synthesis for chiral 
3,3-disubstituted benzofuranones 200, via desymmetrisation of prochiral malonates 197 
(Scheme 3.7). In the presence of Chinchona alkaloid derivatives, malonate 197 reacts 
with quinone 198 and the resulting arylated achiral malonate cyclises to give 
benzofuranones 200 in good yields, preferentially as the (R)-isomer. The intermolecular 
desymmetrisation is suggested to occur via a transition state such 199, where the 
thiourea moiety of the chiral organocatalyst coordinates to both the phenolic and the 
carboxylic groups, favouring the formation of (R)-199.26b 
 
Scheme 3.7: Synthesis of chiral benzofuranones 200 via intramolecular desymmetrisation on 
malonate 197. 
In this chapter, a novel approach towards asymmetric 3,3-disubstituted benzofuranone 
185 is presented. The new methodology involves α-diazo esters and highly Lewis acidic 
boranes, in which the lactone framework is formed and fully functionalised in the C-3 
position in one single step (Scheme 3.3). Parts of the following results are published in 
Angew. Chem. Int. Ed. 2019, 58, 7861–7865. 
  
 Synthesis of Fluorinated Benzofuranones  Micol Santi 
88 
 
3.2 Results and Discussion 
In this work, the ability of the different Lewis acids 106a–ea to undergo α-ester 
functionalisation was investigated (Scheme 3.8). A library of α-diazocarbonyl esters 107 
and 179 was synthesised from ethyl acetoacetate 201 or from the corresponding 
carboxylic acids 202 over two steps. Moreover, α-diazo esters 184, synthesised from 
2-hydroxy phenylacetic acids 203 over three steps, were used to develop a synthesis 
towards asymmetric 3,3-disubstituted benzofuran-2(3H)-ones 185. The relative Lewis 
acidity of triarylboranes 106a–e was determined by the Gutmann-Beckett method27 by 
Dr. Soltani and Darren M. C. Ould (Cardiff University). The Gutmann-Beckett method is 
an experimental method that measure the 31P chemical shifts of the Lewis adduct formed 
between a Lewis acid and triethylphosphine (Et3PO). The difference in 31P chemical 
shifts between the adduct and the free probe is directly related to the strength of the 
Lewis acid and it is indicated by an Acceptor Number (AN).28 
 
Scheme 3.8: Relative Lewis acidity scale for 106a–eb and an overview of the synthetic pathways 
developed for the metal-free α-aryl functionalisation of esters and benzofuranones 185 synthesis. 
 
a. Except 106a, which is commercially available, the synthesis of 106b–e was carried out by Dr. 
Y. Soltani, D. M. C. Ould, Dr. J. Wenz and J. L. Carden. 
b.  The relative Lewis acidity was measured by Dr. Y. Soltani and D. M. C. Ould. 
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3.2.1 α-Functionalisation of Esters 
Initially, the model substrate ethyl 2-diazopropanoate (107) was prepared to investigate 
the reactivity of boranes 106a–e towards the 1,2-aryl transfer into diazo compounds 
reaction (Chapter 1.1.2.2, Scheme 1.26). The synthesis started with the α-methylation of 
ethyl acetoacetate (201) in the presence of methyl iodide and sodium hydride, to afford 
204 in 65% yield (Scheme 3.9). Ethyl 2-diazopropanoate (107) was then obtained in 52% 
yield via Regitz diazo-transfer,29 by treating 204 with p-acetamidobenzenesulfonyl azide 
(p-ABSA, 18e) and DBU in acetonitrile. 
 
Scheme 3.9: Preparation of ethyl 2-diazopropanoate (107). 
Treatment of 107 with boranes 106a–e in a 3:1 ratio, followed by aqueous basic work-up 
(1 M aqueous solution of NaOH) afforded ethyl 2-arylpropanoates 182a–e in poor to very 
good yields (30–89%; Scheme 3.10).  
 
Scheme 3.10: Screening of boranes 106a–e in the 1,2-aryl transfer reaction on the model 
substrate 107. The reaction was performed on a 0.1 mmol scale using 0.33 mol% of boranes 
106a-e. 
The yields of the 1,2-aryl migration reaction, in the presence of triarylboranes 106a–e, 
increased with the Lewis acidity of 106a–e (see Scheme 3.8). When the least Lewis 
acidic triphenylborane (106a) was used, 182a was obtained in 30% yield. The more 
Lewis acidic fluorinated boranes 106b and 106c were found to be slightly more reactive 
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affording 182b and 182c in 37% and 45% yield, respectively. The more Lewis acidic 
B(C6F5)3 (106d) or 3,4,5-fluorinated borane 106e, on the other hand, led to good yields 
in product formation with 182d and 182e isolated in 80% and 89%, respectively. The 
higher reactivity of 106d–e was clearly visible, as the characteristic bright yellow colour 
of the substrate solution turned colourless within 10 minutes from the borane addition, 
suggesting a full consumption of the diazo starting material. Moreover, a gas evolution 
was observed as soon as the borane reagent was added which lasted about 60 minutes, 
indicating the formation of nitrogen. To better follow the reaction progresses, the 
reactions were conducted in sealed Young NMR tubes under nitrogen atmosphere in 
CDCl3. In the case of reactions performed using 106e, the reaction mixtures were easily 
followed by in situ 1H NMR, showing full consumption of the starting material 107 after 
60 minutes. On the other hand, when B(C6F5)3 (106d) was used, both 1H and 19F NMR 
spectra were too complex to be interpreted. Nevertheless, the yields showed that highly 
Lewis acidic boranes such as 106e and 106d were able to transfer more than two aryl 
groups, in agreement with what has been reported previously.30 For this reason, they 
were preferred for further studied over less Lewis acidic boranes such as triphenylborane 
(106a) which is typically used in excess.31 
To further investigate the reactivity of boranes 106 in the α-arylation of diazocarbonyl 
compounds, more sterically demanding α-aryl-α-diazo acetates 179 were prepared from 
the corresponding carboxylic acids over two steps. Apart from the commercially available 
methyl esters 164 and 205f, the other methyl esters 205a–e and 155a were prepared 
from the corresponding carboxylic acids 202a–e and 151 in moderate to excellent yields 
using acetyl chloride in methanol (Scheme 3.11). 
 
Scheme 3.11: Preparation of ester precursors; aCommercially available. 
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The precursors were then treated with p-ABSA and DBU in acetonitrile to afford the 
desired diazo substrates 165 and 179a–g in very high yields (71–99%; Scheme 3.12). 
 
Scheme 3.12: Preparation of the diazo precursors 165, 179a–g. 
Less Lewis acidic boranes 106a–c did not show reactivity with α-aryl-α-diazo esters 165 
and 179a even at 50 °C,c whereas boranes 106d and 106e afforded the pharmaceutically 
useful13 α,α-diaryl esters 182f–o in moderate to excellent yields after 12 hours at room 
temperature (Scheme 3.13). In this case, the boron reagents 106d–e were found to 
transfer only one aryl group to the α-aryl-α-diazo esters 165 and 179a–d after 12 hours 
at room temperature instead of all three as observed for 107 (see Scheme 3.10). 
However, when the 3,4,5-fluorinated borane 106e reacted with methyl phenyldiazo 
acetate (165) in a 1:3 ratio at 50 °C, more aryl groups were transferred from 106e to 165, 
affording 182f in 79% yield after 7 days. Some limitations were encountered with the 
diazo compounds 179e–g that did not show any reaction with boranes 106d–e. While 
the low reactivity of 179e and 179f remains unclear, the absence of reactivity of the 
pyridine derivative 179g, is probably due to the equilibrium between 179g and its isomer 
3-triazolopyridine (179gI), which is shifted towards the latter (Scheme 3.14). 
 
c.  The reaction between 106a–c and diazo compounds 165 and 179a were performed by Dr. J. 
Wanz. 
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Scheme 3.13: Substrate scope of α-diarylester 182f–o. Reactions performed on a 0.1 mmol scale 
using a 1:1 ratio of diazo compounds 165, 179a-d and boranes 106d–e. aReaction performed on 
a 0.5 mmol scale. 
 
Scheme 3.14: Equilibrium between the diazo compound 179g and the triazole 179gI and crystal 
structure for 179gI.d 
 
d. Crystallisation, characterisation and analysis for triazole 179gI was performed by D. C. M. 
Ould. 
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This metal-free 1,2-aryl migration was then applied to the synthesis of 182p, a valuable 
intermediate for the synthesis of diclofensine 206 (Scheme 3.15). Diclofensine (206) is 
an antidepressant drug bearing a tetrahydroisoquinoline scaffold which can be 
synthesised from 182p, typically obtained by rhodium-catalysed α-functionalisation of 
esters.14b For this reason, the 3,4-chlorinated borane 106f was preparede and it was 
found to have a relatively high Lewis acidity (98%, acceptor number AN = 78.06), similar 
to 3,4,5-fluorinated borane (106e, AN = 79.57) and B(C6F5)3 (106d, AN = 77.49). As 
expected, the reaction of 106f with 179c led to the precursor 182p isolated in 92% yield 
after 12 hours (Scheme 3.15). 
 
Scheme 3.15: Synthesis of 182p, a synthetic intermediate for diclofensine 206. 
The attention was then moved to the synthesis of chiral diazo precursors 179h-j, bearing 
a (−)-menthyl substituent as a chiral auxiliary, with the intention to influence the 
stereoselectivity of the 1,2-aryl transfer reaction.32 The (−)-menthyl group in 179h was 
installed by transesterification of ethyl acetoacetate (201) using boronic acid as a catalyst 
(Scheme 3.16).33  
 
Scheme 3.16: Transesterification of acetoacetate 201 to the chiral 207. 
The (−)-menthyl acetoacetate (207) was isolated in 55% yield and treated with sodium 
hydride and methyl iodide in THF overnight. The obtained α-methylated precursor 208 
was then used for the Regitz diazo-transfer reaction (see Chapter 1, pg. 6)29 to afford the 
chiral diazo derivative 179h in 30% yield (Scheme 3.17). 
 
e. Synthesis, characterisation and Lewis acidity measurements for 106f were performed by Dr. 
Y. Soltani. 
 Synthesis of Fluorinated Benzofuranones  Micol Santi 
94 
 
Scheme 3.17: Synthesis of chiral diazo precursor 179h. 
To synthesise the chiral α-aryl-α-diazo esters 179i and 179j, the corresponding 
carboxylic acids 202a and 202b were used in a Steglich esterification34 in the presence 
of N,N'-dicyclohexylcarbodiimide (DCC), (−)-menthol and 4-(dimethylamino) pyridine 
(DMAP), to give the (−)-menthyl derivatives 209a and 209b in 89% and 78% yield, 
respectively (Scheme 3.18). The chiral derivatives 209a and 209b were then used in the 
subsequent Regitz diazo-transfer reaction29 which afforded the desired chiral diazo 
precursor 179i and 178j in 66% and 87% yield, respectively.  
 
Scheme 3.18: Synthesis of chiral diazo precursors 179i and 179j. 
Although high yields of the α-arylated products 182q–u (76–94%) were obtained, the 
observed diastereomeric ratios were extremely low (up to 1.3:1 d.r.; Scheme 1.19). The 
best result was obtained from the reaction of 2-bromo diazo derivative 179i and 106e 
which afforded 182s in 96% yield with a 1.3:1 diastereomeric ratio. On the contrary, the 
reaction of 179i and B(C6F5)3 (106d) afforded a complex mixture and the desired α-diaryl 
ester 182t was isolated in only 12% yield as a couple of diaseteoisomers in a 1.1:1 ratio. 
Given the unencouraging results on inducing chirality by installing a (−)-menthyl group 
as a chiral auxiliary, the stereoselective α-functionalisation of menthyl esters was not 
further investigated. 
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Scheme 3.19: Stereoselective α-arylation of chiral 179h–j using 106d–e on a 0.1 mmol scale. 
For further mechanistic insights, the reactions of 3,4,5-fluorinated borane 106e with diazo 
compounds were monitored by in situ NMR spectroscopy. In these cases, the 1H and 19F 
NMR spectra showed that the diazo compounds 179 were fully converted into the 
corresponding boron enolates 183 as a mixture of E/Z isomers. After 30 minutes at room 
temperature, the reaction of 165 with one equivalent of 106e in CDCl3 showed, by 
1H NMR analysis, two sets of peaks for the methyl group in a 3:1 ratio (Figure 3.2). 
Similarly, the 19F NMR spectrum revealed two sets of fluorine peaks, which were also 
found in a 3:1 ratio. In addition, a broadened 11B-signal was observed at 45 ppm which 
supported the formation of a three-coordinated borane.35 The data suggested the 
formation of boron enolate 183a as a 3:1 ratio of E/Z-isomers, according to literature.30 
Similar results were also observed for the reactions of 179a, 179b, 179d and 179h–j with 
106e, which all showed the formation of two isomers (Table 3.1). When achiral methyl 
esters 179a, 179b and 179d were used as starting materials, the isomeric ratio was 
influenced by the steric hindrance in the ortho-position (entries 1–4). In particular, the 
2-bromo phenyl derivative boron enolate 183b and the naphthyl derivative 183d were 
formed in a 6:1 and 3.5:1 isomeric ratio, respectively (entries 2 and 4) while the 
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4-trifluoromethyl boron enolate 183c was formed as a 1.5:1 mixture of isomers (entry 3). 
Similarly, for the (−)-methyl derivatives 183e–g (entries 5–7), the highest ratio (4:1) was 
registered for the most sterically hindered 2-bromoaryl substituted boron enolate 183f. 
 
 
Figure 3.2: In situ 1H (top) and 19F NMR (bottom) spectrum of boro enolates (E/Z)-183a. The 
spectra show the presence of E/Z isomers as 3:1 mixture. (Major isomer = orange; Minor isomer 
= green). 
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Table 3.1: Isomer ratio for boron enolates (E/Z)-183a–g measured by 1H NMR spectroscopy and 
crystal structure of boron enolate 183a.f 
 
 
Entry Starting Material R1 R2 183 Ratioa 
1 165 C6H5 Me a 3:1 
2 179a 2-BrC6H4 Me b 6:1 
3 179b 4-(CF3)C6H4 Me c 1.5:1 
4 179d naphthyl Me d 3.5:1 
5 179h Me (−)-menthyl e 1.2:1 
6 179i 2-BrC6H4 (−)-menthyl f 4:1 
7 179j 4-(CF3)C6H4 (−)-menthyl g 1.5:1 
General Procedure: Reactions performed on 0.1 mmol scale in CDCl3 under nitrogen atmosphere 
and monitored by 1H and 19F NMR spectroscopy; aOnly the E/Z configuration of 183a was 
assigned according to literature.
 
When B(C6F5)3 (106d) was used, the NMR spectra were not clear enough to identify the 
E/Z ratio, however, regardless of the isomer for the enolate intermediate, product 182 
were still formed in good yields after one hour upon basic work-up.  
The (E)-boron enolate 183a, derived from phenyl diazo acetate (165) and 106e, could 
be crystallised and structurally characterised,f providing further insight into the 
mechanism. Moreover, when 165 reacted with B(C6F5)3 (106d) at −40 °C, the lower 
reactivity led to isolation of the adduct 210 as a colourless crystalline solide 
(Scheme 3.20). It has been recently reported by Tang et al. that 106d bonds oxygen 
faster than the carbon attached to the diazo moiety.36 For this reason, the first step is 
assumed to be the coordination of the triarylborane to the carbonyl group as shown by 
the isolation of 210. The latter could be in equilibrium with the intermediate 211 in which 
the boron atom coordinates to the terminal nitrogen atom of the diazo moiety. 
Subsequently, upon nitrogen gas expulsion, the adduct intermediate undergoes a 
 
f. Crystallisation, characterisation and analysis for compounds 183a and 210 were performed 
by D. C. M. Ould. 
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1,2-aryl transfer reaction leading to the intermediate 212, which is in tautomeric 
equilibrium with its enolate form 183, as proposed in the literature.12b,37 In the final step, 
the boron enolate 183 is hydrolysed to the final product 182 during the basic work-up.  
 
 
Scheme 3.20: Proposed mechanism for the 1,2-aryl transfer reaction. 
Subsequently, attention was focussed on the development of a novel metal-free 
cyclisation mediated by Lewis acids. 
3.2.2 Synthesis of α,α-Disubstituted Benzofuranones 
As mentioned in the previous chapters, diazo carbonyl and aryl diazocarbonyl 
compounds have been widely used in several cyclisation reactions such as 
cyclopropanations38 and intramolecular C–H insertions,39 especially under catalytic 
conditions. In 2009, Doyle and Zhou reported the Lewis acid catalysed indole synthesis 
from ortho-imino phenyl diazo acetate 213 (Scheme 3.21).40  
 
Scheme 3.21: Lewis acid-catalysed synthesis of indole 214.40 
With the aim of investigating the reactivity of the fluorinated boranes 106d and 106e in a 
similar intramolecular cyclisation, the ortho-imine derivative 213 was synthesised from 
2-nitrophenylacetic acid (151; Scheme 3.22). The carboxylic acid 151 was converted 
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quantitatively into the corresponding methyl ester using acetyl chloride in methanol. The 
obtained product was directly reduced in methanol using Pd/C and hydrogen gas to 
afford methyl 2-aminophenylacetate (156a) in 93% yield over the two steps. The imine 
169 was then obtained by reacting 156a with benzaldehyde 168. The desired diazo 
precursor 213 was prepared in 58% yield via Regitz diazo-transfer29 using p-NBSA as 
diazo-transfer reagent. 
 
Scheme 3.22: Synthesis of the diazo precursor 213. 
In the presence of 3,4,5-fluorinated arylborane 106e and pentafluorinated arylborane 
106d (B(C6F5)3), the ortho-imino diazo compound 213 formed the indole derivative 214 
in low yields (up to 23%; Scheme 3.23). Interestingly, when 106e was used, the indoline 
derivative 215 was isolated as the major product in 40% yield.  
 
Scheme 3.23: Synthesis of indole 214 and indoline 215 using 213 and boranes 106d–e. 
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The same reaction was investigated using 153a, synthesised as described in chapter 2. 
At room temperature, no reaction was observed, while the α-aryl ester 216 was isolated 
in 53% yield after 12 hours at 50 °C (Scheme 3.24). 
 
Scheme 3.24: Reaction between diazo compound 153a and borane 106e. 
With the aim to understand and explain the formation of the detosylated product 216, 
some more experiments were performed. In particular, the N-tosyl-N-benzylphenyl 
amine (218) was prepared from N-benzylphenyl amine (217), but when 218 was mixed 
with 106e no detosylated product 219 was observed at room temperature, nor at 50 °C, 
and 218 was completely recovered (Scheme 3.25). Suspecting an involvement of the 
boron enolate 183a in the detosylation reaction, 0.5 equivalents of 165 was added to a 
solution of borane 106e and 218 in CDCl3 to form 183a. After 30 minutes at room 
temperature, the mixture was heated up to 50 °C for 24 hours, nevertheless, only the 
α-aryl ester 182f was formed while 218 did not react. The mechanism for the detosylation 
and the formation of 216 formation remains unclear. 
 
Scheme 3.25: Reactions performed to explain the formation of the detosylated product 216; 
aNMR ratio. 
In the same context, ortho-substituted diazo ether 184a and thioether 224 were prepared 
to investigate the borane-mediated intramolecular cyclisation further (Scheme 3.26). The 
oxygen-substituted diazo precursor 184a was synthesised starting from 
2-hydroxyphenylacetic acid (203) in three steps with 66% overall yield (Scheme 3.26). 
Firstly, the carboxylic acid 203 was converted quantitatively to the corresponding methyl 
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ester using acetyl chloride in methanol. The phenolic moiety of ester 220 was benzylated 
to afford ether 221a in 82% yield. Finally, the diazo compound 184a was obtained in 86% 
yield using p-ABSA as the diazo-transfer reagent and DBU as base in acetonitrile. 
 
Scheme 3.26: Synthesis of the diazo precursor 184a. 
On the other hand, the sulfur analogue 224 was obtained starting from 
2-iodophenylacetic acid (202e; Scheme 3.27).41 Treatment of the in situ generated thiol 
222 with benzyl bromide (160) followed by esterification using acetyl chloride in methanol 
afforded the desired thioether methyl acetate 223 in 22% overall yield. The final diazo 
precursor 224 was obtained in 40% yield by classic Regitz diazo-transfer reaction.29 
 
Scheme 3.27: Synthesis of the diazo precursor 224. 
Interestingly, the reaction of the diazo derivative 184a with tris(3,4,5-trifluoro-
phenyl)borane 106e lead to the formation of the rearranged lactone 185a in 79% yield in 
 Synthesis of Fluorinated Benzofuranones  Micol Santi 
102 
24 hours. Analogously, the rearranged thiolactone 225 was also isolated in 55% along 
with the α-aryl ester 182w (38%) from the reaction of 224 with 106e after 3 days at room 
temperature (Scheme 2.28).  
 
Scheme 3.28: Reaction of diazo compounds 184a and 224 with borane 106e. 
The formation of the above rearranged products 185a and 225, as shown later in this 
chapter, is the result of a cascade reaction which starts with a 1,2-aryl transfer, followed 
by an aryl migration and a final lactonisation. 
3.2.2.1 Benzofuranones Substrate Scope 
The oxygen-substituted diazo compound 184a and the 3,4,5-fluorinated borane 106e 
were chosen as model substrates for further studies (Table 3.2). Firstly, different 
equivalents of diazo starting material 184a were screened while always using one 
equivalent of borane 106e. A much slower reaction was observed by 1H NMR analysis 
when a 2:1 ratio of 184a and 106e was used, with lactone 185a afforded in 45% and 
63% after 24 hours or 7 days, respectively (entry 2–3). Increasing the temperature to 
45 °C, did not increase the rate of lactone 185a formation, which was formed in only 55% 
after 24 hours (entry 4). 
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Table 3.2: Screening conditions for benzofuranone 185a formation. 
 
Entry 184a (equiv.) Temperature Time 185a (%) 
1 1 rt 24 h 72–79a 
2 2 rt 24 h 45 
3 2 rt 7 d 63 
4 2 45 °C 24 h 55 
General Procedure: Reactions performed on a 0.1 mmol scale of 106e in CDCl3 under nitrogen 
atmosphere and followed by 1H, 11B and 19F NMR spectroscopy; aRange of yields over six 
reactions. 
The influence of the Lewis acidity on the rearrangement/cyclisation cascade was 
investigated next. The model substrate 184a was reacted with B(C6F5)3 (106d) and the 
least Lewis acidic triphenyl borane (106a), and the reactions were followed by 1H and 
19F NMR spectroscopy (Scheme 3.29). In the presence of B(C6F5)3 (106d), the starting 
material 184a was fully consumed within five minutes, however, the lactone 185b was 
detected only after 4 days by 1H NMR spectroscopy and isolated in 77% yield after 7 
days at room temperature.  
 
Scheme 3.29: Screening of boranes 106a, and 106d with model diazo precursor 184a. Crystal 
structure for lactone 185b.g 
 
g. Crystallisation, characterisation and analysis for lactone 185b were performed by D. C. M. 
Ould. 
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On the contrary, when the model substrate 184a was reacted with triphenyl borane 106a, 
the consumption of the starting material was slower and 184a was still detectable after 
12 hours by 1H NMR spectroscopy. After 14 days at room temperature, the desired 185c 
was isolated in 21% along with 48% yield of the corresponding α-phenyl ester 182x. 
Subsequently, the influence of different substituents on the migratory aptitude was 
investigated. For this purpose, a library of starting materials was prepared by treating 
2-hydroxyarylacetic acetates 220a–b with sodium iodide and different aryl or alkyl 
halides 161 under basic reaction conditions, to afford the precursors 221a–k in 58–88% 
yield within 1–3 days (Scheme 3.30). Generally, the hydroxy-functionalisation was well-
tolerated by both EWG and EDG in para-position with 221b, 221c, 221d and 221e 
afforded in 87%, 74%, 74% and 66% yields, respectively. The presence of a bromo-
substituent on the phenolic ring did not lower the reactivity of 220b, which afforded 221j 
in 76% yield. More sterically hindered ortho-substituted benzyl derivatives 221f and 221g 
were yielded also in very good yields (88% and 81%), as well as the allyl bromide, which 
afforded 221h in 80% yield. On the contrary, the cinnamyl derivative 221i, as well as the 
n-hexyl derivative 221k, were isolated only in moderate yields (44–58%).  
 
Scheme 3.30: Preparation of ether precursors 221a–k. 
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Subsequently, the precursors 221a–k were reacted with p-ABSA and DBU in acetonitrile 
to obtain the desired diazo compounds 184a–k in moderate to excellent yields 
(Scheme 3.31). Also in this case, all electron-donating substituents, as well as electron-
withdrawing substituents, in para- and meta-positions showed good reactivity affording 
184b–g and 184j in 71–91% yield. The allyl-substituted compound 184h and the 
cinnamyl-derivative 184i were formed only in moderate yields (40–44%), while the 
n-hexyl substrate 184k was isolated in 84% yield. 
 
Scheme 3.31: Preparation of diazo precursors 184a–k. 
The attention moved on studying the influence of different substituents in the migrating 
moiety in the rearrangement (Scheme 3.32). The reaction was also found to be strongly 
influenced by the electronic properties of the migrating group. In particular, when an 
electron-poor substituent was present on the migrating benzyl group, higher reaction 
temperatures (50 °C) were necessary in order to observe the formation of cyclised 
products 185d and 185e by 1H NMR, which were then isolated in 54% and 72% yield, 
respectively, after 24 hours. On the other hand, the more electron-rich benzylic group 
was found to be faster in migrating, with the desired lactones 185g and 185i detected by 
1H NMR after a few hours at room temperature and isolated in 91% and 54% yield after 
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16 and 72 hours, respectively. However, when 106d was employed, the enhanced 
reactivity led to a complex mixture of intermediates and no lactone 185h could be 
isolated. 
 
Scheme 3.32: Substrate scope of the reaction diazo compounds 184b–c with boranes 106a,d,e; 
aComplex mixture of product formed, no desired product observed by 1H NMR spectroscopy. 
The substrate scope of lactones was further expanded including moderate electron-rich 
benzylic and allylic migrating groups, by reacting diazo precursors 184d–k and more 
Lewis acidic boranes 106e and 106d as starting materials (Scheme 3.33). Generally, the 
reactions performed using 3,4,5-fluorinated borane 106e showed good results at room 
temperature in 24 hours, while B(C6F5)3 106d was found to afford higher yields at 50 °C. 
Substrates 184d, 184f, 184g and 184j bearing a moderate electron-donating group in 
para- or ortho-position, as well as the para-brominated benzyl derivative 184e, showed 
good reactivity with both boranes 106d–e, generating the desired rearranged products 
185j–q and 185v in moderate to excellent yields (52–91%). Moreover, the allyl-
substituted diazo precursor 184h reacted with both 106e and 106d, affording 185r and 
185s in 57% and 60%, respectively. Similarly, the cinnamyl diazo derivative 184i reacted 
Micol Santi Synthesis of Fluorinated Benzofuranones  
107 
with 106e to give 185t in 53% yield, however, the migratory aptitude of the cinnamyl 
group was found to be lower when reacted with 106d, affording 185u in only 33% yield. 
 
Scheme 3.33: Extended substrate scope for 185. 
A limitation was encountered when n-hexyl substituted diazo compound 184k was used, 
as no lactone formation was observed but the reaction stopped after the 1,2-aryl transfer 
step, forming 182y in 59% yield. 
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3.2.2.2 Mechanistic Studies 
The diazo compound 184a was used as a model substrate, along with borane 106e, for 
an in situ NMR experiment and further mechanistic studies (Figure 3.3).  
 
 
Figure3.3: In situ 1H NMR (500 MHz, CDCl3) spectra of the reaction between 184a (0.05 mmol) 
and 106e (0.05 mmol) at different time intervals; Ar = 3,4,5-F3C6H2. 
As depicted in Figure 3.3 the 1H NMR spectra showed that the starting material 184a 
was fully consumed within 5 minutes and two main intermediates, 226 (blue) and 227 
(pink), were formed. When the reaction was performed for 48 hours using mesitylene as 
an internal standard, the boron enolate intermediate 226 (Figure 3.4, blue) was found to 
be fully converted into 227 (orange) within one hour. As the reaction proceeded, 
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intermediate 227 was consumed forming lactone 185a (yellow) and another side product, 
which was identified by NMR spectroscopy as the diarylboronic ether 228 (grey). 
 
Figure 3.4: Kinetic study for the formation of lactone 185a; mesitylene was used as the internal 
standard; The kinetic data are reported in Appendix B.  
With this information in hand, a mechanism was proposed (Scheme 3.34). It is assumed 
that the diazo compound 184a initially undergoes a 1,2-aryl shift with the borane 106e, 
leading to the boron enolate 226, with liberation of nitrogen as mentioned earlier in this 
chapter (see Scheme 3.20). Subsequently, the boron enolate 226 undergoes an 
intramolecular benzyl group migration generating 227, possibly via the seven-membered 
ring intermediate 229. Finally, intermediate 227 undergoes intramolecular cyclisation 
forming lactone 185a and diarylboronic ether 228 as the side product within 24 hours. 
Evidence for the formation of 226 and 227 was found by quenching the reaction after 5, 
10, 15 and 20 minutes which showed the formation of the α-aryl ester 182z in 33%, 19%, 
17% and 15% 1H NMR yield, along with phenol 230a in 47%, 49%, 52% and 60% 
1H NMR yield, respectively, after work-up (Table 3.3, entries 1–4). Moreover, the NMR 
ratio between 226 and 227 after 5 minutes (~1:1.4) reflects the ratio between 182z and 
230a (1:1.35) found in the crude mixture. It was also found that increasing the 
temperature to 50 °C accelerated the cyclisation of intermediate 227 into lactone 185 but 
showed no effect on the rate of rearrangement of boron enolate 226 into 227 (entries  
5–6). 
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Scheme 3.34: Proposed mechanism for the formation of lactone 185a. 
Table 3.3: Evidence for the formation of boron enolate 226 and intermediate 227. 
 
Entry Starting Material Temperature Time 182a 230a 185a 
1 184a rt 5 min 33% 47% n.o. 
2 184a rt 10 min 19% 49% n.o. 
3 184a rt 15 min 17% 52% n.o. 
4 184a rt 20 min 15% 60% n.o. 
5 184b rt 24 h 20% 21% 51% 
6 184b 50 °C 24 h 25% n.o. 57% 
General procedure: Reactions performed on 0.1 mmol of starting material 184a using 106e for 
24 h at rt; aNMR yield, mesitylene, used as internal standard; n.o. = not observed. 
Despite the reactivity of the phenolic hydroxy group, some of the phenolic intermediates 
230 were stable enough to be isolated and fully characterised (See Chapter 5). The 
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seven-membered intermediate 229 was not observed by 1H NMR spectroscopy, 
nevertheless, when 184a and 184j were reacted with 106e in a 1:1:2 ratio, only 185a 
and 185v were formed in a 1:1 ratio, with no crossover reaction product 185d observed, 
providing evidence for an intramolecular rearrangement (Figure 3.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: a) 19F NMR (376 MHz, CDCl3) of the crude reaction mixture of 184a (0.1 mmol), 184j 
(0.1 mmol) and 106e (0.2 mmol) at room temperature after 48 h; b) 19F NMR spectra of 185a (red) 
overlapped with 185v (blue); c) 19F NMR spectra of 185a (red) overlapped with 185j (green); 185j 
was not formed during the crossover reaction. 
a) 
b) 
c) 
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Although it was not possible to isolate the diaryl boronic ether 228, it was possible to find 
some evidence from the in situ 19F NMR spectra (Figure 3.6).  
 
 
Figure 3.6: Comparison of in situ 19F NMR (471 MHz, CDCl3) spectra of the reaction between: a) 
184a (0.1 mmol) and 106e (0.1 mmol) after 24 h at room temperature; b) 184a (0.1 mmol), 184j 
(0.1 mmol) and 106e (0.2 mmol) after 24 h at room temperature; boronic ether 228 (purple), 185a 
(red), 185v (blue). 
For instance, the 19F NMR for the crude mixture between the model substrate 184a and 
106e showed two sets of signals for both meta- and for para-19F which were found in a 
2:1 ratio, and they were linked to 228 and 185a, respectively. Similarly, the 19F NMR of 
the reaction between 184a, 184j and 106e showed three sets of 19F signals in a 4:1:1 
ratio for 228, 185a and 185v, respectively. Moreover, the 11B NMR spectra showed a 
signal at 43.0 ppm which was comparable to what was reported in the literature for similar 
compounds.42 
3.2.2.3 Stereoselective Lactonisation 
It was then thought to stereoselectively drive the tandem rearrangement/lactonisation by 
introducing a chiral auxiliary at the ester moiety (Scheme 3.35). To install the chiral 
auxiliary, a Steglich esterification34 of 203 using DCC and DMAP was investigated first 
but no reaction was observed. Hence, the transesterification of 220a catalysed by 
Ti(OEt)4 was attempted next.43 Despite the (−)-menthol derivative 220c, which was 
obtained in good yield (60%), ester 220d was obtained only in 25% and 220e was not 
formed. In the last two cases, lactone 231 was formed as the main product instead.  
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Scheme 3.35: Attempts for the synthesis of chiral esters 220c–e. 
The titanium-catalysed transesterification was then carried on using the benzylated 
derivative 221a as a starting material (Scheme 3.36). However, under the described 
conditions the benzylic group was removed and only 220a and 220c were formed in 66% 
and 23%, respectively. 
 
Scheme 3.36: Attempt of transesterification of 221a. 
To overcome the problem, the phenolic hydroxy group of 203 was protected first, using 
benzyl bromide to afford the benzyl derivative 232 in 49% yield over two steps 
(Scheme 3.37). In this way, the chiral auxiliaries were successfully installed via Steglich 
esterification34 using 232 as starting material. Both (−)-menthol substituted 221l and  
(−)-borneol derivative 221m were afforded in excellent yields (95–96%), whereas the  
(−)-8-phenlymenthol ester 221n was obtained in 64% yield. 
 
Scheme 3.37: An alternative route to chiral esters 221l–n. 
Finally, the chiral diazo precursors 184l–n were synthesised in good yields via Regitz 
diazo-transfer reaction (Scheme 3.38).29 In this case DBU did not lead to any reaction, 
and a stronger base such as NaHMDS was needed. While 184l and 184m were obtained 
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in very good yields (83%), the diazo precursor bearing the (−)-8-phenylmenthyl 
substituent 184n was obtained in ~60% yield and it was not possible to separate it from 
the unreacted starting material 221n by flash column chromatography, hence it could 
only be used without further purification.  
 
Scheme 3.38: Synthesis of chiral diazo compound 184l–n; aIt was not possible to separate the 
product from the unreacted starting material 221n. 
The chiral diazo esters 184l–n were reacted with 3,4,5-fluroinated borane 106e in CDCl3 
and the reaction progress was monitored by 1H and 19F NMR spectroscopy (Table 3.4). 
The (−)-menthol derivative 184l was converted to the rearranged products 230I and 230II 
in 86% yield as a 1:1.8 mixture of diastereomers after one hour, however, lactone 185a 
was not observed by NMR spectroscopy nor formed after the work-up (entry 1). The 
diastereomeric ratio of 230 did not change when the reaction was performed for a longer 
time (12 hours) and at lower temperature (−78 °C, 10 days), affording 230I and 230II in 
very good yields (up to 88%) but, once again, without the formation of 185a (entries 2 
and 3). Nevertheless, when the reactions were carried out at 50 °C for seven days, the 
target 185a was formed in 45% NMR yield (entries 4 and 5). The higher temperature 
favoured the cyclisation of both 230 isomers forming 185a. However, it was not possible 
to control the selective cyclisation of only one of the two 230 isomers, and the final 
lactone 185a was obtained in 41–45% yield and 21–44% ee after 7 days at 50 °C 
(entry 4). When (−)-borneol derivative 184m was used, the diastereomeric ratio for 230 
was inverted, with 230I being the major isomer formed. For the reaction performed for 
four days at room temperature the diastereomers 230 were formed in 83% yield with a 
1:0.8 of diastereomeric ratio (entry 6). A similar result was registered for the reaction at 
−78 °C for 10 days (entry 8), while when the reaction was heated up at 50 °C for 3 days, 
61% of 230 was converted into 185a with 29% ee (entry 7). Despite more sterically 
hindered, the (−)-8-phenylmenthol ester 184n was not found to be more selective than 
184l–m, with the two diastereomers 230 formed in good yields but with only 1:0.5 d.r. 
(entries 9 and 11). Moreover, the phenols 230I and 230II from 184n were found to be 
more stable and only traces of 185a were obtained after a week at 50 °C (entry 10).  
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Table 3.4: Enantioselective reactions between 184l–n and Lewis acid 106e. 
 
Entry Starting Material T (°C) Time 230I:230IIa 
185a 
(%)b 
Yield 
(%)c 
185a ee 
(%)d 
1 184l rt 1 h 1 : 1.8 n.d. 86 n.d. 
2 184l rt 12 h 1 : 1.8 n.d. 80 n.d. 
3 184l −78 °C 10 d 1 : 1.6 n.d. 88 n.d. 
4e 184l 50 °C 5 d 1 : 1.2 41–45 97 21–44 
6 184m rt 4 d 1 : 0.8 traces 83 0 
7 184m 50 °C 3 d 1 : 2.2 61 90 29f 
8 184m −78 °C 10 d 1 : 0.8 n.d. 85 n.d. 
9 184n rt 7 d 1 : 0.5 n.d. 74 n.d. 
10g 184n 50 °C 7 d 1 : 0.6 traces n.d. 14f 
11 184n −78 °C 10 d 1 : 0.5 n.d. 84 n.d. 
General Procedure: Reactions performed on a 0.1 mmol scale of 184 and 106e (1 equiv.) 
in CDCl3; aNMR ratio; bH NMR yield; cCombined yield of 230I, 230I and 185a; dDetermined 
by 2D-HPLC analysis; eRange of two reactions; fOpposite configuration formed; gComplex 
mixture formed; n.d. = not determined. 
Despite the mediocre selectivity observed, these preliminary results proved the concept 
that it is possible to induce a stereoselective rearrangement reaction by installing a chiral 
auxiliary, which will also be cleaved off during the same lactonisation step. 
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3.3 Conclusion and Outlook 
In conclusion, a mild, metal free synthesis of α-aryl-substituted esters was achieved in 
high yields using halogenated triarylboranes. Importantly, when more Lewis acidic 
boranes were used on a less sterically hindered diazo compound, it was possible to use 
sub-stoichiometric amounts of boranes as more than one aryl group was transferred from 
the borane to the diazo substrate. Furthermore, a novel synthesis for asymmetric 
3,3-disubstituted benzofuran-2(3H)-ones from the reaction between α-aryl-α-diazo 
acetates and triarylboranes was presented. After mechanistic investigations it was found 
that in the presence of a 2-oxy substituent on the α-aryl moiety, the initial boron enolate 
intermediate undergoes intramolecular rearrangement to form 3,3-disubstituted 
benzofuranones. To the best of my knowledge, this is the first example of lactone 
framework synthesis in which the C-3 position is fully substituted in a single-step under 
metal-free conditions.  
Future work is focussed on optimising the stereoselective lactone formation, expanding 
the substrate scope to α-diazo amides 239 as starting material (Scheme 3.39).  
 
Scheme 3.39: Attempts for the synthesis of the α-diazo amide 239. 
Preliminary results showed that the direct diazo-transfer reaction on 233 using p-ABSA 
(18e) or p-NBSA (18f) with DBU did not afford any product and the starting material was 
recovered. Stronger bases such as NaHMDS, or higher temperature (50 °C) led to 
decomposition, therefore, the phosphine-mediated conversion of azides into diazo 
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compounds was investigated as a suitable approach toward 239.44 The azide 235 was 
obtained in 60% yield over two steps, after α-bromination of 233 in the presence of NBS, 
followed by nucleophilic substitution with sodium azide. On the other hand, the acyl 
phosphine 237 was synthesised in 45% yield over three steps, from methyl acrylate (236) 
and diphenylphosphine. The reaction between azide 235 and phosphine 237 generated 
the triazene 238. A proper optimisation of the fragmentation of triazene 238, as well as 
installing chiral amide auxiliary, will provide access to the valuable chiral α-diazo amide 
239, that can be investigated as starting materials in the stereoselective 
rearrangement/lactonisation reaction. 
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CHAPTER 4:  Synthesis of N,O-acetals in a Flow 
Electrochemical Microreactor 
4.1 Introduction 
The N-acyl-N,O-acetal moiety is an important functionality in organic chemistry due to its 
presence in bioactive molecules such as the cytotoxic agents psymberin (240)1 and 
pederin (241; Figure 4.1).2 Moreover, it was reported by Floreancig and co-workers that 
the N,O-acetal moiety in 240 and 241 acts as pharmacophore, hence its presence is 
necessary for their bioactivity.3 
 
Figure 4.1: Examples of bioactive compounds bearing N-acyl-N,O-acetals. 
Besides being useful building blocks in organic chemistry, N-acyl-N,O-acetals are also 
used as valuable surrogates of unstable N-acylimines 243 (Scheme 4.1).4 While 
N-acylimines 243 are susceptible to hydrolysis in the presence of water, 
N-acyl-N,O-acetals 242 are air and moisture-stable. They can be readily activated by 
Lewis or Brønsted acids to generate reactive N-acylimines 243, which then undergo 
nucleophilic substitution,4 or transition metal catalysed cross-coupling.5 
 
Scheme 4.1: Utility of N,O-acetals 242 in organic synthesis. 
For these reasons, several protocols have been reported for the preparation of such 
structures. Retrosynthetically, the N-acetylated N,O-acetals 242 can be generated from 
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amides 246, condensed with aldehydes 247, from nitriles 248 or from N-acyl amino acid 
derivatives 249 (Scheme 4.2). 
 
Scheme 4.2: Retrosynthetic approach towards N-acyl-N,O-acetals 242. 
One of the classic protocols for their synthesis is the Katritzky’s benzotriazole method,6 
where an amide 246 condenses with an aldehyde 247 to generate an imine in situ that 
undergoes nucleophilic attack by benzotriazole 250 forming amide 251 (Scheme 4.3a). 
This α-substituted amide 251 is then treated with sodium alkoxides to install the alkoxy 
group on the molecule, giving the N,O-acetal 242. Similarly, amide 246 and aldehyde 
247 can be mixed with the benzenesulfinic acid salt 252 to afford the α-amido sulfone 
253 as a N,O-acetal precursor (Scheme 4.3c).7 However, the substrate scope for these 
reactions is limited to aryl aldehydes, as the exclusive formation of enamides 254 was 
observed when alkyl-aldehyde substrates were employed.8 
 
Scheme 4.3: Strategies to synthesise N-acyl-N,O-acetals 242. 
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More recently, Wen and co-workers reported a concise procedure mediated by titanium 
ethoxide, in which N-acyl-O-ethyl N,O-acetals 242 are synthesised in one single step 
starting from the amide 246 and the aldehyde 247, expanding the substrate scope to 
both aromatic and aliphatic aldehydes 247 (Scheme 4.3b).9 An additional method is the 
hydrozirconation of nitriles 248, which leads to 242 after acylation and nucleophilic 
addition of alcohols to the imine intermediate 255 in a three step one-pot process 
(Scheme 4.3d).10 
The N,O-acetals 242 can be also prepared by decarboxylative oxidation of amino acid 
derivatives 249. For instance, the hypervalent iodine(III) reagent 256 can be used to 
induce an oxidative fragmentation of 249 (Scheme 4.4).11 In this case, 249 reacts with 
the hypervalent iodine(III) reagent 256 generating the five-membered ring 257 after two 
consecutive ligand exchanges. The latter undergoes oxidative cleavage releasing CO2 
and forming the imine 258, which leads to the N-acyl-O-methyl N,O-acetal 242 upon 
addition of methanol. 
 
Scheme 4.4: Oxidative fragmentation of α-amino acids 249 using iodine(III) reagent 256. 
In addition to hypervalent iodine(III) compounds, electricity can be used as a tool to 
prepare N,O-acetals from amino acid derivatives. For example, Miyoshi et al. reported 
the electrochemical alkoxylation of proline derivatives 259 via non-Kolbe electrolysis 
(Scheme 4.5).12 After the electrolysis of the N-acylprolines 259 in methanol with sodium 
methoxide acting as supporting electrolyte and base, the N,O-acetals 260 were afforded 
in very good to excellent yields.  
 
Scheme 4.5: Electrochemical synthesis of N-acyl-N,O-acetals 260. 
Mechanistically, in a non-Kolbe oxidation,13 sometimes referred to as the Hofer-Moest 
reaction,14 the N-acylated amino acid 261 undergoes a one-electron oxidation followed 
by decarboxylation, affording the radical intermediate 263 (Scheme 4.6). A second 
 N,O-acetals in a Flow Electrochemical Microreactor Micol Santi 
124 
one-electron oxidation leads to the formation of the N-acyliminium ion 265. The 
intermediate 265 is then trapped by a nucleophile affording the final product 266. 
Conversely, a classic Kolbe reaction affords the dimerised product 270 upon anodic 
decarboxylation of the carboxylate 268 and consequent coupling of two of the formed 
radicals 269.15 Another electrochemical reaction which affords N,O-acetal as products is 
the anodic oxidation of unfunctionalised amides 271, also known as the Shono 
oxidation.16 Similar to the non-Kolbe reaction, the starting material 271 undergoes a two-
electron oxidation forming the N-acyliminium ion intermediate 273, which gets trapped 
by a nucleophile affording the final product 274. 
 
Scheme 4.6: Example of anodic oxidations: non-Kolbe, Kolbe and Shono oxidation. 
The Shono oxidation has been widely used as a test reaction, since it was found to be 
very successful for the synthesis of N,O-acetals 260.17 Recently, the Wirth group used 
the Ion electrochemical reactor designed by Vapourtec to perform a regioselective 
methoxylation of the pyrrolidine 259 to the monoalkoxylated compound 260 (up to 
86% yield) or the dialkoxylated product 275 (up to 83% yield), applying charges of 2 F or 
8 F, respectively (Scheme 4.7).18 
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Scheme 4.7: Electrochemical synthesis of N-acyl-N,O-acetals reported by Wirth et al.18 
One of the advantages of flow electrochemical microreactor is the reduced distance 
between the anode and the cathode, which allows to minimise or even eliminate the 
addition of wasteful supporting electrolytes. Moreover, the use of flow microchannels 
improves the mass transfer, and the higher electrode surface-to-reactor volume allows 
the substrate to reach the reaction surface more easily compared to a batch reactor. Due 
to the bigger active surface available, a larger volume of solution containing the starting 
material gets in contact with the electrode, leading to shorter reaction times. 
Furthermore, as the solution in constantly pumped through the reactor, as soon the 
substrate reacts, the product it is flushed out of the reactor avoiding side reactions.19 
Given the presence of asymmetric N,O-acetal motifs in natural products and their 
function as synthons, there is a strong interest in developing stereoselective methods 
towards such structures. One approach is based on the employment of chiral Lewis or 
Brønsted acids to mediate the asymmetric N,O-acetalisation.20 Another method is the 
stereoselective electrochemical oxidation of α-amino acids derivatives via memory of 
chirality. It is well-known that an enantiopure starting material such as 276, which 
undergoes a chemical transformation passing via an achiral intermediate such as a 
carbocation sp2 277, generates the final product 278 as a racemic mixture (Scheme 4.8). 
 
Scheme 4.8: Racemisation of a chiral starting material. 
However, in some cases, the chirality in the starting material 276 bearing a chiral sp3 
carbon is preserved in the product 278, although the reaction proceeds through an 
achiral intermediate such as a carbanion,21 a carbenium ion,22 or a monoradical23 or a 
biradical species.24 This phenomenon carries the name “memory of chirality” and, in 
order to occur, some specific requirements need to be satisfied (Scheme 4.9).25 
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Scheme 4.9: Requirements for the memory of chirality. 
Firstly, the chiral substrate undergoes a reaction at the stereogenic centre, which 
generates two conformationally chiral intermediates (M) and (P), and the (M) 
intermediate (a) is formed faster than the (P)-intermediate. Additionally, the racemisation 
rate between the two chiral intermediates (b) needs to be slower than the conversion of 
the (M) intermediate into the (R)-product (c), which must occur with high stereospecificity. 
The first example of memory of chirality via carbenium ion chemistry was reported by 
Onomura et al. in 2000 (Scheme 4.10).22a They observed that when L-serine derivative 
279 was electrochemically oxidised at −20 °C with 1.2 equivalents of NaOMe, using 
platinum as the cathode and graphite as the anode, the optically active α-methoxylated 
product 280 was afforded in good yield and with 39% of enantiomeric excess for the 
(S)-isomer. 
 
Scheme 4.10: First example of memory of chirality in carbenium ion chemistry.22a 
Interestingly, among all the investigated anode materials, only graphite produced 
optically active 280. In particular, the substitution of the carboxyl group occurs with an 
inversion mechanism, possibly due to a specific interaction between the acyliminium ion 
intermediate and a graphite anode.22a Although the exact role of the anode material on 
the memory of chirality it is still not clear, an interaction between the N-acyliminium ion 
intermediate 265 (Scheme 4.6) and the graphite surface was suspected. When 
N-(2-phenyl)benzyl serine derivative 281 was used for the non-Kolbe oxidation under 
similar conditions, the α-methoxylation occurred with retention of configuration affording 
the N,O-acetal (R)-282 in moderate yields but with 72% and 83% ee when graphite or 
platinum were used as the anode, respectively (Scheme 4.11).22c 
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Scheme 4.11: Highly enantioselective N,O-acetal 282 formation via non-Kolbe electrolysis.  
The same group, with the aim to explain the retained configuration, proposed a 
mechanism and reported 281 bearing the ortho-phenyl substituent underneath the 
carboxylic group as the most stable conformation (Scheme 4.12). According to their 
proposal, due to the restricted rotation caused by the bulky ortho-phenyl substituent, the 
iminium ion intermediate 283, formed upon decarboxylation, presents one face more 
available towards nucleophilic attack than the other. Hence the syn-addition is preferred, 
explaining the major formation of product (R)-282. 
 
Scheme 4.12: Proposed mechanism for the memory of chirality with retention of configuration. 
When the non-Kolbe reaction is performed in a batch electrochemical cell with L-proline 
derivative 259, the chirality is completely lost and the N,O-acetal 260 is obtained as a 
racemate (Scheme 4.13).22c However, Onomura and co-workers found that the 
N-(2-phenyl)-benzoyl derivative 284 was able to retain some chirality, affording 285 in 
72% yield and 46% ee. 
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Scheme 4.13: Electrochemical oxidation of L-proline derivatives (S)-259 and (S)-284. 
In the following section of this thesis, the non-Kolbe oxidation of L-proline derivatives 
were translated into a flow electrochemical reactor setup, with the aim of optimising the 
memory of chirality on L-proline derivatives as well as L-acyclic amino acids derivatives. 
Moreover, the flow microreactor was coupled to a 2D-HPLC system for a faster analysis. 
Some of the following results are published in Chem. Eur. J. 2019, 25,16230–16235. 
4.1.1 Continuous Flow Setup and 2D-HPLC 
As illustrated in Figure 4.2, the entire continuous flow setup used for this project 
consisted of a syringe pump, an electrochemical microreactor connected to a power 
supply, a cooling system, an injecting valve (switching valve) and a 2D-HPLC. 
 
Figure 4.2: Picture of the entire continuous flow setup. 
cooling 
system 
power 
supply 
reactor 
2D-HPLC 
switching 
valve 
syringe pump 
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The microreactor used here was the integrated version of the Ion electrochemical reactor 
by Vapourtec (Figure 4.3). The reactor is composed by two electrode-carrier plates (1) 
supplied with a temperature sensor (2) and incorporated heat pipes (3) for temperature 
control. The Ion easy-clampTM (4) holds the two electrode-carriers together allowing 
operations at higher pressures (up to 5 bar). Furthermore, a FEP spacer (0.5 mm thick; 
5) keeps the electrodes apart and defines the reactor channel (600 µL). The two 
electrodes were placed on the carriers with the FEP spacer in between, and then pressed 
together with the clamp. When electrodes that were supplied as a thin foil (i.e. Pt, Ni, 
etc.) were required, a stainless steel plate (6) was used as a backing plate to ensure the 
right thickness that fits into the Ion reactor and ensure a good sealing. Once assembled, 
the Ion reactor was located into a special housing (7) and connected with a Vapourtec 
E-Series. The outlet of the reactor was then connected to a 6-port switching valve 
bearing a 2 µL sample loop, which was used for the online analysis. 
 
Figure 4.3: Integrated version of Ion electrochemical microreactor; a) disassembled reactor; b) 
operating reactor. The system is composed of: 1) two electrode-carrier plates; 2) a temperature 
sensor; 3) heat pipes for precise temperature control; 4) Ion easy-clampTM; 5) FEP spacer; 6) 
stainless steel plates; 7) housing. 
4.1.2 2D-HPLC 
The liquid-liquid bidimensional-chromatography (2D-LC) represents a separating 
technique in which the injected sample is subjected to two different separation steps. 
This can be achieved by using two different chromatographic columns installed in 
sequence with each other. The eluent is transferred from the first column into the second 
column, which presents a different stationary phase. Hence the elutes that were poorly 
resolved in the first separation can be fully separated during the second one.26 
The concept of liquid-liquid bidimensional separation techniques was introduced for the 
first time by Dent and co-workers in 1947, when they reported the separation of 19 amino 
acids extracted from a potato using two-dimensional paper chromatography.27 However, 
the very first 2D-LC instrument was only developed in 1978 by Erin and Frei28 and it was 
1 1 
2 
3 
4 
5 
6 
7 a b 
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until the late 1990s that the interest towards this new technique started increasing. 
Nowadays, 2D-HPLC is a powerful tool to resolve complex mixtures without greatly 
increasing the analysis time. This technique finds application in proteomics,29 
metabolomics30 and in the pharmaceutical field.31 
The 2D-HPLC apparatus used in this work is an Agilent Infinity 1290 2D-LC Solution, 
which consists of two HPLC pumps and two detectors, one for each dimension (nD), an 
autosampler, a column oven and a set of three valves: two 14-port valves (deck A and 
deck B) and one 6-port valve for sampling eluent from the first dimension into the second 
dimension (sampler; Figure 4.4). 
 
 
Figure 4.4: Picture of the Agilent Infinity 1290 2D-LC solution system (top) and simplified scheme 
of a 2D-LC system (bottom). 
To perform an “offline” analysis, the samples are loaded in the autosampler, whereas for 
an “online” analysis a small volume of reaction mixture is injected using a 6-port valve 
column oven 
autosampler 
1D detector 
2D detector 
valve 
deck A 
sampler 
1D pump 
1D degasser 
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deck B 
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supplied with a sample loop and controlled by contact closure. Next, the 1D pump pumps 
the sample through the 1D column and the 1D detector, generating a 1D chromatogram. 
The 1D eluent then reaches the sampler that, when triggered, controls which volumes 
from the 1D will be analysed in the second dimension (2D) and which will go into the 
waste (Figure 4.5). Before going into the waste, the solution flows through deck A, 
continuously loading one of six loops with 1D solution. At the same time, the 2D pump 
continuously flows solvent system through the valve and deck B without mixing with the 
1D solvent system. When a specific time or threshold is reached, the valve switches from 
the loading to the analysis position, which enables the 2D solvent system to carry the 
volume, contained in the loop, from deck A to the 2D column for the analysis. The amount 
of 1D solvent system (40 µL) which is injected in the second dimension, can be neglected 
and does not contaminate the 2D eluent. 
 
Figure 4.5: Comparison between the “loading” and the “analysis” position of the sampler. 
Due to the presence of empty loops in both deck A and B, this system provides the 
opportunity to “park” volumes in the empty loops and analyse them in a second moment, 
while the second dimension is busy with a previous sample (Figure 4.6). 
 
 
 
 
 
a) Loading Position b) Analysis Position 
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Figure 4.6: Example of “parked” volumes. 
There are various ways to perform a two-dimensional analysis, depending on the reason 
why a 2D-LC is chosen as the separating technique. The different methods can be 
divided into two main groups: the comprehensive 2D-LC, also knows as LC×LC, and the 
heart-cutting 2D-LC also knows as LC-LC. During comprehensive 2D-LC (LC×LC), the 
1D eluent is continuously sampled and transferred to the second dimension, providing 
both 1D and 2D analysis for the whole eluent. This technique finds application in the 
analysis of natural occurring complex mixture such as natural extracts or protein 
mixtures.29 In order to do so, the 2D analysis time must be equal or faster than the 
sampling time to avoid washing away samples not yet analysed. On the contrary, in the 
heart-cutting method (LC-LC) and multiple heart-cutting method (mLC-LC), only a few 
selected segments are injected into the second dimension, hence there is no time-limit 
for the 2D analysis. This method works better for less complex samples containing 
compounds with similar retention behaviour such as a mixture of isomers. 
Although multi-dimensional liquid chromatography has received a lot of attention in the 
past decade, most applications use mainly comprehensive reverse-phase liquid 
chromatography (RP-LC) for highly complex mixtures,32 while the protocols using a chiral 
stationary phase in the second dimension for enantiomeric resolution are still  
limited.31,33 
In the following work an example of normal phase heart-cutting analysis using an achiral 
stationary phase in the 1D and a chiral stationary phase in the 2D is presented. 
 
  
a) Loading Position b) Analysis Position 
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4.2 Results and Discussion  
In this last chapter, the stereoselective synthesis of N,O-acetals 285 is presented 
(Scheme 4.14). The electrochemical oxidation of the N-protected amino acids 284 was 
carried out using a flow electrochemical microreactor coupled to a 2D-HPLC for online 
analysis. The performance of this reaction was optimised in terms of yield and the 
enantioselectivity using a DoE approach.  
 
Scheme 4.14: Overview of the project for the electrochemical stereoselective synthesis of 
N,O-acetals 267 via memory of chirality. 
4.2.1 Synthesis of the Starting Materials and Racemates 
For the synthesis of the protecting group precursor 288a, 9-fluorenone 286 was 
hydrolysed using potassium hydroxide in refluxing xylene, affording the biphenyl 
carboxylic acid 287a in 86% yield (Scheme 4.15). Treatment of 287a or the commercially 
available 287b with thionyl chloride and a catalytic amount of DMF, afforded the acyl 
chlorides 288a–b, which were used directly for the N-protection step without further 
purification. 
 
Scheme 4.15: Synthesis of N-protecting group precursors 288a–b. 
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The chiral N-protected starting materials (S)-284a–f were then prepared in very good 
yields from the reaction of acyl chlorides 288a–b and L-amino acids under basic 
conditions (Scheme 4.16). 
 
Scheme 4.16: Synthesis of chiral starting materials (S)-284a–f. 
In order to find the optimal conditions for the 2D-HPLC analysis, the racemates of the 
final products N,O-acetals 285 were prepared. For the synthesis of the racemic N-acyl 
2-methoxypyrrolidine 285a several approaches were investigated (Scheme 4.17). First, 
the flow α-methoxylation of the N-Boc protected amine 290 was carried out, following a 
literature procedure.17c Pyrrolidine 289 was quantitatively protected upon treatment with 
di-tert-butyl dicarbonate (Boc2O) in the presence of a catalytic amount of DMAP. The 
N-Boc pyrrolidine 290 was then subjected to a Shono oxidation conditions in a flow 
microreactor, affording the α-methoxyl N-Boc pyrrolidine 291 also in excellent yield. 
However, after deprotection with trifluoroacetic acid (TFA), the α-methoxyl pyrrolidine 
292 was not isolated nor detected by NMR spectroscopy, and the starting material 291 
was not recovered.  
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Scheme 4.17: First attempts for the synthesis of racemic 285a. 
Alternatively, the Shono oxidation was carried out on the already acylated pyrrolidines 
293a–b bearing the carboxy biphenyl protecting group (Scheme 4.18). 
 
Scheme 4.18: Second attempt for the synthesis of racemic 285a–d. 
The acyl chlorides 288a–b were prepared as shown in Scheme 4.15 then reacted with 
pyrrolidine 289 affording 293a–b in good yields. Subsequently, N-acyl pyrrolidines  
293a–b (0.1 M) were dissolved in methanol, ethanol or propan-2-ol and oxidised in the 
Ion electrochemical reactor using platinum as the cathode and graphite as the anode 
with NEt4BF4 (0.02 M) as supporting electrolyte and base. The desired N,O-acetals 
285a–d were found only in traces together with unreacted 293a–b, although a gas 
formation was observed, probably as consequence of the oxidation of the solvent as side 
reaction. When acyclic N-protected amines were investigated in the above-mentioned 
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Shono oxidations, no product formation was observed. Using an alternative method, the 
racemic N,O-acetals 285e–h were afforded in moderate to good yields via non-Kolbe 
reaction from the N-protected amino acid 284c–f, synthesised in good yields from the 
reaction of acyl chloride 288a and D/L-alanine, D/L-valine, and D/L-phenylalanine, 
respectively (Scheme 4.19). 
 
Scheme 4.19: Synthesis of racemic N,O-acetals 285e–h. 
4.2.2 Optimisation of Asymmetric non-Kolbe Oxidation 
As previously mentioned in this chapter (Scheme 4.13), the non-Kolbe oxidations on 
chiral N-protected amino acids derivatives were found to occur with memory of chirality. 
With the aim of investigating the memory of chirality of a non-Kolbe oxidation in a flow 
electrochemical microreactor, some optimisation studies were carried out using the chiral 
proline derivative (S)-284a as model substrate. 
When (S)-284a was reacted in a batch electrochemical cell,a the N,O-acetal 285a was 
formed in poor to moderate yields (up to 47%) and moderate stereoselectivity (up to 
40% ee) when platinum was used as the anode (Table 4.1). The stereoselectivity was 
found to be influenced by the temperature. When the reactions were performed at  
−30 °C, the desired product 285a was formed in 15% yield and 40% ee (entry 2). 
Moreover, the use of the sodium methoxide was found to be essential for the reaction in 
a batch electrochemical cell, as no reaction was observed without base and (S)-284a 
was recovered. 
 
a.  The reactions in batch were performed by Rossana Cicala. 
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Table 4.1: Non-Kolbe electrolysis of (S)-284a to the N,O-acetal 285a in a batch electrochemical 
cell.b 
 
Entry Base (equiv.) T (°C) 285a yield (%)a 285a ee (%)b 
1 NaOMe (10) rt 47 30 
2 NaOMe (10) −30 15 40 
General Procedure: Reactions performed on 0.5 mmol of (S)-284a using 2 F over 1 h using 
1 cm2 electrodes; aIsolated yield; bDetermined by chiral HPLC; cOnly starting material was 
recovered, no current observed; dNo desired product formed, degradation of (S)-284a observed. 
Some pilot experiments were performed using the continuous flow system in order to 
select the factors and the corresponding ranges to be used in the DoE (Table 4.2). 
When platinum was used as the anode with no supporting electrolyte or base, product 
285a was formed in poor yields (up to 12% HPLC yield) but with 32% ee which was 
increased to 43% ee when the reaction was carried out at −10 °C (entries  
1–4). When the platinum was replaced with a graphite electrode as the anode, the 
N,O-acetal 285a was formed in 51% HPLC yield and 31% ee. A lower concentration 
(6.2 mM) or a lower flow-rate (0.05 mL•min−1) reduced the yield drastically (as low as 
12%, entries 5–6), while at a higher flow-rate (0.2 mL•min−1) 285a was formed in 67% 
HPLC yield, but no effect was observed on the memory of chirality (entries 7–8). 
Furthermore, the reaction was found to be quantitative when the charge was doubled 
from 2 F to 4 F without side product formation and without losing memory of chirality 
(entry 9). It is worth pointing out that most of the Kolbe or non-Kolbe reactions need a 
base to form the active carboxylate species in order to form the final products.34 
Therefore, it is remarkable that quantitative yields were observed here without a base. 
It is suspected that in the microreactor, given the miniaturised flow conditions, the 
methoxide formed at the cathode was sufficient to deprotonate the starting carboxylic 
acid and initiate the reaction without additional base. Subsequently, different electrode 
materials were screened as the anode. Platinum coated on niobium showed the lowest 
yield with only 1% of 285a formed although with 37% ee (entry 10). Surprisingly, when 
glassy carbon was used the product was formed in only 39% HPLC yield but with 
65% ee of “memorised chirality” (entry 11). Other carbon-based electrodes such as 
 
b.  The reactions in batch shown in Table 4.1 were performed by Rossana Cicala. 
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Panasonic® Carbon, carbon on PTFE or boron doped diamond (BDD) electrodes did 
not show much improvements in terms of yields and stereoselectivities (entries 12–14).  
Table 4.2: Pilot experiments for the asymmetric non-Kolbe oxidation of (S)-284a to 285a in a flow 
microreactor using online 2D-HPLC analysis. 
 
Entry Anode Cathode Flow-rate (mL•min−1) 
Charge 
(F) 
285a 
(%)a 
285a  
ee (%)b 
1 Pt Pt 0.1 2 7 32 
2 Pt Pt 0.05 2 0 - 
3 Pt Pt 0.15 2 12 32 
4c Pt Pt 0.15 2 5 43 
5 graphite Pt 0.1 2 51 31 
6d graphite Pt 0.1 2 12 27 
7 graphite Pt 0.05 2 10 30 
8 graphite Pt 0.2 2 67 30 
9 graphite Pt 0.1 4 96 30 
10 Pt on Nb Pt 0.1 2 1 37 
11 glassy C Pt 0.1 2 39 65 
12 Panasonic® Pt 0.1 2 47 19 
13 C on PTFE Pt 0.1 2 5 36 
14 BDD Pt 0.1 2 8 37 
15e Pt graphite 0.2 2 - - 
16 Pt Pt on Ti 0.2 4 6 41 
17 Pt Pt on Nb 0.2 4 3 45 
General Procedure: Reactions performed using different electrodes, FEP spacer 
0.5mm thickness; reactor volume: 600 µL, working area: 12 cm2, with no additional 
supporting electrolyte or base; aHPLC yield (1D) with α,α,α-trifluorotoluene as internal 
standard; bDetermined by chiral HPLC (2D); cReaction performed at −10 °C; 
dReaction performed on a 6.2 mM solution of (S)-284a; eNo reaction observed. 
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At last, different electrodes materials were screened at the cathode using platinum as 
the anode (entries 15–17). Although 285a was formed with more than 40% ee, the 
yields were very low even when the reactions were performed at 0.2 mL•min−1 and with 
4 F. Hence, the platinum electrode was chosen as the cathode for the rest of the studies 
whereas the anode material was included in the design as one of the factors.  
After this preliminary screening, the following two-level fractional factorial design 
(FFD 25–1; see Appendix A for glossary) was designed with four numeric factors 
(temperature, charge, flow-rate and concentration of (S)-284a) and one categoric factor 
(anode material). Among all the screened anodes, graphite was chosen for the better 
yields, while the glassy carbon was selected because despite the lower yields it was 
found to generate 285a with the highest memory of chirality giving the highest ee. The 
two responses (yield and ee%) were measured using online 2D-HPLC analysis. In 
particular, the yield was measured in the first dimension on an achiral stationary phase, 
while the enantiomeric excess was measured in the second dimension on a chiral 
stationary phase. The whole design was composed of a total of 24 experiments, 
16 factorial points and 8 central points, and they were performed in a random order to 
minimise nuisance (see Appendix A). Once the acquired data were fitted into the model, 
the analysis of variance (ANOVA) was carried out next. The models were found to be 
very complex, with numerous significant terms and some anomalies in the diagnostic 
plots. From one of the influential plots (Cook’s distance, Figure 4.7), two factorial points 
(Table 4.3, entries 1 and 3) with very low yields and enantioselectivities were found to 
be outliners (see Appendix A), increasing the degree of complexity. 
 
Figure 4.7: Cook’s distance plot showing outliners. The different yields are represented by a scale 
of colours from blue (= low yields) to red (= high yields). 
entry 1 and 3 
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After several repeats of the two factorial points and a careful evaluation, it was decided 
to not include these two experiments (Table 4.3, entries 1 and 3) in the analysis, 
considering they were leading into a less interesting region of the chemical space (low 
yield and low enantioselectivity).  
Table 4.3: Matrix for the FFD 25−1 with results. Factor generator for E = A*B*C*D. 
 
 Factors Responses 
Std Run 
order 
A: (S)-284a 
(mM) B: Anode 
C: Flow rate 
(mL•min−1) 
D: Charge 
(F) 
E: T 
(°C) 
Yield 
(%)a 
ee 
(%)b 
1 3 6.25 graphite 0.1 2 20 10 31 
2 17 12.5 graphite 0.1 2 –10 76 24 
3 6 6.25 glassy C 0.1 2 –10 16 31 
4 24 12.5 glassy C 0.1 2 20 49 50 
5 13 6.25 graphite 0.2 2 –10 64 25 
6 11 12.5 graphite 0.2 2 20 67 29 
7 20 6.25 glassy C 0.2 2 20 44 48 
8 9 12.5 glassy C 0.2 2 –10 60 70 
9 10 6.25 graphite 0.1 4 –10 98 23 
10 4 12.5 graphite 0.1 4 20 99 27 
11 16 6.25 glassy C 0.1 4 20 83 25 
12 2 12.5 glassy C 0.1 4 –10 85 64 
13 23 6.25 graphite 0.2 4 20 100 28 
14 5 12.5 graphite 0.2 4 –10 100 25 
15 19 6.25 glassy C 0.2 4 –10 90 60 
16 1 12.5 glassy C 0.2 4 20 85 60 
17 14 9.37 graphite 0.15 3 5 87 22 
18 15 9.37 glassy C 0.15 3 5 81 57 
19 21 9.37 graphite 0.15 3 5 79 20 
20 22 9.37 glassy C 0.15 3 5 74 55 
21 12 9.37 graphite 0.15 3 5 83 25 
22 8 9.37 glassy C 0.15 3 5 82 58 
23 18 9.37 graphite 0.15 3 5 78 25 
24 7 9.37 glassy C 0.15 3 5 80 54 
25 1 6.25 graphite 0.1 2 20 11 28 
26 3 6.25 glassy C 0.1 2 –10 17 32 
27 3 6.25 glassy C 0.1 2 –10 15 30 
28 3 6.25 glassy C 0.1 2 –10 20 34 
General Procedure: Reactions were performed according to Table 4.3; aHPLC yield (1D) with 
α,α,α-trifluorotoluene as internal standard; bDetermined by chiral HPLC (2D); Light blue = these 
experiments were not included in the ANOVA. 
Although removing two factorial points may compromise the spot-prediction ability of the 
model, it was possible to simplify the model and have scientifically meaningful results 
(Figure 4.8). From the pareto charts (see Appendix A) it emerged that the most 
significant parameter for the yield of the electrochemical oxidation was the charge (D; 
Figure 4.8a). Although a charge of 2 F should be sufficient for two consecutive single 
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electron-transfer reactions, the desired methoxylated amide 285a was obtained in good 
to quantitative yields (>80%) when a charge of 4 F was applied. Better yields were 
observed when graphite was used instead of glassy carbon as the anode, which was 
also suggested by the ANOVA, identifying a minor effect of the type of anode (B) on the 
yield (Figure 4.8a). 
 
Figure 4.8: Pareto charts showing main effects for the responses a) yield % and b) ee%. 
These effects can also be visualised in the 3D-surface plots for the first response (yield) 
with the concentration of (S)-284a and the charge as variables, and the flow rate as well 
as the temperature fixed (Figure 4.9). First of all, both 3D-surfaces for the yield present 
sharp slopes which indicates a yield improvement when the number of electrons was 
increased from 2 F to 4 F. Secondly, when the glassy carbon was selected as the anode, 
the whole surface shifted toward lower yields, highlighting the effect of the anode material 
on the N,O-acetal formation. 
 
Figure 4.9: 3D-surface plots of the yield of 285a when a) graphite or b) glassy carbon was used 
in the non-Kolbe oxidation at 23 °C and 0.2 mL•min−1. 
a) b) 
a) b) 
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On the other hand, the most critical factor for the second response (enantioselectivity) 
was the type of material used as anode. In particular, when the oxidation of (S)-284a 
was performed using glassy carbon at 0.2 mL•min−1, 285a was afforded in moderate 
(48% ee) to good enantioselectivity (70% ee), whereas graphite showed only moderate 
selectivity (up to 31% ee). Although the relation between anode material and memory of 
chirality is still unclear, this result is in agreement with previous studies in which an 
interaction between the carbenium ion and the electrode surface was suspected.22a 
On the other hand, the temperature itself (E) was not found to be significant for the 
memory of chirality of this transformation, in contrast with what was observed for the 
electrolysis in batch.22 A moderate two-factor interaction (2FI) between type of anode 
and temperature (BE) was observed. Figure 4.10 shows the 3D-surface plots for the 
second response (% ee) with temperature and flow-rate as variable and charge and the 
concentration of (S)-284a as fixed values. When graphite is selected, the surface slope 
remains relatively flat as the temperature decreases (Figure 4.10a), whereas by selecting 
the glassy carbon as anode, the surface shifts to generally better ee% and the memory 
of chirality increases as the temperature decreases (Figure 4.10b). Hence, the 
temperature effect changes depending on the anodic electrode. 
 
Figure 4.10: 3D-surface plots of the ee in % of 285a when a) graphite or b) glassy carbon was 
used in the non-Kolbe oxidation performed with 12.5 mM of (S)-284a and 4 F. 
Although the spot-prediction ability of these models had been compromised by ignoring 
two factorial points, the simplified model was still good enough to provide a set of optimal 
conditions, guiding towards the “sweet spot” (Table 4.4). Glassy carbon was chosen as 
optimal anode in order to have the highest memory of chirality, and the reactions were 
performed on a 12.5 mM solution of (S)-284a in methanol pumped at 0.2 mL•mol−1. 
When a charge of 2 F was used at room temperature or at −10 °C, the N,O-acetal 285a 
was formed in 55% and 60% yield and with 64% and 70% of enantiomeric excess, 
respectively (entries 1 and 2). The yields were increased up to 73% and 77% by using 
a) b) 
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3 F and 4 F, respectively, in good stereoselectivity (>60% ee; entries 3–4). Furthermore, 
the desired product 285a was formed in 81% HPLC yield and with 66% ee when (S)-284a 
was oxidised at −10 °C (entry 5). 
Table 4.4: Optimised conditions for the asymmetric non-Kolbe oxidation of (S)-284a. 
 
Entry Charge (F) Temperature (°C) 285a (%)a 285a ee%b 
1 2 23 55 64 
2 2 −10 60 70 
3 3 23 73 62 
4 4 23 77 60 
5 4 −10 81 66 
General Procedure: Reactions were performed using a glassy carbon anode and a Pt cathode, 
a FEP spacer (0.5 mm thickness; reactor volume: 600 µL; working area: 12 cm2) with no 
additional supporting electrolyte or base; aHPLC yield (1D) with α,α,α-trifluorotoluene as internal 
standard; bDetermined by chiral HPLC (2D). 
With these results in hand other anode materials were screened under the optimised 
conditions at different temperatures (Table 4.5). 
Table 4.5: Further screening of the anode influence on the anodic oxidation of (S)-284a to 
N,O-acetal 285a. 
Entry Anode Temperature (°C) 285a (%)a 285a ee%b 
1 Pt 23 4 49 
2 Pt 0 11 53 
3 Pt −10 13 51 
4 Pt on Nb 23 8 48 
5 Pt on Nb −10 14 48 
6 Pt on Ti 23 8 51 
7 Pt on Ti 0 9 52 
8 Pt on Ti −10 12 54 
9 BDD 23 51 57 
10 BDD 0 58 58 
11 BDD −10 54 60 
General Procedure: Reactions were performed on a 13 mM solution of (S)-284a with 4 F of 
charge, different electrodes as anode and Pt cathode electrodes, a FEP spacer (0.5mm thickness; 
reactor volume: 600 µL; working area: 12 cm2) with no additional supporting electrolyte or base; 
aHPLC yield (1D) with α,α,α-trifluorotoluene as internal standard; bDetermined by chiral HPLC (2D); 
BDD = boron doped diamond. 
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The platinum and platinum coated electrodes showed very poor yields even using higher 
charge, however the memory of chirality was improved to 48–54% ee compared to the 
~30% ee observed in the initial pilot study (see Table 4.2). Moreover, except the platinum 
coated niobium, which was not affected by the temperature (Table 4.5, entries 4–5), a 
small improvement in ee% was observed for the platinum and the platinum coated 
titanium electrode. However, among all anodes, BDD was found to almost as efficient as 
the glassy carbon (entries 9–11). In fact, BDD formed the desired N,O-acetal 285a in 
good yields (up to 58%) and in 57%, 58% and 60% ee for reactions performed at 20 °C, 
0 °C and −10 °C, respectively. 
In conclusion, the final screening performed in a flow microreactor confirmed that, the 
memory of chirality was mainly influenced by the anodic material. However, it seemed to 
be less influenced by lower temperatures than what was observed in the batch process. 
For optimal memory of chirality results, the glassy carbon electrode was chosen as 
anodic material for future studies over the BDD because the latter was found to promote 
side reactions. 
4.2.3 Substrate Scope 
With the aim to study the substrate scope and to calculate the isolated yields, different 
N-protected amino acids (S)-284a–f (see Scheme 4.16) were subjected to the 
electrochemical oxidation using the optimal conditions suggested by the DoE. 
Firstly, the N-acyl amino acids were oxidised using graphite as optimal anodic material 
for the yield, with 2 F or 4 F of charge at room temperature (Scheme 4.20). The solutions 
of starting material were pumped at 0.2 mL•min−1 and the microreactor was kept at 23 °C. 
The stream were equilibrated for ~20 minutes before being collected for 1.5 hours, then 
the N,O-acetals 285a–h were isolated and the ee% was measured offline on the pure 
products. The model N,O-acetal 285a and the 2-methoxyphenyl derivative 285b were 
isolated in 56% and 62% yield, when 2 F were applied, and in 90% and 87% yield, when 
4 F were used instead. When the electrolysis of (S)-284a was performed using 2 F in 
ethanol or propan-2-ol instead of methanol, the desired products 285c and 285d were 
afforded in 53% and 40% yields, respectively. When the reactions were attempted with 
more electricity (>2 F), remarkably high voltages were observed, probably due to the 
lower conductivity of the solvents, and the reactions had to be stopped. This issue may 
be avoided by using supporting electrolytes or a base to help the conductivity of the 
electrons between the electrodes. On the other hand, the acyclic amino acid derivatives 
(S)-284c–f were fully consumed with 2 F of charge, and the desired products 285e–h 
were isolated in good yields (up to 73%). As expected, the graphite anode did not provide 
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great memory of chirality. In particular, the pyrrolidine derivatives 285a–d were afforded 
in moderate enantioselectivities (up to 26% ee), whilst less constrained derivatives 
285e–h were formed with poor or no selectivity. Interestingly, when the electrolysis was 
performed on the sterically less hindered L-alanine derivative 284c, the (S)-285e was 
found as the major isomer in 8% ee, in contrast with the observation for the other 
substrates and with what is reported in literature.22b,35 Nevertheless, the hypothesis of an 
inversion of configuration seemed possible as in agreement with what reported for 
substrates bearing less a bulky N-protecting group.22a Moreover, no enantioselectivity 
was observed for the isopropyl-substituted 285f, while the N,O-acetals 285g–h bearing 
bulkier alkyl chains were formed as (R)-isomers, which supports the hypothesis of a 
relation between bulkier substrates and retention of configuration. 
 
Scheme 4.20: Reactions were performed at 23 °C on a 13 mM scale of (S)-284a–f using a 
graphite anode and a Pt cathode, a FEP spacer (0.5mm thickness; reactor volume: 600 µL; 
working area: 12 cm2) with no additional supporting electrolyte or base; Isolated yields are shown; 
the absolute configuration for 285a was assigned according to literature,35 and for 285b–h were 
assigned in analogy to 285a. aNo starting material detected by 1H NMR.  
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The same library of compounds (S)-284a–f was then subjected to oxidation using the 
optimal conditions for the memory of chirality reported in Table 4.4, entry 2 
(Scheme 4.21). The solutions of starting material were pumped at 0.2 mL•min–1 and the 
microreactor was cooled to −10 °C. Again, the solutions were equilibrated for 
~20 minutes before being collected for 1.5 hours, then the N,O-acetals 285a–h were 
isolated and the ee% was measured offline on the pure products. 
 
Scheme 4.21: Reactions were performed at −10 °C on a 0.13 mmol (13 mM solution) of  
(S)-284a–f using a glassy carbon anode and a Pt cathode, a FEP spacer (0.5 mm thickness; 
reactor volume: 600 µL; working area: 12 cm2) with no additional supporting electrolyte or base; 
Isolated yields are shown; the absolute configuration for 285a was assigned according to 
literature,35 and for 285b–h were assigned in analogy with 285a. aReaction performed on a 
1.25 mmol scale (50 mM solution); bReaction performed at 0.1 mL•min−1; cReactions performed 
on recrystalised starting materials at room temperature; (*) Reactions in which the side product 
294 was formed. 
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Generally, the products 285a–h were isolated in poor to good yields and with poor to 
good enantioselectivity. The model substrate 285a, was isolated in 50% yield with 
60% ee. When a more electron-rich biphenyl group was used, the corresponding 
N,O-acetal 285b was isolated only in 28% yield with 50% ee. When the electrolysis of 
(S)-284a was performed in ethanol or propan-2-ol instead of methanol, the desired 
products 285c and 285d were isolated in 57% and 42% yield with 61% ee and 67% ee, 
respectively. When the reaction was performed in propan-2-ol the flow rate was reduced 
to 0.1 mL•min−1 to avoid an unsafe high voltage, since the conductivity was lower in this 
solvent. A moderate memory of chirality was also observed in non-constrained acyclic 
amino acids (S)-284c–f, which increased with the steric demand of the side chain with 
285e–h formed in 7–14% ee. Furthermore, when the oxidation was performed on 
L-alanine and L-leucine derivatives (S)-284c and (S)-284e, the products 285e and 285g 
were isolated only in 22% and 13% yield, respectively, along with the side product 294 
isolated in 17% and 30% yield, respectively. This was not the case for L-valine and L-
phenylalanine substrates (S)-284d and (S)-284f, which formed the tricyclic compound 
294 in less than 10% yield, and the corresponding N,O-acetal 285f and 285h in 43% and 
52% yield, respectively. The formation of benzocoumarin derivatives such as 294 was 
recently reported as product of the electrochemical cyclisation of 2-arylbenzoic acids 
such as 287a (Scheme 4.22).36 
 
Scheme 4.22: Electrochemical C–H lactonization of aromatic carboxylic acids 287a.36 
Therefore, a second recrystallisation of (S)-284c and (S)-284e was performed to remove 
any traces of 2-arylbenzoic acid 287a. The recrystallised (S)-284c and (S)-284e were 
then subjected to electrolysis with glassy carbon at room temperature affording 285e and 
285g in 80% and 62% yield, respectively. In this case, when the electrolysis on (S)-284c 
was performed with glassy carbon as the anode, the (R)-285e enantiomer was formed 
as the major enantiomer with 7–10% of enantiomeric excess, instead of the (S)-isomer 
which was formed as the major product with a graphite anode. For a further scale-up, 
higher concentrated solutions (0.05 M, 1.25 mmol scale) were used and it was possible 
to reproduce the same results without a remarkable loss in reactivity or enantioselectivity.  
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Finally, to prove the importance of the biphenyl substituent on the memory of chirality, 
the benzoyl L-proline 259, prepared from benzoyl chloride and L-proline, was subjected 
to the non-Kolbe oxidation in the flow microreactor. As expected, 260 was obtained as 
racemate regardless the type of anode used. (Scheme 4.23). 
 
Scheme 4.23: Flow non-Kolbe oxidation of (S)-259. 
In summary, the DoE conclusions were confirmed also in the substrate scope with the 
graphite anodes affording the desired products in better yields and the glassy carbon 
anodes providing generally better ee. Moreover, some moderate memory of chirality was 
observed also in unstrained substrates, albeit still poor (up to 14% ee). Additionally, the 
presence of the biphenyl N-protecting group was confirmed to be fundamental for the 
memory of chirality in the flow process, as already reported for the batch electrolysis.22a 
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4.3 Conclusions and Outlook 
To conclude, the asymmetric electrochemical non-Kolbe oxidation of N-acyl L-proline 
was successfully translated into a flow electrochemical microreactor coupled to an online 
2D-HPLC and the reaction was optimised using a DoE-approach. The short reaction 
times combined with a fast analysis time made it possible to rapidly screen charges as 
well as electrodes, flow rates, concentrations and temperatures. The graphite anodes 
were found to provide good to quantitative yields, while the best memory of chirality 
(70% ee) was achieved using glassy carbon anodes. The optimal conditions were then 
applied to the synthesis of a series of cyclic and acyclic N,O-acetals in moderate to good 
yields and enantioselectivities. These results proved the concept that the combination of 
a flow system coupled with an online 2D-HPLC and DoE offers an efficient method to 
intensively screen several parameters and quickly optimise reactions. Hence, the 
presented methodology might find useful applications in the optimisation of other 
asymmetric transformations. Future work is focussed on the complete automation of 
such systems with all units (reactor and HPLC) controlled by a computer.  
The absolute configuration of the final products has been assigned according to 
literature, however the crystallisation of one of the final N,O-acetals could be included as 
part of the future work as further evidence. 
Moreover, all the reactions were performed without any supporting electrolytes nor base. 
Although most of the Kolbe or non-Kolbe reactions need a base to form the active 
carboxylate species, in the flow microreactor the methoxide formed at the cathode is 
suspected to be enough to deprotonate the starting material and initiate the reaction. 
Further studies should be included in the future work to fully understand the mechanism 
behind this unusual base-free non-Kolbe electrolysis. Furthermore, it might be interesting 
to study the electrolysis in the presence of supporting electrolytes, which can be used to 
improve yields especially in less conductive solvents. 
Future work should also investigate the role of the electrode type in the memory of 
chirality, which remains still unclear. For example, electrode-surface modifications might 
give some insights on the electrode/acyliminium ion interaction or on how to further 
improve the memory of chirality. 
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CHAPTER 5: Experimental Part 
5.1 General Methods 
The reactions were performed using standard laboratory equipment. In all the reactions, 
standard reagent grade solvents and chemicals from Sigma Aldrich, Alfa Aesar, Acros 
Organic, and FluoroChem were used without further purification, unless otherwise 
specified. All air sensitive reactions were carried out under a nitrogen atmosphere using 
oven dried glassware. All the batch reactions were stirred using a stirrer plate and a 
magnetic stirrer bar and heating if necessary, over a hotplate with a temperature probe 
control and adapted heating block. Lower temperatures were achieved using ice/water 
bath (0 °C), ice/NaCl (−20 °C) and dry ice/acetone bath (−78 °C) or using a chiller to 
perform overnight reactions (0 to −20 °C). All reactions and manipulations of boranes 
were carried out under an atmosphere of dry, O2-free nitrogen using standard double-
manifold techniques with a rotary oil pump. A N2-filled glove box (MBraun) was used to 
store the borane starting materials, setup reactions and sample preparation for analysis. 
Dry ether, acetonitrile, n-hexane, toluene and THF were collected from a solvent 
purification system (SPS) from the company MBRAUN (MB SPS-800). Dry CH2Cl2 was 
distilled over calcium hydride under nitrogen atmosphere. Büchi rotavapors were used 
for solvent evaporations (reduced pressure up to 8 mbar) and a high vacuum apparatus 
was used to further dry the products.  
Thin-layer chromatography (TLC) and prep-TLC were performed on pre-coated 
aluminium sheets of Merck silica gel 60 F254 (0.20 mm) and visualised by UV radiation 
(254 nm). Manual column chromatography was performed using silica gel 60 (Merck, 
230-400 mesh) under increased pressure. Automated column chromatography was 
performed on a Biotage® Isolera Four using Biotage® cartridges SNAP Ultra 10 g, SNAP 
Ultra 25 g, SNAP Ultra 50 g, SNAP Ultra 100 g. The solvents used for the purification 
are indicated in the text and were purchased from Fischer Scientific as laboratory grade. 
The HPLC measurements were carried out on a Shimadzu apparatus or on an Agilent 
1290 2D-LC Solution. The different modules of the Shimadzu apparatus: SIL-10ADVP 
(autoinjector), LC-10ATVP (liquid chromatograph), FCV-10ALVP (pump), DGU-14A 
(degasser), CTO-10ASVP (column oven), SCL-10AVP (system controller) and SPD-
M10A (diode array detector). The different modules of the Agilent system: G7129A (1290 
vial sampler), G1312A (1D binary pump), G1322A (degasser), G7120A (1290 high speed 
2D binary pump), G1316A (1260 column oven), G7115A (1260 diode array detector), 
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G7114A (1260 variable wavelength detector) and G1170A (1290 valve drive). For the 
online analysis. For the online analysis, a Cheminert® C2-1006D switching valve was 
used. The solvents used were n-hexane, ethanol, methanol and 2-propanol and were 
bought from Fischer scientific as HPLC grade. The column used for the achiral 
separation was a Varian Si (250 × 4.6 mm, 5 µm pore size). The columns used for the 
chiral separation were Chiralcel® OD-H (250 × 4.6 mm, 5 μm pore size), Chiralcel® OB-
H (250 × 4.6 mm, 5 μm pore size) and YMC Chiral Amylose-C (250 × 4.6 mm, 5 μm pore 
size) depending on the substrate.  
1H, 13C, and 19F NMR spectra were recorded at 298 K on Bruker DPX 300, 400 or 
500 MHz apparatus and referenced to the residual proton solvent peak (H: CDCl3, δ = 
7.26 ppm; CD3CN, δ = 1.94 ppm) and residual 13C signal (CDCl3, δ = 77.2 ppm).13C and 
19F NMR spectra were measured as 1H-decoupled unless otherwise stated. Chemical 
shifts δ were reported in ppm downfield of Si(CH3)4 (1H, 13C), CFCl3 (19F), multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, qi = quintet, sex = sextet, hep = septet, dd = 
doublet of doublets, m = multiplet, br. s = broad singulet; and coupling constants (J) in 
Hertz. Yields are given as isolated yields unless noted otherwise. 
Mass spectrometric measurements were performed by the EPSRC Mass Spectrometry 
Facility in Swansea University on a Waters Xevo G2-S and on a Thermo Scientific LTQ 
Orbitrap XL machine S3 or by R. Jenkins, R. Hick, T. Williams and S. Waller at Cardiff 
University on a Water LCR Premier XE-TOF for high resolution mass spectroscopy 
(HRMS). Ions were generated by the Atmospheric Pressure Ionisation Techniques 
(APCI), Atmospheric Solids Analysis Probe (ASAP), Electrospray (ES), Electron 
Ionisation (EI) or Nanospray Ionisation (NSI). The molecular ion peaks values quoted for 
either molecular ion (M+), molecular ion plus or minus hydrogen (M+H+, M−H−), molecular 
ion minus hydride (M−H+), molecular ion plus ammonium ion (M+NH4+) or molecular ion 
plus sodium (M+Na+). 
IR spectra were recorded on a Shimadzu FTIR Affinity-1S apparatus. Wavenumbers are 
quoted in cm−1. All compounds were measured neat directly on the crystal of the IR 
machine. Melting points were measured using a Gallenkamp variable heater with 
samples in open capillary tubes.  
Optical rotations were measured with a SCHMIDT and HAENSCH UniPol polarimeter at 
20 °C in cuvette of 50–100 mm length with a sodium light (589.30 nm). HPLC grade 
chloroform, dichloromethane or methanol were used to prepare the solution and the 
concentration is indicated in the experimental section. 
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All the flow reactions were performed using a Chemyx Fusion 200 syringe pump and 
FEP tubing (OD: 1/16’’, ID: 0.2–1 mm). The electrochemical reactions were carried out 
in a galvanostatic mode using a Vapourtec Ion Electrochemical flow reactor1 powered 
up by an Aim-tti bench power supply (300 Watt). The cyclic voltammogram studies were 
performed using an Orygalys OGF500 Potentiostat / Galvanostat with OGFPWR power 
supply.  
X-Ray crystallographic studies were carried out at the X-Ray Crystallography Service at 
Cardiff University or by Darren M. C. Ould. The structures were solved by direct methods 
and refined using the SHELXTL software package. In general, all non-hydrogen atoms 
were refined anisotropically. Hydrogen atoms were assigned at idealised locations. 
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5.2 Experimental Data for Chapter 2:  
Synthesis of novel trans-Dihydroindoles 
The Rh(II) catalyst were purchased from Strem Chemicals. The diazo-transfer reagents 
p-ABSA (18e) was purchased by TCI and the p-NBSA (18f) was synthetised according 
to the literature procedure.2  
5.2.1 Synthesis of Starting Materials 
General Procedure 1: 
 
2-Nitrophenylacetic acid 151 (10.0 g, 55 mmol) was dissolved in methanol (100 mL) and 
the solution was cooled down to 0 °C before addition of acetyl chloride (9.8 mL, 
138 mmol). The reaction was stirred overnight at room temperature and checked by TLC 
(n-hexane/ethyl acetate 4:1). The solvent was evaporated in vacuo and the residual oil 
washed with an aqueous saturated solution of NaHCO3 (20 mL) and extracted with 
diethyl ether (3 × 25 mL). Subsequently, the combined organic fractions were washed 
with water (20 mL) and brine (20 mL), dried over MgSO4 and concentrated in vacuo to 
afford 155a-b as a solid or oil depending on the substrate. 
Methyl 2-(2-nitrophenyl) acetate 155a: 
 Performed according to the General Procedure 1 on a 55 mmol scale; 
155a (10.7 g, 55 mmol, 99%) was obtained as a pale-yellow oil that 
solidified at room temperature, m.p.: 36–40 °C. 
1H NMR (300 MHz, CDCl3): δ = 8.13 (dd, J = 8.1, 0.9 Hz, 1H, ArH), 7.62 (td, J = 7.5, 1.3 
Hz, 1H, ArH), 7.49 (td, J = 8.1, 1.4 Hz, 1H, ArH), 7.37 (dd, J = 7.6, 1.0 Hz, 1H, ArH), 4.04 
(s, 2H, CH2), 3.72 (s, 3H, OCH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 170.4 (C=O), 148.7 
(ArC–N), 133.6 (ArC), 133.3 (ArC), 129.7 (ArC), 128.6 (ArC), 125.3 (ArC), 52.3 (OCH3), 
39.6 (CH2) ppm. Spectroscopic data are in agreement with literature.3 
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Isopropyl 2-(2-nitrophenyl) acetate 155b: 
Performed according to the General Procedure 1 on a 13.8 mmol scale; 
155b (2.7 g, 12.3 mmol, 88%) was obtained as a pale orange oil.  
1H NMR (300 MHz, CDCl3): δ = 7.99 (d, J = 8.1 Hz, 1H, ArH), 7.47 (td, 
J = 7.4, 1.0 Hz, 1H, ArH), 7.35 (t, J = 7.7 Hz, 1H, ArH), 7.23 (d, J = 7.4 Hz, 1H, ArH), 
4.91 (hep, J = 6.2 Hz, 1H, OCH(CH3)2), 3.87 (s, 2H, CH2), 1.12 (d, J = 6.2 Hz, 6H, 
OCH(CH3)2) ppm; 13C NMR (75 MHz, CDCl3): δ = 169.5 (C=O), 148.8 (ArC–N),133.5 
(ArC), 133.3 (ArC), 130.0 (ArC–CH2), 128.5 (ArC), 125.2 (ArC), 68.9 (OCH), 40.2 (CH2), 
21.7 (2 × CH3) ppm; IR (neat) ν = 3726w, 3628w, 2981m,2360s, 2341s, 728s, 1614m, 
1579m, 1523s, 1465m, 1454m, 1344s, 1217s, 1176m, 1105s, 956m,840m, 789m, 759m, 
736m, 715s cm−1; HRMS (ASAP): exact mass calculated for C11H14NO4 
[M+H]+:224.0923, found: 224.0921. 
General Procedure 2: 
 
A two-neck flask was twice evacuated and filled with N2; 10% Pd/C (233 mg) was added 
to the flask and the residue was washed with a small amount of dichloromethane. 
Methanol (20 mL) was added carefully before addition of 2-nitroaryl ester 155a–b (4.0 g, 
21 mmol) dissolved in methanol (2 mL). Subsequently, the flask was evacuated and filled 
with N2 twice, evacuated again and filled with H2 (1 atm). The reaction was stirred at 
room temperature for 12 hours and monitored by TLC (n-hexane/ethyl acetate 4:1). The 
mixture was filtered through Celite and the solvent was evaporated in vacuo to afford 
156a–b as oils. 
Methyl 2-(2-aminophenyl) acetate 156a: 
Performed according to the General Procedure 2 on a 21 mmol scale of 
155a; 156a (3.3 g, 21 mmol, 99%) was obtained as a red oil.  
1H NMR (300 MHz, CDCl3): δ = 7.26–7.06 (m, 2H, ArH), 6.80–6.68 (m, 
2H, ArH), 4.07 (br. s, 2H, NH2), 3.71 (s, 3H, OCH3), 3.59 (s, 2H, CH2) ppm; 13C NMR 
(75 MHz, CDCl3): δ = 172.4 (C=O), 145.6 (ArC–N), 131.3 (ArC), 128.7 (ArC), 119.6 
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(ArC–CH2), 119.1 (ArC), 116.7 (ArC), 52.3 (OCH3), 38.4 (CH2) ppm. Spectroscopic data 
are in agreement with literature.3 
Isopropyl 2-(2-aminophenyl) acetate 156b: 
Performed according to the General Procedure 2 on a 8.9 mmol scale of 
155b; 156b (1.21 g, 6.26 mmol, 70%) was obtained as an orange oil.  
1H NMR (400 MHz, CDCl3): δ = 7.12–7.08 (m, 2H, ArH), 6.77–6.70 (m, 
2H, ArH), 5.00 (hep, J = 6.3 Hz, 1H, OCH), 4.10 (s, 2H, NH2), 3.54 (s, 
2H, CH2), 1.24 (d, J = 6.3 Hz, 6H, 2 × CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 171.5 
(C=O), 145.6 (ArC–N), 131.1 (ArC), 128.5 (ArC), 119.8 (ArC–CH2), 118.9 (ArC), 116.5 
(ArC), 68.5 (OCH), 38.9 (CH2), 21.7 (2 × CH3) ppm; IR (neat) ν = 3736w, 3446w, 3365w, 
2980w, 2358s, 2341s, 1712s, 1627m, 1585w, 1496m, 1458m, 1373w, 1357w, 1159m, 
1103s, 964m, 908m, 731s, 669m, 648m, 522m cm−1; HRMS (NSI): exact mass 
calculated for C11H16NO2 [M+H]+: 194.1173, found: 194.1176. 
2-(2-Nitrophenyl)ethan-1-ol 157: 
To a solution of 155a (200 mg, 1 mmol) in dry THF (5 mL), NaBH4 (79 
mg, 2.2 mmol) and AlCl3 (133 mg, 1 mmol) were added at 0 °C. After 2 
hours the reaction was quenched with 1mL of water then filtered over 
Celite. The product was extracted with Et2O (3 × 5 mL). The combined organic layers 
were washed with brine and dried over MgSO4 before being concentrated under reduced 
pressure. The crude was purified by column chromatography to afford 157 (28 mg, 0.17 
mmol, 17%) as a colourless oil. 
1H NMR (300 MHz, CDCl3): δ = 7.91 (d, J = 8.1 Hz, 1H, ArH), 7.63–7.48 (m, 1H, ArH), 
7.48–7.30 (m, 2H, ArH), 3.92 (td, J = 6.4, 1.2 Hz, 2H, CH2OH), 3.15 (t, J = 6.4 Hz, 2H, 
CH2), 2.05 (br, 1H, OH) ppm; 13C NMR (75 MHz, CDCl3): δ = 149.7 (ArC–N), 133.7 (ArC), 
133.0 (ArC), 132.8 (ArC), 127.6 (ArC), 124.8 (ArC), 62.7 (CH2OH), 36.1 (CH2) ppm. 
Spectroscopic data are in agreement with literature.4 
Indolin-2-one 158: 
To a suspension of Pd/C 10% (50 mg, 5 mol%) in dry menthol (500 μL), 
a solution of 155a (200 mg, 1 mmol) in dry methanol (2 mL) was added 
dropwise. The formic acid (500 μL, 5 mmol) was added and the 
suspension was stirred over night at room temperature. The solvent was evaporated, 
and the residue was washed with an aqueous saturated solution of NaHCO3 (5 mL), 
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water (5 mL) and extracted with dichloromethane (3 × 5 mL). The combined organic 
layers were washed with brine and dried over MgSO4 before being concentrated under 
reduced pressure. The crude was purified by column chromatography to afford 158 (92 
mg, 0.69 mmol, 69%) as a pale pink solid, m.p.: 128–130 °C. 
1H NMR (300 MHz, CDCl3) δ = 9.12 (s, 1H, NH), 7.22 (dd, J = 14.4, 6.9 Hz, 2H, ArH), 
7.10–6.97 (m, 1H, ArH), 6.90 (d, J = 7.7 Hz, 1H, ArH), 3.55 (s, 2H,CH2) ppm; 13C NMR 
(75 MHz, CDCl3) δ = 178.7 (C=O), 142.8 (ArC–N), 128.0 (ArC), 125.4 (ArC–CH2), 124.5 
(ArC), 122.3 (ArC), 110.0 (ArC), 36.4 (CH2) ppm. Spectroscopic data are in agreement 
with literature.5 
General Procedure 3: 
 
A solution of 156a–b (3 g, 18 mmol) in pyridine (20 mL) was cooled down to 0 °C. 
p-Toluenesulfonyl chloride (4.16 g, 22 mmol) was added dropwise. The reaction was 
stirred at room temperature for 24 hours and monitored via TLC (n-hexane/ethyl acetate 
4:1). An aqueous solution of HCl (1 M, 25 mL) was added and the reaction mixture was 
extracted with ethyl acetate (2 × 20 mL), the organic layer was washed with further 
aqueous solution of HCl (1 M, 20 mL), water (2 × 20 mL), brine and dried over MgSO4. 
Subsequent evaporation of the solvent in vacuo and liquid column chromatography 
furnished the desired products 159a–b as solids. 
Methyl 2-(2-((4-methylphenyl)sulfonamido)phenyl) acetate 159a: 
Performed according to the General Procedure 3 on a 18 mmol scale 
of 156a; 159a (5.6 g, 17 mmol, 96%) was obtained as a pale orange 
solid, m.p.: 82–84 °C.  
1H NMR (300 MHz, CDCl3): δ = 8.04 (br. s, 1H, NH), 7.60 (d, J = 
8.3 Hz, 2H ArH), 7.29 (d, J = 7.9 Hz, 1H, ArH), 7.23–7.12 (m, 3H, 
ArH), 7.12–7.06 (m, 2H, ArH), 3.63 (s, 3H, OCH3), 3.33 (s, 2H, CH2), 2.34 (s, 3H, CH3) 
ppm; 13C NMR (75 MHz, CDCl3): δ = 172.6 (C=O), 143.7 (ArC–N), 137.2 (ArC), 135.4 
(ArC), 131.1 (ArC), 129.7 (2 × ArC), 128.6 (ArC), 128.5 (ArC), 127.0 (2 × ArC), 126.5 
(ArC), 125.9 (ArC), 52.5 (OCH3), 37.7 (CH2), 21.5 (CH3) ppm; IR (neat) ν = 3226m, 
1708s, 1597m, 1587m, 1496m, 1435m, 1417m, 1336s, 1278s, 1238w, 1157s, 1089s, 
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1010s, 947m, 920m, 819m, 742m, 661s cm−1; HRMS (NSI): Exact mass calculated for 
C16H21N2O4S [M+NH4]+: 320.0951, found: 320.0955. 
Isopropyl 2-(2-((4-methylphenyl)sulfonamido)phenyl) acetate 159b: 
Performed according to General Procedure 3 on a 6.2 mmol scale of 
156b; 159b (2.1 g, 6.0 mmol, 98%) was obtained as a pale-yellow 
solid, m.p.: 74–78 °C.  
1H NMR (400 MHz, CDCl3): δ = 8.25 (br. s, 1H, NH), 7.68 (d, J = 
8.3 Hz, 2H, ArH), 7.42 (d, J = 8.0 Hz, 1H, ArH), 7.35–7.20 (m, 3H, 
ArH), 7.13 (d, J = 4.1 Hz, 2H, ArH), 5.00 (hep, J = 6.2 Hz, 1H, OCH), 3.26 (s, 2H, CH3), 
2.42 (s, 3H, CH3), 1.25 (d, J = 6.3 Hz, 6H, 2 × CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 
172.0 (C=O), 143.7 (ArC–N), 137.7 (ArC), 135.8 (ArC), 131.2 (ArC), 129.8 (2 × ArC), 
128.8 (ArC), 128.0 (ArC), 127.0 (2 × ArC), 126.3 (ArC), 125.5 (ArC), 69.8 (OCH), 38.9 
(CH2), 21.8 (2 × CH3), 21.7 (CH3) ppm; IR (neat): ν = 3259m, 2980w, 1728m, 1707m, 
1597w, 1585, 1492m, 1332s, 1290m, 1159s, 1089s, 956m, 898m, 812m, 659s, 547s, 
528s cm−1; HRMS (NSI): Exact mass calculated for C18H25N2O4S [M+NH4]+: 365.1530, 
found: 365.1532. 
General Procedure 4: 
 
A solution of starting material 159a–b (2.6 g, 8.1 mmol) was dissolved in acetonitrile 
(25 mL). After the addition of triethylamine (3.2 mL, 24.3 mmol), the reaction mixture was 
cooled down to 0 °C. Next, aryl halide 161 was added (24.3 mmol) dropwise and the 
reaction mixture was stirred at room temperature for around 48–72 hours and monitored 
via TLC (n-hexane/ethyl acetate 4:1). Subsequently, the solvent was evaporated 
in vacuo and the residual oil was dissolved in CH2Cl2 (15 mL), washed with water (20 mL) 
and brine (20 mL). After drying over MgSO4, the mixture was concentrated in vacuo and 
purified via column chromatography to afford 152a–l as solids. 
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Methyl 2-(2-((N-benzyl-4-methylphenyl)sulfonamido)phenyl) acetate 152a: 
Performed according to General Procedure 4 on a 2.0 mmol scale 
of 159a with bromo benzene; 152a (655 mg, 1.6 mmol, 82%) was 
obtained as a pale, pink solid, m.p.: 78–81 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.45 (d, J = 8.3 Hz, 2H, ArH), 7.21–
6.91 (m, 10H, ArH), 6.48 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 4.92 (d, 
J = 13.6 Hz, 1H, 1 × NCH2), 4.12 (d, J = 13.6 Hz, 1H, 1 × NCH2), 3.50–3.38 (m, 5H, 
CH2CO2Me + OCH3), 2.30 (s, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 171.4 (C=O), 
143.7 (ArC–N), 137.6 (ArC), 136.0 (ArC), 135.4 (ArC), 135.1 (ArC), 131.3 (ArC), 129.5 
(2 × ArC), 129.3 (2 × ArC), 128.3 (ArC), 128.2 (2 × ArC), 128.0 (ArC), 127.9 (2 × ArC), 
127.7 (ArC), 127.4 (ArC), 56.0 (NCH2), 51.6 (OCH3), 35.6 (CH2), 21.4 (CH3) ppm; IR 
(neat) ν = 3062w, 3032w, 2949w, 1722s, 1597m, 1492m, 1348s, 1263s, 1161s, 1091m, 
885m, 812s, 705s, 657s, 549s cm−1; HMRS (NSI): Exact mass calculated for C23H23NO4S 
[M+H]+: 410.1421; found: 410.1418. 
Isopropyl 2-(2-((N-benzyl-4-methylphenyl)sulfonamido)phenyl) acetate 152b: 
Performed according to General Procedure 4 on a 1.47 mmol 
scale of 159b with bromo benzene; 152b (398 mg, 0.91 mmol, 
62%) was obtained as a pale-yellow solid, m.p.: 88–90 °C.  
1H NMR (400 MHz, CDCl3): δ = 7.50 (d, J = 7.9 Hz, 2H, ArH), 7.26–
6.96 (m, 10H, ArH), 6.49 (d, J = 8.0 Hz, 1H, ArH), 4.93–4.81 (m, 
2H, 1 × NCH2 + COCH), 4.27 (d, J = 13.7 Hz, 1H, 1 × NCH2), 3.47 (d, J = 16.8 Hz, 1H, 
1 × CH2), 3.41 (d, J = 16.8 Hz, 1H, 1 × CH2), 2.38 (s, 3H, CH3), 1.13 (t, J = 6.2 Hz, 6H, 
2 × CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 170.9 (C=O), 143.7 (ArC–N), 137.7 (ArC), 
136.5 (ArC), 135.9 (ArC), 135.4 (ArC), 131.3 (ArC), 129.6 (2 × ArC), 129.5 (2 × ArC), 
128.6 (ArC), 128.5 (2 × ArC), 128.1 (2 × ArC), 128.0 (ArC), 127.3 (ArC), 68.1 
(OCH(CH3)2), 56.1 (NCH2), 36.4 (CH2), 21.9 (2 × CH3), 21.7 (CH3) ppm; IR (neat) ν = 
2984w, 1716s, 1597w, 1490m, 1456m, 1344s, 1261s, 1161s, 1105m, 1089m, 1045m, 
977m, 864m, 815m, 756s, 709s, 657s, 611s, 590s, 447w, 428w cm−1; HMRS (NSI): 
Exact mass calculated for C25H28NO4S [M+H]+: 438.1734; found: 438.1734. 
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Methyl 2-(2-((N-(4-methoxybenzyl)-4-methylphenyl)sulfonamido)phenyl) acetate 152c: 
Performed according to General Procedure 4 on a 0.63 mmol 
scale of 159a with 4-methoxybenzyl chloride; 152c (206 mg, 
0.47 mmol, 75%) was obtained as a pale-yellow solid, m.p.: 
108–110 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.64–7.54 (m, 2H, ArH), 7.35–
7.23 (m, 4H, ArH), 7.10 (td, J = 7.5, 1.8 Hz, 1H, ArH), 7.06–7.00 (m, 2H, ArH), 6.76–6.68 
(m, 2H, ArH), 6.59 (dd, J = 8.0, 1.2 Hz, 1H, ArH), 4.97 (d, J = 13.5 Hz, 1H, 1 × NCH2), 
4.23 (d, J = 13.5 Hz, 1H, 1 × NCH2), 3.75 (s, 3H, OCH3), 3.60 (s, 3H, OCH3), 3.55 (s, 2H, 
CH2), 2.47 (s, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 171.8 (C=O), 159.4  
(ArC–O), 143.7 (ArC–N), 137.8 (ArC), 136.4 (ArC), 136.0 (ArC), 131.5 (ArC), 130.8 (2 × 
ArC), 129.7 (2 × ArC), 128.5 (ArC), 128.4 (ArC), 128.2 (2 × ArC), 127.5 (ArC), 127.4 
(ArC), 113.9 (2 × ArC), 55.7, 55.3, 51.9, 35.7 (CH2), 21.5 ppm; IR (neat): ν = 2953w, 
2835w, 1737s, 1614m, 1587m, 1514s, 1436m, 1340s, 1271m, 1244s, 1157s, 1028s, 
873s, 694s, 653s, 574s cm−1; HRMS (NSI): Exact mass calculated for C24H29N2O5S 
[M+NH4]+: 457.1792, found: 457.1788. 
Methyl 2-(2-((4-methyl-N-(4-(trifluoromethyl)benzyl)phenyl)sulfonamido)phenyl) acetate 
152d: 
Performed according to General Procedure 4 on a 
0.63 mmol scale of 159a with 4-(trifluoromethyl)benzyl 
chloride; 152d (162 mg, 0.34 mmol, 55%) was obtained as a 
pale pink solid, m.p.: 102–106 °C.  
1H NMR (300 MHz, CDCl3): δ = 7.51 (d, J = 8.2 Hz, 2H, ArH), 
7.42 (d, J = 8.1 Hz, 2H, ArH), 7.30–7.16 (m, 6H, ArH), 7.06 (td, J = 8.3, 1.4 Hz, 1H, ArH), 
6.56 (d, J = 7.9 Hz, 1H, ArH), 5.0 (d, J = 13.9 Hz, 1H, 1 × NCH2), 4.27 (d, J = 13.9 Hz, 
1H, 1 × NCH2), 3.58 (d, J = 16.8 Hz, 1H, 1 × CH2), 3.53–3.35 (m, 4H, OCH3 1 × CH2), 
2.40 (s, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 171.5 (C=O), 144.0 (ArC–N), 
139.6 (ArC), 137.7 (ArC), 136.0 (ArC), 135.3 (ArC), 131.6 (ArC), 130.0 (q, J = 32.2 Hz, 
ArC–CF3), 129.7 (ArC), 129.6 (ArC), 128.7 (ArC), 128.2 (ArC), 128.0 (ArC), 127.7 (ArC), 
125.3 (q, J = 3.7 Hz, ArC), 124.0 (q, J = 272.1 Hz, CF3), 55.6 (NCH2), 51.6 (OCH3), 35.8 
(CH2), 21.5 ppm (CH3); IR (neat): ν = 2954w, 2922w, 1726s, 1620w, 1595w, 1492m, 
1438m, 1423m, 1348m, 1323s, 1271m, 1159s, 1109s, 1089s, 1066s, 1020s, 848m, 
812m, 707m, 698m, 657m, 634m, 547s, 451w cm−1; HRMS (NSI): Exact mass calculated 
for C24H26F3N2O4S [M+NH4]+: 495.1560, found: 495.1547. 
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Methyl 2-(2-((4-methyl-N-(4-nitrobenzyl)phenyl)sulfonamido)phenyl) acetate 152e: 
Performed according to General Procedure 4 on a 
0.63 mmol scale of 159a with 4-nitrobenzyl bromide; 152e 
(291 mg, 0.45 mmol, 71%) was obtained after 
recrystallisation over Et2O in n-hexane as a yellow solid, 
m.p.: 106–110 °C.  
1H NMR (400 MHz, CDCl3): δ = 8.09 (d, J = 8.3 Hz, 2H, ArH), 7.58 (d, J = 8.0 Hz, 2H, 
ArH), 7.53–7.23 (m, 6H, ArH), 7.14 (t, J = 7.6, 1.9 Hz, 1H, ArH), 6.61 (dd, J = 8.0, 0.9 
Hz, 1H, ArH), 5.09 (d, J = 14.0 Hz, 1H, 1 × NCH2), 4.42 (d, J = 14.0 Hz, 1H, 1 × NCH2), 
3.83–3.41 (m, 5H, CH2 + OCH3), 2.47 (s, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 
171.5 (C=O), 147.6 (ArC–N), 144.3 (ArC–N), 142.9 (ArC), 137.5 (ArC), 135.9 (ArC), 
134.9 (ArC), 131.7 (ArC), 130.2 (2 × ArC), 129.8 (2 × ArC), 128.9 (ArC), 128.1 (ArC), 
128.0 (2 × ArC), 127.9 (ArC), 123.7 (2 × ArC), 55.4 (NCH2), 51.9 (OCH3), 35.9 (CH2), 
21.7 (CH3) ppm; IR (neat): ν = 3066w, 2949w, 2854w, 1737s, 1597m, 1519s, 1435m, 
1338s, 1207m, 1155s, 1105m, 1085m, 1064m, 854m, 815m, 711s, 690s, 650s, 569s, 
557s cm−1; HRMS (NSI): Exact mass calculated for C23H26N3O6S [M+NH4]+: 472.1537, 
found: 472.153. 
Methyl 2-(2-((4-methyl-N-(4-methylbenzyl)phenyl)sulfonamido)phenyl) acetate 152f: 
Performed according to General Procedure 4 on a 0.63 mmol 
scale of 159a with 4-methylbenzyl chloride; 152f (161 mg, 0.33 
mmol, 61%) was obtained as a pale white solid, m.p.: 94–96 °C.  
1H NMR (300 MHz, CDCl3): δ = 7.60 (d, J = 7.4 Hz, 2H, ArH), 
7.41–7.18 (m, 4H, ArH), 7.11 (t, J = 6.7 Hz, 1H, ArH), 7.00 (s, 
4H, ArH), 6.59 (d, J = 7.9 Hz, 1H, ArH), 5.01 (d, J = 13.5 Hz, 1H, 1 × NCH2), 4.20 (d, J = 
13.3 Hz, 1H, 1 × NCH2), 3.67–3.47 (m, 5H, CH2 + OCH3), 2.47 (s, 3H), 2.28 (s, 3H, CH3) 
ppm; 13C NMR (75 MHz, CDCl3): δ = 171.8 (C=O), 143.8 (ArC–N), 137.8 (ArC), 137.6 
(ArC), 136.3 (ArC), 135.7 (ArC), 132.1 (ArC), 131.5 (ArC), 129.6 (ArC), 129.5 (ArC), 
129.1 (ArC), 128.5 (ArC), 128.2 (ArC), 128.1 (ArC), 127.5 (ArC), 55.9 (NCH2), 51.9 
(OCH3), 35.8 (CH2), 21.7 (CH3), 21.3 (CH3) ppm; IR (neat): ν = 2364w, 1722s, 1346m, 
1261m, 1159s, 1089m, 1043m, 1024m, 887w, 812s, 759w, 707m, 657s, 603m, 582s, 
549s cm−1; HRMS (NSI): Exact mass calculated for C24H26NO4S [M+H]+: 424.1577, 
found: 424.1577. 
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Methyl 2-(2-((4-methyl-N-(3-methylbenzyl)phenyl)sulfonamido)phenyl) acetate 152g: 
Performed according to General Procedure 4 on a 0.60 mmol 
scale of 159a with 3-methylbenzyl bromide; 152g (182 mg, 0.43 
mmol, 69%) was obtained as a pale white solid, m.p.: 84–86 °C.  
1H NMR (400 MHz, CDCl3): δ = 7.54 (d, J = 8.2 Hz, 2H, ArH), 
7.32–7.23 (m, 3H, ArH), 7.19 (t, J = 7.5 Hz, 1H, ArH), 7.09–6.90 
(m, 4H, ArH), 6.83 (d, J = 7.3 Hz, 1H, ArH), 6.52 (d, J = 8.0 Hz, 1H, ArH), 4.98 (d, J = 
13.6 Hz, 1H, 1 × NCH2), 4.16 (d, J = 13.6 Hz, 1H, 1 × NCH2), 3.62–3.42 (m, 5H, CH2 + 
OCH3), 2.41 (s, 3H, CH3), 2.20 (s, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 171.6 
(C=O), 143.7 (ArC–N), 137.9 (ArC), 137.7 (ArC), 136.1 (ArC), 135.4 (ArC), 135.1 (ArC), 
131.3 (ArC), 130.0 (ArC), 129.5 (2 × ArC), 128.5 (ArC), 128.3 (ArC), 128.1 (ArC), 128.0 
(ArC), 128.0 (2 × ArC), 127.4 (ArC), 126.3 (ArC), 56.0 (NCH2), 51.8 (OCH3), 35.8 (CH2), 
21.6 (CH3), 21.3 (CH3) ppm; IR (neat): ν = 3028w, 1732m, 1492w, 1344m, 1222w, 1163s, 
1091w, 815w, 769s, 657m, 565m, 410m cm−1; HRMS (NSI): Exact mass calculated for 
C24H26NO4S [M+H]+: 424.1577, found: 424.1577. 
Methyl 2-(2-((N-([1,1'-biphenyl]-2-ylmethyl)-4-methylphenyl)sulfonamido)phenyl) 
acetate 152h: 
Performed according to General Procedure 4 on a 0.63 mmol scale 
of 159a with 2-(phenyl)benzyl bromide; 152h (207 mg, 0.50 mmol, 
79%) was obtained as a pale yellow solid, m.p.: 94–96 °C.  
1H NMR (300 MHz, CDCl3): δ = 7.74 (dd, J = 7.8, 1.0 Hz, 1H, ArH), 
7.50–7.43, (m, 2H, ArH), 7.36 (td, J = 7.5, 1.3 Hz, 1H, ArH), 7.3–
7.07 (m, 8H, ArH), 7.02 (dd, J = 7.6, 1.2 Hz, 1H, ArH), 6.87 (td, J = 7.9, 1.7 Hz, 1H, ArH), 
6.67 (dd, J = 8.0, 1.3 Hz, 2H, ArH), 6.12 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 5.00 (d, J = 13.9 
Hz, 1H, 1 × NCH2), 4.24 (d, J = 13.9 Hz, 1H, 1 × NCH2), 3.56–3.45 (m, 5H, CH2 + OCH3), 
2.41 (s, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 171.7 (C=O), 143.7 (ArC–N), 
142.4 (ArC), 140.3 (ArC), 137.8 (ArC), 136.2 (ArC), 135.6 (ArC), 133.0 (ArC), 131.4 
(ArC), 130.9 (ArC), 130.0 (ArC), 129.6 (2 × ArC), 129.2 (2 × ArC), 128.3 (ArC), 128.2 
(ArC), 128.1 (2 × ArC), 127.9 (ArC), 127.8 (2 × ArC), 127.6 (ArC), 127.5 (ArC), 126.7 
(ArC), 52.3 (OCH3), 47.0 (NCH2), 35.6 (CH2), 21.6 (CH3) ppm; IR (neat): ν = 3062w, 
3028w, 2956w, 2929w, 1743s, 1342s, 1203m, 1190m, 1153s, 1087m, 1057m, 867m, 
817m, 759m, 692s, 653s, 547s cm−1; HRMS (NSI): Exact mass calculated for 
C29H31N2O4S [M+NH4]+: 503.1999, found: 503.1985. 
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Methyl 2-(2-((4-methyl-N-(2-methylbenzyl)phenyl)sulfonamido)phenyl) acetate 152i: 
Performed according to General Procedure 4 on a 0.63 mmol scale 
of 159a with 2-methylbenzyl bromide; 152i (215 mg, 0.50 mmol, 
82%) was obtained as a pale white solid, m.p.: 96–98 °C.  
1H NMR (400 MHz, CDCl3) δ = 7.60 (d, J = 8.1 Hz, 2H, ArH), 7.37–
7.19 (m, 4H, ArH), 7.18–7.01 (m, 3H, ArH), 6.83 (t, J = 7.2 Hz, 1H, 
ArH), 6.80 (d, J = 7.6 Hz, 1H, ArH), 6.60 (d, J = 8.0 Hz, 1H, ArH), 5.19 (d, J = 13.1 Hz, 
1H, 1 × NCH2), 4.15 (d, J = 13.1 Hz, 1H, 1 × NCH2), 3.55 (s, 3H, OCH3), 3.50 (d, J = 
16.8 Hz, 1H, 1 × CH2), 3.39 (d, J = 16.8 Hz, 1H, 1 × CH2), 2.47 (s, 3H, CH3), 2.30 (s, 3H, 
CH3) ppm; 13C NMR (101 MHz, CDCl3) δ = 171.5 (C=O), 143.9 (ArC–N), 137.7 (ArC), 
137.6 (ArC), 136.7 (ArC), 135.3 (ArC), 132.7 (ArC), 131.5 (ArC), 131.1 (ArC), 130.6 
(ArC), 129.7 (2 × ArC), 128.5 (ArC), 128.3 (2 × ArC), 128.2 (ArC), 127.8 (ArC), 127.4 
(ArC), 125.8 (ArC), 53.6, 51.9, 35.5 (CH2), 21.7 (CH3), 19.0 (CH3) ppm; IR (neat) ν = 
2943w, 2362w, 1741s, 1492m, 1435m, 1338s, 1193m, 1157s, 1089m, 1037m, 879m, 
823m, 746m, 727m, 694s, 655m, 569s, 547m, 536m cm−1; HRMS (NSI): Exact mass 
calculated for C24H26NO4S [M+H]+: 424.1577, found: 424.1577. 
Methyl 2-(2-((4-methyl-N-(2-nitrobenzyl)phenyl)sulfonamido)phenyl) acetate 152j: 
Performed according to General Procedure 4 on a 0.63 mmol 
scale of 159a with 2-nitrobenzyl bromide; 152j (174 mg, 
0.38 mmol, 62%) was obtained as a yellow solid m.p.:  
116–118 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.80 (d, J = 7.7 Hz, 1H, ArH), 7.71 
(d, J = 8.1 Hz, 1H, ArH), 7.50 (t, J = 7.3 Hz, 1H, ArH), 7.43 (d, J = 8.2 Hz, 2H, ArH), 7.29 
(t, J = 7.4 Hz, 1H, ArH), 7.34–7.22 (m, 4H, ArH), 7.02 (t, J = 7.6 Hz, 1H, ArH), 6.59 (d, 
J = 7.9 Hz, 1H, ArH), 5.18 (d, J = 15.7 Hz, 1H, 1 × NCH2), 4.82 (d, J = 15.7 Hz, 1H, 
1 × NCH2), 3.65–3.35 (m, 5H, CH2 + OCH3), 2.36 (s, 3H, CH3) ppm; 13C NMR (101 MHz, 
CDCl3): δ = 171.5 (C=O), 148.8 (ArC), 144.3 (ArC), 138.1 (ArC), 135.4 (ArC), 134.4 
(ArC), 133.3 (ArC), 131.8 (ArC), 131.6 (ArC), 131.5 (ArC), 129.7 (2 × ArC), 128.7 (ArC), 
128.6 (ArC), 128.5 (ArC), 128.2 (2 × ArC), 127.9 (ArC), 124.6 (ArC), 52.0 (NCH2), 51.9 
(OCH3), 36.1 (CH2), 21.6 (CH3) ppm; IR (neat): ν = 2951w, 2358s, 2341s, 1735s, 1597w, 
1525s, 1492m, 1435m, 1346s, 1267m, 1163s, 1091m, 1058w, 1039w, 856w, 815w, 
736m, 694m, 655m, 572m cm−1; HRMS (ASAP): Exact mass calculated for C23H23N2O6S 
[M+H]+: 455.1277, found: 455.1284. 
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Methyl 2-(2-((N-((1-bromonaphthalen-2-yl)methyl)-4-methylphenyl)sulfonamido) phenyl) 
acetate 152k: 
Performed according to General Procedure 4 on a 
0.63 mmol scale of 159a with 1-bromo-2-(bromomethyl) 
naphthalene; 152k (262 mg, 0.49 mmol, 77%) was obtained 
as a pale white solid, m.p.: 140–142 °C.  
1H NMR (400 MHz, CDCl3): δ = 8.11 (d, J = 8.4 Hz, 1H, ArH), 
7.68 (d, J = 7.8 Hz, 1H, ArH), 7.62 (d, J = 8.5 Hz, 1H, ArH), 7.57–7.50 (m, 3H, ArH), 7.42 
(dt, J = 14.7, 6.9 Hz, 2H, ArH), 7.25 (d, J = 8.0 Hz, 2H, ArH), 7.19–7.09 (m, 2H, ArH), 
7.05–6.99 (m, 1H, ArH), 6.66 (d, J = 7.9 Hz, 1H, ArH), 5.31 (d, J = 13.8 Hz, 1H, 1 × NCH2), 
4.72 (d, J = 13.8 Hz, 1H, 1 × NCH2), 3.56 (d, J = 16.8 Hz, 1H, 1 × CH2), 3.46 (d, J = 16.8 
Hz, 1H, 1 × CH2), 3.11 (s, 3H, OCH3), 2.40 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): 
δ = 171.5 (C=O), 144.0(ArC–N), 137.6 (ArC), 136.3 (ArC), 135.1 (ArC), 134.1 (ArC), 
132.8 (ArC), 132.3 (ArC), 131.4 (ArC), 129.7 (ArC), 128.6 (ArC), 128.4 (ArC), 128.3 
(ArC), 128.2 (ArC), 127.9 (ArC), 127.9 (ArC), 127.5 (ArC), 127.5 (ArC), 126.9 (ArC), 
124.9 (ArC), 56.3 (NCH2), 51.5 (OCH3), 35.9 (CH2), 21.8 (CH3) ppm; IR (neat): ν = 
2953w, 1741s, 1593w, 1496w, 1433w, 1340s, 1157s, 1112m, 1087m, 1072m, 993w, 
854m, 815s, 767m, 746m, 715m, 690m, 659s, 549s, 530m, 505m, 495m cm−1; HRMS 
(NSI): Exact mass calculated for C27H25BrNO4S [M+H]+: 538.0682, found: 538.0678. 
Methyl 2-(2-((N-cinnamyl-4-methylphenyl)sulfonamido)phenyl) acetate 159l: 
Performed according to General Procedure 4 on a 0.94 mmol 
scale of 159a with (E)-(3-bromoprop-1-en-1-yl)benzene; 152l 
(278 mg, 0.64 mmol, 68%) was obtained as a white solid, 
m.p.: 106–110 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.58 (d, J = 8.2 Hz, 2H, ArH), 
7.41 (d, J = 7.0 Hz, 1H, ArH), 7.35–7.16 (m, 8H, ArH), 7.12 (td, J = 7.6, 1.1 Hz, 1H, ArH), 
6.61 (d, J = 7.8 Hz, 1H, ArH), 6.31 (d, J = 15.8 Hz, 1H, Hb), 6.10 (dt, J = 15.7 Hz, 6.9 Hz, 
1H, Ha), 4.50 (dd, J = 14.2 Hz, 6.2 Hz, 1H, 1 × NCH2), 4.12 (d, J = 16.4 Hz, 1H, 1 × CH2), 
4.05 (dd, J = 14.3, 6.7 Hz, 1H, 1 × NCH2), 3.69 (d, J = 16.4 Hz, 1H, 1 × CH2), 3.55 (s, 
3H, OCH3), 2.45(s, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 172.1 (C=O), 143.8 
(ArC–N), 138.3 (ArC), 136.5 (ArC), 136.4 (ArC), 135.7 (ArC), 134.5 (ArC), 131.6 (ArC), 
129.6 (2 × ArC), 128.7 (ArC), 128.6 (2 × ArC), 128.5 (ArC), 128.3 (2 × ArC), 128.0 (ArC), 
127.8 (ArC), 126.7 (2 × ArC), 123.5 (ArC), 54.7 (NCH2), 52.0 (OCH3), 36.7 (CH2), 21.7 
(CH3) ppm; IR (neat): ν = 3034w, 2947m, 2856w, 1730s, 1595m, 1490m, 1433m, 1313m, 
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1257s, 1184m, 1153s, 881m, 657s, 580s cm−1; HRMS (NSI): Exact mass calculated for 
C25H29N2O4S [M+NH4]+: 453.1843, found: 453.1837. 
General Procedure 5: 
 
To a solution of starting material 159a (300 mg, 0.94 mmol), triphenylphosphine (271 mg, 
1.03 mmol) and alkyl alcohol 162 (128 µL, 1.03 mmol) in THF, diisopropyl-
azodicarboxylate (DIAD, 203 µL, 1.03 mmol) was added at 0 °C. The mixture was stirred 
overnight refluxing and cooled to room temperature. After THF was removed under 
reduced pressure, the residue was purified by flash column chromatography 
(n-hexane/ethyl acetate) to afford 152m–o as oils. 
Methyl 2-(2-((N-hexyl-4-methylphenyl)sulfonamido)phenyl) acetate 152m: 
Performed according to General Procedure 5 on a 0.94 mmol 
scale of 159a with hexan-1-ol; 152m (260 mg, 0.64 mmol, 
68%) was obtained as a colourless oil.  
1H NMR (300 MHz, CDCl3): δ = 7.43 (d, J = 8.1 Hz, 2H, ArH), 
7.36 (d, J = 7.2 Hz, 1H, ArH), 7.24–7.14 (m, 3H, ArH), 7.04 (t, 
J = 7.2 Hz, 1H, ArH), 6.47 (d, J = 8.1 Hz, 1H, ArH), 4.01 (d, J = 16.5 Hz, 1H, 1 × CH2), 
3.75–3.49 (m, 5H, OCH3 + 1 × CH2), 3.15–2.85 (m, 1H), 2.35 (s, 3H, CH3), 1.47–1.04 
(m, 8H), 0.75 (t, J = 6.6 Hz, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 172.1 (C=O), 
143.6 (ArC–N), 138.4 (ArC), 136.4 (ArC), 135.1 (ArC), 131.4 (ArC), 129.4 (2 × ArC), 
128.4 (ArC), 128.1 (2 × ArC), 127.6 (ArC), 127.4 (ArC), 52.2, 51.9, 36.4, 31.4, 28.2, 26.5, 
22.5, 21.6, 14.0 ppm; IR (neat): ν = 2951m, 2929m, 2856m, 1739s, 1597w, 1492m, 
1452m, 1435m, 1348s, 1211w, 1165s, 1089m, 1066w, 812m, 713m, 694m, 655m, 582m 
cm−1; HRMS (NSI): Exact mass calculated for C22H30NO4S [M+H]+: 404.1890, found: 
404.1884. 
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Methyl 2-(2-((N-(sec-butyl)-4-methylphenyl)sulfonamido)phenyl) acetate 152n: 
Performed according to General Procedure 5 on a 0.94 mmol scale 
of 159a with butan-2-ol; 152n (227 mg, 0.60 mmol, 64%) was 
obtained as a colorless oil as a 1:1 mixture of rotamers. 
 
1H NMR (300 MHz, CDCl3): δ = 7.48 (dd, J = 8.2, 3.0 Hz, 4H, ArH), 
7.39 (d, J = 7.8 Hz, 2H, ArH), 7.29–7.04 (m, 8H, ArH), 6.71 (d, J = 
7.9 Hz, 1H, ArH), 6.63 (d, J = 7.9 Hz, 1H, ArHI), 4.21–4.12 (m, 2H, NCH
 
+ NCHI), 3.90 
(t, J = 16.5 Hz, 2H), 3.97–3.83 (m, 2H), 3.75–3.60 (m, 8H), 2.34 (s, 6H, CH3 + CHI3), 
1.65–1.31 (m, 3H), 1.21–0.91 (m, 7H), 0.91–0.76 (m, 7H), 0.76–0.65 (m, 3H) ppm; 
13C NMR (75 MHz, CDCl3): δ = 172.2 (C=O), 172.1 (CI=O), 143.3 (ArC–N), 143.2  
(ArCI–N), 138.1 (ArC), 137.8 (ArC), 137.6 (ArC), 137.5 (ArC), 134.9 (ArC), 134.8 (ArC), 
131.6 (ArC), 131.3 (ArC), 129.5 (ArC), 129.4 (ArC), 128.7 (ArC), 128.7 (ArC), 127.7 
(ArC), 127.6 (ArC), 127.1 (ArC), 126.9 (ArC), 58.9 (NCH), 58.4 (NCIH), 52.0 (OCH3), 
51.9 (OCIH3), 36.6, 28.6, 28.6, 21.6, 18.4, 17.9, 11.8, 11.5 ppm; IR (neat): ν = 2978w, 
2881w 2394m, 2341m, 1708s, 1475w, 1419w, 1361m, 1336m, 1220m, 1174w, 1159m, 
1114w, 1097w, 1082m, 1037m, 1012w, 964w, 912w, 842w, 790w, 763w cm−1; HRMS 
(NSI): Exact mass calculated for C22H26NO4S [M+H]+: 376.1577, found: 376.1580. 
Methyl 2-(2-((N-allyl-4-methylphenyl)sulfonamido)phenyl) acetate 152o: 
Performed according to General Procedure 5 on a 0.93 mmol 
scale of 159a and prop-2-en-1-ol; 152o (286 mg, 0.80 mmol, 
86%) was obtained as a colourless oil.  
1H NMR (400 MHz, CDCl3): δ = 7.50 (d, J = 8.1 Hz, 2H, ArH), 
7.38 (d, J = 7.7 Hz, 1H, ArH), 7.25–7.22 (m, 3H, ArH), 7.07 (t, 
J = 7.7 Hz, 1H, ArH), 6.51 (d, J = 8.0 Hz, 1H, ArH), 5.77–5.62 (m, 1H, Ha), 5.07–4.80 (m, 
2H, Hb + Hc), 4.32 (dd, J = 14.1, 5.9 Hz, 1H, 1 × NCH2), 4.04 (d, J = 16.4 Hz, 1H, 1 × CH2), 
3.82 (dd, J = 14.1, 7.6 Hz, 1H, 1 × NCH2), 3.77–3.63 (m, 4H, 1 × CH2 + OCH3), 2.39 (s, 
3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 170.9 (C=O), 142.7 (ArC–N), 137.0 
(ArC), 135.1 (ArC), 134.1 (ArC), 131.3, 130.4, 128.5 (2 × ArC), 127.5, 127.2, 127.1 (2 × 
ArC), 126.5, 118.5 (CH=CH2), 53.9 (NCH2), 50.9 (OCH3), 35.5 (CH2), 20.5 (CH3) ppm. 
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1-Benzylindolin-2-one 163: 
To a solution of 159ca (200 mg. 0.75 mmol) and triethylamine 
(210 μL, 1.5 mmol) in acetonitrile (3 mL) at 0 °C benzyl bromide 
(134 μL, 1.1 mmol) was added and the mixture was stirred for 
24 hours at 50 °C. The solution was cooled down, the solvent was 
concentrated, and the residual oil was dissolved in CH2Cl2 (10 mL), washed with water 
(10 mL) and then brine (10 mL). After drying over MgSO4, the mixture was concentrated 
in vacuo and purified via column chromatography to afford 163 (140 mg, 0.63 mmol, 
84%) as a colourless solid, m.p.: 66–70 °C.  
1H NMR (300 MHz, CDCl3): δ = 7.36–7.17 (m, 6H, ArH), 7.12 (td, J = 7.8, 1.2 Hz, 1H, 
ArH), 6.96 (td, J = 7.7, 1.0 Hz, 1H, ArH), 6.68 (d, J = 7.8 Hz, 1H, ArH), 4.87 (s, 2H, NCH2), 
3.57 (s, 2H, CH2) ppm; 13C NMR (75 MHz, CDCl3): δ = 175.3 (C=O), 144.5 (ArC–N), 
136.0 (ArC), 128.9 (2 × ArC), 127.9 (ArC), 127.7(ArC), 127.5 (2 × ArC), 124.6 (ArC), 
124.5 (ArC), 122.5 (ArC), 109.2 (ArC), 43.9 (NCH2), 35.9 (CH2) ppm. Spectroscopic data 
are in agreement with literature.6 
Methyl 2-(2-(benzylamino)phenyl)acetate 170: 
 
To neat starting material 156a (600 mg, 3.6 mmol) benzaldehyde 168 (3.0 mmol) was 
added dropwise and an exothermic reaction was observed, hence some MgSO4 
(~100 mg) was added to remove the water formed. The suspension was stirred for 
20 minutes then the MgSO4 was filtered off and the product was washed off the salt with 
CH2Cl2 (5 mL). A pre-mixed solid mixture of 1:1 NaBH4/H3BO3 (3 mmol) was added 
portion wise and the solution was stirred vigorously overnight at room temperature. 
Water was added and the phases were separated. The organic layer was washed with 
brine and dried over MgSO4 and concentrated under reduced pressure. The crude was 
purified by column chromatography to afford 170 (450 mg, 1.7 mmol, 49% yield) as a 
colourless oil. 
 
a.  Synthesised by Dr. S. T. R. Müller. 
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1H NMR (500 MHz, CDCl3): δ = 7.42–7.30 (m, 4H, ArH), 7.30–7.25 (m, 1H, ArH), 7.19–
7.08 (m, 2H, ArH), 6.71 (td, J = 7.4, 1.0 Hz, 1H, ArH), 6.66 (d, J = 8.1 Hz, 1H, ArH), 4.92 
(br. s, 1H, NH), 4.39 (s, 2H, NCH2), 3.67 (s, 3H, OCH3), 3.60 (s, 2H, CH2) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 172.4 (C=O), 146.7 (ArC–N), 139.5 (ArC), 131.2 (ArC), 128.9 
(ArC), 128.8 (2 × ArC), 127.5 (2 × ArC), 127.3 (ArC), 119.3 (ArC), 117.7 (ArC), 111.8 
(ArC), 52.4 (OCH3), 48.1 (NCH2), 38.7 (CH2) ppm; IR (neat): ν = 3385w, 3026w, 2949w, 
2845w, 1720s, 1602m, 1516m, 1452m, 1261m, 1147m, 748s cm−1; HRMS (NSI): Exact 
mass calculated for C16H18NO2 [M+H]+: 256.1332; found: 256.1333. 
Methyl 2-(2-(benzyl(methyl)amino)phenyl)acetate 171: 
 
To a solution of starting material 170 (417 mg, 1.6 mmol) and triethylamine (3.2 mmol) 
in DMF (16 mL), methyl iodide (6.5 mmol) was added dropwise. The solution was stirred 
overnight at room temperature. The solution was concentrated under reduced pressure 
inside a fume-cupboad to remove the unreacted methyl iodide. The residue was washed 
with water (50 mL) and the product was extracted with Et2O (5 × 20 mL). The combined 
organic layers were washed with brine, dried over MgSO4 and concentrated under 
reduced pressure. The crude was purified by column chromatography to afford 171 
(86 mg, 0.32 mmol, 20% yield) as a colourless oil. 
1H NMR (300 MHz, CDCl3): δ = 7.31–7.10 (m, 8H, ArH), 7.08–6.98 (m, 1H, ArH), 3.90 
(s, 2H, CH2), 3.76 (s, 2H, CH2), 3.60 (s, 3H, CH3), 2.45 (s, 3H, CH3) ppm; 13C NMR 
(75 MHz, CDCl3): δ = 172.9 (C=O), 152.7 (ArC), 138.7 (ArC), 131.0 (ArC), 130.8 (ArC), 
128.8 (ArC), 128.3 (ArC), 128.3 (ArC), 127.2 (ArC), 124.5 (ArC), 122.1 (ArC), 61.7, 52.0, 
42.0, 36.9 ppm; IR (neat): ν = 3057w, 3032w, 2922w, 1701s, 1614s, 1466s, 1344s, 
1165s, 516m cm−1; HRMS (NSI): Exact mass calculated for C17H20NO2 [M+H]+: 
270.1489; found: 270.149. 
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5.2.2 Diazo-transfer Reaction in Batch 
Phenyldiazoacetate 165: 
 
A 0.2 M solution of methyl phenylacetate 164 (600 mg, 4.0 mmol) and p-ABSA 18e 
(1.9 g, 8 mmol) in acetonitrile (10 mL) was cooled to 0 °C before the addition of DBU 
(897 µL, 6 mmol). The reaction was stirred at room temperature for 12 hours and 
monitored by TLC (n-hexane/ethyl acetate). The mixture was quenched with a saturated 
aqueous solution of NH4Cl and the product was extracted with CH2Cl2 (3 × 5 mL). The 
combined organic layers were washed with water, brine, dried over MgSO4 and 
concentrated under reduced pressure. The crude was purified by flash column 
chromatography to afford 165 was afforded as a red oil (580 mg, 3.3 mmol, 83% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.52–7.45 (m, 2H, ArH), 7.45–7.34 (m, 2H, ArH), 7.22–
7.11 (m, 1H, ArH), 3.87 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 165.8 
(C=O), 129.1 (ArC), 126.0 (ArC), 125.6 (ArC–C), 124.1 (ArC), 52.1 (OCH3) ppm (C=N2 
not observed); IR (neat): v = 3059w, 2953w, 2843w, 2362w, 2083s, 1699s, 1597w, 
1575w, 1498m, 1435m, 1352m, 1247m cm−1. Spectroscopic data are in agreement with 
the literature.7 
p-Nitrobenzenesulfonyl azide 18f:2 
 
A solution of sodium azide (290 mg, 4.5 mmol) in water (2 mL) was added dropwise to a 
solution of p-nitrobenzenesulfonyl chloride 97%wt (685 mg, 3 mmol) in acetone (6 mL) 
cooled to 0 °C. The mixture was allowed to warm up to room temperature and stirred 
overnight. Acetone was then removed under reduced pressure (water bath at 25 °C). 
The residue was washed with water (10 mL) and Et2O (10 mL). The organic layer was 
further washed with 5%wt Na2CO3 aqueous solution, water and brine then dried over 
MgSO4 and concentrated under reduced pressure (water bath at 25 °C) to afford 18f 
(622 mg, 2.73 mmol, 91%) as a pale yellow solid, m.p.: 100–102 °C. 
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1H NMR (500 MHz, CDCl3): δ = 8.51–8.43 (m, 1H, ArH), 8.25–8.06 (m, 1H, ArH) ppm; 
13C NMR (126 MHz, CDCl3): δ = 151.2 (ArC–N), 143.7 (ArC–S), 129.0 (2 × ArC), 125.1 
(2 × ArC) ppm; IR (neat): ν = 3107m, 2318w, 2140s, 1604m, 1527s, 1404m, 1348s, 
1155s, 1109m, 1083s, 1012m, 854s, 761s, 742s, 731s, cm−1. Spectroscopic data are in 
accordance with the literature.8 
General Procedure 6: 
 
A solution containing the ester 152a–n (1 mmol) and p-NBSA 18f2 (456 mg, 2 mmol) in 
CH3CN (4 mL) was cooled down to 0 °C. DBU (374 μL, 2.5 mmol) was added dropwise. 
The reaction stirred for 48 hours at room temperature or 45 °C and checked by TLC 
(n-hexane/ethyl acetate 4:1). Then, the reaction mixture was cooled down to 0 °C and a 
pH 7 phosphate buffer (10 mL) was added to quench the reaction. The reaction mixture 
was extracted with CH2Cl2 (2 × 20 mL) and the combined organic fractions were washed 
with pH 7 phosphate buffer (10 mL), brine (15 mL) and dried over MgSO4. The solvent 
was evaporated in vacuo (water temperature: 25 °C) and the crude reaction mixture was 
purified via flash column chromatography to afford 153a–n. 
Methyl 2-(2-((N-benzyl-4-methylphenyl)sulfonamido)phenyl)-2-diazoacetate 153a: 
Performed according to General Procedure 6 on a 1.0 mmol scale 
of 152a; 153a (280 mg, 0.65 mmol, 65%) was obtained as a yellow 
solid, m.p.: 110–112 °C (N2 loss > 80 °C). 
1H NMR (400 MHz, CDCl3): δ = 7.64 (d, J = 8.2 Hz, 2H, ArH), 7.46 
(dd, J = 7.8, 1.0 Hz, 1H, ArH), 7.33 (d, J = 8.2 Hz, 2H, ArH), 7.26 
(d, J = 7.6 Hz, 1H, ArH), 7.13–7.22 (m, 3H, ArH), 7.05–7.11 (m, 3H, ArH), 6.54 (dd, 
J = 8.1, 1.0 Hz, 1H, ArH), 5.08 (br. s, 1H, N–CH2), 4.07 (br. s, 1H, N–CH2), 3.61 (s, 3H, 
OCH3), 2.46 (s, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 166.1 (C=O), 144.1  
(ArC–N), 137.0 (ArC), 135.9 (ArC), 134.5 (ArC), 131.3 (ArC), 129.8 (2 × ArC), 129.6 
(2 × ArC), 128.8 (ArC), 128.5 (3 × ArC), 128.4 (2 × ArC), 128.3 (ArC), 128.1 (ArC), 127.8 
(ArC), 60.6 (C=N2), 57.0 (NCH2), 51.9 (OCH3), 21.8 (CH3) ppm; IR (neat): ν = 3064w, 
3032w, 2954w, 2924w, 2096s, 1693s, 1494m, 1429m, 1344s, 1242m, 1159s, 1151s, 
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1045m, 1029s, 858m, 812m, 717s cm−1; HRMS (NSI): Exact mass calculated for 
C23H21N3O4SNa [M+Na]+: 458.1145; found: 458.1142. The structure was confirmed by 
X-Ray analysis (Figure 5.1). 
 
Figure 5.1: X-ray structure of 153a.b 
Methyl 2-azido-2-(2-((N-benzyl-4-methylphenyl)sulfonamido)phenyl) acetate 166: 
Side product 166 (1:1.1 mixture of two rotamers) was obtained as 
a pale-yellow solid.  
1H NMR (300 MHz, CDCl3): δ = 7.51 (dd, J = 8.3, 2.9 Hz, 4H, ArH), 
7.17 (m, 23H, ArH), 6.57 (t, J = 7. Hz, 2H, ArH), 5.48 (s, 1H, N3CH), 
5.26 (s, 1H, N3CHI), 5.02 (d, J = 13.4 Hz, 1H, NCH2I), 4.90 (d, J = 
13.9 Hz, 1H, NCH2), 4.33 (d, J = 13.9 Hz, 1H, NCH2), 4.11 (d, J = 13.4 Hz, 1H, NCH2I), 
3.69 (s, 3H, OCH3I), 3.38 (s, 3H, OCH3), 2.38 (s, 6H, 2 × Ar–CH3) ppm; 13C NMR 
(75 MHz, CDCl3): δ = 169.5 (C=O), 169.4 (C=O), 144.1 (ArC–N), 144.0 (ArC–N), 137.9 
(ArC), 137.7 (ArC), 135.9 (ArC), 135.6 (ArC), 135.2 (ArC), 135.1 (ArC), 135.0 (ArC), 
134.7 (ArC), 129.7 (ArC), 129.6 (ArC), 129.5 (ArC), 129.4 (ArC), 129.2 (ArC), 129.1 
(ArC), 129.0 (ArC), 128.8 (ArC), 128.6 (ArC), 128.4 (ArC), 128.3 (ArC), 128.2 (ArC), 
128.0 (ArC), 127.9 (ArC), 60.1 (CH–N3), 59.9 (CIH–N3), 56.3 (NCH2), 56.4 (NCIH2), 53.0 
(OCH3), 52.8 (OCIH3), 21.6 (2 × CH3) ppm; IR (neat): ν = 3062w, 3030w, 2954m, 2926m, 
2875w, 2850w, 2100s, 1735s, 1595m, 1490m, 1456m, 1448m, 1436m, 1354s, 1257w, 
1211s, 1161s, 1089s, 1029s, 867m, 758m, 661s, 522m, 476w cm−1; HRMS: Exact mass 
calculated for C23H22N4O4SNH4 [M+NH4]+: 468.1700; found: 468.1695. The structure was 
confirmed by X-Ray analysis (Figure 5.2). 
 
Figure 5.2: X-ray structure of 166.c
 
b.  Measured by Dr. Benson Kariuki at Cardiff University, School of Chemistry 
c.  Measured by Dr. Benson Kariuki at Cardiff University, School of Chemistry 
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Isopropyl 2-(2-((N-benzyl-4-methylphenyl)sulfonamido)phenyl)-2-diazoacetate 153b: 
Performed according to General Procedure 6 at 45 °C on a 
0.37 mmol scale of 152b; 153b (86 mg, 0.19 mmol, 51%) obtained 
as yellow solid, m.p.: 86–90 °C (N2 loss > 80 °C). 
1H NMR (300 MHz, CDCl3): δ = 7.67 (d, J = 8.1 Hz, 2H, ArH), 7.58 
(d, J = 7.2 Hz, 1H, ArH), 7.40–6.71 (m, 9H, ArH), 6.56 (d, J = 
7.6 Hz, 1H), 5.23–4.70 (m, 2H, 1 × NCH2 + OCH), 4.18 (br. s, 1H, 1 × NCH2), 2.49 (s, 
3H, CH3), 1.16 (d, J = 6.1 Hz, 6H, 2 × CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 165.3 
(C=O), 144.2 (ArC–N), 136.7 (ArC), 135.9 (ArC), 134.6 (ArC), 131.0 (ArC), 129.8 
(2 × ArC), 129.6 (2 × ArC), 128.7 (2 × ArC), 128.5 (2 × ArC), 128.4 (2 × ArC), 128.3 (ArC), 
128.2 (ArC), 127.4 (ArC), 68.5 (OCH), 60.7 (C=N2), 56.9 (NCH2), 22.2 (CH3), 21.8 (CH3) 
ppm; IR (neat): ν = 2916m, 2848m, 2104s, 1695s, 1595w, 1490m, 1448m, 1336s, 1238s, 
1151s, 1105s, 1089s, 1012s, 910w, 856m, 817m, 715s, 698m, 659s, 615m, 586m, 561s, 
547s cm−1; HRMS (NSI): Exact mass calculated for C25H29N2O4S [M−N2+NH4]+: 
453.1843; found: 453.1838. 
Methyl 2-diazo-2-(2-((N-(4-methoxybenzyl)-4-methylphenyl)sulfonamido)phenyl) 
acetate 153c: 
Performed according to General Procedure 6 at 45 °C on a 
0.41 mmol scale of 152c; 153c (105 mg, 0.23 mmol, 56%) 
obtained as a yellow solid, m.p.: 132–135 °C (N2 loss 
> 80 °C). 
 
1H NMR (400 MHz, CDCl3): δ = 7.66 (d, J = 8.2 Hz, 2H, ArH), 
7.50 (d, J = 8.1 Hz, 1H, ArH), 7.34 ( d, J = 8.1 Hz, 2H, ArH), 7.29 (t, J = 7.7 Hz, 1H, ArH), 
7.09 (td, J = 8.0, 1.3 Hz, 1H, ArH), 7.00 (d, J = 8.6 Hz, 2H, ArH), 6.70 (d, J = 8.6 Hz, 2H, 
ArH), 6.55 (d, J = 7.8 Hz, 1H, ArH), 5.05 (d, J = 11.4 Hz, 1H, 1 × NCH2), 4.04 (d, J = 11.6 
Hz, 1H, 1 × NCH2), 3.74 (s, 3H, OCH3), 3.65 (s, 3H, OCH3), 2.48 (s, 3H, CH3) ppm; 13C 
NMR (75 MHz, CDCl3): δ = 166.1 (C=O), 159.5 (ArC–O), 144.1 (ArC–N), 136.9 (ArC), 
136.0 (ArC), 131.2 (ArC), 130.8 (2 × ArC), 129.8 (ArC), 128.8 (ArC), 128.5 (ArC), 128.4 
(2 × ArC), 128.2 (ArC), 127.7 (ArC), 126.6 (ArC), 113.8 (ArC), 56.5, 55.2, 51.8, 31.0, 
21.7 (CH3) ppm; IR (neat): ν = 2953w, 2096s, 1703s, 1612w, 1589w, 1512m, 
1492m,1435m, 1340s, 1263s, 1240s, 1149s, 1028s, 877m, 813m, 758s, 727s, 658s, 
607s cm−1; HRMS (NSI): Exact mass calculated for C24H23N3O4SNa [M+Na]+: 488.1251; 
found: 488.1245. 
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Methyl 2-diazo-2-(2-((4-methyl-N-(4-(trifluoromethyl)benzyl)phenyl)sulfonamido) 
phenyl) acetate, 153d: 
Performed according to General Procedure 6 at 45 °C on a 
0.21 mmol scale of 152d; 153d (84 mg, 0.17 mmol, 79%) 
obtained as a yellow solid, m.p.: 116–118 °C (N2 loss > 
80 °C). 
1H NMR (400 MHz, CDCl3): δ = 7.63 (d, J = 8.3 Hz, 2H, ArH), 
7.55–7.40 (m, 3H, ArH), 7.32 (d, J = 8.0 Hz, 2H, ArH), 7.28–7.21 (m, 3H, ArH), 7.10 (td, 
J = 7.9, 1.6 Hz, 1H, ArH), 6.55 (dd, J = 8.0, 1.2 Hz, 1H, ArH), 5.09 (br. s, 1H, 1 × NCH2), 
4.08 (br. s, 1H, 1 × NCH2), 3.57 (s, 3H, OCH3), 2.45 (s, 3H, CH3) ppm; 13C NMR (125 
MHz, CDCl3): δ = 165.9 (C=O), 144.5 (ArC–N), 138.8 (ArC), 137.3 (ArC), 135.8 (ArC), 
131.8 (ArC), 130.4 (q, J = 32.4 Hz, ArC–CF3), 129.9 (2 × ArC), 129.8 (2 × ArC), 129.1 
(ArC), 128.5 (2 × ArC), 128.4 (ArC), 128.2 (ArC), 128.1 (ArC), 125.3 (q, J = 3.7 Hz, ArC), 
124.0 (q, J = 273.5 Hz, ArC–CF3), 60.3 (C=N2), 56.5 (NCH2), 51.8 (OCH2), 21.8 (CH3) 
ppm; IR (neat): ν = 2954w, 2926w, 2096s, 1741w, 1695s, 1618w, 1597w, 1492m, 1448w, 
1435m, 1421w, 1323s, 1240s, 1161s, 1111s, 1066s, 1020s, 817m, 713s, 661s, 547s 
cm−1; HRMS (ES): Exact mass calculated for C24H20F3N3O4SNa [M+Na]+: 526.1024; 
found: 526.0999. 
Methyl 2-diazo-2-(2-((4-methyl-N-(4-methylbenzyl)phenyl)sulfonamido)phenyl) acetate 
153f: 
Performed according to General Procedure 6 at 45 °C on a 
0.35 mmol scale of 152f; 153f (108 mg, 0.24 mmol, 69%) 
obtained as a yellow solid, m.p.: 102–104 °C (N2 loss > 80 °C). 
 
1H NMR (300 MHz, CDCl3): δ = 7.59 (d, J = 8.1 Hz, 2H, ArH), 
7.42 (d, J = 7.3 Hz, 1H, ArH), 7.39–7.17 (m, 3H, ArH), 7.02 (t, J 
= 7.0 Hz, 1H, ArH), 6.90 (s, 4H, ArH), 6.48 (d, J = 7.7 Hz, 1H, ArH), 4.97 (br. s, 1H, 
1 × CH2), 3.98 (br. s, 1H, 1 × CH2), 3.57 (s, 3H, OCH3), 2.41 (s, 3H, CH3), 2.19 (s, 3H, 
CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 166.0 (C=O), 154.6 (ArC–N), 144.0 (ArC), 
137.8 (ArC), 136.8 (ArC), 135.7 (ArC), 131.3 (ArC), 131.1 (ArC), 129.7 (ArC), 129.4 
(ArC), 129.0 (ArC), 128.7 (ArC), 128.3 (ArC), 128.0 (ArC), 127.6 (ArC), 60.7 (C=N2), 56.7 
(NCH2), 51.8 (OCH3), 21.7 (CH3), 21.2 (CH3) ppm; IR (neat): ν = 2951w, 2918w, 2360m, 
2100s, 1699s, 1597w, 1492m, 1435m, 1348s, 1290m, 1265m, 1246m, 1192w, 1161s, 
1116w, 1089w, 1033m, 912m, 815w, 779w, 734s, 663m, 574s cm−1; HRMS (NSI): Exact 
mass calculated for C24H27N2O4S [M−N2+NH4]+: 439.1686; found: 439.1682. 
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Methyl 2-diazo-2-(2-((4-methyl-N-(3-methylbenzyl)phenyl)sulfonamido)phenyl) acetate 
153g: 
Performed according to General Procedure 6 at 45 °C on a 0.28 
mmol scale of 152g; 153g (78 mg, 0.17 mmol, 61%) obtained 
as a yellow solid, m.p.: 100–102 °C (N2 loss > 80 °C). 
1H NMR (400 MHz, CDCl3): δ = 7.59 (d, J = 8.1 Hz, 2H, ArH), 
7.42 (d, J = 7.8 Hz, 1H, ArH), 7.37–7.12 (m, 3H, ArH), 7.10–
6.92 (m, 4H, ArH), 6.72 (d, J = 6.1 Hz, 1H, ArH), 6.48 (d, J = 7.9 Hz, 1H, ArH), 5.00 (br. 
s, 1H, 1 × CH2), 3.98 (br. s, 1H, 1 × CH2), 3.56 (s, 3H, OCH3), 2.41 (s, 3H, CH3), 2.16 (s, 
3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.1 (C=O), 144.2 (ArC–N), 138.3 
(ArC), 137.1 (ArC), 136.0 (ArC), 134.5 (ArC), 131.3 (ArC), 130.3 (ArC), 129.8 (2 × ArC), 
128.8 (ArC), 128.7 (ArC), 128.5 (ArC), 128.4 (2 × ArC), 128.3 (ArC), 128.2 (ArC), 127.7 
(ArC), 126.6 (ArC), 60.6 (C=N2), 57.0 (NCH2), 51.8 (OCH3), 21.8 (CH3), 21.3 (CH3) ppm; 
IR (neat): ν = 2951w, 2918w, 2358m, 2341m, 2098s, 1697s, 1595m, 1492m, 1435m, 
1344m, 1288s, 1246m, 1155s, 1118w, 1089m, 1049m, 752m, 723s, 705m, 661s, 565s 
cm−1; HRMS (NSI): Exact mass calculated for C24H23N3O4SNa [M+Na]+: 472.1301; found: 
472.1295. 
Methyl 2-(2-((N-([1,1'-biphenyl]-2-ylmethyl)-4-methylphenyl)sulfonamido)phenyl)-2-
diazoacetate 153h:  
Performed according to General Procedure 6 at 45 °C on a 
0.30 mmol scale of 152h; 153h (117 mg, 0.23 mmol, 76%) was 
obtained as a yellow solid, m.p.: 144–146 °C (N2 loss > 80 °C). 
1H NMR (400 MHz, CDCl3): δ = 7.82 (d, J = 7.7 Hz, 1H, ArH), 7.49 
(d, J = 8.0 Hz, 2H, ArH), 7.36–7.12 (m, 6H, ArH), 7.04–6.86 (m, 
4H, ArH), 6.73 (t, J = 7.5 Hz, 1H, ArH), 6.51 (d, J = 7.2 Hz, 2H, ArH), 5.96 (d, J = 7.9 Hz, 
1H, ArH), 4.94 (br. s, 1H, 1 × NCH2), 4.10 (br. s, 1H, 1 × NCH2), 3.51 (s, 3H, OCH3), 2.35 
(s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.0 (C=O), 144.0 (ArC–N), 142.3 
(ArC), 140.1 (ArC), 137.6 (ArC), 136.1 (ArC), 132.5 (ArC), 131.8 (ArC), 130.5 (ArC), 
129.9 (ArC), 129.8 (2 × ArC), 129.0 (2 × ArC), 128.5 (ArC), 128.3 (2 × ArC), 128.2 (ArC), 
128.1 (ArC), 128.0 (ArC), 127.8 (ArC), 127.7 (2 × ArC), 127.4 (ArC), 126.4 (ArC), 60.2 
(C=N2), 53.1 (NCH2), 51.7 (OCH3), 21.7 (CH3) ppm; IR (neat): ν = 3062w, 2953w, 2102s, 
1693s, 1431m, 1342s, 1255m, 1238m, 1155s, 1045m, 854m, 712s, 659s, 569s, 542s 
cm−1; HRMS (APCI): Exact mass calculated for C29H25N3O4SNa [M+Na]+: 534.1463; 
found: 534.1453. 
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Methyl 2-diazo-2-(2-((4-methyl-N-(2-methylbenzyl)phenyl)sulfonamido)phenyl) acetate 
153i:  
Performed according to General Procedure 6 at 45 °C on a 
0.30 mmol scale of 152i; 153i (79 mg, 0.17 mmol, 59%) was 
obtained as a yellow solid. 
1H NMR (400 MHz, CDCl3): δ = 7.71 (d, J = 8.1 Hz, 2H, ArH), 7.51–
7.33 (m, 3H, ArH), 7.33–7.19 (m, 1H, ArH), 7.18–6.99 (m, 3H, 
ArH), 6.90 (t, J = 7.3 Hz, 1H, ArH), 6.76 (d, J = 7.6 Hz, 1H, ArH), 6.60 (d, J = 8.0 Hz, 1H, 
ArH), 5.24 (br. s, 1H, 1 × NCH2), 4.03 (br. s, 1H, 1 × NCH2), 3.59 (s, 3H, OCH3), 2.50 (s, 
3H, CH3), 2.24 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 165.9 (C=O), 144.3 
(ArC–N), 138.0 (ArC), 137.4 (ArC), 135.7 (ArC), 132.1 (ArC), 131.7 (ArC), 130.9 (ArC), 
130.4 (ArC), 129.9 (2 × ArC), 128.9 (ArC), 128.8 (ArC), 128.6 (2 × ArC), 128.2 (ArC), 
127.9 (ArC), 127.8 (ArC), 125.9 (ArC), 60.4 (C=N2), 54.7 (NCH2), 51.8 (OCH3), 21.8  
(Ar–CH3), 18.8 (CH3) ppm; IR (neat): ν = 2951w, 2922w, 2858w, 2362w, 2098s, 1697s, 
1595w, 1514w, 1435m, 13344s, 1155s, 1089w, 1033m, 912m, 754m, 729s, 663s, 607w, 
580s, 553m cm−1; HRMS (NSI): Exact mass calculated for C24H27N2O4S [M−N2+NH4]+: 
439.1686; found: 439.1682. 
Methyl 2-(2-((N-((1-bromonaphthalen-2-yl)methyl)-4-methylphenyl)sulfonamido)phenyl) 
2-diazoacetate 153k: 
Performed according to General Procedure 6 at 45 °C on a 
0.34 mmol scale of 152k; 153k (146 mg, 0.26 mmol, 76%) 
was obtained as a yellow solid, m.p.: 136–138 °C (N2 loss > 
80 °C). 
1H NMR (400 MHz, CDCl3): δ = 8.11 (d, J = 8.4 Hz, 1H, ArH), 
7.69 (t, J = 6.9 Hz, 3H, ArH), 7.61 (d, J = 8.4 Hz, 1H, ArH), 7.53–7.36 (m, 3H, ArH), 7.33 
(d, J = 8.0 Hz, 2H, ArH), 7.20 (dt, J = 7.8, 7.0 Hz, 2H, ArH), 7.06 (t, J = 7.6 Hz, 1H, ArH), 
6.62 (d, J = 8.0 Hz, 1H, ArH), 5.35 (br. s, 1H, 1 × NCH2), 4.59 (br. s, 1H, 1 × NCH2), 2.87 
(s, 3H, OCH3), 2.44 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 165.6 (C=O), 
144.4 (ArC–N), 137.9 (ArC), 134.7 (ArC), 135.9 (ArC), 134.2 (ArC), 132.2 (ArC), 132.1 
(ArC), 132.0 (ArC), 129.9 (2 × ArC), 128.9 (ArC), 128.6 (2 × ArC), 128.5 (ArC), 128.4 
(ArC), 128.2 (ArC), 128.17 (2 × ArC), 128.16 (2 × ArC), 127.9 (ArC), 127.5 (ArC), 126.9 
(ArC), 125.4 (ArC), 60.4 (C=N2), 57.4 (NCH2), 51.3 (OCH3), 20.6 (CH3) ppm; IR (neat): ν 
= 2956w, 2094s, 1697s, 1597w, 1492m, 1438m, 1344s, 1247m, 1192w, 1155s, 854m, 
813s, 752s, 736m, 717s, 661s, 648m, 590w, 576s, 547m, 528m cm−1; HRMS (NSI): 
Exact mass for C27H26N2O4SBr [M−N2+NH4]+: 553.1009; found: 553.0786. 
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Methyl 2-(2-((N-cinnamyl-4-methylphenyl)sulfonamido)phenyl)-2-diazoacetate 153l: 
Performed according to General Procedure 6 at 22 °C on a 
0.62 mmol scale of 152l with 1.2 mmol p-NBSA and 1.2 mmol 
of DBU. 153l (116 mg, 0.25 mmol, 42%) was obtained as a 
yellow solid, m.p.: 106–108 °C (N2 loss > 60 °C). The 
compound was unstable and decomposed during 
characterisation. The mixture of unreacted starting material, diazo compound and side 
product was used for the following step without further purification. 
1H NMR (400 MHz, CDCl3): δ = 7.54 (d, J = 8.2 Hz, 2H, ArH), 7.26–7.10 (m, 9H, ArH), 
7.08–7.03 (m, 1H, ArH), 6.59 (d, J = 8.0 Hz, 1H, ArH), 6.26 (d, J = 15.8 Hz, 1H,  
CH=CH–Ph), 6.05–5.93 (m, 1H, NCH2CH=CH), 4.39 (br. s, 1H, 1 × NCH2), 3.95 (br. s, 
1H, 1 × NCH2), 3.55 (s, 3H, OCH3), 2.37 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): 
δ = 166.4 (C=O), 144.1 (ArC–N), 137.3 (ArC), 136.2 (ArC), 135.6 (ArC), 135.2 (ArC), 
131.5 (ArC), 129.7 (2 × ArC), 128.9 (ArC), 128.6 (2 × ArC), 128.6 (ArC), 128.4 (2 × ArC), 
128.1 (ArC), 126.6 (2 × ArC), 122.6 (ArC), 54.6 (NCH2), 52.0 (OCH3), 21.7 (CH3) ppm; 
IR (neat): v = 3038w, 2953w, 2099s, 1697s, 1491m, 1431m, 1348s, 1149s cm−1. The 
product decomposed during mass spectrometric analysis.  
Methyl 2-diazo-2-(2-((N-(n-hexyl)-4-methylphenyl)sulfonamido)phenyl) acetate 153m: 
Performed according to the General Procedure 6 at 45 °C on 
a 0.24 mmol scale of 152m. After column chromatography 
153m (41% by 1H NMR) was still obtained as a 1.8 : 1 : 0.4 
mixture of 152m, 153m and a side azide (rotamers 1.3 : 1). 
The mixture of unreacted starting material, diazo compound 
and side product was used for the following step without further purification. 
Methyl 2-diazo-2-(2-((N-(sec-butyl)-4-methylphenyl)sulfonamido)phenyl) acetate 153n: 
Performed according to General Procedure 6 at 45 °C on a 
0.15 mmol scale of 152n; 153n (17 mg, 0.042 mmol, 28%) was 
obtained as a yellow oil, 1:1.3 mixture or rotamers (air-sensitive). 
1H NMR (400 MHz, CDCl3): δ = 7.73–7.59 (m, 3H, ArH), 7.39 (t, J = 
7.7 Hz, 1H, ArH), 7.35–7.28 (m, 2H, ArH), 7.22–7.12 (m, 1H, ArH), 
6.75 (d, J = 8.0 Hz, 0.4H, ArH), 6.69 (d, J = 7.9 Hz, 0.6H, ArHI), 4.27–4.13 (m, 1H, NCH 
+ NCHI), 3.86–3.82 (m, 3H, OCH3 + OCHI3), 2.49–2.42 (m, 0.7H), 1.74–1.62 (m, 0.4H), 
1.30–1.08 (m, 2H), 1.07–0.91 (m, 2H), 0.90–0.71 (m, 3H) ppm; 13C NMR (101 MHz, 
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CDCl3): δ = 167.1 (C=O), 167.0 (CI=O), 143.8 (ArC–N), 143.8 (ArC–N), 138.3 (ArC), 
138.1 (ArC), 134.7 (ArC), 134.5 (ArC), 133.0 (ArC), 132.3 (ArC), 131.4 (ArC), 131.3 
(ArC), 129.8 (2 × ArC), 129.7 (2 × ArC), 129.09 (ArC), 129.08 (ArC), 128.3 (2 × ArC), 
128.1 (2 × ArC), 128.1 (ArC), 127.8 (ArC), 127.6 (2 × ArC), 59.3 (NCH), 59.1 (NCIH), 
52.3 (OCH3), 28.8, 27.8, 21.7, 18.0, 11.6, 11.5 ppm; IR (neat): ν = 2960w, 2850w, 2098s, 
1697s, 1358s, 1165s cm−1. The isolated product decomposed during mass spectrometric 
analysis.  
5.2.3 Diazo-transfer in Flow and DoE 
 
The starting material 152a (81.9–164 mg, 0.2–0.4 mmol) was dissolved in 2 mL of 
acetonitrile together with DBU (1.5–2.5 equiv.) and the internal standard  
(1,3,5-trimethoxybenzene 1 equiv.) and a HSW NORM-JECT® 2 mL syringe was 
equipped with the mixture. At the same time p-NBSA 18f (1–3 equiv.) was dissolved in 
2 mL of acetonitrile and a second HSW NORM-JECT® 2 mL syringe was equipped with 
this solution. Next, the two syringes were loaded on a Chemyx Fusion syringe pump and 
connected to a flow setup via a T-piece mixer and a 1 mL coil (FEP, i.d. = 0.5 mm). The 
pump was then set to 0.1 mL•min−1 (for t = 10 minutes) or 0.02 mL•min−1 (for 
t = 50 minutes) and the entire setup run for 25 or 100 minutes, respectively, to ensure 
the achievement of the steady state. Afterwards, the solution was collected for  
20–60 minutes in a 0.1 M phosphate buffer solution (pH = 7) as quenching agent. 
Extraction was performed with CH2Cl2 (3 × 5 mL), the combined organic layers were 
washed with water, dried over a MgSO4 plug and concentrated under reduced pressure. 
When isolated the desired diazo compound 153a was purified by column 
chromatography (n-hexane / ethyl acetate 80:20). The data from the FFD 25-1 were 
analysed using a FFD and Design Expert® 10.9 
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Table 5.1: Real and coded values (+1 = higher level, −1 = lower level, 0 = central point) for the 
independent variables (k) and responses. 
Factor (k) Type Unit −1 0 +1 
A: 152a Numeric M 0.1 0.15 0.2 
B: Temperature Numeric °C 22 43.5 65 
C: DBU Numeric equiv. 1.5 2 2.5 
D: p-NBSA Numeric equiv. 1 2 3 
E: Time Numeric min 10 30 50 
Responses: 152a (%) 153a (%) 166 (%) 
aYield determined by 1H NMR with 1,3,5-trimethoxybenzene as internal standard. 
 
Table 5.2: Experimental Matrix of the FFD 25-1 in coded values and factor generator. 
Std A B C D E = A*B*C*D 
1 −1 −1 −1 −1 1 
2 1 −1 −1 −1 −1 
3 −1 1 −1 −1 −1 
4 1 1 −1 −1 1 
5 −1 −1 1 −1 −1 
6 1 −1 1 −1 1 
7 −1 1 1 −1 1 
8 1 1 1 −1 −1 
9 −1 −1 −1 1 −1 
10 1 −1 −1 1 1 
11 −1 1 −1 1 1 
12 1 1 −1 1 −1 
13 −1 −1 1 1 1 
14 1 −1 1 1 −1 
15 −1 1 1 1 −1 
16 1 1 1 1 1 
17 0 0 0 0 0 
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Figure 5.3: Half-normal plots for starting material 152a left. 
ANOVA for R1: Starting Material Residue 
 Sum of Squares df Mean Square F-value p-value  
Model 3820.50 5 764.10 28.72 < 0.0001 significant 
B-Temperature 1806.25 1 1806.25 67.89 < 0.0001  
C-DBU 9.00 1 9.00 0.3383 0.5716  
D-p-NBSA 1764.00 1 1764.00 66.31 < 0.0001  
E-time 72.25 1 72.25 2.72 0.1253  
CE 169.00 1 169.00 6.35 0.0269  
Curvature 0.3553 1 0.3553 0.0134 0.9099  
Residual 319.25 12 26.60    
Lack of Fit 311.25 10 31.13 7.78 0.1192 not significant 
Pure Error 8.00 2 4.00    
Cor Total 4140.11 18     
Fit Statistics 
Std. Dev. 5.16  R² 0.9229 
Mean 40.32  Adjusted R² 0.8907 
   Predicted R² 0.8032 
   Adeq Precision 16.9289 
Equations in Terms of Coded Values 
Starting Material Residue = 40.375 + 10.625B − 0.75C − 10.5D − 2.125E + 3.25CE 
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Figure 5.4: Half-normal plots for diazo compound 153a formation. 
ANOVA for R2: Formation of Diazo Compound 
 Sum of Squares df Mean Square F-value p-value  
Model 1215.63 2 607.81 32.92 < 0.0001 significant 
B-Temperature 473.06 1 473.06 25.62 0.0001  
D-p-NBSA 742.56 1 742.56 40.21 < 0.0001  
Curvature 7.92 1 7.92 0.4290 0.5224  
Residual 276.98 15 18.47    
Lack of Fit 258.31 13 19.87 2.13 0.3646 not significant 
Pure Error 18.67 2 9.33    
Cor Total 1500.53 18     
Fit Statistics 
Std. Dev. 4.30  R² 0.8144 
Mean 31.16  Adjusted R² 0.7897 
  
 Predicted R² 0.7097 
   Adeq Precision 12.4261 
 
Equation in Terms of Coded Values 
Diazo Compound Formation = 31.4375 − 5.4375B + 6.8125D 
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Figure 5.5: Half-normal plot for azide 166 formation. 
ANOVA for R3: Formation of Azide 
 Sum of Squares df Mean Square F-value p-value  
Model 243.25 4 60.81 11.48 0.0003 significant 
B-Temperature 189.06 1 189.06 35.70 < 0.0001  
C-DBU 3.06 1 3.06 0.5782 0.4606  
E-time 18.06 1 18.06 3.41 0.0877  
CE 33.06 1 33.06 6.24 0.0267  
Curvature 1.05 1 1.05 0.1989 0.6629  
Residual 68.85 13 5.30    
Lack of Fit 58.19 11 5.29 0.9918 0.6038 not significant 
Pure Error 10.67 2 5.33    
Cor Total 313.16 18     
Fit Statistics 
Std. Dev. 2.30  R² 0.7794 
Mean 15.79  Adjusted R² 0.7115 
C.V. % 14.58  Predicted R² 0.5287 
   Adeq Precision 9.1821 
Equations in Terms of Coded Values 
Azide Formation = 15.6875 − 3.4375B + 0.4375C + 1.0625E − 1.4375CE 
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5.2.4 Synthesis of Dihydroindoles 
General Procedure 7: 
 
An oven-dried 25 mL round bottom flask was equipped with a magnetic stirring bar and 
flushed with argon. Molecular sieves (3 Å, 1.2 g), and Rh2(R-DOSP)4 71a 
(1–0.5 mol%) were added in dry n-hexane. Subsequently, diazo compound 153a–k 
(0.23 mmol) were added (final concentration of starting material 0.13 M) and the yellow 
suspension was vigorously stirred at room temperature under inert atmosphere and 
checked by TLC (100% CH2Cl2) until all diazo compound were consumed  
(12–24 h). The mixture was filtered through a silica-plug, washed with CH2Cl2 (3 × 5 mL) 
and concentrated under vacuum to afford the corresponding product 154a–k as a 
mixture of trans and cis isomers, separated by prep-TLC or column chromatography in 
CH2Cl2. 
Methyl (2S,3S)-2-phenyl-1-tosylindoline-3-carboxylate (S,S)-154a: 
Performed according to General Procedure 7 on a 0.23 mmol scale 
of 153a using 0.5 mol% of Rh2(R-DOSP)4 over 12 h; (S,S)-154a 
(79 mg, 0.19 mmol, 82%, 11:1 d.r., 85% ee) was obtained as a 
colourless solid, m.p.: 130–134 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.76 (d, J = 8.2 Hz, 1H, ArH), 7.65 (d, J = 8.3 Hz, 2H, 
ArH), 7.42–7.25 (m, 7H, ArH), 7.19 (d, J = 8.0 Hz, 2H, ArH), 7.08 (td, J = 7.5, 0.9 Hz, 1H, 
ArH), 5.78 (d, J = 3.7 Hz, 1H, N–CH), 3.91 (d, J = 3.7 Hz, 1H, CH–CO2Me), 3.55 (s, 3H, 
OCH3), 2.36 (s, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 170.6 (C=O), 144.1 (ArC), 
142.3 (ArC), 141.9 (ArC), 134.8 (ArC), 129.6 (2 × ArC), 128.9 (2 × ArC), 128.0 (ArC), 
127.7 (2 × ArC), 127.5 (ArC), 126.4 (ArC), 125.9 (2 × ArC), 124.5 (ArC), 115.8 (ArC), 
67.0, 55.8, 52.8, 21.7(CH3) ppm; IR (neat): ν = 3032w, 2954w, 1732s, 1597m, 1477m, 
1354s, 1238m, 1166s, 1155s, 1103m, 1089m, 1014m, 952m, 810m, 678s, 570s, 543s 
cm−1; HMRS: Exact mass calculated for C23H21NO4SNH4 [M+NH4]+: 425.1530; found: 
425.1525; HPLC (7:93 e.r.): Chiracel® OD-H (250 × 4.6 mm, 5 μm), 
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n-hexane/isopropanol 99:1 (v/v), 1.0 mL•min−1, 10 °C, λ = 254 nm, retention time 
(R,R)-154a = 33.1 min, retention time (S,S)-154a = 36.7 min. 
In a similar reaction with Rh2(S-DOSP)4 the product (R,R)-154a was obtained as the 
major isomer and crystallised for the determination of the X-ray structure. (R,R)-154a: [𝛼]𝐷20: +40° (c 0.10, CHCl3). 
 
Figure 5.6: X-ray structure of (R,R)-154a.d 
 
Peak # Time (min) Area (%) 
1 33.318 49.594 
2 38.876 50.406 
 
 
Peak # Time (min) Area (%) 
1 33.086 7.423 
2 36.694 92.577 
Figure 5.7: HPLC chromatograms of trans-154a enantiomers. From the top: racemic mixture, 
85% ee of (S,S)-154a. 
 
 
d.  Measured by Dr. Benson Kariuki at Cardiff University, School of Chemistry 
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Methyl (2R,3S)-2-phenyl-1-tosylindoline-3-carboxylate (R,S)-154a: 
cis-154a was obtained as the minor product as a colourless oil after 
prep-TLC. 
1H NMR (500 MHz, CDCl3): δ = 7.71 (d, J = 8.2 Hz, 1H, ArH), 7.52 
(d, J = 8.0 Hz, 2H, ArH), 7.34 (t, J = 7.5 Hz, 1H, ArH), 7.24–7.06 (m, 9H. ArH), 5.59 (d, 
J = 10.0 Hz, 1H, N–CH), 4.37 (d, J = 9.8 Hz, 1H, CH–CO2Me), 3.22 (s, 3H, OCH3), 2.36 
(s, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 169.7 (C=O), 144.2 (ArC), 142.8 
(ArC), 137.5 (ArC), 135.4 (ArC), 129.8 (2 × ArC), 129.1 (ArC), 128.7 (ArC), 128.5 (ArC), 
128.3 (2 × ArC), 127.3 (2 × ArC), 127.2 (2 × ArC), 127.0 (ArC), 124.9 (ArC), 116.2 (ArC), 
67.4, 52.8, 51.8, 21.7 (CH3) ppm; IR (neat): ν = 3032w, 2954w, 1732s, 1597m, 1477m, 
1354s, 1238m, 1166s, 1155s, 1103m, 1089m, 1014m, 952m, 810m, 678s, 570s, 543s 
cm−1; HMRS: Exact mass calculated for C23H21NO4SNH4 [M+NH4]+: 425.1530; found: 
425.1525; HPLC: YMC Chiral Amylose-C S (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 
90:10 (v/v), 1.0 mL•min−1, 25 °C, λ = 254 nm, retention time first isomer = 17.5 min, 
retention time second isomer = 37.9 min. 
Isopropyl (2S,3S)-2-phenyl-1-tosylindoline-3-carboxylate (S,S)-154b: 
Performed according to General Procedure 7 on a 0.10 mmol scale 
of 153b using 1 mol% of Rh2(R-DOSP)4 over 12 h; 154b (27 mg, 
0.062 mmol, 62%, 2.2:1 d.r., 35% ee) was obtained as a colourless 
solid m.p.: 120–124 °C; [𝛼]𝐷20: +5.6° (c 0.36, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.64 (d, J = 8.1 Hz, 1H, ArH), 7.55 (d, J = 7.8 Hz, 2H, 
ArH), 7.37–7.12 (m, 7H, ArH), 7.07 (d, J = 8.1, Hz, 2H, ArH), 6.96 (t, J = 7.5 Hz, 1H, 
ArH), 5.69 (d, J = 4.0 Hz, 1H, N–CH), 4.78 (septet, J = 6.2 Hz, 1H, OCH), 3.77 (d, J = 
3.8 Hz, 1H, CH–CO2i-Pr), 2.24 (s, 3H, CH3), 1.10 (d, J = 6.2 Hz, 3H, CH3), 1.01 (d, J = 
6.2 Hz, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 169.7 (C=O), 144.0 (ArC), 142.6 
(ArC), 142.0 (ArC), 134.8 (ArC), 129.6 (2 × ArC), 129.4 (ArC), 128.9 (2 × ArC), 128.0 
(ArC), 127.7 (2 × ArC), 127.6 (ArC), 126.3 (ArC), 126.0 (ArC), 124.3 (ArC), 115.6 (ArC), 
69.4, 66.9, 56.0, 21.8 (CH3), 21.6 (2 × CH3) ppm; IR (neat): ν = 2962w, 2341s, 2262w, 
1735m, 1724w, 1597w, 1477m, 1458m, 1357m, 1323w, 1259m, 1238w, 1166s, 1101s, 
1010m, 908s, 864w, 798m cm−1; HRMS (NSI): Exact mass calculated for C26H21NO4S 
[M+H]+: 426.1577; found: 426.1571; HPLC (32:68) YMC Chiral Amylose-C S (250 × 
4.6 mm, 5 μm), n-hexane / isopropanol 90:10 (v/v), 1.0 mL•min−1, 25 °C, λ = 254 nm, 
retention time minor isomer = 9.9 min, retention time second isomer = 14.9 min. The 
HPLC chromatograms are reported in literature.10 
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Methyl (2S,3S)-2-(4-methoxyphenyl)-1-tosylindoline-3-carboxylate (S,S)-154c: 
Performed according to General Procedure 7 on a 
0.14 mmol scale of 153c using 1 mol% of Rh2(R-DOSP)4 
over 24 h; 154c (32 mg, 0.080 mmol, 57%, 4:1 d.r, 55% ee) 
was obtained as a pale yellow solid m.p.: 60–64 °C; [𝛼]𝐷20: 
+23.2° (c 0.11, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.73 (d, J = 8.2 Hz, 1H, ArH), 7.63 (d, J = 8.3 Hz, 2H, 
ArH), 7.35–7.24 (m, 4H, ArH), 7.18 (d, J = 8.1 Hz, 2H, ArH), 7.06 (td, J = 7.5, 1.0 Hz, 1H, 
ArH), 6.84 (dt, J = 8.9, 2.2 Hz, 2H, ArH), 5.71 (d, J = 3.7 Hz, 1H, N–CH), 3.90 (d, J = 
3.7 Hz, 1H, CH–CO2Me), 3.78 (s, 3H, OCH3), 3.54 (s, 3H, OCH3), 2.35 (s, 3H, CH3) ppm; 
13C NMR (101 MHz, CDCl3): δ = 170.8 (C=O), 159.4 (ArC), 144.0 (ArC), 141.9 (ArC), 
134.9 (ArC), 134.6 (ArC), 129.5 (2 × ArC), 127.7 (2 × ArC), 127.5 (ArC), 127.2 (2 × ArC), 
126.4 (ArC), 124.4 (ArC), 115.7 (ArC), 114.3 (2 × ArC), 66.7, 55.8, 55.4, 52.7, 21.6 (CH3) 
ppm; IR (neat): ν = 2937w, 1740s, 1512m, 1477m, 1460m, 1362m, 1217m, 1163s, 
1105m, 1090m, 1026m, 812m, 706m, 658m cm−1; HRMS (APCI): Exact mass calculated 
for C24H23NO5S [M+H]+: 438.1375; found: 438.1375; HPLC (24:76 e.r.): YMC Chiral 
Amylose-C S (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 85:15 (v/v), 1.0 mL•min−1, 
10 °C, λ = 254 nm, retention time minor isomer = 26.1 min, retention time major isomer 
= 62.5 min. 
 
Peak # Time (min) Area (%) 
1 26.237 50.805 
2 62.870 49.195 
Figure 5.8: HPLC chromatograms of the racemic mixture of trans-154c. 
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Peak # Time (min) Area (%) 
1 24.040 24.115 
2 57.720 75.885 
Figure 5.9: HPLC chromatograms of trans-154c enantiomers (55% ee). 
Methyl (2S,3S)-1-tosyl-2-(4-(trifluoromethyl)phenyl)indoline-3-carboxylate (S,S)-154d: 
Performed according to General Procedure 7 on a 0.12 mmol 
scale of 153d using 0.5 mol% of Rh2(R-DOSP)4 over 12 h; 154d 
(45 mg, 0.09 mmol, 82%, 5:1 d.r., 80% ee) was obtained as a 
colourless solid m.p.: 66–70 °C; [𝛼]𝐷20: +25.9° (c 0.15, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.78 (d, J = 8.2 Hz, 1H, ArH), 7.65 (d, J = 8.3 Hz, 2H, 
ArH), 7.59 (d, J = 8.3 Hz, 2H, ArH), 7.50 (d, J = 8.4 Hz, 2H), 7.38–7.32 (m, 1H, ArH), 
7.31–7.24 (m, 1H, ArH), 7.20 (d, J = 8.0 Hz, 2H, ArH), 7.09 (td, J = 7.5, 0.9 Hz, 1H, ArH), 
5.81 (d, J = 3.8 Hz, 1H, N–CH), 3.87 (d, J = 3.8 Hz, 1H, CH–CO2Me), 3.57 (s, 3H, OCH3), 
2.35 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 170.4 (C=O), 146.1 (ArC), 144.4 
(ArC), 141.7 (ArC), 134.4 (ArC), 130.0 (q, J = 32.6 Hz, ArC–CF3), 129.8 (ArC), 129.7 
(2 × ArC), 127.7 (2 × ArC), 126.9 (ArC), 126.5 (ArC), 126.4 (2 × ArC), 126.0 (q, J = 3.7 
Hz, ArC), 124.6 (ArC), 123.7 (q, J = 222.6 Hz, CF3), 115.8 (ArC), 66.5, 55.6, 52.9, 21.7 
(CH3) ppm; IR (neat): ν = 2955w, 2925w, 1736s, 1597w, 1477m, 1462m, 1358s, 1323s, 
1161s, 1109s, 1089s, 1066m, 812m, 752m, 656m cm−1; HRMS (APCI): Exact mass 
calculated for C24H21NO4SF3 [M+H]+: 476.1143, found: 476.1154; HPLC (10:90 e.r.): 
YMC Chiral Amylose-C S (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 95:5 (v/v), 
1.0 mL•min−1, 10 °C, λ = 254 nm, retention time minor isomer = 25.3 min, retention time 
major isomer = 35.7 min. The HPLC chromatograms are reported in literature.10 
Methyl (2S,3S)-2-(p-tolyl)-1-tosylindoline-3-carboxylate (S,S)-154e: 
Performed according to General Procedure 7 on a 0.13 mmol 
scale of 153f using 0.5 mol% of Rh2(R-DOSP)4 for 12 h; 154e (52 
mg, 0.12 mmol, 92%, 14:1 d.r., 42% ee) was obtained as a 
colourless solid m.p.:132–134 °C; [𝛼]𝐷20: +33.7° (c 0.29, CHCl3). 
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1H NMR (400 MHz, CDCl3): δ = 7.75 (d, J = 8.1 Hz, 1H, ArH), 7.65 (d, J = 8.2 Hz, 2H, 
ArH), 7.37–7.22 (m, 4H, ArH), 7.19 (d, J = 8.0 Hz, 2H, ArH), 7.13 (d, J = 7.9 Hz, 2H, 
ArH), 7.06 (t, J = 7.5 Hz, 1H, ArH), 5.65 (d, J = 3.6 Hz, 1H, N–CH), 3.82 (d, J = 3.4 Hz, 
1H, CH–CO2Me), 3.47 (s, 3H, OCH3), 2.28 (s, 3H, CH3), 2.25 (s, 3H, CH3) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 170.8 (C=O), 144.0 (ArC), 142.0 (ArC), 139.4 (ArC), 137.8 (ArC), 
134.9 (ArC), 129.6 (2 × ArC), 129.5 (2 × ArC), 127.7 (2 × ArC), 127.5 (ArC), 126.4 (ArC), 
125.9 (2 × ArC), 124.3 (ArC), 115.7 (ArC), 66.9, 55.8, 52.7, 21.6 (CH3), 21.2 (CH3) ppm; 
IR (neat): ν = 3022w, 2953w, 1735s, 1597m, 1514m, 1477m, 1460m, 1433m, 1354s, 
1307w, 1238m, 1161s, 1089m, 1020m, 960m,914m, 813s, 680s, 657s, 617m, 574s 
cm−1; HRMS (NSI): Exact mass calculated for C24H24NO4S [M+H]+: 422.1426, Found: 
422.1428; HPLC (29:71 e.r.): YMC Chiral Amylose-C S (250 × 4.6 mm, 5 μm), 
n-hexane/isopropanol 90:10 (v/v), 1.0 mL•min−1, 25 °C, λ = 254 nm, retention time minor 
isomer = 18.2 min, retention time major isomer = 39.2 min. The HPLC chromatograms 
are reported in literature.10 
Methyl (2S,3S)-2-(m-tolyl)-1-tosylindoline-3-carboxylate (S,S)-154f: 
Performed according to General Procedure 7 on a 0.08 mmol scale 
of 153g using 0.5 mol% of Rh2(R-DOSP)4 for 12 h; 154f (22 mg, 
0.051 mmol, 73%, 8:1 d.r., 71% ee) was obtained as a colourless 
solid m.p.: 38–40 °C; [𝛼]𝐷20: +24.7° (c 0.24, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.76 (d, J = 8.2 Hz, 1H, ArH), 7.64 (d, J = 7.9 Hz, 2H, 
ArH), 7.30–7.25 (m, 1H, ArH), 7.23–7.12 (m, 5H, ArH), 7.10–7.03 (m, 2H, ArH), 5.74 (d, 
J = 3.0 Hz, 1H, N–CH), 3.90 (d, J = 2.9 Hz, 1H, CH–CO2Me), 3.55 (s, 3H, OCH3), 2.35 
(s, 3H, CH3), 2.31 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 170.8 (C=O), 144.0 
(ArC), 142.2 (ArC), 142.0 (ArC), 138.7 (ArC), 134.9 (ArC), 129.5 (2 × ArC), 128.9 (ArC), 
128.8 (ArC), 127.7 (2 × ArC), 127.5 (ArC), 126.5 (ArC), 126.4 (ArC), 124.4 (ArC), 123.0 
(ArC), 115.8 (ArC), 67.0, 55.9, 52.7, 21.6 (CH3), 21.6 (CH3) ppm; IR (neat): ν = 3030w, 
2951w, 2922w, 2850w, 1735s, 1597m, 1477s, 1460s, 1433m, 1354s, 1234m, 1163s, 
1089s, 1024m, 881w, 812m, 754s, 704s, 680s, 657s cm−1; HRMS (NSI): Exact mass 
calculated for C24H27N2O4S [M+NH4]+: 439.1686; found: 439.1682; HPLC (15:85 e.r.): 
YMC Chiral Amylose-C S (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 90:10 (v/v), 
1.0 mL•min−1, 25 °C, λ = 254 nm, retention time minor isomer = 11.6 min, retention time 
major isomer = 22.8 min. The HPLC chromatograms are reported in literature.10 
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Methyl (2R,3R)-2-([1,1'-biphenyl]-2-yl)-1-tosylindoline-3-carboxylate (S,S)-154g: 
Performed according to General Procedure 7 on a 0.10 mmol scale 
of 153h using 1 mol% of Rh2(R-DOSP)4 for 24 h; (S,S)-154g (35 mg, 
0.072 mmol, 72%, 8:1 d.r., 80% ee) was obtained as a colourless 
solid m.p.: 199–201 °C; [𝛼]𝐷20: +40.0° (c 0.10, CHCl3).  
1H NMR (400 MHz, CDCl3): δ = 7.75 (d, J = 8.2 Hz, 1H, ArH), 7.51–7.38 (m, 8H, ArH), 
7.35–7.21 (m, 4H, ArH), 7.14–7.08 (m, 3H), 7.00 (td, J = 7.5, 1.0 Hz, 1H, ArH), 5.83 (d, 
J = 3.6 Hz, 1H, N–CH), 3.77 (d, J = 3.6 Hz, 1H, CH–CO2Me), 3.15 (s, 3H, OCH3), 2.31 
(s, 3H, Ar–CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 170.1 (C=O), 143.8 (ArC), 142.1 
(ArC), 140.8 (ArC), 140.6 (ArC), 140.0 (ArC), 134.6 (ArC), 130.0 (ArC), 129.9 (2 × ArC), 
129.6 (ArC), 129.4 (2 × ArC), 128.4 (ArC), 128.3 (2 × ArC), 127.8 (2 × ArC), 127.6 (ArC), 
127.5 (ArC), 127.3 (ArC), 125.7 (ArC), 125.6 (ArC), 124.3 (ArC), 115.4 (ArC), 64.1, 56.0, 
52.2, 21.6 (Ar–CH3) ppm; IR (neat): ν = 2983w, 1735s, 1356m, 1228.7m, 1217m, 1167m, 
1091w, 959w, 752m, 692m cm−1; HRMS (APCI): Exact mass calculated for C29H26NO4S 
[M+H]+: 484.1583; found: 484.1573; HPLC (10:90 e.r.): YMC Chiral Amylose-C S 
(250 × 4.6 mm, 5 μm), n-hexane/isopropanol 95:5 (v/v), 1.0 mL•min−1, 10 °C, λ = 254 
nm, retention time first isomer = 21.7 min, retention time second isomer = 32.5 min. 
 
Peak # Time (min) Area (%) 
1 23.061 50.273 
2 33.427 49.727 
Figure 5.10: HPLC chromatograms of racemic mixture of trans-154e enantiomers. 
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Peak # Time (min) Area (%) 
1 22.217 10.188 
2 33.005 89.812 
Figure 5.11: HPLC chromatograms of trans-154e enantiomers (80% ee). 
Methyl (2S,3S)-2-(o-tolyl)-1-tosylindoline-3-carboxylate (S,S)-154h: 
Performed according to General Procedure 7 on a 0.08 mmol scale 
of 153i using 0.5 mol% of Rh2(R-DOSP)4 for 12 h; 154h (29 mg, 
0.07 mmol, 86%, 8:1 d.r., 61% ee) was obtained as a colourless 
solid m.p.: 40–42 °C; [𝛼]𝐷20: +22.9° (c 0.34, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.68 (d, J = 8.2 Hz, 1H, ArH), 7.62 (d, J = 8.1 Hz, 2H, 
ArH), 7.26 (t, J = 7.8 Hz, 1H, ArH), 7.22–7.02 (m, 7H, ArH), 6.98 (t, J = 7.5 Hz, 1H, ArH), 
5.94 (d, J = 3.4 Hz, 1H, N–CH), 3.72 (d, J = 3.1 Hz, 1H, CH–CO2Me), 3.47 (s, 3H, OCH3), 
2.35 (s, 3H, CH3), 2.29 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 170.8 (C=O), 
144.0 (ArC), 142.1 (ArC), 140.5 (ArC), 135.2 (ArC), 134.1 (ArC), 130.9 (ArC), 129.6 
(ArC), 129.6 (2 × ArC), 127.8 (ArC), 127.7 (2 × ArC), 127.4 (ArC), 126.7 (ArC), 126.4 
(ArC), 125.9 (ArC), 124.3 (ArC), 115.4 (ArC), 64.3, 55.2, 52.7, 21.7 (CH3), 19.6 (CH3) 
ppm; IR (neat): ν = 2953w, 2922w, 1734s, 1597m, 1477s, 1460s, 1354s, 1305m, 1290s, 
1089m, 1024m, 958m, 918w, 812m, 750s, 727m, 705m, 680s, 657s cm−1; HRMS (NSI): 
Exact mass calculated for C24H24NO4S [M+H]+: 422.1421; found: 422.1422; HPLC (19:81 
e.r.): YMC Chiral Amylose-C S (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 90:10 (v/v), 
1.0 mL•min−1, 25 °C, λ = 254 nm, retention time major isomer = 11.5 min, retention time 
minor isomer = 30.0 min. 
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Peak # Time (min) Area (%) 
1 10.527 50.625 
2 28.113 49.375 
 
Peak # Time (min) Area (%) 
1 11.527 19.323 
2 29.981 80.677 
Figure 5.12: HPLC chromatograms of trans-154f enantiomers. From the top: racemic mixture, 
61% ee. 
Methyl (2S,3S)-2-(1-bromonaphthalen-2-yl)-1-tosylindoline-3-carboxylate (S,S)-154i: 
Performed according to General Procedure 7 on a 0.048 mmol 
scale of 153k using 0.5 mol% of Rh2(R-DOSP)4 for 12 h; 
(S,S)-154i (13 mg, 0.023 mmol, 48%, 6:1 d.r, 75% ee) was 
obtained as a colourless oil; [𝛼]𝐷20: +14.0° (c 0.14, CHCl3).  
1H NMR (300 MHz, CDCl3): δ = 8.34 (d, J = 8.1 Hz, 1H, ArH), 8.01–7.66 (m, 5H, ArH), 
7.66–7.45 (m, 3H, ArH), 7.36 (t, J = 7.7 Hz, 1H, ArH), 7.31–7.09 (m, 3H, ArH), 7.06 (t, 
J = 7.4 Hz, 1H, ArH), 6.43 (d, J = 3.4 Hz, 1H, N–CH), 3.90 (d, J = 2.5 Hz, 1H,  
CH–CO2Me), 3.56 (s, 3H, OCH3), 2.39 (s, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ 
=
 170.6 (C=O), 144.3 (ArC), 142.0 (ArC), 139.6 (ArC), 134.8 (ArC), 134.3 (ArC), 132.5 
(ArC), 129.9 (ArC), 129.7 (2 × ArC), 128.7 (ArC), 128.3 (ArC), 128.0 (2 × ArC), 127.8 
(ArC), 127.5 (ArC), 126.9 (ArC), 126.0 (ArC), 124.5 (ArC), 124.4 (ArC), 124.4 (ArC), 
121.6 (ArC), 115.4 (ArC), 67.5, 55.3, 52.8, 21.7 (CH3) ppm; IR (neat): ν = 3752w, 3629w, 
2952w, 2917w, 2849w, 2342s, 1734s, 1596m, 1478m, 1461m, 1356s, 1326m, 1255m, 
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1239m, 1164s, 1108s, 1090s, 1024m, 962m, 906w, 812s, 729s, 575s cm−1; HRMS (NSI): 
Exact mass calculated for C27H23BrNO4S [M+H]+: 539.0526; found: 539.0522; HPLC 
(12:88 e.r.): YMC Chiral Amylose-C S (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 90:10 
(v/v), 1.0 mL•min−1, 25 °C, λ = 254 nm, retention time first isomer = 24.3 min, retention 
time second isomer = 38.6 min. The HPLC chromatograms are reported in literature.10 
Methyl (2S,3S)-2-((E)-styryl)-1-tosylindoline-3-carboxylate (S,S)-154j: 
Performed according to General Procedure 7 on a 0.11 mmol scale 
of 153l using 0.5 mol% of Rh2(R-DOSP)4 for 24 h; 154j (23 mg, 
0.053 mmol, 53%, 7:1 d.r., 33% ee) was obtained as a colourless 
solid m.p.: 52–54 °C; [𝛼]𝐷20: +7.2° (c 0.28, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.70–7.59 (m, 2H, ArH), 7.33–7.15 (m, 8H, ArH), 7.12 
(d, J = 8.0 Hz, 2H, ArH), 6.98 (t, J = 7.6 Hz, 1H, ArH), 6.70 (d, J = 15.6 Hz, 1H,  
CH=CH–Ph), 6.16 (dd, J = 15.8, 7.2 Hz, 1H, CH=CH–Ph), 5.31 (dd, J = 6.5, 3.1 Hz, 1H, 
N–CH), 3.76 (d, J = 2.9 Hz, 1H, CH–CO2Me), 3.46 (s, 3H, OCH3), 2.28 (s, 3H, CH3) ppm; 
13C NMR (101 MHz, CDCl3): δ = 170.5 (C=O), 144.0 (ArC), 141.4 (ArC), 136.2 (ArC), 
135.2 (ArC), 131.9 (ArC), 129.6 (2 × ArC), 129.5, 128.5 (2 × ArC), 128.1, 128.0, 127.7 
(2 × ArC), 127.6, 126.9 (2 × ArC), 126.4, 124.3, 116.0 (ArC), 66.1, 53.0, 52.7, 21.6 (CH3) 
ppm; IR (neat): ν = 3026w, 2949w, 2850w, 2358w, 1735s, 1597m, 1477m, 1460m, 
1435m, 1354s, 1228s, 1217s, 1163s, 1105m, 1089m, 1024m, 962m, 812m, 754m cm−1; 
HRMS (NSI): Exact mass calculated for C25H24NO4S [M+H]+: 434.1400; found: 434.1410; 
HPLC (66:34 e.r.): Chiracel® OD-H (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 95:5 
(v/v), 1.0 mL•min−1, 25 °C, λ = 254 nm, retention time major isomer = 22.5 min, retention 
time minor isomer = 29.1 min. The HPLC chromatograms are reported in literature.10 
Methyl (2S,3S)-2-pentyl-1-tosylindoline-3-carboxylate (S,S)-154k: 
Performed according to General Procedure 7 on a 0.09 mmol 
scale of 153m using 0.5 mol% of Rh2(R-DOSP)4 for 12 h; 154k 
(23 mg, 0.058 mmol, 64%, >20:1 d.r, 48% ee) was obtained as a 
pale yellow oil; [𝛼]𝐷20: +44.1° (c 0.41, CHCl3). 
1H NMR (300 MHz, CDCl3): δ = 7.67 (d, J = 8.1 Hz, 1H, ArH), 7.62–7.53 (m, 2H, ArH), 
7.33–7.22 (m, 2H, ArH), 7.15 (d, J = 8.0 Hz, 2H, ArH), 7.04 (td, J = 7.6, 1.0 Hz, 1H, ArH), 
4.62 (ddd, J = 8.0, 4.6, 3.1 Hz, 1H, N–CH), 3.61 (d, J = 2.9 Hz, 1H, CH–CO2Me), 3.41 
(s, 3H, OCH3), 2.33 (s, 3H, CH3), 2.03–1.86 (m, 1H), 1.86–1.64 (m, 1H), 1.44–1.20 (m, 
6H), 0.88 (t, J = 6.9, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 13C NMR (101 MHz, 
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CDCl3) δ = 171.1 (C=O), 143.8 (ArC), 141.6 (ArC), 134.8 (ArC), 129.4 (2 × ArC), 129.3 
(ArC), 128.7 (ArC), 127.6 (2 × ArC), 126.4 (ArC), 124.4 (ArC), 116.7 (ArC), 65.0, 52.4, 
51.5, 37.1, 31.5, 24.1, 22.6, 21.6, 14.1 ppm; IR (neat): ν = 3736w, 3601w, 3005w, 2360s, 
2341s, 1707s, 1363m, 1224m, 1166w, 669m, 534m, 420w cm−1; HRMS (NSI): Exact 
mass calculated for C22H28NO4S [M+H]+: 402.1734; found: 402.1728; HPLC (26:74 e.r.): 
Chiracel® OD-H (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 99:1 (v/v), 1.0 mL•min−1, 
25 °C, λ = 254 nm, retention time minor isomer = 13.4 min, retention time major isomer = 
15.1 min. The HPLC chromatograms are reported in literature.10 
5.2.5 In-Situ 1H NMR Experiment: Temperature Effect 
  
Figure 5.13: 1H NMR (300 MHz, CD3CN). a) Comparison of crude mixtures for reaction performed 
at room temperature, 45 °C and 65 °C; b) Thermostability test for 153a at 65 °C for 48 h. 
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5.2.6 Evidence for Triazene 167 
  
 
Figure 5.14: Crude NMR (300 MHz, CDCl3) of triazene 167b as a 1:2 mixture of rotamers. The 
reaction was performed on a 0.24 mmol scale of 152a (100 mg), quenched with cold H2O after 
10 minutes and extracted with dichloromethane. 
  
CH2Cl2 
CHCl3 DBU 
 Experimental Part Micol Santi 
 
196 
5.3 Experimental Data for Chapter 3: 
Synthesis of Fluorinated Benzofuranones 
Triphenylborane 106a was purchased from Sigma Aldrich. The synthesis of boranes 
106b–f was performed by Darren M. C. Ould, Dr. Jan Wenz, Dr. Yashar Soltani and 
Jamie L. Carden. The Lewis acidity was determined by Dr. Soltani according to the 
Gutmann-Beckett method.11  
5.3.1 Synthesis of Diazo Precursors 
 Synthesis of Diazo Compound 107 
 
Ethyl 2-methyl-3-oxobutanoate 204: 
To a stirred suspension of NaH (60%wt in mineral oil, 2.3 g, 60 mmol), 
in dry THF (40 mL), acetoacetate 201 (7.6 mL, 60 mmol), was added 
at 0 °C. Once the grey suspension turned into a brown clear solution, 
methyl iodide (2.5 mL, 40 mmol) was added and the reaction was heated under reflux 
overnight. A saturated solution of aqueous NH4Cl was added at room temperature, and 
the product was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were 
washed with brine and dried over MgSO4 and the solvent was evaporated under reduced 
pressure. The crude was purified by column chromatography to afford 204 as a 
colourless oil (3.8 g, 26 mmol, 65% yield). 
1H NMR (500 MHz, CDCl3): δ = 4.29–4.12 (m, 2H, OCH2), 3.49 (q, J = 7.2 Hz, 1H, CH), 
2.23 (s, 3H, CH3), 1.34 (d, J = 7.2 Hz, 3H, CHCH3), 1.27 (t, J = 7.0 Hz, 3H, 
OCH2CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 203.8 (C=O), 170.7 (C=O), 61.5 
(OCH2), 53.8 (CHCH3), 28.5 (CH3), 14.2 (CH3), 12.8 (CH3) ppm. The spectroscopic data 
are in agreement with the literature.12 
Ethyl 2-diazopropanoate 107: 
To a stirred solution of 204 (1.8 g, 12 mmol) and 
p-acetamidobenzenesulfonyl azide, (p-ABSA, 4.3 g, 18 mmol) in 
acetonitrile (30 mL) at 0 °C, 8-diazabicyclo(5.4.0)undec-7-ene (DBU, 
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2.7 mL, 1.8 mmol) was added dropwise. The reaction was stirred for 12 hours before 
quenching with a saturated aqueous solution of NH4Cl. The product was extracted with 
CH2Cl2 (3 × 20 mL). The combined organic layers were washed with water, brine and 
dried over MgSO4. Compound 107 was afforded as a volatile bright yellow oil (802 mg, 
6.3 mmol, 52% yield) after column chromatography. 
1H NMR (500 MHz, CDCl3): δ = 4.21 (q, J = 7.1 Hz, 2H, OCH2), 1.95 (s, 3H, CH3), 1.27 
(t, J = 7.1 Hz, 3H, OCH2CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 60.9 (OCH2), 14.7 
(CH3), 8.6 (CH3) ppm (C=N2 and C=O not observed); IR (neat): v = 2980w, 2075s, 1682s, 
1304s, 1124s, 734m cm−1. The spectroscopic data are in agreement with the literature.13 
 Synthesis of Diazo Compounds 179a–g 
 
Except for 202f which was commercially available 202a–e were obtained following 
General Procedure 8: The arylacetic acid 205a–e (4–10 mmol) was dissolved in 
methanol and the 0.5 M solution was cooled down at 0 °C before addition of acetyl 
chloride (2.5 equiv.). The reaction was stirred at room temperature for 4–12 hours and 
checked by TLC (n-hexane/ethyl acetate). The solvent was evaporated in vacuo and the 
residual oil washed with a saturated solution of NaHCO3 and extracted with diethyl ether. 
Subsequently, the combined organic layers were washed with water and brine, dried 
over MgSO4 and concentrated in vacuo to afford the pure product 202a–e as an oil or a 
solid depending on the substrate. 
Methyl 2-(2-bromopheyl)acetate 202a:  
Performed according to General Procedure 8 on a 4.6 mmol scale 
of 205a; 202a (1.1 g, 4.4 mmol, 96% yield) was obtained as a 
pale-yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 7.54 (d, J = 7.7 Hz, 1H, ArH), 7.28–7.21 (m, 2H, ArH), 
7.15–7.08 (m, 1H, ArH), 3.77 (s, 2H, CH2), 3.68 (s, 3H, OCH3) ppm; 13C NMR (101 MHz, 
CDCl3): δ = 171.0 (C=O), 134.2 (ArC), 132.9 (ArC), 131.6 (ArC), 128.9 (ArC), 127.6 
(ArC), 125.1 (ArC), 52.3 (OCH3), 41.6 (CH2) ppm. Spectroscopic data are in accordance 
with the literature.14 
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Methyl 2-(4-(trifluoromethyl)phenyl)acetate 202b: 
Performed according to General Procedure 8 on a 4.9 mmol 
scale of 205b; 202b (900 mg, 4.1 mmol, 84% yield) was 
obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.59 (d, J = 8.1 Hz, 2H, ArH), 7.40 (d, J = 8.0 Hz, 2H, 
ArH), 3.71 (s, 3H, OCH3), 3.69 (s, 2H, CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 171.3 
(C=O), 138.1 (q, J = 1.3 Hz, ArC), 129.8 (2 × ArC), 129.6 (q, J = 32.5 Hz, ArC–CF3), 
125.6 (q, J = 3.8 Hz, 2 × ArC), 124.3 (q, J = 272.0 Hz, CF3), 52.3 (OCH3), 41.0 (CH2) 
ppm; Spectroscopic data are in accordance with the literature.15 
methyl 2-(4-methoxyphenyl)acetate 202c: 
Performed according to General Procedure 8 on a 6.0 mmol 
scale of 205c; 202c (857 mg, 4.7 mmol, 80% yield) was 
obtained as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.26–7.11 (m, 2H, ArH), 6.95–6.80 (m, 2H, ArH), 3.79 
(s, 3H, OCH3), 3.69 (s, 3H, OCH3), 3.57 (s, 2H, CH2) ppm; 13C NMR (101 MHz, CDCl3): 
δ = 172.5 (C=O), 158.8 (ArC–OMe), 130.4 (2 × ArC), 126.2 (ArC), 114.1 (2 × ArC), 55.4 
(OCH3), 52.1 (OCH3), 40.4 (CH2) ppm. Spectroscopic data are in accordance with the 
literature.16 
Methyl 2-(naphthalen-1-yl)acetate 202d: 
Performed according to General Procedure 8 on a 10.7 mmol 
scale of 205d; 202d (1.9 g, 9.5 mmol, 89% yield) was obtained as 
a colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 8.02–7.97 (m, 1H, ArH), 7.87 (dd, J = 8.3, 1.1 Hz, 1H, 
ArH), 7.81 (dd, J = 7.5, 1.7 Hz, 1H, ArH), 7.58–7.39 (m, 4H, ArH), 4.09 (s, 2H, ArCH2), 
3.69 (s, 3H, OCH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 172.2 (C=O), 133.9 (ArC), 
132.2 (ArC), 130.6 (ArC), 128.9 (ArC), 128.2 (ArC), 128.2 (ArC), 126.6 (ArC), 125.9 
(ArC), 125.6 (ArC), 123.9 (ArC), 52.3 (OCH3), 39.2 (CH2) ppm. Spectroscopic data are 
in accordance with the literature.17 
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Methyl 2-(2-iodopheyl)acetate 202e: 
Performed according to General Procedure 8 on a 11.5 mmol scale 
of 205e; 202e (2.1 g, 7.6 mmol, 66% yield) was obtained as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.85 (dd, J = 7.9, 1.1 Hz, 1H, ArH), 7.37–7.25 (m, 2H, 
ArH), 7.03–6.87 (m, 1H, ArH), 3.81 (s, 2H, CH2), 3.73 (s, 3H, OCH3) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 171.1 (C=O), 139.7 (ArC), 137.8 (ArC), 130.8 (ArC), 129.1 (ArC), 
128.6 (ArC), 101.1 (ArC–I), 52.4 (OCH3), 46.3 (CH2) ppm. Spectroscopic data are in 
accordance with the literature.18 
General Procedure 9: A 0.2 M solution of methyl arylacetates 202a–f or 155a  
(2–4 mmol) and p-ABSA (2 equiv.) in acetonitrile was cooled down to 0 °C before the 
addition of DBU (2.5 equiv.). The reaction was stirred at room temperature for  
4–48 hours and monitored by TLC (n-hexane/ethyl acetate). The mixture was quenched 
with a saturated aqueous solution of NH4Cl saturated solution and the product was 
extracted with CH2Cl2. The combined organic layers were washed with water, brine, dried 
over MgSO4 and concentrated under reduced pressure. The crudes were purified by 
flash column chromatography to afford the pure products 179a–g as an oil or a solid 
depending on the substrate. 
Methyl 2-(2-bromopheyl)diazoacetate 179a: 
Performed according to General Procedure 9 on a 2.0 mmol scale of 
202a; 179a (500 mg, 1.9 mmol, 96% yield) was obtained as a bright 
yellow oil. 
1H NMR (500 MHz, CDCl3): δ = 7.63 (dd, J = 8.1, 1.2 Hz, 1H, ArH), 7.52 (dd, J = 7.8, 
1.6 Hz, 1H, ArH), 7.38 (td, J = 7.6, 1.3 Hz, 1H, ArH), 7.24–7.18 (m, 1H, ArH), 3.84 (s, 
3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 133.5 (ArC), 133.1 (ArC), 130.3 (ArC), 
127.9 (ArC), 125.9 (ArC–Br), 52.4 (OCH3) ppm (C=N2 and C=O not observed); IR (neat): 
v = 2951w, 2100s, 1697s, 1475m, 1433m, 1350m, 1240s, 1153s, 1066s, 1022s, 914w, 
752s, 642m, 441m cm−1. The spectroscopic data are in agreement with the literature.19 
Methyl 2-(4-(trifluoromethyl)phenyl)diazoacetate 179b: 
Performed according to General Procedure 9 on a 3.8 mmol 
scale of 202b; 179b (941 mg, 3. mmol, 98% yield) was obtained 
as a bright yellow solid. 
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1H NMR (400 MHz, CDCl3): δ = 7.66–7.54 (m, 4H, ArH), 3.88 (s, 3H, OCH3) ppm; 
13C NMR (126 MHz, CDCl3): δ = 164.9 (C=O), 130.3–130.2 (m, ArC–CN2), 129.2 (ArC), 
127.7 (q, J = 33.0 Hz, ArC–CF3), 125.5 (q, J = 3.8 Hz, 2 × ArC), 124.15 (q, J = 271.1 Hz, 
CF3), 123.5 (2 × ArC), 52.3 (OCH3) ppm (C=N2 not observed); IR (neat): v = 2960w, 
2102s, 1685s, 1618m, 1521w, 1242s, 823s, 744s, 592m cm−1. The spectroscopic data 
are in agreement with the literature.20  
Methyl 2-(4-(methoxy)phenyl)diazoacetate 179c: 
Performed according to General Procedure 9 on a 2.8 mmol 
scale of 202c; 179c (377 mg, 1.8 mmol, 65% yield) was obtained 
as a red solid. 
1H NMR (400 MHz, CDCl3): δ = 7.42–7.31 (m, 2H, ArH), 7.01–6.88 (m, 2H, ArH), 3.84 
(s, 3H, OCH3), 3.80 (s, 3H, OCH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.2 (C=O), 
158.2 (ArC–O), 126.0 (2 × ArC), 116.9 (ArC–CN2), 114.7 (2 × ArC), 55.4 (OCH3), 52.0 
(OCH3) ppm (C=N2 not observed); IR (neat): v = 3005w, 2959w, 2839w, 2085s, 1690s, 
1609m, 1510s, 1437s, 1356m, 1294m, 1244s, 1028s, 833s, 739s, 606m cm−1. The 
spectroscopic data are in agreement with the literature.20 
Methyl 2-(naphthalen-1-yl)diazoacetate 179d: 
Performed according to General Procedure 9 on a 2.5 mmol scale 
of 202d; 179d (465 mg, 2.1 mmol, 84% yield) was obtained as a 
bright yellow oil. 
1H NMR (500 MHz, CDCl3): δ = 7.94–7.88 (m, 2H, ArH), 7.87 (d, J = 8.4 Hz, 1H, ArH), 
7.64 (dd, J = 7.2, 1.0 Hz, 1H, ArH), 7.58 (dd, J = 8.3, 1.4 Hz, 1H, ArH), 7.54 (dd, J = 12.4, 
4.4 Hz, 2H, ArH), 3.86 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 134.1 (ArC), 
131.6 (ArC), 129.8 (ArC), 129.7 (ArC), 128.9 (ArC), 126.9 (ArC), 126.3 (ArC), 125.61 
(ArC), 124.3 (ArC), 122.0 (ArC), 52.4 (OCH3) ppm (C=N2 and C=O not observed); 
IR (neat): v = 2951w, 2360w, 2083s, 1701s, 1433s, 1103s, 993w, 977w, 773s, 657m  
cm−1. The spectroscopic data are in agreement with the literature.20  
Methyl 2-(2-iodopheyl)diazoacetate 179e: 
Performed according to General Procedure 9 on a 1.8 mmol scale of 
202e; 179e (480 mg, 1.6 mmol, 88% yield) was obtained as a bright 
yellow oil. 
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1H NMR (500 MHz, CDCl3): δ = 7.88 (d, J = 8.0 Hz, 1H, ArH), 7.45 (dd, J = 7.8, 1.5 Hz, 
1H, ArH), 7.38 (t, J = 7.6 Hz, 1H, ArH), 7.06–6.95 (m, 1H, ArH), 3.80 (s, 3H, OCH3) ppm; 
13C NMR (126 MHz, CDCl3,): δ = 165.7 (C=O), 139.7 (ArC), 132.9 (ArC), 130.4 (ArC), 
129.5 (ArC–CN2), 128.5 (ArC), 101.0 (ArC–I), 52.2 (OCH3) ppm (C=N2 not observed); 
IR (neat): v = 2949w, 2088s, 1693s, 1579w, 1558w, 1469m, 1431m, 1348m, 1242s, 
1026s, 1006s, 752s, 638m cm−1; HRMS (NSI): Exact mass calculated for C9H8IN2O2 
[M+H]+: 302.9625, found 302.9627. 
Methyl 2-(2-nitrophenyl)diazoacetate 179f: 
Performed according to General Procedure 9 on a 1.3 mmol scale of 
155a; 179f (200 mg, 0.90 mmol, 71% yield) was obtained as a bright 
yellow solid. 
1H NMR (500 MHz, CDCl3): δ = 8.02 (d, J = 8.2 Hz, 1H, ArH), 7.63 (t, J = 7.6 Hz, 1H, 
ArH), 7.53 (d, J = 7.7 Hz, 1H, ArH), 7.46 (t, J = 7.8 Hz, 1H, ArH), 3.79 (s, 3H, OCH3) 
ppm; 13C NMR (126 MHz, CDCl3): δ = 165.1 (C=O), 147.2 (ArC–NO2), 133.3 (ArC), 131.1 
(ArC), 128.9 (ArC), 125.6 (ArC), 120.9 (ArC–CN2), 52.5 (OCH3) ppm (C=N2 not 
observed); IR (neat): v = 2954w, 2362w, 2094s, 1697s, 1604m, 1523s, 1435m, 1352s, 
1284s, 1246s, 1193s, 1161s, 1089m, 1029s, 956w, 916w, 852m, 783m, 543w, 516w  
cm−1. The spectroscopic data are in agreement with the literature.21 
Methyl 2-diazo-2-(pyridin-2-yl)acetate 179g: 
Performed according to General Procedure 9 on a 2.0 mmol scale of 
commercially available 202f; 179g (270 mg, 1.5 mmol, 75% yield) was 
obtained as a white solid, m.p.: 134–138 °C. 
1H NMR (400 MHz, CDCl3): δ = 8.84 (dt, J = 7.0, 1.0 Hz, 1H, ArH), 8.29 (dt, J = 8.9, 1.2 
Hz, 1H, ArH), 7.56 (ddd, J = 8.9, 6.8, 1.0 Hz, 1H, ArH), 7.17 (td, J = 6.9, 1.2 Hz, 1H, 
ArH), 4.05 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 161.4 (C=O), 134.8 
(ArC), 129.3 (ArC), 128.9 (ArC), 125.8 (ArC), 118.9 (ArC), 116.4 (ArC), 51.8 (OCH3) ppm; 
IR (neat): v = 3092m, 3044m, 2953m, 1984w, 1819w, 1693s, 1637m, 1544m, 1523s, 
1215s, 1068s cm−1. The spectroscopic data are in agreement with the literature.22 
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 Synthesis of Diazo Compound 179h 
 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 3-oxobutanoate 207: 
A mixture of acetoacetate 201 (1.47 mL, 
12 mmol), (−)-menthol (2.8 g, 18 mmol) 
and catalytic amount of H3BO3 (74 mg, 
1.2 mmol, 10 mol%) was stirred in 
toluene at 115 °C and refluxed overnight for 12 hours using a Dean-Stark trap to remove 
the ethanol. The solvent was then removed under vacuum and the crude purified by 
column chromatography to afford 207 (1.58 g, 6.6 mmol, 55% yield) as a pale-yellow oil 
(5:1 mixture of the two tautomers 207:207I by 1H NMR spectroscopy). 
1H NMR (400 MHz, CDCl3): δ = 12.18 (s, 0.19 H, OHI), 5.05–4.89 (m, 0.19 H, C=CHI), 
4.72 (td, J = 10.9, 4.4 Hz, 1H, CO2–CH), 3.42 (s, 2H, CH2), 2.25 (s, 3H, CH3), 2.05–1.97 
(m, 1H), 1.90–1.81 (m, 1H), 1.67 (d, J = 11.6 Hz, 2H), 1.53–1.40 (m, 1H), 1.36 (t, J = 
11.6 Hz, 1H), 1.11–0.80 (m, 9H), 0.75 (d, J = 7.0 Hz, 3H, CHCH3) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 200.8 (C=O), 175.4 (CH=CI), 172.5(CI=O), 166.7 (C=O), 90.2 
(CIH=C),75.6 (CO2–CH), 73.8 (CO2–CIH) 50.7 (C(O)–CH2–CO2), 47.1 (CI), 47.0 (C), 41.1 
(CIH2) 40.8 (CH2), 34.3 (CIH2), 34.2 (CH2),34.3, 31.5 (C), 30.2 (CI), 26.4 (CI), 26.2 (C), 
23.6 (CIH2), 23.4 (CH2), 22.1 (C), 21.3 (CI), 20.9 (C), 20.8 (CI), 16.5 (CI), 16.2 (C) ppm. 
The spectroscopic data are in agreement with the literature.23 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 2-methyl-3-oxobutanoate 208: 
To a stirring suspension of NaH (60 wt% in mineral oil, 124 mg, 3.1 
mmol), in dry THF (5 mL), 207 (750 mg, 3.1 mmol), was added at 
0 °C. Once the grey suspension turned into a clear solution, methyl 
iodide (129 µL, 2.1 mmol) was added. The reaction was heated 
under reflux overnight. A saturated aqueous solution of NH4Cl was added at room 
temperature, and the product was extracted with CH2Cl2 (3 × 5 mL). The combined 
organic layers were washed with brine and dried over MgSO4 and the solvent was 
evaporated under reduced pressure. The desired product 208 was obtained as a yellow 
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oil (365 mg, 1.36 mmol, 66% yield, as mixture of two isomers 208:208I d.r. = 1:1 by 1H 
NMR spectroscopy). 
1H NMR (500 MHz, CDCl3): δ = 4.79–4.42 (m, 1H, CO2–CH), 3.48–3.41 (m, 1H,  
C(O)–CHCO2), 2.20 (s, 3H, CH3), 1.96 (t, J = 5.9 Hz, 1H, alkylH), 1.89–1.72 (m, 1H, 
alkylH), 1.70–1.59 (m, 2H, alkylH), 1.55–1.18 (m, 5H, alkylH), 1.14–0.75 (m, 9H), 0.75 
(dd, J = 7.0, 2.3 Hz, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 203.8 (C=O), 203.7 
(CI=O), 170.3 (C=O), 170.2 (CI=O’), 75.5 (CO2–CH), 75.4 (CO2–CIH), 54.2  
(C(O)–CHCO2), 54.0 (C(O)–CIHCO2), 47.03 (C), 47.01 (CI), 40.7 (C), 40.6 (CI), 34.3 
(C+CI), 31.52 (C), 31.51(CI), 28.49 (C), 28.47 (CI), 26.4 (C), 26.2 (CI), 23.5 (C), 23.3 (CI), 
22.1(C+CI), 20.9 (C), 20.8 (CI), 16.3 (C), 16.1 (CI), 12.9 (C), 12.8 (CI) ppm. The crude 
mixture was used without further purification. 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 2-diazopropanoate 179h: 
208 (300 mg, 1.2 mmol) was dissolved in acetonitrile (2 mL) and 
p-ABSA (430 mg, 1.8 mol) was added. The solution was cooled to 0 °C 
before the addition of DBU (300 µL, 1.8 mmol). The solution was stirred 
at room temperature for 12 h. A saturated aqueous solution of NH4Cl 
was added and the product was extracted with CH2Cl2 (3 × 5 mL). The combined organic 
layers were washed with water, brine and dried over MgSO4. The pure compound 179h 
was obtained after column chromatography as a volatile yellow oil (80 mg. 0.36 mmol, 
30% yield). 
1H NMR (400 MHz, CDCl3): δ = 4.73 (td, J = 10.9, 4.4 Hz, 1H, CO2–CH), 2.06–1.99 (m, 
1H), 1.95 (s, 3H, CH3), 1.90–1.82 (m, 1H), 1.71–1.62 (m, 2H), 1.54–1.43 (m, 1H), 1.42–
1.32 (m, 1H), 1.13–0.86 (m, 9H), 0.77 (d, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (101 MHz, 
CDCl3): δ = 74.8 (CO2–CH), 47.3, 41.5, 34.4, 31.5, 26.6, 23.8, 22.2, 20.8, 16.7, 8.6 ppm 
(C=N2 and C=O not observed); IR (neat): v = 2954w, 2926w, 2870w, 2075s, 1684s, 
1456w, 1303m, 1128s, 986w, 953w, 732m cm−1. The spectroscopic data are in 
agreement with the literature.24 
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 Synthesis of Diazo Compounds 179i–j 
 
General Procedure 10: The arylacetic acid 202 (5 mmol) was dissolved in CH2Cl2, then 
(−)-menthol (2.5 mmol), DCC (5 mmol) and catalytic amount of DMAP (0.75 mmol, 
0.3 equiv.) were added. The reaction was stirred at room temperature for 24 hours, 
monitored by TLC (n-hexane/ethyl acetate) and then filtered. The filtrate was washed 
with a saturated aqueous solution of NaHCO3 and extracted with CH2Cl2. The combined 
organic layers were dried over MgSO4 and the solvent was evaporated under vacuum. 
The crude was purified by column to afford the pure ester 209. 
(1R,2R,5R)-2-Isopropyl-5-methylcyclohexyl 2-(2-bromophenyl)acetate 209a: 
Performed according to General Procedure 10 on a 4.7 mmol 
scale of 202a and 2.3 mmol of (−)-menthol; 209a (718 mg, 
2.0 mmol, 89% yield) was obtained as a colourless oil.  
1H NMR (400 MHz, CDCl3): δ = 7.54 (d, J = 7.8 Hz, 1H, ArH), 7.31–
7.20 (m, 2H, ArH), 7.10 (ddd, J = 8.0, 6.8, 2.4 Hz, 1H. ArH), 4.71 (td, J = 10.9, 4.4 Hz, 
1H, CO2–CH), 4.10–3.55 (m, 2H, Ar–CH2–CO2), 2.10–1.95 (m, 1H), 1.83 (dtd, J = 13.9, 
7.0, 2.7 Hz, 1H), 1.72–1.58 (m, 2H), 1.53–1.41 (m, 1H), 1.39–1.27 (m, 1H), 1.13–0.79 
(m, 9H), 0.73 (d, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 170.0 (C=O), 
134.6 (ArC), 132.7 (ArC), 131.5 (ArC), 128.8 (ArC), 127.5 (ArC), 125.1 (ArC), 74.9  
(CO2–CH), 47.0, 42.1, 40.8, 34.3, 31.4, 26.2, 23.4, 22.1, 20.8, 16.4 ppm; IR (neat): v = 
2948m, 2860m, 1725s, 1469m, 1234s, 1163s, 1010s cm−1; HRMS (NSI): Exact mass 
calculated for C18H29BrO2N [M+NH4]+: 370.1380; found: 370.1376; [𝛼]𝐷20: +44.1° (c 0.41, 
CHCl3). 
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(1R,2R,5R)-2-Isopropyl-5-methylcyclohexyl-2-(4(trifluoromethyl)phenyl)acetate 209b: 
Performed according to General Procedure 10 on a 5.0 mmol 
scale of 202b and 2.5 mmol of (−)-menthol; 209b (666 mg, 
2.0 mmol, 78% yield) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.58 (d, J = 8.1 Hz, 2H, ArH), 
7.40 (d, J = 8.0 Hz, 2H, ArH), 4.68 (td, J = 10.9, 4.4 Hz, 1H, CO2–CH), 3.65 (s, 2H, 
ArCH2–CO2), 2.09–1.92 (m, 1H), 1.76–1.62 (m, 2H), 1.56 (d, J = 2.6 Hz, 1H), 1.52–1.42 
(m, 1H), 1.35 (ddt, J = 14.3, 10.9, 3.1 Hz, 1H), 1.12–0.80 (m, 9H), 0.68 (d, J = 7.0 Hz, 
3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 170.5 (C=O), 138.5 (m, ArC), 129.7 (2 × 
ArC), 129.5 (q, J = 32.5 Hz, ArC–CF3), 125.5 (q, J = 3.8 Hz, 2 × ArC), 124.3 (q, J = 
271.9 Hz, CF3), 75.3 (CO2–CH), 47.2, 41.7, 40.9, 34.3, 31.5, 26.3, 23.5, 22.1, 20.8, 
16.4 ppm; IR (neat): v = 2949m, 2864m, 1730s, 1323s, 1153s, 824m, 698m, 598m  
cm−1; HRMS (ASAP): Exact mass calculated for C19H24O2F [M−H4]+: 341.1728; found: 
341.1723; [𝛼]𝐷20: +44.1° (c 0.41, CHCl3). 
General Procedure 11: A 0.2 M solution of (−)-menthyl arylacetate 209 (2 mmol) and 
p-ABSA (4 mmol) in THF was cooled to 0 °C before the addition of DBU (8 mmol). The 
reaction was stirred at room temperature for 24 hours and monitored by TLC 
(n-hexane/ethyl acetate). The mixture was quenched with a saturated aqueous solution 
of NH4Cl saturated solution and the product was extracted with ethyl acetate. The 
combined organic layers were washed with water, brine, dried over MgSO4 and 
concentrated under reduced pressure. The crude was purified by flash column 
chromatography to afford the pure product 179i–j as an oil or solid depending on the 
substrate. 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 2-diazo-2-(2-bromophenyl)acetate 179i: 
Performed according to General Procedure 11 on a 1.3 mmol 
scale of 209a; 179i (316 mg, 0.85 mmol, 66% yield) was obtained 
as a bright yellow oil.  
1H NMR (400 MHz, CDCl3): δ = 7.61 (dd, J = 8.1, 1.2 Hz, 1H, ArH), 
7.52 (dd, J = 7.8, 1.6 Hz, 1H, ArH), 7.36 (td, J = 7.6, 1.3 Hz, 1H, ArH), 7.19 (ddd, J = 8.0, 
7.4, 1.7 Hz, 1H, ArH), 4.85 (td, J = 10.9, 4.4 Hz, 1H, CO2–CH), 2.21–2.06 (m, 1H), 1.91 
(dhep, J = 6.9, 2.7 Hz, 1H), 1.69 (d, J = 11.6 Hz, 2H), 1.58–1.34 (m, 2H), 1.17–0.97 (m, 
2H), 0.95–0.75 (m, 10H) ppm; 13C NMR (101 MHz, CDCl3): δ = 165.2 (C=O), 133.4 (ArC), 
133.0 (ArC), 130.0 (ArC), 127.7 (ArC), 126.1 (ArC), 124.6 (ArC), 75.5 (CO2–CH), 47.2, 
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41.4, 34.3, 31.5, 26.7, 23.8, 22.1, 20.8, 16.8 ppm (C=N2 not observed); IR (neat): v = 
2956m, 2868m, 2090s, 1693s, 1476m, 1236s, 1165s, 1009s, 752s, 644m cm−1; HRMS 
(NSI): Exact mass calculated for C18H24BrN2O2 [M+H]+: 379.1016, found 379.1016; [𝛼]𝐷20: −54.5° (c 0.70, CH2Cl2). 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 2-diazo-2-(4-(trifluoromethyl)phenyl) 
acetate 179j: 
Performed according to General Procedure 11 on a 1.7 mmol 
scale of 209b; 179j (368 mg, 1.5 mmol, 87% yield) was 
obtained as a bright yellow solid. 
1H NMR (400 MHz, CDCl3): δ = 7.61 (s, 4H, ArH), 4.89 (td, 
J = 10.9, 4.4 Hz, 1H, CO2–CH), 2.19–2.00 (m, 1H), 1.99–1.81 (m, 1H), 1.75–1.68 (m, 
2H), 1.61–1.41 (m, 2H), 1.17–1.03 (m, 2H), 0.98–0.85 (m, 7H), 0.81 (d, J = 7.0 Hz, 3H, 
CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 164.2 (C=O), 130.8–130.6 (m, ArC), 127.6 
(q, J = 32.7 Hz, ArC–CF3), 126.0 (q, J = 3.8 Hz, 2 × ArC), 124.3 (q, J = 272.2 Hz, CF3), 
123.6 (2 × ArC), 75.7 (CO2–CH), 47.3, 41.4, 34.3, 31.6, 26.7, 23.8, 22.1, 20.9, 16.7 ppm 
(C=N2 not observed); IR (neat): v = 2956m, 2930m, 2870w, 2087s, 1695s, 1616m, 
1319s, 1238s, 1165s, 1115s 1070s, 1011s, 841m cm−1; HRMS (NSI): Exact mass 
calculated for C19H24F3N2O2 [M+H]+: 369.1784, found 369.1788; [𝛼]𝐷20: −62.6° (c 0.80, 
CH2Cl2). 
 Synthesis of Diazo Compound 213 
 
Methyl (E)-2-(2-(benzylideneamino)phenyl)acetate 169: 
To neat aniline derivative 156a (3 g, 18 mmol), benzaldehyde 168 
(1.1 equiv.) was added dropwise. The orange solution turned into an 
emulsion and MgSO4 was added. The suspension was stirred for 
1 hour, the salt was filtered off and washed with CH2Cl2 and the 
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mixture was concentrated under vacuo to afford 169 as an orange oil (3.8 g, 15 mmol, 
83% yield). 
1H NMR (500 MHz, CDCl3): δ = 8.42 (s, 1H, N=CH), 7.92–7.86 (m, 2H, ArH), 7.51–7.43 
(m, 3H, ArH), 7.35–7.28 (m, 2H, ArH), 7.21 (td, J = 7.5, 1.2 Hz, 1H, ArH), 7.04 (dd, J = 
7.8, 1.0 Hz, 1H, ArH), 3.84 (s, 2H, CH2), 3.61 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 172.5 (C=O), 160.1 (ArC–N), 150.7 (ArC), 136.5 (ArC), 131.5 (ArC), 130.6 
(ArC), 129.2 (ArC), 129.1 (ArC), 129.0 (ArC), 128.9 (ArC), 128.6 (ArC), 126.3 (ArC), 
117.7 (ArC), 52.0 (OCH3), 37.6 (CH2) ppm. The spectroscopic data are in agreement 
with the literature.25 
Methyl (E)-2-(2-(benzylideneamino)phenyl)-2-diazoacetate 213: 
A solution of 169 (340 mg, 1.3 mmol) and of p-NBSA 18f2 (1.5 equiv.) 
in acetonitrile (5 mL) was cooled to 0 °C before the addition of DBU 
(4 equiv.). The dark solution was stirred for 12 hours and checked 
by TLC (n-hexane/ethyl acetate). A saturated aqueous solution of 
NH4Cl (10 mL) was added and the product extracted with CH2Cl2 (3 × 10 mL). The 
combined organic layers were washed with H2O, brine, dried over MgSO4 and 
concentrated under vacuo to afford 213 (211 mg, 0.75 mmol, 58% yield) as a yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 8.40 (s, 1H, N=CH), 7.99–7.88 (m, 2H, ArH), 7.75–7.67 
(m, 1H, ArH), 7.57–7.46 (m, 3H, ArH), 7.34–7.27 (m, 2H, ArH), 7.14–6.98 (m, 1H, ArH), 
3.84 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.7 (C=O), 159.8 (ArC–N), 
148.1 (ArC), 136.0 (ArC), 131.8 (ArC), 129.8 (ArC), 129.3 (ArC), 128.9 (ArC), 128.4 
(ArC), 126.6 (ArC), 120.1 (ArC), 118.0 (ArC), 52.0 (OCH3) ppm (C=N2 not observed). 
The spectroscopic data are in agreement with the literature.25 
 Synthesis of Diazo Compounds 184a–k 
 
General Procedure 12: The corresponding aryl acetic acid 203 was dissolved in 
methanol and the 0.5 M solution was cooled down to 0 °C before addition of acetyl 
chloride (2.5 equiv.). The reaction was stirred at room temperature for 16 hours and 
 Experimental Part Micol Santi 
 
208 
checked by TLC (n-hexane/ethyl acetate). The solvent was evaporated in vacuo and the 
residual oil washed with a saturated aqueous solution of NaHCO3 and extracted with 
Et2O. Subsequently, the combined organic layers were washed with water and brine, 
dried over MgSO4 and concentrated in vacuo to afford the pure methyl 2-hydroxyaryl 
acetate 220 which was used without further purification. 
Methyl 2-(2-hydroxyphenyl)acetate 220a: 
Performed according to General Procedure 12 on a 33 mmol scale of 
203a; 220a (5.1 g, 31 mmol, 93% yield) was obtained as a colourless 
solid, m.p.: 68–70 °C. 
1H NMR (500 MHz, CDCl3): δ = 7.43 (s, 1H, OH), 7.17 (t, J = 7.5 Hz, 1H, ArH), 7.11 (d, 
J = 7.2 Hz, 1H, ArH), 6.96–6.75 (m, 2H, ArH), 3.74 (s, 3H, OCH3), 3.69 (s, 2H, CH2) ppm; 
13C NMR (126 MHz, CDCl3): δ = 174.3 (C=O), 155.0 (ArC–O), 131.1 (ArC), 129.1 (ArC), 
120.8 (ArC), 120.7 (ArC), 117.1 (ArC), 52.7 (OCH3), 37.2 (CH2) ppm. The spectroscopic 
data are in agreement with the literature.26  
Methyl 2-(5-bromo-2-hydroxyphenyl)acetate 220b: 
Performed according to General Procedure 12 on a 2.2 mmol scale of 
203b; 220b (515 mg, 2.1 mmol, 96% yield) was obtained as a 
colourless solid, m.p.: 76–80 °C. 
1H NMR (500 MHz, CDCl3): δ = 7.37 (s, 1H, OH), 7.32–7.05 (m, 2H, 
ArH), 6.66 (d, J = 8.5 Hz, 1H, ArH), 3.67 (s, 3H, OCH3), 3.55 (s, 2H, CH2) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 173.9 (C=O), 154.4 (ArC–O), 133.5 (ArC), 131.9 (ArC), 122.8 
(ArC), 119.0 (ArC), 112.6 (ArC), 52.9 (OCH3), 37.0 (CH2) ppm. The spectroscopic data 
are in agreement with the literature.27  
 
General Procedure 13: The methyl ester 220 was dissolved in DMF (0.5 M solution), and 
K2CO3 (2.5 equiv.), NaI (1.1 equiv.) were added. The solution was cooled down to 0 °C 
before the addition of the corresponding halide 161 (1.2 equiv.). The reaction was 
performed for 12–72 hours at room temperature and checked by TLC (n-hexane/ethyl 
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acetate). The suspension was filtrate, washed with water (40 mL) and the product 
extracted with Et2O (3 × 15 mL). The combined organic layers were washed with brine, 
dried over MgSO4 and concentrate under vacuum and purified by column to afford the 
desired product 221 as an oil or solid depending on the substrate. 
Methyl 2-(2-(benzyloxy)phenyl)acetate 221a: 
Performed according to General Procedure 13 on a 21 mmol scale of 
220a; 221a (4.4 g, 17 mmol, 82% yield) was obtained as a colourless 
solid, m.p.: 70–72 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.46–7.35 (m, 4H, ArH), 7.35–7.28 
(m, 1H, ArH), 7.28–7.18 (m, 2H, ArH), 6.98–6.90 (m, 2H, ArH), 5.09 
(s, 2H, OCH2), 3.69 (s, 2H, CH2), 3.64 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): 
δ = 172.4 (C=O), 156.7 (ArC–O), 137.2 (ArC), 131.1 (ArC), 128.7 (ArC), 128.6 (2 × ArC), 
127.9 (ArC), 127.2 (2 × ArC), 123.6 (ArC), 120.9 (ArC), 111.9 (ArC), 70.0 (OCH2), 51.9 
(OCH3), 36.2 (CH2) ppm. The spectroscopic data are in agreement with the literature.28 
Methyl 2-(2-((4-(trifluoromethyl)benzyl)oxy)phenyl)acetate 221b: 
Performed according to General Procedure 13 on a 1.5 mmol scale of 
220a; 221b (422 mg, 1.3 mmol, 87%) was obtained as a colourless 
solid, m.p.: 58–60 °C.  
1H NMR (400 MHz, CDCl3): δ = 7.60 (d, J = 8.2 Hz, 2H, ArH), 7.49 (d, 
J = 8.0 Hz, 2H, ArH), 7.25–7.15 (m, 2H, ArH), 6.92 (td, J = 7.5, 1.0 Hz, 
1H, ArH), 6.84 (d, J = 8.1 Hz, 1H, ArH), 5.10 (s, 2H, OCH2), 3.66 (s, 
2H, CH2), 3.60 (s, 3H, OCH3) ppm; 13C NMR (101 MHz, CDCl3,): δ = 172.3 (C=O), 156.4 
(ArC–O), 141.3–141.2 (m, ArC), 131.4 (ArC), 130.1 (q, J = 32.4 Hz, ArC–CF3), 128.8 
(ArC), 128.3 (2 × ArC), 125.6 (q, J = 3.8 Hz, 2 × ArC), 124.3 (d, J = 276.0 Hz, CF3), 123.6 
(ArC), 121.3 (ArC), 111.8 (ArC), 69.2 (OCH2), 51.9 (OCH3), 36.2 (CH2) ppm; IR (neat): 
v = 2949w, 1734s, 1605m, 1499m, 1452m, 1325s, 1258s, 1157s, 1107s, 820s, 754s, 
696m, 586m, 565m cm−1; HRMS (ES): Exact mass calculated for C17H16F3O3 [M+H]+: 
325.1052, found 325.1047. 
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Methyl 2-(2-((4-methoxybenzyl)oxy)phenyl)acetate 221c: 
Performed according to General Procedure 13 on a 3.0 mmol scale of 
220a; 221c (634 mg, 2.2 mmol, 74%) was obtained as a colourless 
oil.  
1H NMR (500 MHz, CDCl3): δ = 7.33 (d, J = 8.3 Hz, 2H, ArH), 7.28–
7.17 (m, 2H, ArH), 6.99–6.87 (m, 4H, ArH), 5.01 (s, 2H, OCH2), 3.82 
(s, 3H, OCH3), 3.66 (s, 2H, CH2), 3.63 (s, 3H, OCH3) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 172.4 (C=O), 159.4 (ArC–O), 156.8 (ArC–O), 131.1 (ArC), 129.8 
(ArC), 128.9 (2 × ArC), 128.7, 123.6 (ArC), 120.9 (ArC), 114.0 (2 × ArC), 112.0 (ArC), 
69.9 (OCH2), 55.4 (OCH3), 51.9 (OCH3), 36.2 (CH2) ppm; IR (neat): v = 2951w, 2837w, 
1735s, 1612m, 3080w, 1514s, 1454m, 1240s, 1174s, 1029s, 819s, 750s cm−1; HRMS 
(ES): Exact mass calculated for C17H18O4Na [M+Na]+: 309.1103, found 309.1116.  
Methyl 2-(2-((4-methylbenzyl)oxy)phenyl)acetate 221d: 
Performed according to General Procedure 13 on a 1.5 mmol scale of 
220a; 221d (302 mg, 1.1 mmol, 74% yield) was afforded as a 
colourless solid, m.p.: 42–44 °C.  
1H NMR (300 MHz, CDCl3): δ = 7.29 (d, J = 8.0 Hz, 2H, ArH), 7.27–
7.15 (m, 4H, ArH), 6.97–6.89 (m, 2H, ArH), 5.04 (s, 2H, CH2), 3.68 (s, 
2H, CH2), 3.64 (s, 3H, OCH3), 2.36 (s, 3H, CH3) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 172.4 (C=O), 156.8 (ArC–O), 137.6 (ArC), 134.2 (ArC), 131.1 
(ArC), 129.3 (2 × ArC), 128.7 (ArC), 127.3 (2 × ArC), 123.5 (ArC), 120.9 (ArC), 111.9 
(ArC), 70.0 (OCH2), 52.0 (OCH3), 36.2 (CH2), 21.3 (CH3) ppm; IR (neat): v = 3026w, 
2949w, 2866w, 1736s, 1602m, 1589m, 1492s, 1454m, 1379w, 1242s, 1155s, 1012s, 
800m, 750s cm−1; HRMS (ES): Exact mass calculated for C17H18O3Na [M+Na]+: 
293.1154, found 293.1157. 
Methyl 2-(2-((4-bromobenzyl)oxy)phenyl)acetate 221e: 
Performed according to General Procedure 13 on a 3.0 mmol scale of 
220a; 221e (664 mg, 2.0 mmol, 66% yield) was afforded as a 
colourless solid, m.p.: 48–50 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.50 (d, J = 8.4 Hz, 2H, ArH), 7.32–
7.17 (m, 4H, ArH), 6.94 (t, J = 7.4 Hz, 1H, ArH), 6.88 (d, J = 8.2 Hz, 
1H, ArH), 5.03 (s, 2H, OCH2), 3.67 (s, 2H, CH2), 3.63 (s, 3H, OCH3) 
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ppm; 13C NMR (101 MHz, CDCl3): δ = 172.3 (C=O), 156.5 (ArC–O), 136.2 (ArC), 131.8 
(2 × ArC), 131.3 (ArC), 128.8 (2 × ArC), 128.8 (ArC), 123.6 (ArC), 121.8 (ArC), 121.2 
(ArC), 111.9 (ArC), 69.3 (OCH2), 52.0 (OCH3), 36.2 (CH2) ppm; IR (neat): v = 2951w, 
2918w, 2864, 1743s, 1602m, 1500m, 1256s, 1157s, 1117s, 1009s, 800s, 752s cm−1; 
HRMS (AP): Exact mass calculated for C16H16O3Br [M+H]+: 335.0283, found 335.0287.  
Methyl 2-(2-((2-methylbenzyl)oxy)phenyl)acetate 221f: 
Performed according to General Procedure 13 on a 1.5 mmol scale of 
220a; 221f (356 mg, 1.3 mmol, 88% yield) was afforded as a 
colourless solid, m.p.: 54–56 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.36 (d, J = 7.3 Hz, 1H, ArH), 7.32–
7.05 (m, 5H, ArH), 7.03–6.78 (m, 2H, ArH), 4.99 (s, 2H, OCH2), 3.62 
(s, 2H, CH2), 3.54 (s, 3H, OCH3), 2.30 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): 
δ = 172.4 (C=O), 156.8 (ArC–O), 136.3 (ArC), 135.0 (ArC), 131.1 (ArC), 130.3 (ArC), 
128.7 (ArC), 128.1 (ArC), 128.1 (ArC), 126.1 (ArC), 123.5 (ArC), 120.9 (ArC), 111.6 
(ArC), 68.5 (OCH2), 51.8 (OCH3), 36.1 (CH2), 18.9 (CH3) ppm; IR (neat): v = 3076w, 
2949w, 1735s, 1600m, 1498m, 1456m, 1348m, 1298m, 1250s, 1201s, 1121s, 1053s, 
850m, 756s, 691s cm−1; HRMS (ES): Exact mass calculated for C17H18O3Na [M+Na]+: 
293.1154, found 293.1158.  
Methyl 2-(2-([1,1'-biphenyl]-2-ylmethoxy)phenyl)acetate 221g: 
Performed according to General Procedure 13 on a 1.5 mmol scale of 
220a; 221g (405 mg, 1.2 mmol, 81% yield) was afforded as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.65–7.54 (m, 1H, ArH), 7.47–7.29 
(m, 8H, ArH), 7.21–7.13 (m, 2H, ArH), 6.91 (td, J = 7.5, 1.0 Hz, 1H, 
ArH), 6.72 (d, J = 7.9 Hz, 1H, ArH), 4.96 (s, 2H, OCH2), 3.66 (s, 2H, CH2), 3.62 (s, 3H, 
OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 172.4 (C=O),156.6 (ArC–O), 141.6 (ArC), 
140.6 (ArC), 134.2 (ArC), 131.1 (ArC), 130.1 (ArC), 129.2 (ArC), 129.0 (ArC), 128.6 
(ArC), 128.5 (ArC), 128.0 (ArC), 127.7 (ArC), 127.5 (ArC), 123.4 (ArC), 120.9 (ArC), 
111.8 (ArC), 68.2 (OCH2), 51.9 (OCH3), 36.2 (CH2) ppm; IR (neat): v = 3076w, 2993w, 
2949w, 2921w, 1736s, 1601m, 1589m, 1499m, 1456m, 1348m, 1298m, 1250s, 1201m, 
1161s, 1121s, 1053s, 1003m, 851m, 756s, 736s, 690m cm−1; HRMS (ES): Exact mass 
calculated for C22H20O3Na [M+Na]+: 355.1310, found 355.1317.  
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Methyl 2-(2-(allyloxy)phenyl)acetate 221h: 
Performed according to General Procedure 13 on a 1.5 mmol scale of 
220a; 221h (247 mg, 1.2 mmol, 80% yield) was afforded as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.26–7.16 (m, 2H, ArH), 6.92 (td, J = 
7.4, 1.1 Hz, 1H, ArH), 6.86 (d, J = 8.2 Hz, 1H, ArH), 6.02 (ddt, J = 17.3, 
10.6, 4.9, 1H, CHa), 5.40 (dq, J = 17.3, 1.7 Hz, 1H, CHc), 5.26 (dq, J = 10.6, 1.5 Hz, 1H, 
CHb), 4.55 (dt, J = 4.9, 1.6 Hz, 2H, OCH2), 3.68 (s, 3H, OCH3), 3.66 (s, 2H, CH2) ppm; 
13C NMR (101 MHz, CDCl3): δ = 172.5 (C=O) 156.6 (ArC–O), 133.3, 131.1, 128.6, 123.6, 
120.9, 117.0, 111.9, 68.8 (OCH2), 52.0 (OCH3), 36.2 (CH2) ppm; IR (neat): v = 2951w, 
1736s, 1603m, 1589w, 1493s, 1340m, 1244s, 1155s, 997s, 926m, 750s cm−1; 
HRMS (ES): Exact mass calculated for C12H14O3Na [M+Na]+: 229.0841, found 229.0842.  
Methyl 2-(2-(cinnamyloxy)phenyl)acetate 221i: 
Performed according to General Procedure 13 on a 3.0 mmol scale of 
220a; 221i (378 mg, 1.3 mmol, 44% yield) was afforded as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.34–7.30 (m, 2H, ArH), 7.27–7.21 
(m, 2H, ArH), 7.19–7.10 (m, 3H, ArH), 6.89–6.79 (m, 2H, ArH), 6.64 
(d, J = 16.0 Hz, 1H, Hb), 6.28 (dt, J = 16.0, 5.4 Hz, 1H, Ha), 4.61 (dd, 
J = 5.4, 1.6 Hz, 2H, OCH2), 3.61 (s, 3H, OCH3), 3.58 (s, 2H, CH2) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 172.4 (C=O), 156.7 (ArC–O), 136.7, 132.3, 131.1, 128.7, 128.6, 
127.9, 126.6, 124.6, 123.6, 120.9, 112.0, 68.7 (OCH2), 52.0 (OCH3), 36.2 (CH2) ppm; IR 
(neat): v = 3026w, 2949w, 1734s, 1600m, 1589m, 1493s, 1452m, 1242s, 1155s, 1113m, 
734s, 690 cm−1; HRMS (ES): Exact mass calculated for C18H18O3Na [M+Na]+: 305.1154, 
found 305.1157.  
Methyl 2-(5-bromo-2-((4-methylbenzyl)oxy)phenyl) acetate 221j: 
Performed according to General Procedure 13 on a 1.7 mmol scale of 
220b; 221j (457 mg, 1.3 mmol, 76% yield) was afforded as a 
colourless solid, m.p.: 82–84 °C. 
1H NMR (500 MHz, CDCl3): δ = 7.35 (d, J = 6.4 Hz, 2H, ArH), 7.31–
7.27 (m, 2H, ArH), 7.21 (d, J = 7.7 Hz, 2H, ArH), 6.81 (d, J = 9.3 Hz, 
1H, ArH), 5.04 (s, 2H, OCH2), 3.67 (s, 3H, OCH3), 3.65 (s, 2H, CH2), 
2.38 (s, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 171.7 (C=O), 
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156.0 (ArC–O), 137.9 (ArC), 133.8 (ArC), 133.6 (ArC), 131.3 (ArC), 129.4 (ArC), 127.3 
(ArC), 125.8 (ArC), 113.6 (ArC), 112.9 (ArC), 70.4 (OCH2), 52.1 (OCH3), 35.8 (CH2), 21.3 
(CH3) ppm; IR (neat): v = 2951w, 1738s, 1493m, 1250s, 1198s, 1157s, 1124s, 1014s, 
997s cm−1; HRMS (ES): Exact mass calculated for C17H17O3BrNa [M+Na]+: 371.0259, 
found 371.0259.  
Methyl 2-(2-(hexyloxy)phenyl) acetate 221k: 
Performed according to General Procedure 13 on a 1.5 mmol scale of 
220a; 221k (217 mg, 0.87 mmol, 58% yield) was afforded as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.23 (td, J = 8.0, 1.8 Hz, 1H, ArH), 
7.18 (dd, J = 7.4, 1.6 Hz, 1H, ArH), 6.90 (td, J = 7.4, 1.0 Hz, 1H, ArH), 6.85 (d, J = 8.2 Hz, 
1H, ArH), 3.95 (t, J = 6.4 Hz, 2H, OCH2), 3.68 (s, 3H, OCH3), 3.63 (s, 2H, CH2), 1.82–
1.67 (m, 2H), 1.49–1.40 (m, 2H), 1.37–1.30 (m, 4H), 0.94–0.88 (m, 3H, CH3) ppm; 
13C NMR (101 MHz, CDCl3): δ = 172.5 (C=O), 157.2 (ArC–O), 131.0 (ArC), 128.6 (ArC), 
123.3 (ArC), 120.4 (ArC), 111.3 (ArC), 68.1 (OCH2), 51.9 (OCH3), 36.2, 31.7, 29.4, 25.8, 
22.8, 14.2 ppm; IR (neat) v = 2951m, 2929m, 2858w, 1738s, 1602w, 1495m, 1456m, 
1244s, 1155s, 748s cm−1; HRMS (ES): Exact mass calculated for C15H22O3Na [M+Na]+: 
273.1467, found 273.1469. 
General Procedure 14: A 0.2 M solution of methyl arylacetate 221a–k and p-ABSA 
(3 equiv.) in acetonitrile was cooled down to 0 °C before the addition of DBU (4 equiv.). 
The reaction was stirred at room temperature for 12–48 hours and monitored by TLC 
(n-hexane/ethyl acetate). The mixture was quenched with a saturated aqueous solution 
of NH4Cl saturated solution and the product was extracted with CH2Cl2. The combined 
organic layers were washed with water, brine, dried over MgSO4 and concentrated under 
reduced pressure (20 °C water bath). The crude was purified by flash column 
chromatography to afford the pure product 184a–k as a yellow oil or solid. 
Methyl 2-(2-(benzyloxy)phenyl)-2-diazoacetate 184a: 
Performed according to General Procedure 14 on a 1.4 mmol scale of 
221a; 184a (340 mg, 1.2 mmol, 86% yield) was afforded as a bright 
yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 7.57 (dd, J = 7.8, 1.7 Hz, 1H, ArH), 
7.44–7.32 (m, 5H, ArH), 7.27–7.21 (m, 1H, ArH), 7.04 (td, J = 7.6, 
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1.1 Hz, 1H, ArH), 6.97 (dd, J = 8.3, 1.1 Hz, 1H, ArH), 5.11 (s, 2H, OCH2), 3.82 (s, 3H, 
OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 166.8 (C=O), 154.8 (ArC–O), 136.4 (ArC), 
130.5 (ArC), 128.7 (ArC), 128.3 (ArC), 127.7 (ArC), 121.7 (ArC), 114.1 (ArC), 112.3 
(ArC), 70.8 (OCH2), 52.1 (OCH3) ppm (C=N2 not observed); IR (neat): v = 3032w, 2951w, 
2093s, 1693s, 1494m, 1448m, 1433m, 1246s, 1149s, 1032s, 1009s, 744s, 696s cm−1. 
The spectroscopic data are in agreement with the literature.28 
Methyl 2-(2-((4-(trifluoromethyl)benzyl)oxy)phenyl)-2-diazoacetate 184b: 
Performed according to General Procedure 14 on a 0.9 mmol scale of 
221b; 184b (273 mg, 0.78 mmol, 87% yield) was afforded as a bright 
yellow solid. 
1H NMR (400 MHz, CDCl3): δ = 7.66 (d, J = 8.2 Hz, 2H, ArH), 7.58 
(dd, J = 7.8, 1.7 Hz, 1H, ArH), 7.53 (d, J = 8.0 Hz, 2H, ArH), 7.28–7.23 
(m, 1H, ArH), 7.07 (td, J = 7.5, 1.0 Hz, 1H, ArH), 6.94 (dd, J = 8.3, 
1.0 Hz, 1H, ArH), 5.16 (s, 2H, OCH2), 3.83 (s, 3H, OCH3) ppm; 13C NMR (101 MHz, 
CDCl3): δ = 166.6 (C=O), 154.5 (ArC–O), 140.4 (ArC), 130.7 (ArC), 130.4 (q, J = 32.5 Hz, 
ArC–CF3), 128.8 (ArC), 127.6 (ArC), 125.7 (q, J = 3.8 Hz, 2 × ArC), 124.2 (q, J = 
272.1 Hz, CF3), 121.9 (ArC), 114.2 (ArC), 112.3 (ArC), 69.9 (OCH2), 52.1 (OCH3) ppm 
(C=N2 not observed); IR (neat): v = 2859w, 2097s, 1693s, 1497m, 1437m, 1325s, 1248s, 
1155s, 824s, 750s cm−1; HRMS (ES): Exact mass calculated for C17H14F3O3 [M−N2+H]+: 
323.0895, found 323.0901. 
Methyl 2-diazo-2-(2-((4-methoxybenzyl)oxy)phenyl)acetate 184c: 
Performed according to General Procedure 14 on a 0.52 mmol scale 
of 221c; 184c (125 mg, 0.40 mmol, 77% yield) was afforded as a 
bright yellow solid. 
1H NMR (400 MHz, CDCl3): δ = 7.59 (dd, J = 7.8, 1.6 Hz, 1H, ArH), 
7.34 (d, J = 8.5 Hz, 2H, ArH), 7.30–7.17 (m, 1H, ArH), 7.05 (t, J = 
7.6 Hz, 1H, ArH), 6.99 (d, J = 8.3 Hz, 1H, ArH), 6.94 (d, J = 8.6 Hz, 
2H, ArH), 5.03 (s, 2H, OCH2), 3.83 (s, 3H, OCH3), 3.82 (s, 3H, OCH3) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 166.7 (C=O), 159.6 (ArC–O), 154.8 (ArC–O), 130.4 (ArC), 129.4 
(2 × ArC), 128.6 (ArC), 128.4 (ArC), 121.4 (ArC), 114.1 (ArC), 114.0 (2 × ArC), 112.3 
(ArC), 70.5 (OCH2) 55.3 (OCH3), 52.01 (OCH3) ppm (C=N2 not observed); IR (neat): v = 
3001m, 2955m, 2839w, 2098s, 1689s, 1514s, 1435s, 1028s, 995s, 814s, 754s cm−1. 
The spectroscopic data are in agreement with the literature.29 
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Methyl 2-(2-((4-(methylbenzyl)oxy)phenyl)-2-diazoacetate 184d: 
Performed according to General Procedure 14 on a 0.55 mmol scale 
of 221d; 184d (137 mg, 0.46 mmol, 84% yield) was afforded as a 
bright yellow solid. 
1H NMR (400 MHz, CDCl3): δ = 7.57 (dd, J = 7.8, 1.7 Hz, 1H, ArH), 
7.30 (d, J = 8.0 Hz, 2H, ArH), 7.27–7.17 (m, 3H, ArH), 7.03 (td, J = 
7.6, 1.1 Hz, 1H, ArH), 6.97 (dd, J = 8.3, 0.9 Hz, 1H, ArH), 5.06 (s, 2H, 
CH2), 3.82 (s, 3H, OCH3), 2.37 (s, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.8 
(C=O), 154.8 (ArC–O), 138.0 (ArC), 133.4 (ArC), 130.5 (ArC), 129.4 (ArC), 128.7 (ArC), 
127.8 (ArC), 121.5 (ArC), 114.1 (ArC), 112.3 (ArC), 70.7 (OCH2), 52.1 (OCH3), 21.3 
(CH3) ppm (C=N2 not observed); IR (neat): v = 3057w, 3030w, 2949w, 2091s, 1692s, 
1429m, 1254s, 1149s, 1005s, 802s, 744s, 662m cm−1. The spectroscopic data are in 
agreement with the literature.29 
Methyl 2-(2-((4-bromobenzyl)oxy)phenyl)-2-diazoacetate 184e: 
Performed according to General Procedure 14 on a 0.89 mmol scale 
of 221e; 184e (230 mg, 0.64 mmol, 71% yield) was afforded as a 
bright yellow solid. 
1H NMR (400 MHz, CDCl3): δ = 7.48 (dd, J = 7.8, 1.4 Hz, 1H, ArH), 
7.41 (d, J = 8.3 Hz, 2H, ArH), 7.20–7.08 (m, 3H, ArH), 6.95 (t, J = 
7.6 Hz, 1H, ArH), 6.83 (d, J = 8.3 Hz, 1H, ArH ), 4.92 (s, 2H, CH2), 
3.72 (s, 3H, OCH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.6 (C=O), 154.5 (ArC–O), 
135.3 (ArC), 131.8 (ArC), 130.6 (ArC), 129.2 (ArC), 128.7 (ArC), 122.2 (ArC), 121.7 
(ArC), 114.1 (ArC), 112.3 (ArC), 70.0 (OCH2), 52.1 (OCH3) ppm (C=N2 not observed); 
IR (neat): v = 2988m, 2947m, 2097s, 1691s, 1495s, 1431s, 1229s, 1153s, 804s, 741s  
cm−1. HRMS (AP): Exact mass calculated for C16H14O3Br [M−N2+H]+: 333.0126, found 
333.0117. 
Methyl 2-diazo-2-(2-((2-methylbenzyl)oxy)phenyl)acetate 184f: 
Performed according to General Procedure 14 on a 1.8 mmol scale of 
221f; 184f (388 mg, 1.3 mmol, 71% yield) was afforded as a bright 
yellow solid. 
1H NMR (500 MHz, CDCl3): δ = 7.53 (dd, J = 7.8, 1.6 Hz, 1H, ArH), 
7.35–7.28 (m, 1H, ArH), 7.25–7.15 (m, 4H, ArH), 7.00 (td, J = 7.7, 
1.1 Hz, 1H, ArH), 6.95 (dd, J = 8.3, 0.8 Hz, 1H, ArH), 5.03 (s, 2H, OCH2), 3.76 (s, 3H, 
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OCH3), 2.30 (s, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 166.8 (C=O), 154.9 
(ArC–O), 136.5 (ArC), 134.3 (ArC), 130.5 (ArC), 128.7 (ArC), 128.6 (ArC), 128.4 (ArC), 
126.2 (ArC), 121.5 (ArC), 114.0 (ArC), 112.2 (ArC), 69.1 (OCH2), 52.1 (OCH3), 18.9 
(CH3) ppm (C=N2 not observed); IR (neat): v = 3055w, 2953w, 2098s, 1697s, 1497s, 
1452s, 1246s, 1153s, 1003w, 733s cm−1; HRMS (AP): Exact mass calculated for 
C16H14O3Br [M−N2+H]+: 333.0126, found 333.0117. 
Methyl 2-(2-((2-(phenylbenzyl)oxy)phenyl)-2-diazoacetate 184g: 
Performed according to General Procedure 14 on a 1.0 mmol scale of 
221g; 184g (269 mg, 0.75 mmol, 75% yield) was afforded as a bright 
yellow oil. 
1H NMR (300 MHz, CDCl3): δ = 7.63–7.48 (m, 2H, ArH), 7.48–7.32 
(m, 8H, ArH), 7.16 (ddd, J = 8.3, 7.5, 1.7 Hz, 1H, ArH), 7.01 (td, J = 
7.6, 1.2 Hz, 1H, ArH), 6.75 (dd, J = 8.3, 0.9 Hz, 1H, ArH), 5.01 (s, 2H, OCH2), 3.83 (s, 
3H, OCH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.8 (C=O), 154.7 (ArC–O), 141.8 
(ArC), 140.5 (ArC), 133.5 (ArC), 130.4 (ArC), 130.2 (ArC), 129.3 (ArC), 129.2 (ArC), 
128.7 (ArC), 128.5 (ArC), 128.3 (ArC), 127.8 (ArC), 127.5 (ArC), 121.5 (ArC), 114.0 
(ArC), 112.4 (ArC), 68.8 (OCH2), 52.1 (OCH3) ppm (C=N2 not observed); IR (neat): v = 
3059w, 2987m, 2951m, 2094s, 1697s, 1435s, 1246s, 742s, 702s cm−1. HRMS (EI): 
Exact mass calculated for C22H18N2O3 [M]+: 358.1317, found 358.1320. 
Methyl 2-(2-(allyloxy)phenyl)-2-diazoacetate 184h: 
Performed according to General Procedure 14 on a 0.97 mmol scale 
of 221h; 184h (90 mg, 0.39 mmol, 40% yield) was afforded as a bright 
yellow oil. 
1H NMR (500 MHz, CDCl3): δ = 7.56 (dd, J = 7.8, 1.5 Hz, 1H, ArH), 
7.26–7.22 (m, 1H, ArH), 7.03 (td, J = 7.8, 1.1 Hz, 1H, ArH), 6.90 (d, 
J = 8.3 Hz, 1H, ArH), 6.05 (ddt, J = 17.2, 10.5, 5.3 Hz, 1H, CHa), 5.41 (ddd, J = 17.3, 3.0, 
1.6 Hz, 1H, CHc), 5.30 (dd, J = 10.6, 1.4 Hz, 1H, CHb), 4.58 (dt, J = 5.2, 1.3 Hz, 2H, 
OCH2), 3.84 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 166.8 (C=O), 154.6 
(ArC–O), 132.8, 130.4, 128.6, 121.4, 118.0, 114.0, 112.1, 69.4 (OCH2), 52.1 (OCH3) ppm 
(C=N2 not observed); IR (neat): v = 2953w, 2099s, 1697s, 1489s, 1450s, 1433s, 1244s, 
1155s, 752s cm−1; HRMS (EI): Exact mass calculated for C12H13O3 [M−N2+H]+: 205.0865, 
found 205.0870.  
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Methyl 2-(2-(cinnamyloxy)phenyl)-2-diazoacetate 184i: 
Performed according to General Procedure 14 on a 0.88 mmol scale 
of 221i; 184i (120 mg, 0.39 mmol, 44% yield) was afforded as a bright 
yellow oil. 
1H NMR (500 MHz, CDCl3): δ = 7.51 (dd, J = 7.8, 1.5 Hz, 1H, ArH), 
7.39–7.32 (m, 2H, ArH), 7.30–7.24 (m, 2H, ArH), 7.24–7.06 (m, 2H, 
ArH), 6.97 (td, J = 7.8, 1.1 Hz, 1H, ArH), 6.88 (dd, J = 8.3, 0.6 Hz, 1H, 
ArH), 6.66 (d, J = 16.0 Hz, 1H, CHb), 6.32 (dt, J = 16.0, 5.8 Hz, 1H, CHa), 4.66 (d, J = 
5.8 Hz, 2H, CH2), 3.76 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 166.8 (C=O), 
154.6 (ArC–O), 136.4, 133.3, 130.4, 129.0, 128.7, 128.7, 128.1, 126.7, 126.6, 123.9, 
121.5, 114.1, 112.3, 69.3 (OCH2), 52.1 (OCH3) ppm (C=N2 not observed); IR (neat): v = 
3025w, 2951w, 2856w, 2093s, 1695s, 1493s, 1433s, 1248, 1151s, 1031s, 964s, 733s, 
690s cm−1; HRMS (AP): Exact mass calculated for C18H17O3 [M−N2+H]+: 281.1178, found 
281.1176. 
Methyl 2-(5-bromo-2-((4-methylbenzyl)oxy)phenyl)-2-diazoacetate 184j: 
Performed according to General Procedure 14 on a 0.88 mmol scale 
of 221j; 184j (270 mg, 0.72 mmol, 91% yield) was afforded as a bright 
yellow solid. 
1H NMR (400 MHz, CDCl3): δ = 7.68 (d, J = 2.5 Hz, 1H, ArH), 7.27–
7.16 (m, 3H, ArH), 7.13 (d, J = 7.9 Hz, 2H, ArH), 6.75 (d, J = 8.8 Hz, 
1H, ArH), 4.95 (s, 2H, OCH2), 3.75 (s, 3H, OCH3), 2.30 (s, 3H, 
CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.1 (C=O), 153.5  
(ArC–O), 138.2 (ArC), 132.8 (ArC), 132.3 (ArC), 130.9 (ArC), 129.4 (ArC), 127.8 (ArC), 
116.3 (ArC), 113.8 (ArC), 113.7 (ArC), 71.0 (OCH2), 52.2 (OCH3), 21.3 (CH3) ppm (C=N2 
not observed); IR (neat): v = 2951w, 2100s, 1697s, 1487s, 1435s, 1404m, 1333m, 
1248s, 1153s, 1040s, 906s, 802s, 727s cm−1; HRMS (ES): Exact mass calculated for 
C18H17O3 [M−N2+H]+: 347.0283, found 347.0283. 
Methyl 2-(2-(hexyloxy)phenyl)-2-diazoacetate 184k: 
Performed according to General Procedure 14 on a 0.40 mmol scale 
of 221k; 184k (93 mg, 0.34 mmol, 84%) was afforded as a bright 
yellow oil. 
1H NMR (400 MHz, CDCl3): δ = 7.56 (dd, J = 7.8, 1.7 Hz, 1H, ArH), 
7.23 (ddd, J = 8.3, 7.5, 1.7 Hz, 1H, ArH), 7.00 (td, J = 7.6, 1.1 Hz, 1H, 
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ArH), 6.88 (dd, J = 8.3, 1.1 Hz, 1H, ArH), 3.99 (t, J = 6.5 Hz, 2H, OCH2), 3.84 (s, 3H, 
OCH3), 1.85–1.73 (m, 2H), 1.52–1.42 (m, 2H), 1.38–1.32 (m, 4H), 0.92 (t, J = 7.1 Hz, 
3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.9 (C=O), 155.1 (ArC–O), 130.2 
(ArC), 128.6 (ArC), 121.0 (ArC), 113.6 (ArC), 111.6 (ArC), 68.6 (OCH2), 52.1 (OCH3), 
31.7, 29.2, 26.0, 22.7, 14.1 ppm (C=N2 not observed); IR (neat): v = 2951m, 2930m, 
2858m, 2093s, 1701s, 1497m, 1450m, 1433m, 1248s, 1150s, 1032m, 746s cm−1; HRMS 
(ES): Exact mass calculated for C15H21O3 [M−N2+H]+: 249.1491, found 249.1495. 
 Synthesis of Diazo Compounds 184l–n 
 
General Procedure 15: 2-(2-(Benzyloxy)phenyl)acetic acid 232 (4 mmol), prepared from 
203 according to literature procedure,30 was dissolved in CH2Cl2 (2 mL) and added to a 
solution of chiral alcohol (2 mmol) in CH2Cl2 (3 mL), DCC (3 mmol) and DMAP (0.6 mmol) 
were added. The reaction was stirred over night at room temperature. The reaction was 
filtered, washed with H2O and extracted with CH2Cl2 (3 × 10 mL). The combined organic 
layers were washed with brine, dried over MgSO4 and concentrated under vacuum. The 
crude was purified by column chromatography to afford 221l–n as a colourless solid or 
an oil. 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 2-(2-(benzyloxy)phenyl)acetate 221l: 
Performed according to General Procedure 15 on a 2.0 mmol 
scale of (−)-menthol; 221l (543 mg, 1.43 mmol, 95% yield) was 
afforded as a colourless solid, m.p.: 52–56 °C. 
1H NMR (500 MHz, CDCl3): δ = 7.35 (d, J = 7.1 Hz, 2H, ArH), 7.32–
7.26 (m, 2H, ArH), 7.23 (t, J = 7.3 Hz, 1H, ArH), 7.18–7.10 (m, 2H, 
ArH), 6.88–6.76 (m, 2H, ArH), 5.11–4.87 (m, 2H, OCH2), 4.59 (td, 
J = 10.9, 4.4 Hz, 1H, OCH), 3.60 (s, 2H, CH2), 1.90–1.80 (m, 1H), 1.76–1.65 (m, 1H), 
1.61–1.50 (m, 2H), 1.42–1.29 (m, 1H), 1.27–1.18 (m, 1H), 0.99–0.87 (m, 1H), 0.85–0.71 
(m, 8H), 0.59 (d, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 171.5 (C=O), 
156.7 (ArC–O), 137.3 (ArC), 131.1 (ArC), 128.6 (ArC), 128.5 (ArC), 127.8 (ArC), 127.1 
(ArC), 123.8 (ArC), 120.8 (ArC), 111.7 (ArC), 74.5 (OCH), 69.9 (OCH2), 47.1, 40.9, 36.6, 
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34.3, 31.4, 26.2, 23.5, 22.2, 20.8, 16.4 ppm; IR (neat): v = 3030m, 2947m, 1730s, 1499m, 
1365s, 1217s, 763s, 737s, 694s cm−1; HRMS (ES): Exact mass calculated for 
C25H32O3Na [M+Na]+: 403.2249, found 403.2266; [𝛼]𝐷20: −39.5° (c 0.40, CH2Cl2). 
(1R,2R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-yl 2-(2-(benzyloxy)phenyl)acetate 221m: 
Performed according to General Procedure 15 on a 2.0 mmol 
scale of (−)-borneol; 221m (545 mg, 1.44 mmol, 96% yield) was 
afforded as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.33 (d, J = 7.7 Hz, 2H, ArH), 
7.27 (t, J = 7.5 Hz, 2H, ArH), 7.20 (t, J = 7.1 Hz, 1H, ArH), 7.13 
(dd, J = 8.1, 3.7 Hz, 2H, ArH), 6.87–6.79 (m, 2H, ArH), 4.98 (s, 2H, OCH2), 4.81–4.76 
(m, 1H, OCH), 3.61 (s, 2H, CH2), 2.27–2.14 (m, 1H), 1.73–1.63 (m, 1H), 1.62–1.48 (m, 
2H), 1.13–1.04 (m, 1H), 1.04–0.96 (m, 1H), 0.81 (dd, J = 13.7, 3.3 Hz, 2H), 0.77 (s, 3H, 
CH3), 0.74 (s, 3H, CH3), 0.65 (s, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 172.1 
(C=O), 156.7 (ArC–O), 137.2 (ArC), 131.1 (ArC), 128.6 (ArC), 128.4 (ArC), 127.8 (ArC), 
127.1 (ArC), 123.9 (ArC), 120.8 (ArC), 111.7 (ArC), 80.1 (OCH), 69.9 (OCH2), 48.8, 47.8, 
44.9, 36.7, 36.5, 28.0, 27.0, 19.7, 18.9, 13.5 ppm; IR (neat): v = 2951m, 2926m, 1730s, 
1602w, 1589w, 1494s, 1452s, 1244s, 1153s, 1022s, 748s, 694s cm−1; HRMS (ES): Exact 
mass calculated for C25H31O3 [M+H]+: 379.2268, found 379.2270; [𝛼]𝐷20: −22.1° (c 1.4, 
CH2Cl2).  
(1R,2S,5R)-5-Methyl-2-(2-phenylpropan-2-yl)cyclohexyl 2-(2-(benzyloxy)phenyl) 
acetate 221n: 
Performed according to General Procedure 15 on a 1.59 mmol 
scale of (−)-8-phenylmentho; 221n (468 mg, 1.02 mmol, 64% 
yield) was afforded as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.42–7.34 (m, 4H, ArH), 7.33–7.28 
(m, 5H, ArH), 7.20 (t, J = 7.8 Hz, 1H, ArH), 7.14–7.10 (m, 1H, ArH), 
7.07 (d, J = 7.3 Hz, 1H, ArH), 6.93–6.83 (m, 2H, ArH), 5.05 (s, 2H, 
OCH2), 4.80 (td, J = 10.6, 4.1 Hz, 1H, OCH), 3.21 (d, J = 16.3 Hz, 1H, 1 × CH2), 3.10 (d, 
J = 16.4 Hz, 1H, 1 × CH2), 1.95 (t, J = 10.5 Hz, 1H), 1.80 (d, J = 12.2 Hz, 1H), 1.59 (t, 
J = 10.1 Hz, 2H), 1.46–1.34 (m, 1H), 1.28–1.13 (m, 7H), 1.08–0.94 (m, 1H), 0.92–0.76 
(m, 5H) ppm; 13C NMR (126 MHz, CDCl3): δ = 171.0 (C=O), 156.8 (ArC–O), 151.7 (ArC), 
137.3 (ArC), 131.2 (ArC), 128.6 (ArC), 128.4 (ArC), 128.1 (ArC), 127.9 (ArC), 127.3 
(ArC), 125.7 (ArC), 125.2 (ArC), 123.7 (ArC), 120.8 (ArC), 111.7 (ArC), 74.6 (OCH), 70.0 
(OCH2), 50.5, 41.7, 39.9, 36.2, 34.7, 31.3, 27.5, 26.8, 25.6, 21.9 ppm; IR (neat): v = 
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3030w, 2951m, 2922m, 2868w, 1730s, 1601m, 1494s, 1452s, 1242s, 987s, 748s, 696s 
cm−1; HRMS (ES): Exact mass calculated for C31H36O3Na [M+Na]+: 479.2562, found 
479.2564; [𝛼]𝐷20: +19.2° (c 0.52, CH2Cl2). 
General Procedure 16: 
 
To a solution of aryl acetate 221l–n in dry THF (5 mL), a 2 M THF solution of NaHMDS 
(1.1 equiv.) was added at −78 °C. The solution was stirred for 15 minutes before adding 
a solution of p-NBSA 18f2 (1.1 equiv.) in dry THF (1 mL) dropwise. The dark solution was 
stirred at −78 °C for 1 hour before being allowed to warm up to room temperature for  
12–48 h. The reaction was quenched with pH 7 phosphate buffer, the product extracted 
with CH2Cl2 (3 × 10 mL), the combined organic layers washed with H2O, brine and finally 
dried over MgSO4 and concentrated under reduced pressure (20 °C water bath). The 
crude was purified by column chromatography to afford the products 184l–n as yellow 
oils. 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 2-(2-(benzyloxy)phenyl)-2-diazoacetate 
184l: 
Performed according to General Procedure 16 on a 0.63 mmol 
scale of 221l; 184l (213 mg, 0.52 mmol, 83% yield) was afforded 
as a bright yellow oil.  
1H NMR (500 MHz, CDCl3): δ = 7.58 (dd, J = 7.8, 1.3 Hz, 1H, ArH), 
7.39–7.26 (m, 5H, ArH), 7.18 (ddd, J = 8.5, 6.8, 3.0 Hz, 1H, ArH), 
6.99 (t, J = 7.6 Hz, 1H, ArH), 6.92 (d, J = 8.3 Hz, 1H, ArH), 5.07 
(s, 2H, OCH2), 4.81 (td, J = 10.9, 4.4 Hz, 1H, OCH), 2.10–2.03 (m, 1H), 1.89 (dtd, J = 
13.9, 6.9, 2.6 Hz, 1H), 1.68–1.61 (m, 1H), 1.52–1.42 (m, 1H), 1.41–1.34 (m, 1H), 1.11–
0.96 (m, 2H), 0.87 (t, J = 6.5 Hz, 6H), 0.77 (d, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 165.9 (C=O), 154.7 (ArC–O), 136.5 (ArC), 130.3 (ArC), 128.7 
(ArC), 128.4 (ArC), 128.2 (ArC), 127.6 (ArC), 121.5 (ArC), 114.5 (ArC), 112.4 (ArC), 75.0 
(OCH), 70.8 (OCH2), 47.2, 41.5, 34.4, 31.6, 26.6, 23.8, 22.2, 20.9, 16.7 ppm (C=N2 not 
observed); IR (neat): v = 2953m, 2924m, 2868m, 2093s, 1690s, 1448m, 1240m, 1011s, 
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746s, 694m cm−1; HRMS (ES): Exact mass calculated for C25H31O3 [M−N2+H]+: 
379.2273, found 379.2272; [𝛼]𝐷20−49.7° (c 0.52, CH2Cl2).  
(1R,2R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-yl 2-(2-(benzyloxy)phenyl)-2-diazo 
acetate 184m: 
Performed according to General Procedure 16 on a 1.1 mmol 
scale of 221m; 184m (371 mg, 0.92 mmol, 83% yield) was 
afforded as a bright yellow oil.  
1H NMR (500 MHz, CDCl3): δ = 7.62 (d, J = 7.8 Hz, 1H, ArH), 
7.45–7.32 (m, 5H, ArH), 7.25–7.19 (m, 1H, ArH), 7.03 (t, J = 7.6 
Hz, 1H, ArH), 6.97 (d, J = 8.3 Hz, 1H, ArH), 5.12 (s, 2H, OCH2), 5.04 (d, J = 9.7 Hz, 1H, 
OCH), 2.41 (td, J = 9.9, 4.9 Hz, 1H), 1.90–1.81 (m, 1H), 1.78–1.68 (m, 2H), 1.33–1.20 
(m, 2H), 1.09 (dd, J = 13.7, 2.9 Hz, 1H),0.93 (s, 3H, CH3), 0.88 (s, 3H, CH3), 0.87 (s, 3H, 
CH3) ppm; 13C NMR (126 MHz, CDCl3) δ = 166.6 (C=O), 154.6 (ArC–O), 136.5 (ArC), 
130.2 (ArC), 128.7 (ArC), 128.4 (ArC), 128.3 (ArC), 127.7 (ArC), 121.5 (ArC), 114.4 
(ArC), 112.4 (ArC), 80.8 (OCH), 70.9 (OCH2), 49.1, 47.9, 45.1, 37.1, 28.2, 27.2, 19.9, 
19.0, 13.7 ppm (C=N2 not observed); IR (neat): v = 2953m, 2876w, 2091s, 1693s, 
1497m, 1450m, 1242s, 1151s, 1022s, 746s, 694s cm−1; HRMS (ES): Exact mass 
calculated for C25H29O3 [M−N2+H]+: 377.2117, found 377.2115; [𝛼]𝐷20 −21.9° (c 0.64, 
CH2Cl2). 
(1R,2S,5R)-5-methyl-2-(2-phenylpropan-2-yl)cyclohexyl 2-(2-(benzyloxy)phenyl)-2-
diazoacetate 184n: 
Performed according to General Procedure 16 on a 0.63 mmol 
scale of 221n; It was not possible to have full conversion nor 
purified 184n from the starting material left and it was carried on 
as crude mixture material (product/starting material ratio = 1:0.6) 
for the following step.  
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 Synthesis of Diazo Compound 224 
Methyl 2-(2-(benzylthio)phenyl) acetate 223: 
 
An oven-dried Schlenk tube under nitrogen was loaded with 2-iodophenylacetic acid 
202e (660 mg, 2.5 mmol), CuI (10 mol%), sulfur powder (3 equiv.) and K2CO3 (2 equiv.). 
Dry DMF (5 mL) was added and the mixture was stirred at 90 °C for 16 hours under inert 
atmosphere. The dark brown muddy suspension was then cooled down to 0 °C before 
the addition of NaBH4 (284 mg, 3 equiv.) and stirred for further 7 hours at 40 °C. The 
orange suspension was cooled down to 0 °C before the addition of benzyl bromide 160 
(300 µL, 2 equiv.) then stirred at room temperature for 16 h. HCl 1 M was added to the 
dark solution until pH 2, and the product extracted with ethyl acetate (3 × 5 mL). The 
combined organic layers were washed with H2O (2 × 5 mL), brine then dried over MgSO4 
and concentrated under reduced pressure to afford a yellow oil. The oil was dissolved in 
MeOH (8 mL), cooled to 0 °C and treated with acetyl chloride (540 µL) dropwise. The 
reaction was stirred at room temperature for 6 h. The solvent was removed under 
reduced pressure, the residue diluted with Et2O and washed with a saturated aqueous 
solution of NaHCO3 (10 mL), H2O (10 mL) and brine. The organic layer was then dried 
over MgSO4, concentrated under reduced pressure and purified by column 
chromatography (10% EtOAc in petroleum ether). Compound 223 was afforded as a 
yellow oil (152 mg, 0.55 mmol, 22% overall yield). 
1H NMR (500 MHz, CDCl3): δ = 7.42–7.34 (m, 1H, ArH), 7.34–7.14 (m, 8H, ArH), 4.03 
(s, 2H, SCH2), 3.75 (s, 2H, CH2), 3.69 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): 
δ = 172.0 (C=O), 137.5 (ArC), 136.0 (ArC), 135.9 (ArC), 132.5 (ArC), 130.7 (ArC), 129.0 
(ArC), 128.6 (ArC), 128.0 (ArC), 127.5 (ArC), 127.3 (ArC), 52.2 (OCH3), 40.2, 39.5 ppm; 
IR (neat): v = 3061w, 2949w, 1732s, 1433m, 1339m, 1213w, 1155s, 739s cm−1; HRMS 
(ES): Exact mass calculated for C16H16O2S [M]+: 272.0871, found 272.0867. 
 
 
 
Micol Santi Experimental Part  
 
223 
Methyl 2-(2-(benzylthio)phenyl) acetate 224: 
 
A solution of 223 (115 mg, 0.42 mmol) in dry acetonitrile (4 mL) was cooled down to 0 °C 
before the addition of p-ABSA (121 mg, 1.2 equiv.) and DBU (75 µL, 1.2 equiv.) and 
stirred for 16 hours at room temperature under nitrogen and monitored by TLC 
(n-hexane/ethyl acetate, 9:1). The mixture was quenched with a saturated aqueous 
solution of NH4Cl (10 mL) and the product was extracted with CH2Cl2 (3 × 5 mL). The 
combined organic layers were washed with water, brine, dried over MgSO4 and 
concentrated under reduced pressure (20 °C water bath). The crude was purified by flash 
column chromatography to afford 224 as a yellow oil (51 mg, 0.17 mmol, 40% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.45–7.38 (m, 1H, ArH), 7.39–7.34 (m, 1H, ArH), 7.30–
7.16 (m, 7H, ArH), 4.08 (s, 2H, SCH2), 3.81 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 166.6 (C=O), 137.4 (ArC), 136.9 (ArC), 132.1 (ArC), 131.0 (ArC), 129.4 
(ArC), 129.0 (ArC), 128.7 (ArC), 128.6 (ArC), 127.4 (ArC), 127.2 (ArC), 127.1 (ArC), 
126.1 (ArC), 52.3 (OCH3), 39.3 (SCH2) ppm (C=N2 not observed); IR (neat): v = 2951w, 
2089s, 1693s, 1433s, 1344m, 1286s, 1153s, 1078m, 1028s, 914w, 754s cm−1; HRMS 
(ES): Exact mass calculated for C16H14N2O2S [M]+: 298.0775, found 298.0776. 
5.3.2 Synthesis of α-Aryl Esters 
General Procedure 17: 
 
Ethyl 2-diazopropanoate 107 (0.3 mmol) was dissolved in CDCl3 (0.5 mL) and the 
triarylborane 106a–e (0.1 mmol) was added under nitrogen and the reaction was 
performed for 1 hour at room temperature. A strong gas development was observed for 
15–30 minutes, meanwhile the colour changed from orange to pale yellow. The reaction 
was monitored by NMR spectroscopy then it was quenched with 1 M aqueous solution 
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of NaOH (1 mL). The aqueous phase was extracted with CHCl3 (3 × 1 mL). The combined 
organic layers were filtrated over SiO2 plug and dried in vacuo, affording the products 
182a–e as a colourless oil. 
Ethyl 2-phenylpropanoate 182a: 
Performed according to General Procedure 17 on a 0.3 mmol scale of 107 
and 0.1 mmol of 106a; 182a (16 mg, 0.092 mmol, 30% yield) was obtained 
as a volatile colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.30–7.24 (m, 4H, ArH), 7.22–7.18 (m, 1H, 
ArH), 4.13–4.02 (m, 2H, OCH2), 3.66 (q, J = 7.2 Hz, 1H, CH), 1.45 (d, J = 7.2 Hz, 3H, 
CHCH3), 1.16 (t, J = 7.1 Hz, 3H, OCH2CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 174.7 
(C=O), 140.8 (ArC–CH), 128.7 (2 × ArC), 127.6 (2 × ArC), 127.2 (ArC), 60.8 (OCH2), 
45.7 (CH), 18.7 (CH3), 14.3 (CH3) ppm. The spectroscopic data are in agreement with 
the literature.31 
Ethyl 2-(4-fluorophenyl)propanoate 182b: 
Performed according to General Procedure 17 on a 0.3 mmol scale of 107 
and 0.1 mmol of 106b; 182b (20 mg, 0.11 mmol, 37% yield) was obtained 
as a volatile colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.30–7.24 (m, 2H, ArH), 7.01–6.96 (m, 2H, 
ArH), 4.18–4.04 (m, 2H, OCH2), 3.69 (q, J = 7.2 Hz, 1H, CH), 1.48 (d, J = 
7.2 Hz, 3H, CH3), 1.21 (t, J = 7.1 Hz, 3H, OCH2CH3) ppm; 13C NMR (126 MHz, CDCl3): 
δ = 174.6 (C=O), 162.1 (d, J = 245.2 Hz, ArC–F), 136.5 (d, J = 8.3 Hz, ArC–CH), 129.2 
(d, J = 8.0 Hz, 2 × ArC), 115.5 (d, J = 21.4 Hz, 2 × ArC), 61.0 (OCH2), 44.9 (CH), 18.8 
(CH3), 14.3 (CH3) ppm; 19F NMR (471 MHz, CDCl3): δ = −115.9 (s) ppm. The 
spectroscopic data are in agreement with the literature.32 
Ethyl 2-(2,4-difluorophenyl)propanoate 182c:  
Performed according to General Procedure 17 on a 0.35 mmol scale of 107 
and 0.1 mmol of 106c; 182c (34 mg, 0.16 mmol, 45% yield) was obtained 
as a volatile colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.30–7.23 (m, 1H, ArH), 6.89–6.73 (m, 2H, 
ArH), 4.20–4.09 (m, 2H, OCH2), 3.96 (q, J = 7.2 Hz, 1H, CH), 1.48 (d, J = 
7.2 Hz, 3H, CHCH3), 1.21 (t, J = 7.1 Hz, 3H, OCHCH3) ppm; 13C NMR (126 MHz, CDCl3): 
δ = 173.8 (C=O), 162.3 (dd, J = 200.2, 12.0 Hz, ArC–F), 160.3 (dd, J = 201.0, 12.0 Hz, 
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ArC–F), 129.6 (dd, J = 9.6, 5.7 Hz, ArC), 124.0 (dd, J = 15.1, 3.9 Hz, ArC), 111.5 (dd, J 
= 21.1, 3.7 Hz, ArC), 105.9–101.8 (m, ArC), 61.2 (OCH2), 38.1 (d, J = 2.3 Hz, CH), 17.7 
(CH3), 14.2 (CH3) ppm; 19F NMR (376 MHz, CDCl3): δ = −112.1 (d, J = 6.9 Hz, 1F), 
−114.0 (d, J = 6.9 Hz, 1F) ppm; IR (neat): ν = 2916w, 1734s, 1618w, 1506s, 1194m, 
964s cm−1. HRMS (EI): Exact mass calculated for C11H12F2O2 [M]+: 214.0805, found 
214.0807. 
Ethyl 2-(pentafluorophenyl)propanoate 182d: 
Performed according to General Procedure 17 on a 0.35 mmol scale of 
107 and 0.1 mmol of 106d; 182d (64 mg, 0.25 mmol, 80% yield) was 
obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 4.30–4.10 (m, 2H, CH2), 4.05 (q, J = 
7.3 Hz, 1H, CH), 1.54 (d, J = 7.4 Hz, 3H, CH3), 1.23 (t, J = 7.1 Hz, 3H, 
OCH2CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 171.3 (C=O), 145.4 (d, J = 247.3 Hz, 
2 × ArC–F), 140.5 (d, J = 247.5 Hz, ArC–F), 137.7 (d, J = 252.4 Hz, 2 × ArC–F), 115.1 
(dt, J = 17.0, 4.2 Hz, ArC–CH), 61.8 (OCH2), 35.0 (CH), 16.3 (CH3), 14.2 (CH3) ppm; 
19F NMR (376 MHz, CDCl3): δ = −143.1 (dd, J = 22.0, 7.0 Hz, 2F), −156.3 (t, J = 20.7 
Hz, 1F), −162.4 (dt, J = 21.1, 6.8 Hz, 2F, m-F) ppm; IR (neat): ν = 2960w, 2926w, 2854w, 
1739m, 1521m, 1504s, 1261s, 1012s, 970s, 800s cm−1; HRMS (EI): Exact mass 
calculated for C11H9F5O2 [M]+: 268.0523, found 268.0520. 
Ethyl 2-(3,4,5-trifluorophenyl)propanoate 182e: 
Performed according to General Procedure 17 on a 0.35 mmol scale of 
107 and 0.1 mmol of 106e; 182e (44 mg, 0.19 mmol, 89% yield) was 
obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.03–6.78 (m, 2H, ArH), 4.21–4.06 (m, 
2H, OCH2), 3.63 (q, J = 7.2 Hz, 1H, CH), 1.46 (d, J = 7.2 Hz, 3H, CH3), 
1.22 (t, J = 7.1 Hz, 3H, OCH2CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 173.4 (C=O), 
150.9 (ddd, J = 249.8, 9.9, 4.1 Hz, 2 × ArC–F), 139.0 (dt, J = 250.0, 15.6 Hz, ArC–F), 
136.8 (td, J = 7.4, 4.7 Hz, 2 × ArC), 112.0–111.7 (m, ArC–CH), 61.4 (OCH2), 44.9 (CH), 
18.5 (CH3), 14.2 (CH3) ppm; 19F NMR (376 MHz, CDCl3): δ = −134.2 (d, J = 21.4 Hz, 2F), 
−162.5 (t, J = 20.5 Hz, 1F) ppm; IR (neat): v = 2986w, 1732s, 1620m, 1530s, 1447m, 
1348m, 1329m, 1236m, 1211m, 1179s, 1038s, 945w, 860m, 797m, 771m cm−1; HRMS 
(ES): Exact mass calculated for C11H10F3O2 [M−H]−: 231.0633, found 231.0644. 
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General Procedure 18: 
 
The α-aryl-α-diazoacetates 165 or 179a–d (0.1 mmol) was dissolved in CDCl3 (0.5 mL) 
and the triarylborane 106d–f (0.1 mmol) was added under nitrogen and the reaction was 
performed for 12 hours at room temperature. A strong gas development was observed 
for 1 hour, meanwhile the colour changed from orange to pale yellow. The reaction was 
monitored by NMR spectroscopy then it was quenched with 1 M aqueous solution of 
NaOH (1 mL). The aqueous phase was extracted with CHCl3 (3 × 1 mL). The combined 
organic layers were filtrated over SiO2 plug and the crude where purified by column 
chromatography, affording the products 182f–o. 
Methyl 2-Phenyl-2-(3,4,5-trifluorophenyl)acetate 182f: 
Performed according to General Procedure 18 on a 0.12 mmol scale 
of 165 and 0.12 mmol of 106e; 182f (28 mg, 0.096 mmol, 80% yield) 
was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.39–7.25 (m, 5H, ArH), 6.98–6.91 
(m, 2H, ArH), 4.93 (s, 1H, CH), 3.76 (s, 3H, OCH3) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 172.0 (C=O), 151.2 (ddd, J = 250.0, 9.6, 4.2 Hz, 2 × ArC–F), 
139.2 (td, J = 252.0, 15.3 Hz, ArC–F), 137.3 (ArC), 135.1–134.8 (m, ArC), 129.2 (2 × 
ArC), 128.5 (2 × ArC), 128.1 (ArC), 113.2–112.9 (m, 2 × ArC), 56.0 (CH), 52.8 (OCH3) 
ppm; 19F NMR (376 MHz, CDCl3): δ = −133.9 (d, J = 20.5 Hz, 2F), −162.0 (t, J = 20.3 Hz, 
1F) ppm; IR (neat): ν = 2955w, 2924w, 2851w, 1735s, 1618m, 1528s, 1449m, 1435m, 
1155s, 1043s, 698s cm−1; HRMS (ASAP): Exact mass calculated for C15H11F3O2 [M]+: 
280.0711, found 280.0713. 
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Methyl 2-phenyl-2-(pentafluorophenyl)acetate 182g: 
Performed according to General Procedure 18 on a 0.12 mmol scale 
of 165 and 0.12 mmol of 106d; 182g (27 mg, 0.087 mmol, 73% yield) 
was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.41–7.26 (m, 5H, ArH), 5.29 (s, 1H, 
CH), 3.80 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 170.01 
(C=O), 135.6 (ArC), 129.0 (2 × ArC), 128.9–128.8 (m, 2 × ArC), 128.2 (ArC), 53.2 
(OCH3), 46.2 (CH) ppm (ArC–F not observed); 19F NMR (471 MHz CDCl3): δ = −140.9 
(dd, J = 21.7, 6.7 Hz, 2F), −155.0 (t, J = 20.9 Hz, 1F), −161.5 (dt, J = 21.0, 6.7 Hz, 2F) 
ppm; IR (neat): ν = 2957w, 1748s, 1522s, 1500s, 1300m, 1265m, 1205s, 1121s, 908s, 
729s, 698s cm−1; HRMS (EI): Exact mass calculated for C15H9F5O2 [M]+: 316.0523, found 
316.0522.  
Methyl 2-(2-bromophenyl)-2-(3,4,5-trifluorophenyl)acetate 182h: 
Performed according to General Procedure 18 on a 0.11 mmol scale 
of 179a and 0.12 mmol of 106e; 182h (31 mg, 0.86 mmol, 79% yield) 
was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.61 (dd, J = 7.9, 1.2 Hz, 1H, ArH), 
7.39–7.27 (m, 2H, ArH), 7.19 (ddd, J = 8.0, 6.7, 2.3 Hz, 1H, ArH), 6.92 
(dd, J = 8.4, 6.5 Hz, 2H, ArH), 5.42 (s, 1H, CH), 3.77 (s, 3H, OCH3) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 171.5 (C=O), 151.2 (ddd, J = 250.0, 9.6, 5.7 Hz, 2 × ArC–F), 
139.3 (dt, J = 252.2, 15.2 Hz, ArC–F), 136.8 (ArC), 133.6 (ArC), 133.6–133.4 (m, ArC), 
129.7 (ArC), 129.6 (ArC), 128.1 (ArC), 125.1 (ArC), 113.6–113.3 (m, 2 × ArC), 55.2 (CH), 
53.0 (OCH3) ppm; 19F NMR (376 MHz, CDCl3): δ = −133.7 (d, J = 20.5 Hz, 2F), −162.5 
(t, J = 20.6 Hz, 1F); IR (neat): ν = 2954w, 2924w, 2851w, 1740s, 1620w, 1530s, 1449m, 
1435m, 1348s, 1163s, 1043s, 1020s, 800.5 735s cm−1; HRMS (ASAP): Exact mass 
calculated for C15H11BrF3O2 [M+H]+: 358.9895, found 358.9883. 
Methyl 2-(2-bromophenyl)-2-(pentafluorophenyl) acetate 182i: 
Performed according to General Procedure 18 on a 0.11 mmol scale 
of 179a and 0.12 mmol of 106d; 182i (46 mg, 0.12 mmol, 99% yield) 
was obtained as a colourless oil. 
 
1H NMR (500 MHz, CDCl3): δ = 7.60 (dd, J = 8.0, 1.2 Hz 1H, ArH), 
7.66–7.53 (m, 1H, ArH), 7.24–7.15 (m, 2H, ArH), 5.74 (s, 1H, CH), 
3.80 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 168.6 (C=O), 145.5 (d, J = 
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245.6 Hz, 2 × ArC–F), 141.1 (d, J = 254.9 Hz, ArC–F), 137.8 (d, J = 253.7 Hz, 2 × ArC–
F), 134.4 (ArC), 133.4 (ArC), 130.1 (t, J = 3.0 Hz, ArC), 129.9 (ArC), 127.9 (ArC), 125.1 
(ArC), 112.1 (ArC), 53.4 (OCH3), 46.5 (CH) ppm; 19F NMR (376 MHz, CDCl3): δ = −139.4 
(d, J = 18.0 Hz, 1F), −154.0 (t, J = 21.0 Hz, 1F), −161.5 (t, J = 20.7 Hz, 2F) ppm; IR 
(neat): ν = 2955w, 1743s, 1522s, 1472m, 1435m, 1206m, 1123s cm−1; HRMS (EI): Exact 
mass calculated for C15H11BrF3O2 [M+H]+: 393.9628, found 393.9635. 
Methyl 2-(4-trifluoromethylphenyl)-2-(3,4,5-trifluorophenyl)acetate 182j: 
Performed according to General Procedure 18 on a 0.12 mmol 
scale of 179b and 0.12 mmol of 106e; 182j (37 mg, 0.11 mmol, 
89% yield) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.62 (d, J = 8.2 Hz, 2H, ArH), 
7.41 (d, J = 8.2 Hz, 2H, ArH), 6.94 (dd, J = 8.3, 6.5 Hz, 2H, ArH), 
4.98 (s, 1H, CH), 3.78 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 171.3 (C=O), 
151.3 (ddd, J = 251.0, 9.6, 4.2 Hz, 2 × ArC–F), 141.1 (ArC), 139.4 (td, J = 252.6, 15.2 Hz, 
ArC–F), 134.5–133.5 (m, ArC), 130.4 (q, J = 32.7 Hz, ArC–CF3), 128.9 (2 × ArC), 126.1 
(q, J = 3.7 Hz, 2 × ArC), 124.0 (q, J = 272.2 Hz, CF3), 113.2–112.9 (m, ArC), 55.7 (CH), 
53.0 (OCH3) ppm; 19F NMR (376 MHz, CDCl3): δ = −62.7 (s, 3F), −133.2 (d, J = 20.5 Hz, 
2F), −161.2 (t, J = 20.5 Hz, 1F) ppm; IR (neat) ν = 3055w, 2928w, 2855w, 1742m, 1620w, 
1531m, 1325m, 1263s, 1167m cm−1. HRMS (ASAP): Exact mass calculated for 
C16H10F6O2 [M]+: 348.0585, found 348.0593. 
Methyl 2-(4-trifluoromethylphenyl)-2-(pentafluorophenyl)acetate 182k:  
Performed according to General Procedure 18 on a 0.12 mmol 
scale of 179b and 0.12 mmol of 106d; 182k (33 mg, 0.087 mmol, 
73% yield) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.61 (d, J = 8.4 Hz, 2H, ArH), 
7.43 (d, J = 8.2 Hz, 2H, ArH), 5.33 (s, 1H, CH), 3.81 (s, 3H, 
OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 169.4 (C=O), 144.9 (d, J = 248.1 Hz, 2 × 
ArC–F), 139.4 (ArC), 137.8 (d, J = 268.9 Hz, 2 × ArC–F) 130.6 (q, J = 31.2 Hz,  
ArC–CF3), 129.4 (2 × ArC), 126.0 (q, J = 4.1 Hz, 2 × ArC), 124.0 (q, J = 272.2 Hz, CF3), 
123.6 (ArC), 53.4 (OCH3), 45.7 (CH) ppm, (1 × ArC not observed); 19F NMR (376 MHz, 
CDCl3): δ = −62.78 (s, 3F), −140.9 (dd, J = 20.0, 6.0 Hz, 2F), −153.86 (t, J = 20.9 Hz, 
1F), −160.8 (dt, J = 21.6, 6.6 Hz, 2F); IR (neat) ν = 2957w, 2926w, 2855w, 1749m, 
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1524m, 1505s, 1325s, 1265m, 1169m, 1124s, 1069s cm−1; HRMS (EI): Exact mass 
calculated for C16H8F8O2 [M]+: 384.0397, found 384.0397. 
Methyl 2-(4-methphenyl)-2-(3,4,5-trifluorophenyl)acetate 182l: 
Performed according to General Procedure 18 on a 0.05 mmol 
scale of 179c and 0.05 mmol of 106e; 182l (12 mg, 0.039 mmol, 
76% yield) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.22–7.18 (m, 2H, ArH), 6.97–
6.82 (m, 4H, ArH), 4.87 (s, 1H, CH), 3.80 (s, 3H, OCH3), 3.75 
(s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 172.3 (C=O), 159.4 (ArC–O), 151.2 
(ddd, J = 250.0, 10.0, 4.1 Hz, 2 × ArC–F), 139.0 (dt, J = 251.6, 15.3 Hz, ArC–F), 135.3–
135.1 (m, ArC), 129.6 (2 × ArC), 129.3 (ArC), 114.5 (2 × ArC), 113.4–111.7 (m, 2 × ArC), 
55.5 (OCH3), 55.2 (CH), 52.7 (OCH3) ppm; 19F NMR (376 MHz, CDCl3): δ = −134.0 (d, 
J = 20.6 Hz, 2F), −162.2 (t, J = 20.6 Hz, 1F) ppm; IR (neat): ν = 2955w, 2841w, 1735s, 
1611m, 1528s, 1510s, 1435m, 1155s, 1042s, 970m, 833m cm−1; HRMS (ASAP): Exact 
mass calculated for C16H14F3O3 [M+H]+: 311.0895, found 311.0893. 
Methyl 2-(4-methoxyphenyl)-2-(pentafluorophenyl)acetate 182m: 
Performed according to General Procedure 18 on a 0.05 mmol 
scale of 179c and 0.05 mmol of 106d; 182m (14 mg, 
0.042 mmol, 83% yield) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ = 7.25–7.17 (m, 2H, ArH), 6.90–
6.84 (m, 2H, ArH), 5.23 (s, 1H, CH), 3.79 (s, 6H, 2 × OCH3) ppm; 
13C NMR (126 MHz, CDCl3): δ = 170.4 (C=O), 159.4 (ArC–O), 144.9 (d, J = 243.6 Hz, 
2 × ArC–F), 140.7 (d, J = 254.0 Hz, ArC–F), 137.8 (d, J = 252.1 Hz, 2 × ArC–F), 130.4 
(ArC), 130.0 (2 × ArC), 127.7 (ArC), 114.4 (2 × ArC), 114.2 (ArC), 55.4 (OCH3), 53.1 
(OCH3), 45.4 (CH) ppm; 19F NMR (376 MHz, CDCl3): δ = −141.3 (d, J = 18.4 Hz, 2F), 
−155.3 (t, J = 20.9 Hz, 1F), −161.5 (t, J = 19.6 Hz, 2F) ppm; IR (neat): ν = 2916w, 2849w, 
1748m, 1514s, 1502s, 1252m, 1207m, 1180m, 1119m, 997m, 974m, 908w cm−1; HRMS 
(ASAP): Exact mass calculated for C16H12F5O2 [M+H]+: 347.0706, found 347.0699. 
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Methyl 2-(naphthalen-1-yl)-2-(3,4,5-trifluorophenyl)acetate 182n: 
Performed according to General Procedure 18 on a 0.12 mmol scale 
of 179d and 0.12 mmol of 106e; 182n (35 mg, 0.11 mmol, 88% yield) 
was obtained as a colourless oil. 
 
1H NMR (500 MHz, CDCl3): δ = 7.92–7.82 (m, 3H, ArH), 7.56–7.44 
(m, 3H, ArH), 7.39 (d, J = 7.1 Hz, 1H, ArH), 7.01–6.88 (m, 2H, ArH), 
5.70 (s, 1H, CH), 3.78 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): 
δ = 172.4 (C=O), 151.3 (d, J = 240.2 Hz, 2 × ArC–F), 134.5–134.4 (m, ArC), 134.3 (ArC), 
132.9 (ArC), 131.3 (ArC), 129.3 (ArC), 129.1 (ArC), 127.1 (ArC), 126.2 (2 × ArC), 125.6 
(ArC), 123.0 (ArC), 114.4–111.7 (m, 2 × ArC), 52.8 (OCH3), 52.5 (CH) ppm (1 × ArC–F 
not observed); 19F NMR (376 MHz, CDCl3): δ =  −133.8 (d, J = 20.5 Hz, 2F), −161.7 (t, 
J = 20.5 Hz, 1F) ppm; IR (neat): ν = 3055w, 2954w, 2854w, 1740m, 1620w, 1530s, 
1449w, 1435w, 1263s, 1045s cm−1; HRMS (ASAP): Exact mass calculated for 
C19H13F3O2 [M]+: 330.0868, found 330.0868. 
Methyl 2-(naphthalen-1-yl)-2-(pentafluorophenyl)acetate 182o:  
Performed according to General Procedure 18 on a 0.12 mmol scale 
of 179d and 0.12 mmol of 106d; 182o (27 mg, 0.075 mmol, 63% 
yield) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 8.00–7.77 (m, 3H, ArH), 7.70–7.30 
(m, 4H, ArH), 6.08 (s, 1H, CH), 3.82 (s, 3H, OCH3) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 170.6 (C=O), 145.5 (d, J = 236.5 Hz, 2 ×  
ArC–F), 134.1 (ArC), 131.5 (ArC), 131.0 (ArC), 129.4 (ArC), 129.2 (ArC), 128.4 (ArC), 
127.2 (ArC), 126.8 (t, J = 3.0 Hz, ArC), 126.1 (ArC), 125.4 (ArC), 122.2 (ArC), 113.0 
(ArC), 53.3 (OCH3), 43.0 (CH) ppm; 19F NMR (376 MHz, CDCl3): δ = −140.0 (dd, 
J = 18.5 Hz, 2F), −154.5 (t, J = 20.8 Hz, 1F), −161.5 (t, J =19.8 Hz, 2F) ppm; IR (neat): 
ν = 3053w, 2954w, 2848w, 1742m, 1654w, 1522s, 1501s, 1468m, 986s, 908m, 775s, 
731s cm−1; HRMS (EI): Exact mass calculated for C19H11F5O2 [M]+: 366.0679, found 
366.0686. 
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Methyl 2-(3,4-dichlorophenyl)-2-(4-methoxyphenyl)acetate 182p: 
Performed according to General Procedure 18 on a 0.08 mmol 
scale of 179c and 0.08 mmol of 106f; 182p (24 mg, 0.074 mmol, 
92% yield) was obtained as a colourless oil. 
1H NMR (500 MHz CDCl3): δ = 7.38 (t, J = 5.6 Hz, 2H, ArH), 
7.23–7.18 (m, 2H, ArH), 7.14 (dd, J = 8.3, 2.1 Hz, 1H, ArH), 
6.89–6.85 (m, 2H, ArH), 4.91 (s, 1H, CH), 3.80 (s, 3H, OCH3), 3.75 (s, 3H, OCH3) ppm; 
13C NMR (126 MHz, CDCl3): δ = 172.5 (C=O), 159.2 (ArC–O), 139.3 (ArC), 132.7 (ArC), 
131.6 (ArC), 130.6 (ArC), 130.6 (ArC), 129.7 (ArC), 129.6 (2 × ArC), 128.0 (ArC), 114.4 
(2 × ArC), 55.4, 55.3, 52.7 ppm; Spectroscopic data are in accordance with the 
literature.33 
(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl2-(3,4,5-trifluorophenyl)propanoate 182q: 
Performed according to General Procedure 18 on a 0.11 mmol scale 
of 179h and 0.11 mmol of 106e; 182q (36 mg, 0.11 mmol, 96% yield, 
1.1:1 d.r.) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.00–6.81 (m, 4H, ArH), 4.77–4.52 
(m, 2H, OCH), 3.75–3.45 (m, 2H, CH), 2.02–1.93 (m, 1H), 1.88–1.80 
(m, 1H), 1.79–1.59 (m, 6H), 1.51–1.40 (m, 8H), 1.41–1.26 (m, 2H), 
1.13–0.80 (m, 15H), 0.77 (d, J = 7.0 Hz, 3H, CH3), 0.73 (d, J = 7.0 Hz, 3H, CH3), 0.59 (d, 
J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 173.0 (C=O), 172.9 (CI=O), 
151.0 (d, J = 255.3 Hz, 2 × ArC–F), 112.5–110.4 (m, 2 × ArC), 75.3 (OCH2), 75.2 (OCIH2), 
47.2, 47.1, 45.3, 45.2, 40.9, 40.6, 34.3, 34.3, 31.5, 31.5, 26.5, 26.2, 23.5, 23.4, 22.1, 
22.1, 20.8, 20.7, 18.4, 18.3, 16.4, 16.1 ppm (1 × ArC–F not observed); 19F NMR (376 
MHz, CDCl3): δ = −134.4 (d, J = 20.4 Hz, 4F), −162.6 (t, J = 20.4 Hz, 2F) ppm; IR (neat): 
ν = 2957w, 2872w, 1728s, 1530s, 1449s, 1348m, 1175s, 1038s, 856m, 797m cm−1; 
HRMS (ASAP): Exact mass calculated for C19H24F3O2 [M−H]+: 341.1728, found 
341.1728. 
 
 
 
 
 Experimental Part Micol Santi 
 
232 
(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 2-(pentafluorophenyl)propanoate 182r: 
Performed according to General Procedure 18 on a 0.06 mmol scale 
of 179h and 0.06 mmol of 106d; 182r (22 mg, 0.058 mmol, 94% 
yield, 1.2:1 d.r.) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 4.74 (td, J = 10.9, 4.4 Hz, 1.16H, 
OCH), 4.67 (td, J = 10.9, 4.4 Hz, 1H, OCHI), 4.16–3.82 (m, 2.12H), 
2.09–2.00 (m, 1H), 1.98–1.92 (m, 1.2H), 1.84–1.58 (m, 6.3H), 1.54–
1.44 (m, 10.4H), 1.36–1.21 (m, 2.4H), 1.12–0.73 (m, 23H), 0.70 (d, J = 7.0 Hz, 3H, 
CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 170.9 (C=O), 76.1 (OCH2), 75.9 (OCIH2), 
47.0, 47.0, 40.7, 40.4, 35.2, 34.3, 31.5, 31.5, 26.5, 26.2, 23.7, 23.3, 22.1, 20.8, 16.5, 
16.3, 16.1, 16.0 ppm (ArC not observed); 19F NMR (376 MHz, CDCl3): δ = −142.5 (d, J = 
19.0 Hz, 2F), −142.8 (d, J = 18.6 Hz, 2.3F), −154.6– −157.3 (m, 2.16F), −160.5– −166.5 
(m, 4.6F) ppm; IR (neat): ν = 2957w, 2872w, 1740m, 1521m, 1503s, 1456m, 1207m, 
968s, 740m cm−1; HRMS (ASAP): Exact mass calculated for C19H23F5O2 [M−H]+: 
377.1540, found 377.1536. 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl2-(2-bromophenyl)-2-(3,4,5-trifluoro-phenyl) 
acetate 182s: 
Performed according to General Procedure 18 on a 0.07 mmol 
scale of 179i and 0.07 mmol of 106e; 182s (32 mg, 0.067 mmol, 
96% yield, 1.3:1 d.r.) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.60 (d, J = 8.0 Hz, 2.3H, ArH), 
7.35–7.21 (m, 4.6H, ArH), 7.21–7.15 (m, 2.3H, ArH), 6.97–6.86 
(m, 4.6H, ArH), 5.38 (s, 1.3H, CH), 5.34 (s, 1H, CHI), 4.80–4.66 
(m, 2.3H, OCH), 2.06–1.98 (m, 2.3H), 1.71–1.57 (m, 6.9H), 1.53–1.43 (m, 2.3H), 1.39–
1.30 (m, 2.3H), 1.10–0.79 (m, 18H), 0.78 (d, J = 7.0 Hz, 3H, CH3), 0.70 (d, J = 7.0 Hz, 
3.9H, CH3), 0.65 (d, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 170.6 
(C=O), 170.5 (CI=O), 151.3 (d, J = 249.8 Hz, 2 × ArC–F), 139.2 (d, J = 252.3 Hz,  
ArC–F), 137.1 (ArC), 137.0 (ArCI), 134.0–133.7 (m, ArC), 133.5 (ArCI), 133.4 (ArC), 
129.8 (ArC), 129.7 (ArCI), 129.6 (ArCI), 129.5 (ArC), 127.9 (ArC), 127.8 (ArCI), 125.2 
(ArCI), 125.1 (ArC), 113.6–113.0 (m, 2 × ArC), 76.3 (OCH), 76.2 (OCIH), 55.8, 55.7, 47.0, 
46.9, 40.6, 40.5, 34.2, 31.6, 31.5, 26.2, 25.9, 23.4, 23.3, 22.1, 20.8, 20.7, 16.2, 16.1 ppm; 
19F NMR (376 MHz, CDCl3): δ = −133.8 (d, J = 20.6 Hz, 2.6F), −134.0 (d, J = 20.7 Hz, 
2F), −161.6 (t, J = 20.8 Hz, 1.3F), −161.8 (t, J = 20.5 Hz, 1F) ppm; IR (neat): ν = 2955w, 
2926w, 2870w, 1732m, 1527s, 1447m, 1348w, 1310w, 1279w, 1171s, 1045s, 739s cm−1; 
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HRMS (ES): Exact mass calculated for C24H26Br F3O2 [M−H]−: 481.0990, found 
481.1009. 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl2-(2-bromophenyl)-2-(pentafluorophenyl) 
acetate 182t: 
Performed according to General Procedure 18 on a 0.10 mmol 
scale of 179i and 0.10 mmol of 106d; 182t (10 mg, 0.019 mmol, 
19% yield, 1.15:1 d.r.) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.63–7.55 (m, 2.25H, ArH), 7.33–
7.15 (m, 4.7H, ArH), 5.78–5.51 (m, 2.25H, CH), 4.95–4.59 (m, 
2.25H, OCH), 2.22–2.02 (m, 2.25H), 1.84–1.61 (m, 6.7H), 1.51–
1.43 (m, 2.25H), 1.33–1.25 (m, 2.25H), 1.10–0.70 (m, 27H) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 168.6 (C=O), 168.5 (CI=O), 135.0 (ArCI), 134.9 (ArC), 133.2 (ArC), 133.2 
(ArCI), 130.0 (dt, J = 5.1, 2.8 Hz, ArC), 129.7 (ArC), 129.6 (ArCI), 127.7 (ArCI), 127.6 
(ArC), 125.3 (ArC), 125.1 (ArCI), 77.0 (CH) 46.9, 46.8, 40.3, 40.3, 34.2, 34.2, 31.5, 31.5, 
29.9, 26.2, 26.1, 23.4, 23.2, 22.1, 20.8, 20.7, 16.2, 16.1 (ArC–F not observed) ppm; 
19F NMR (376 MHz, CDCl3): δ = −139.1 (d, J = 18.4 Hz, 2F), −139.3 (d, J = 18.1 Hz, 2F), 
−154.28 (t, J = 21.1 Hz, 2.25F), −161.40– −162.02 (m, 4.5F) ppm; IR (neat): 2957w, 
2926w, 2872w, 1734m, 1522m, 1503s, 1215m, 999m, 953m, cm−1; HRMS (ES): Exact 
mass calculated for C24H23BrF5O2 [M−H]−: 517.0802, found 517.0798. 
(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 2-(4-(trifluoromethyl)phenyl)-2-(3,4,5-
trifluorophenyl) acetate 182u: 
Performed according to General Procedure 18 on a 
0.13 mmol scale of 179j and 0.13 mmol of 106e; 182u 
(56 mg, 0.12 mmol, 91% yield, 1.2:1 d.r.) was obtained as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.73–7.56 (m, 4.4H, ArH), 
7.47–7.31 (m, 4.4H, ArH), 6.00–6.88 (m, 4.4H, ArH), 4.95 (s, 
1.2H, CH), 4.94 (s, 1H, CHI), 4.81–4.68 (m, 2.2H, OCH), 2.06–1.92 (m, 2.2H), 1.74–1.30 
(m, 12.5H), 1.12–0.74 (m, 20H), 0.68 (d, J = 7.0 Hz, 3.4H, CH3), 0.62 (d, J = 6.9 Hz, 3H, 
CH3I) ppm; 13C NMR (126 MHz, CDCl3): δ = 170.4 (C=O), 151.3 (d, J = 250.2 Hz, 2 × 
ArC–F’), 141.5 (ArC), 141.4 (ArCI), 139.3 (dt, J = 252.6, 15.3 Hz, ArC–F), 139.3 (dt, J = 
252.6, 15.3 Hz, ArCI–F), 134.4–134.1 (m, ArC), 130.4 (q, J = 32.8 Hz, ArC–CF3), 130.3 
(q, J = 32.8 Hz, ArCI–CF3), 130.0 (2 × ArC), 129.9 (2 × ArCI), 130.9–129.6 (m, 2 × ArC), 
124.0 (q, J = 272.2 Hz, CF3), 124.1 (q, J = 272.2 Hz, CIF3), 118.6–118.2 (m, ArC), 113.5–
112.7 (m, 2 × ArCI), 76.4 (OCH2), 56.2, 47.1, 47.07, 40.8, 40.7, 34.2, 31.6, 31.6, 26.3, 
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26.2, 23.4, 23.4, 22.1, 20.7, 20.7, 16.2, 16.1 ppm; 19F NMR (376 MHz, CDCl3): δ = −62.6– 
−62.7 (m, 6.6F), −133.3 (d, J = 20.6 Hz, 2.4F), −133.5 (d, J = 20.5 Hz, 2F), −161.3 (t, J 
= 20.5 Hz, 1.2F) 161.4 (t, J = 20.4 Hz, 1F) ppm; IR (neat): ν = 2959w, 2930w, 2872w, 
1734m, 1620m, 1530s, 1449m, 1325s, 1166s, 1128s, 1068s, 1047s, 1018m, 907s, 729s 
cm−1; HRMS (ES): Exact mass calculated for C25H25F6O2 [M−H]−: 471.1759, found 
471.1772. 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 2-(pentafluorophenyl)-2-(4-(trifluoromethyl)- 
phenyl)acetate 182v: 
Performed according to General Procedure 18 on a 
0.13 mmol scale of 179j and 0.13 mmol of 106d; 182v 
(54 mg, 0.11 mmol, 82% yield, 1.1:1 d.r.) was obtained as a 
colourless oil. 
 
1H NMR (500 MHz, CDCl3): δ = 7.61 (dd, J = 8.4, 2.4 Hz, 4H, 
ArH), 7.64–7.58 (m, 4H, ArH) 5.30 (s, 1H, CH), 5.29 (s, 1H, 
CHI), 4.87–4.73 (m, 2H, OCH’), 2.17–2.09 (m, 1H), 2.09–2.03 (m, 1H), 1.74–1.54 (m, 
6H), 1.52–1.43 (m, 2H), 1.33–1.25 (m, 2H), 1.11–0.68 (m, 24H) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 168.4 (C=O), 145.0 (d, J = 248.5 Hz, 2 × ArC–F), 140.97 (d, J = 
253.9 Hz, ArC–F), 139.7 (ArC), 139.6 (ArCI), 137.9 (d, J = 252.4 Hz, 2 × ArC–F), 131.1–
129.7 (m, ArC), 129.4 (2 × ArC), 129.3 (2 × ArC), 128.4, 125.9 (q, J = 3.8 Hz, 2 × ArC), 
124.0 (q, J = 272.2 Hz, CF3), 113.6–112.9 (m, ArC), 77.2 (OCH), 77.1 (OCIH), 46.9, 46.9, 
46.2, 46.2, 40.5, 40.4, 34.2, 34.2, 31.5, 26.4, 26.3, 23.5, 23.3, 22.1, 20.8, 20.7, 16.3, 
16.0 ppm; 19F NMR (376 MHz, CDCl3): δ = −62.7– −62.8 (m, 6F), −140.2 (dd, J = 18.2 Hz, 
2F), −140.5 (dd, J = 18.3 Hz, 2F), −154.1 (t, J = 20.9 Hz, 2F), −161.0– −161.3 (m, 
4F) ppm; IR (neat): ν = 2958w, 2872w, 1734m, 1521m, 1504s, 1325s, 1169m, 1069m, 
904s, 727s cm−1; HRMS (ES): Exact mass calculated for C25H23F8O2 [M−H]−: 507.1570, 
found 507.1574. 
Methyl 2-(2-(benzylthio)phenyl)-2-(3,4,5-trifluorophenyl)acetate 182w: 
Performed according to General Procedure 18 on a 0.083 mmol scale 
of 224 and 0.083 mmol of 106e; 182w (12 mg, 0.032 mmol, 38% yield) 
was obtained as a colourless oil after 72 h. 
1H NMR (500 MHz, CDCl3): δ = 7.48–7.41 (m, 1H, ArH), 7.29–7.19 
(m, 6H, ArH), 7.18–7.11 (m, 2H, ArH), 6.76 (dd, J = 8.4, 6.6 Hz, 2H, 
ArH), 5.56 (s, 1H, CH), 4.02 (d, J = 12.8 Hz, 1H, 1 × SCH2), 3.99 (d, J = 12.9 Hz, 1H,  
1 × SCH2), 3.72 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 172.0 (C=O), 151.0 
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(ddd, J = 250, 10.0, 4.1 Hz, 2 × ArC–F), 138.9 (dt, J = 252, 15.3 Hz, ArC–F), 138.8 (ArC), 
134.3 (ArC), 132.9 (ArC), 128.8 (ArC), 128.5 (ArC), 128.5 (ArC), 128.4 (ArC), 127.7 
(ArC), 127.4 (ArC), 113.7–112.2 (m, 2 × ArC), 52.7 (OCH3), 40.5 (SCH2) ppm; 19F NMR 
with 1H coupling (471 MHz, CDCl3, 298 K) δ = −134.1 (dd, J = 20.7, 8.6 Hz, 2F), −162.1 
(tt, J = 20.6, 6.4 Hz, 1F) ppm; IR (neat): ν = 3030w, 2953w, 1736s, 1618m, 1528s, 
1448m, 1435m, 1348m, 1163m, 1045s, 698s cm−1; HRMS (ES): Exact mass calculated 
for C21H23F3O2S [M−H]−: 401.0823, found 401.0826. 
Methyl 2-(2-(benzyloxy)phenyl)-2-phenylacetate 182x: 
Performed according to General Procedure 18 on a 0.1 mmol scale of 
184a and 0.1 mmol of 106a; 182x (16 mg, 0.048 mmol, 48% yield) 
was obtained as a colourless oil after 7 days. 
1H NMR (500 MHz, CDCl3): δ = 7.28–7.17 (m, 9 H, ArH), 7.17–7.08 
(m, 2H, ArH), 7.36–7.08 (m, 1H, ArH), 6.90 (d, J = 7.0, 1H, ArH, ArH), 6.87–6.75 (m, 2H, 
ArH), 5.24 (s, 1H, CH), 4.98 (s, 2H, OCH2), 3.50 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 173.5 (C=O), 156.1 (ArC–O), 137.6 (ArC), 137.0 (ArC), 129.3 (ArC), 128.7 
(ArC), 128.6 (ArC), 128.6 (ArC), 128.2 (ArC), 128.0 (ArC), 127.4 (ArC), 127.4 (ArC), 
120.9 (ArC), 111.7 (ArC), 70.2 (OCH2), 52.2, 51.3 ppm; HRMS (ES): Exact mass 
calculated for C22H21O3 [M+H]+: 333.1487, found 333.1487. 
Methyl 2-(2-(hexyloxy)phenyl)-2-(3,4,5-trifluorophenyl)acetate 182y: 
Performed according to General Procedure 18 on a 0.1 mmol 
scale of 184k and 0.1 mmol of 106e; 182y (22 mg, 0.059 mmol, 
59% yield) was obtained as a colourless oil after 24 h. 
1H NMR (500 MHz, CDCl3): δ = 7.30–7.24 (m, 1H, ArH), 7.10 (d, 
J = 7.5 Hz, 1H, ArH), 6.97–6.90 (m, 3H, ArH), 6.87 (d, J = 8.2 Hz, 
1H, ArH), 5.22 (s, 1H, CH), 4.01–3.89 (m, 2H, OCH2), 3.73 (s, 3H, OCH3), 1.78–1.68 (m, 
2H), 1.39 (dd, J = 14.2, 6.5 Hz, 2H), 1.37–1.29 (m, 4H), 0.90 (t, J = 6.3 Hz, 3H, CH3) ppm; 
13C NMR (126 MHz, CDCl3): δ = 172.5 (C=O), 156.2 (ArC–O), 151.1 (ddd, J = 249.0, 
10.0, 4.1 Hz, 2 × ArC–F), 139.1 (d, J = 251.0 Hz, ArC–F), 134.6–134.4 (m, ArC), 129.2 
(ArC), 128.7 (ArC), 126.3 (ArC), 120.7 (ArC), 113.6–113.2 (m, ArC), 111.6 (m, ArC), 68.2 
(OCH2), 52.6, 50.3, 31.7, 29.3, 25.9, 22.7, 14.1 ppm; 19F NMR (376 MHz, CDCl3): δ =  
−134.6 (d, J = 20.7 Hz, 2F), −162.5 (t, J = 20.5 Hz, 1F) ppm; IR (neat): ν = 2955m, 
2932m, 2860m, 1742s, 1618m, 1599m, 1528s, 1493s, 1449s, 1348m, 1244s, 1043s, 
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750s, 675s cm−1; HRMS (EI): Exact mass calculated for C21H23F3O3 [M]+: 380.1599, 
found 380.1591. 
Methyl (E)-2-(2-(benzylideneamino)phenyl)-2-(3,4,5-trifluorophenyl)acetate 216: 
Performed according to General Procedure 18 on a 0.1 mmol scale 
of 153a and 0.1 mmol of 106e; 216 (20 mg, 0.053 mmol, 53% yield) 
was obtained as a colourless oil after 12 hours at 50 °C. 
1H NMR (500 MHz, CDCl3): δ = 8.39 (s, 1H, N=CH), 7.89 (d, J = 
7.3 Hz, 1H, ArH), 7.55–7.38 (m, 2H, ArH), 7.39–7.33 (m, 3H, ArH), 
7.32–7.20 (m, 1H, ArH), 7.09 (d, J = 7.8 Hz, 2H, ArH), 6.99 (t, J = 7.4 Hz, 1H, ArH), 5.52 
(s, 1H, CH), 3.67 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 172.5 (C=O), 
160.5 (ArC–N), 151.1 (ddd, J = 250, 10.0, 4.0 Hz, 2 × ArC–F), 140.2 (ArC), 139.2 (dt, J 
= 251.2, 15.3 Hz, ArC–F), 136.1, 135.2–134.3 (m, ArC), 132.6 (ArC), 131.9 (ArC), 129.1 
(ArC), 129.1 (ArC), 129.0 (ArC), 128.5 (ArC), 126.7 (ArC), 118.0 (ArC), 114.1–112.9 (m, 
2 × ArC), 52.6, 51.6 ppm; 19F NMR with 1H coupling (471 MHz, CDCl3): δ = −133.0–  
−138.4 (m, 2F), −162.5 (ddd, J = 20.6, 13.5, 6.4 Hz, 1F) ppm; IR (neat): ν = 3017m, 
1738s, 1612m, 1529s, 1472s, 1447s, 1364m, 1229s, 1043s cm−1; HRMS (ES): Exact 
mass calculated for C22H17NO2F3 [M+H]+: 384.1211, found 384.1211. 
5.3.3 Synthesis of Cyclised Products 
5.3.3.1 Synthesis on Indole 214 and Indoline 215 
 
The diazo compound 213 (0.1 mmol) was dissolved in dry CDCl3 and borane 106e 
(0.1 mmol) was added. The reaction was performed under nitrogen and gas evolution 
was observed. After 30 minutes the reaction was quenched with aqueous solution of 
NaOH (0.1 M) and the crude was filtered over SiO4 plug then purified by preparative TLC 
affording indole 214 and indoline 215 in 23% and 42% yields, respectively. 
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Methyl 2-phenyl-1H-indole-3-carboxylate 214: 
The minor product 214 (6 mg, 0.023 mmol, 23% yield) was afforded as 
a colourless solid. 
1H NMR (500 MHz, CDCl3): δ = 8.49 (s, 1H, NH), 8.22 (d, J = 6.6 Hz, 
1H, ArH), 7.67 (d, J = 6.5 Hz, 2H, ArH), 7.47 (d, J = 5.6 Hz, 3H, ArH), 7.40 (d, J = 6.5 Hz, 
1H, ArH), 7.29 (d, J = 5.4 Hz, 2H, ArH), 3.85 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 165.9 (C=O), 144.7 (ArC–N), 135.2 (ArC), 132.1 (ArC), 129.7 (ArC), 129.4 
(ArC), 128.4 (ArC), 127.7 (ArC), 123.4 (ArC), 122.4 (ArC), 122.3 (ArC), 111.1 (ArC), 
104.7 (ArC), 51.0 (OCH3) ppm. The spectroscopic data are in agreement with the 
literature.25 
Methyl 2-phenyl-3-(3,4,5-trifluorophenyl)indoline-3-carboxylate 215: 
The major product 215 (16 mg, 0.042 mmol, 42% yield) was afforded 
as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.28 (d, J = 7.5 Hz, 1H, ArH), 7.22–
7.12 (m, 6H, ArH), 7.12–7.06 (m, 2H, ArH), 6.81 (t, J = 7.3 Hz, 1H, 
ArH), 6.69 (d, J = 7.8 Hz, 1H, ArH), 4.99 (s, 1H, CH), 4.11 (s, 1H, 
NH), 3.18 (s, 3H, OCH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 170.6 (C=O), 151.0 (ddd, 
J = 249.2, 9.8, 4.1 Hz, 2 × ArC–F), 150.4 (ArC–N), 140.4 (ArC), 139.7–139.5 (m, (ArC), 
139.1 (dt, J = 230.6, 15.5 Hz, Ar–F), 129.7 (ArC), 128.7 (ArC), 128.5 (ArC), 127.8 (ArC), 
127.7 (ArC), 127.3 (ArC), 119.9 (ArC), 111.7–111.3 (m, 2 × ArC), 74.4 (N–CH), 66.6  
(C–CO2Me), 52.1 (OCH3) ppm; 19F NMR (376 MHz, CDCl3): δ = −133.8 (d, J = 20.8 Hz, 
2F), −161.8 (t, J = 20.8 Hz, 1F) ppm; IR (neat): ν = 3364w, 3032w, 2951w, 1732s, 1525s, 
1431s, 1259s, 1238s, 1045s, 1028s, 736s cm−1; HRMS (ES): Exact mass calculated for 
C22H17NO2F3 [M+H]+: 384.1211, found 384.1209. 
5.3.3.2 Synthesis of Lactones 185 and Thiolactone 225 
 
General Procedure 19: The diazo compound 184a–j or 224 (0.1 mmol) was dissolved in 
dry CDCl3 and borane 106 (0.1 mmol) was added. The reaction was performed under 
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nitrogen and gas evolution was observed. The reaction was then quenched with aqueous 
solution of NaOH (0.1 M), the crude was filtered over SiO4 plug and purified by column 
chromatography to afford the final lactone 185 or thiolactone 225 as solids or oils. 
3-Benzyl-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185a: 
Performed according to General Procedure 19 on a 0.1 mmol scale 
of 184a and 0.1 mmol of 106e; 185a (26 mg, 0.079 mmol, 79% 
yield) was obtained after 24 hours at room temperature as a 
colourless solid, m.p.: 110–112 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.34–7.27 (m, 1H, ArH), 7.26–7.03 (m, 7H, ArH), 6.96 
(d, J = 7.9 Hz, 1H, ArH), 6.84–6.79 (m, 2H, ArH), 3.59 (d, J = 13.2 Hz, 1H, 1 × CH2), 3.42 
(d, J = 13.2 Hz, 1H, 1 × CH2) ppm; 13C NMR (101 MHz, CDCl3): δ = 176.5 (C=O), 153.1 
(ArC–O), 151.3 (ddd, J = 251.0, 9.9, 4.1 Hz, 2 × ArC–F), 139.58 (dt, J = 254, 15.3 Hz, 
ArC_F), 134.8–134.6 (m, ArC), 133.9 (ArC), 130.1 (ArC), 130.0 (ArC), 128.3 (ArC), 127.6 
(ArC), 127.5 (ArC), 126.0 (ArC), 124.5 (ArC), 112.4–111.7 (m, 2 × ArC), 111.3 (ArC), 
56.6 (C), 45.5 (CH2) ppm; 19F NMR (376 MHz, CDCl3): δ = −132.5 (d, J = 20.6 Hz),  
−160.2 (t, J = 20.6 Hz) ppm; IR (neat): ν = 1790s, 1620m, 1531s, 1462s, 1435s, 1354m, 
1292w, 1225m, 1120s, 1051s, 887m, 752s, 698s cm−1; HRMS (ASAP): Exact mass 
calculated for C21H14F3O2 [M+H]+: 355.0946, found 355.0948; NCH21D: Varian Polaris 
Silica (254 × 4.6 mm, 5μm), n-hexane/propan-2-ol: 99.9:0.1, 1.0 mL•min−1, 20 °C, 210 
and 254 nm, retention time 200a = 4.1 min; 2D: YMC Chiral Amylose-C (254 × 4.6 mm, 
5μm), n-hexane/propan-2-ol: 90:10, 1.0 mL•min−1, 20 °C, 254 nm, retention time minor 
isomer = 4.8 min, retention time major isomer = 5.3 min. 
 
Figure 5.15: 1D HPLC chromatograms for the enantiomers of 185a. 
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Peak# Time Area 
1 4.797 49.745 
2 5.355 50.255 
 
 
Peak# Time Area 
1 4.830 27.748 
2 5.311 72.252 
Figure 5.16: 2D HPLC chromatograms for the enantiomers of 185a. From the top: racemic mixture 
and 44% ee mixture. 
3-Benzyl-3-(pentafluorophenyl)benzofuran-2(3H)-one 185b: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184a and 0.1 mmol of 106d; 185b (30 mg, 0.077 mmol, 
77% yield) was obtained after 7 days at room temperature as a 
colourless solid, m.p.: 148–150 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.33–7.25 (m, 2H, ArH), 7.23–7.13 (m, 2H, ArH), 7.07 (t, 
J = 7.5 Hz, 2H, ArH), 6.84 (d, J = 7.9 Hz, 1H, ArH), 6.73 (d, J = 7.4 Hz, 2H, ArH), 3.97 
(dt, J = 12.8, 2.4 Hz, 1H, 1 × CH2), 3.73 (d, J = 12.5 Hz, 1H, 1 × CH2) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 175.2 (C=O), 153.1 (ArC–O), 146.0 (d, J = 250.0 Hz, 2 × ArC–F), 
141.1 (d, J = 257.0 Hz, ArC–F), 138.2 (d, J = 254.1 Hz, 2 × ArC–F), 132.7 (ArC), 130.5 
(ArC), 130.2 (ArC), 128.8 (ArC), 128.2 (ArC), 127.8 (ArC), 124.9 (ArC), 123.8 (ArC), 
114.0–113.3 (m, 2 × ArC), 111.1 (ArC), 54.5 (C), 42.1 (t, J = 7.2 Hz, CH2) ppm; 19F NMR 
(376 MHz, CDCl3): δ = −36.2 (d, J = 18.8 Hz, 2F), −152.8 (t, J = 20.9 Hz, 1F), −160.4 (t, 
J = 20.8 Hz, 2F) ppm; IR (neat): ν = 1807s, 1653w, 1524s, 1485s, 1464s, 1116.8s, 1061s, 
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1011s, 966s, 885m, 754s, 704s, 577m cm−1; HRMS (EI): Exact mass calculated for 
C21H11F5O2 [M]+: 390.0679, found: 390.0676. 
3-Benzyl-3-phenylbenzofuran-2(3H)-one 185c: 
Performed according to General Procedure 19 on a 0.1 mmol scale of 
184a and 0.1 mmol of 106a; 185c (6.3 mg, 0.021 mmol, 21% yield) 
was obtained after 14 days at room temperature as a colourless solid, 
m.p.: 118–120 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.55–7.51 (m, 2H, ArH), 7.41–7.36 (m, 2H, ArH), 7.36–
7.32 (m, 1H, ArH), 7.29–7.26 (m, 1H, ArH), 7.25–7.16 (m, 3H, ArH), 7.14–7.04 (m, 3H, 
ArH), 6.94 (ddd, J = 7.9, 1.1, 0.6 Hz, 1H, ArH), 6.87 (dd, J = 8.0, 1.5 Hz, 2H, ArH), 3.74 
(d, J = 13.1 Hz, 1H, 1 × CH2), 3.53 (d, J = 13.1 Hz, 1H, 1 × CH2) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 177.7 (C=O), 153.2 (ArC–O), 138.6 (ArC), 134.9 (ArC), 130.2 (ArC), 129.3 
(ArC), 129.0 (ArC), 128.2 (ArC), 128.1 (ArC), 127.3 (ArC), 127.2 (ArC), 126.1 (ArC), 
124.0 (ArC), 111.0 (ArC), 57.6 (C), 45.1 (CH2) ppm; IR (neat): ν =3030w, 2928w, 2851w, 
1788s, 1618w, 1495m, 1460, 1292w, 1231m, 1063s, 951m, 881m cm−1; HRMS (EI): 
Exact mass calculated for C21H16O2 [M]+: 300.1150, found 300.1151. 
3-(4-(Trifluoromethyl)benzyl)-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185d: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184b and 0.1 mmol of 106e; 185d (24 mg, 0.054 
mmol, 54% yield) was obtained after 24 hours at 50 °C as a 
colourless solid, m.p.: 118–120 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.39–7.32 (m, 3H, ArH), 7.32–7.14 (m, 4H, ArH), 7.00 
(d, J = 8.0 Hz, 1H, ArH), 6.96 (d, J = 8.1 Hz, 2H, ArH), 3.68 (d, J =13.2 Hz, 1H, 1 × CH2), 
3.47 (d, J = 13.2 Hz, 1H, 1 × CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 176.2 (C=O), 
153.1 (ArC–O), 151.4 (ddd, J = 251.1, 9.9, 4.2 Hz, 2 × ArC–F), 139.7 (dt, J = 254.0, 
15.2 Hz, ArC–F), 138.1–137.9 (m, ArC), 134.4–134.2 (m, ArC), 130.4 (2 × ArC), 129.9 
(q, J = 32.6 Hz, ArC–CF3), 127.2 (ArC), 125.7 (ArC), 125.29 (q, J = 3.7 Hz, 2 × ArC), 
124.7 (ArC), 123.9 (q, J = 272.3 Hz, CF3), 112.1–111.8 (2 × ArC), 111.7 (ArC), 56.4 (C), 
45.1 (CH2) ppm; 19F NMR (376 MHz, CDCl3): δ = −62.7 (s, 3F), −132.1 (d, J = 20.4 Hz, 
2F), −159.7 (t, J = 20.4 Hz, 1F) ppm; IR (neat): ν = 2922w, 1792s, 1620m, 1531s, 1466m, 
1331s, 1109s, 1068s, 1045s, 1016s, 872m, 839m, 752s, 625s cm−1; HRMS (ASAP): 
Exact mass calculated for C22H13O2F6 [M+H]+: 423.0820, found 423.0828.  
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3-(4-(Trifluoromethyl)benzyl)-3-(pentafluorophenyl)benzofuran-2(3H)-one 185e: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 84b and 0.1 mmol of 106d; 185e (33 mg, 
0.072 mmol, 72% yield) was obtained after 24 hours at 50 °C 
as a colourless solid, m.p.: 128–130 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.37–7.29 (m, 4H, ArH), 7.25–7.19 (m, 1H, ArH), 6.89–
6.83 (m, 3H, ArH), 4.02 (dt, J = 12.8, 2.2 Hz, 1H, 1 × CH2), 3.77 (d, J = 12.8, 1H, 
1 × CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 174.9 (C=O), 153.0 (ArC–O), 146.0 (d, 
J = 250.0 Hz, 2 × ArC–F), 141.3 (d, J = 257.1 Hz, ArC–F), 138.3 (d, J = 254.3 Hz, 
2 × ArC–F) 136.9 (ArC), 130.9 (ArC), 130.6 (ArC), 130.1 (q, J = 32.5 Hz, ArC–CF3), 128.2 
(ArC), 125.1 (ArC), 125.1 (q, J = 3.8 Hz, 2 × ArC), 124.4 (q, J = 272.2 Hz, CF3), 113.3 
(m, ArC), 111.4 (ArC), 54.2 (C), 41.8 (t, J = 7.3 Hz, CH2) ppm; 19F NMR (376 MHz, 
CDCl3): δ = −62.7 (s, 3F), −136.4 (d, J = 18.9 Hz, 2F), −152.4 (t, J = 21.1 Hz, 1F), −160.07 
(t, J = 21.4 Hz, 2F) ppm; IR (neat): ν = 2924w, 2853w, 1803s, 1738m, 1531m, 1485s, 
1331s, 1221m, 1119s, 970s, 885, 856m, 748s, 675m cm−1; HRMS (ASAP): Exact mass 
calculated for C22H10O2F8 [M+H]+: 459.0631, found 459.0629. 
3-(4-(Trifluoromethyl)benzyl)-3-Benzylbenzofuran-2(3H)-one 185f: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184b and 0.1 mmol of 106a; 185f (9.6 mg, 0.026 mmol, 
26% yield) was obtained after 24 hours at 50 °C as a colourless 
solid, m.p.: 112–114 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.55–7.49 (m, 2H, ArH), 7.44–7.27 (m, 6H, ArH), 7.25–
7.19 (m, 2H, ArH), 7.01–6.93 (m, 3H, ArH), 3.79 (d, J = 13.2 Hz, 1H, 1 × CH2), 3.58 (d, 
J = 13.1 Hz, 1H, 1 × CH2) ppm; 13C NMR (101 MHz, CDCl3): δ = 177.3 (C=O), 153.1 
(ArC–O), 138.1 (ArC), 130.6 (ArC), 129.7 (ArC), 129.1 (ArC), 128.7 (ArC), 128.4 (ArC), 
127.1 (ArC), 125.9 (ArC), 125.1 (q, J = 3.5 Hz, ArC), 124.3 (ArC), 111.3 (ArC), 57.3 (C), 
44.7 (CH2) ppm; IR (neat): ν = 3059w, 2918w, 2848w, 1798s, 1618w,1599m, 1462m, 
1323s, 1122s, 1111s, 1064s, 879m, 844m, 754s cm−1; HRMS (ASAP): Exact mass 
calculated for C22H15O2F3 [M]+: 369.1102, found 369.1102. 
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3-(4-Methoxybenzyl)-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185g: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184c and 0.1 mmol of 106e; 185g (35 mg, 
0.091 mmol, 91% yield) was obtained after 16 hours at room 
temperature as a colourless solid, m.p.: 98–102 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.31 (dd, J = 7.7, 1.4 Hz, 1H, ArH), 7.28–7.14 (m, 4H, 
ArH), 6.98 (d, J = 8.0 Hz, 1H, ArH), 6.75–6.70 (m, 2H, ArH), 6.64–6.59 (m, 2H, ArH), 
3.70 (s, 3H, OCH3), 3.53 (d, J = 13.3 Hz, 1H, 1 × CH2), 3.37 (d, J = 13.3 Hz, 1H, 
1 × CH2) ppm; 13C NMR (101 MHz, CDCl3): δ = 176.6 (C=O), 159.0 (ArC–O), 153.2 
(ArC–O), 151.3 (ddd, J = 251.0, 9.9, 4.1 Hz, 2 × ArC–F), 139.5 (dt, J = 254.2, 15.3 Hz, 
ArC–F), 135.1–134.5 (m, ArC), 131.2 (ArC), 130.0 (ArC), 127.6 (ArC), 126.0 (ArC), 125.9 
(ArC), 124.4 (ArC), 113.7 (ArC), 112.2–111.8 (m, 2 × ArC), 111.4 (ArC), 56.7 (C), 55.2 
(OCH3), 44.9 (CH2) ppm; 19F NMR (376 MHz, CDCl3): δ = −132.6 (d, J = 20.3 Hz, 2F), 
−160.3 (t, J = 20.3 Hz, 1F) ppm; IR (neat): ν = 3076w, 2951w, 2835w, 1792s, 1616m, 
1528s, 1462w, 1431m, 1248s, 1178m, 1119m, 1036s, 752s cm−1; HRMS (EI): Exact 
mass calculated for C22H15O3F3 [M]+: 384.0973, found 384.0971. 
3-(4-(Trifluoromethyl)benzyl)-3-benzylbenzofuran-2(3H)-one 185i: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184c and 0.1 mmol of 106a; 185i (18 mg, 0.054 mmol, 
54% yield) was obtained after 72 hours at room temperature as 
a colourless solid, m.p.: 112–114 °C. 
1H NMR (500 MHz, CDCl3): δ = 7.52 (d, J = 7.4 Hz, 2H, ArH), 7.35–7.27 (m, 2H, ArH), 
7.25–7.17 (m, 2H, ArH), 6.96 (d, J = 8.0 Hz, 1H, ArH), 6.77 (d, J = 8.5 Hz, 2H, ArH), 6.61 
(d, J = 8.6 Hz, 2H, ArH), 3.71 (s, 3H, OCH3), 3.67 (d, J = 13.3 Hz, 1H, 1 × CH2), 3.48 (d, 
J = 13.4 Hz, 1H, 1 × CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 177.7 (C=O), 158.7 
(ArC–O), 153.2 (ArC–O), 138.6 (ArC), 131.2 (ArC), 129.4 (ArC), 129.2 (ArC), 129.0 
(ArC), 128.1 (ArC), 127.2 (ArC), 126.9 (ArC), 126.0 (ArC), 124.0 (ArC), 113.5 (ArC), 
111.0 (ArC), 57.7 (C), 55.2 (OCH3), 44.3 (CH2) ppm; IR (neat): ν = 3019w, 2928w, 2841w, 
1794s, 1610m, 1512m, 1460m, 1246s, 1068s, 1026s, 760s, 694s cm−1; HRMS (ES): 
Exact mass calculated for C22H17O3 [M−H]−: 329.1178, found 329.1188. 
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3-(4-Methylbenzyl)-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185j: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184d and 0.1 mmol of 106e; 185j (32 mg, 0.087 mmol, 
87% yield) was obtained after 24 hours at room temperature as 
a colourless solid, m.p.: 94–96 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.33 (dt, J = 7.9, 1.6 Hz, 1H, ArH), 7.26–7.17 (m, 4H, 
ArH), 6.99 (d, J = 8.0 Hz, 1H, ArH), 6.90 (d, J = 7.9 Hz, 2H, ArH), 6.71 (d, J = 8.0 Hz, 
2H, ArH), 3.55 (d, J = 13.2 Hz, 1H, 1 × CH2), 3.40 (d, J = 13.2 Hz, 1H, 1 × CH2), 2.23 (s, 
3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 176.6 (C=O), 153.2 (ArC–O), 151.3 (ddd, 
J = 251.1, 9.9, 4.2 Hz, 2 × ArC–F), 139.5 (dt, J = 253.4, 15.3 Hz, ArC–F), 137.3 (ArC), 
135.1–134.4 (m, ArC), 130.8 (ArC), 130.0 (ArC), 129.9 (ArC), 129.0 (ArC), 127.6 (ArC), 
126.0 (ArC), 124.4 (ArC), 112.5–111.9 (m, 2 × ArC), 111.4 (ArC), 56.6 (C), 45.2 (CH2), 
21.1 (CH3) ppm; 19F NMR (376 MHz, CDCl3): δ = −132.6 (d, J = 19.9 Hz, 2F), −160.3 (t, 
J = 20.2 Hz, 1F) ppm; IR (neat): ν = 3075w, 3036w, 1794s, 1705s, 1618s, 1528s, 1464s, 
1337m, 1234s, 885s, 829m, 814m, 752s, 586s, 475s cm−1; HRMS (EI): Exact mass 
calculated for C22H15F3O2 [M]+: 368.1024, found 368.1027.  
3-(4-Methylbenzyl)-3-(pentafluorophenyl)benzofuran-2(3H)-one 185k: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184d and 0.1 mmol of 106d; 185k (25 mg, 0.063 mmol, 
63% yield) was obtained after 24 hours at 50 °C as a colourless 
solid, m.p.: 124–126 °C. 
1H NMR (500 MHz, CDCl3): δ = 7.32–7.25 (m, 2H, ArH), 7.23–7.16 (m, 1H, ArH), 6.89–
6.83 (m, 3H, ArH), 6.60 (d, J = 8.0 Hz, 2H, ArH), 3.92 (d, J = 12.9 Hz, 1H, 1 × CH2), 3.68 
(d, J = 12.9 Hz, 1H, 1 × CH2), 2.23 (s, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 
175.3 (C=O), 153.1 (ArC–O), 146.0 (d, J = 243.3 Hz, 2 × ArC–F), 141.1 (d, J = 257.1 Hz, 
ArC–F), 138.1 (d, J = 247.0 Hz, 2 × ArC–F), 137.5 (ArC), 130.4 (ArC), 130.2 (ArC), 129.6 
(ArC), 129.0 (ArC), 129.9 (ArC), 124.8 (ArC), 123.8 (ArC), 113.9–113.6 (m, ArC), 111.1 
(ArC), 54.6 (C), 41.8 (t, J = 7.2 Hz, CH2), 21.2 (CH3) ppm; 19F NMR (376 MHz, CDCl3): 
δ = −136.1 (d, J = 19.4 Hz, 2F), −153.0 (t, J = 21.1 Hz, 1F), −160.4 (t, J = 21.4 Hz, 2F) 
ppm; IR (neat) ν = 2924w, 1803s, 1526s, 1487s, 1119s, 968s, 883s, 739s, 615m, 573s, 
cm−1; HRMS (ASAP): Exact mass calculated for C22H14O2F5 [M+H]+: 405.0914, found 
405.0911. 
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3-(4-Bromobenzyl)-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185l: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184e and 0.1 mmol of 106e; 185l (32 mg, 0.074 mmol, 
74% yield) was obtained after 24 hours at room temperature 
as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.35 (ddd, J = 8.1, 7.5, 1.6 Hz, 1H, ArH), 7.30–7.14 (m, 
6H, ArH), 7.01 (d, J = 8.0 Hz, 1H, ArH), 6.74–6.61 (m, 2H, ArH), 3.57 (d, J = 13.2 Hz, 
1H, 1 × CH2), 3.37 (d, J = 13.2 Hz, 1H, 1 × CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 
176.3 (C=O), 153.1 (ArC–O), 151.4 (ddd, J = 251.0, 9.9, 4.1 Hz, 2 × ArC–F), 139.6 (dt, 
J = 254.1, 15.3 Hz, ArC–F), 135.4–133.7 (m, ArC), 132.9 (ArC), 131.8 (ArC), 131.5 (ArC), 
130.3 (ArC), 127.1 (ArC), 125.8 (ArC), 124.6 (ArC), 121.9 (ArC), 112.2–111.7 (m, 
2 × ArC), 111.7 (ArC) 56.4 (C), 44.8 (CH2) ppm; 19F NMR (376 MHz, CDCl3): δ = −132.2 
(d, J = 20.7 Hz, 2F), −159.9 (t, J = 20.7 Hz, 1F) ppm; IR (neat): ν = 3080w, 2924w, 1798s, 
1529s, 1232m, 1047s, 1011s, 754s cm−1; HRMS (ES): Exact mass calculated for 
C21H11F3O2Br [M−H]−: 430.9895, found 430.9903.  
3-(4-Bromobenzyl)-3-(pentafluorophenyl)benzofuran-2(3H)-one 185l: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184e and 0.1 mmol of 106d; 185l (34 mg, 0.073 mmol, 
73% yield) was obtained after 24 hours at 50 °C as a 
colourless solid, m.p.: 116–118 °C. 
1H NMR (500 MHz, CDCl3): δ = 7.33–7.27 (m, 2H, ArH), 7.23–7.17 (m, 3H, ArH), 6.89 
(d, J = 8.1 Hz, 1H, ArH), 6.60 (d, J = 8.4 Hz, 2H, ArH), 3.93 (dt, J = 10.8, 2.1 Hz, 1H, 
1 × CH2), 3.67 (d, J = 12.9 Hz, 1H, 1 × CH2) ppm; 13C NMR (101 MHz, CDCl3): δ = 175.0 
(C=O), 153.0 (ArC–O), 146.0 (d, J = 250.1 Hz, 2 × ArC–F), 141.23 (d, J = 262.4 Hz,  
ArC–F), 138.2 (d, J = 253.0 Hz, 2 × ArC–F), 132.2 (ArC), 131.7 (ArC), 131.4 (ArC), 130.5 
(ArC), 128.4 (ArC), 125.0 (ArC), 123.7 (ArC), 122.2 (ArC), 113.8–113.1 (m, ArC), 111.4 
(ArC), 54.2 (C), 41.5 (m, CH2) ppm; 19F NMR (376 MHz, CDCl3): δ = −136.3 (d, J = 18.6 
Hz, 2F), −152.5 (t, J = 21.0 Hz, 1F), −160.2 (t, J = 21.2 Hz, 2F) ppm; IR (neat): ν = 2930w, 
1798s, 1524s, 1487s, 1121m, 968s, 750s, 671m cm−1; HRMS (EI): Exact mass 
calculated for C21H10F5O2Br [M]+: 467.9784, found 467.9767. 
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3-(2-Methylbenzyl)-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185n: 
Performed according to General Procedure 19 on a 0.1 mmol scale 
of 184f and 0.1 mmol of 106e; 185n (29 mg, 0.078 mmol, 78% 
yield) was obtained after 24 hours at room temperature as a 
colourless solid, m.p.: 82–84 °C.  
1H NMR (500 MHz, CDCl3): δ = 7.34 (td, J = 8.0, 1.3 Hz, 1H, ArH), 7.24–7.17 (m, 2H, 
ArH), 7.14 (td, J = 7.6, 0.9 Hz, 1H, ArH), 7.09–6.98 (m, 3H, ArH), 6.92–6.82 (m, 2H, ArH), 
6.53 (d, J = 7.5 Hz, 1H, ArH), 3.57 (d, J = 13.9 Hz, 1H, 1 × CH2), 3.49 (d, J = 13.9 Hz, 
1H, 1 × CH2), 1.96 (s, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 176.8 (C=O), 153.1 
(ArC–O), 151.2 (ddd, J = 251.2, 9.9, 4.1 Hz, 2 × ArC–F), 139.5 (dt, J = 254.0, 15.3 Hz, 
ArC–F), 137.5 (ArC), 134.5 (m, ArC), 134.6 (ArC), 134.5 (ArC), 134.5 (ArC), 134.5 (ArC), 
134.5 (ArC), 134.4 (ArC), 132.5 (ArC), 130.8 (ArC), 130.1 (ArC), 129.7 (ArC), 127.8 
(ArC), 127.2 (ArC), 126.4 (ArC), 125.8 (ArC), 124.3 (ArC), 113.3–111.8 (m, 2 × ArC), 
111.4 (ArC), 55.5 (C), 41.6 (CH2), 20.0 (CH3) ppm; 19F NMR (376 MHz, CDCl3): δ =  
−132.6 (d, J = 20.6 Hz, 2F), −160.2 (t, J = 20.6 Hz, 1F) ppm; IR (neat): ν = 3086w, 2924w, 
2854w, 1794s, 1620m, 1526m, 1458m, 1435m, 1346m, 1232m, 760s cm−1; HRMS 
(ASAP): Exact mass calculated for C22H16O2F3 [M+H]+: 369.1102, found 369.1103. 
3-(2-Methylbenzyl)-3-(pentafluorophenyl)benzofuran-2(3H)-one 185o:  
Performed according to General Procedure 19 on a 0.1 mmol scale 
of 184f and 0.1 mmol of 106d; 185o (24 mg, 0.059 mmol, 59% 
yield) was obtained after 24 hours at 50 °C as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.36–7.28 (m, 2H, ArH), 7.20 (t, 
J = 7.5 Hz, 1H, ArH), 7.10–7.00 (m, 2H, ArH), 6.91 (d, J = 8.0 Hz, 1H, ArH), 6.83 (t, J = 
7.2 Hz, 1H, ArH), 6.43 (d, J = 7.7 Hz, 1H, ArH), 3.97 (d, J = 13.5 Hz, 1H, 1 × CH2), 3.89 
(d, J = 13.4 Hz, 1H, 1 × CH2), 2.18 (s, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 
175.4 (C=O), 153.2 (ArC–O), 146.0 (d, J = 246.0 Hz, 2 × ArC–F), 141.1 (d, J = 257.2 Hz, 
ArC–F), 138.3 (d, J = 253.0 Hz, 2 × ArC–F), 137.8 (ArC), 131.4 (ArC), 130.9 (ArC), 130.4 
(ArC), 130.3 (ArC), 129.1 (ArC), 127.9 (ArC), 125.5 (ArC), 124.8 (ArC), 124.2 (ArC), 
114.4–114.0 (m, ArC), 111.2 (ArC), 54.3 (C), 37.9 (t, J = 7.1 Hz, CH2), 20.0 (CH3) ppm; 
19F NMR (376 MHz, CDCl3): δ = −135.8 (d, J = 18.6 Hz, 2F), −153.0 (t, J = 21.0 Hz, 1F), 
−160.37 (t, J = 20.9 Hz, 2F) ppm; IR (neat): ν = 3024w, 1807s, 1524s, 1487s, 1464s, 
1121s, 968s, 883m, 677m, 478m cm−1; HRMS (ASAP): Exact mass calculated for 
C22H14O2F5 [M+H]+: 405.0914, found 405.0909. 
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3-(2-Phenylbenzyl)-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185p: 
Performed according to General Procedure 19 on a 0.1 mmol scale 
of 184g and 0.1 mmol of 106e; 185p (39 mg, 0.09 mmol, 91%) was 
obtained after 24 hours at room temperature as a colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.35–7.27 (m, 4H, ArH), 7.22 (td, 
J = 7.5, 1.4 Hz, 1H, ArH), 7.15 (td, J = 7.6, 1.6 Hz, 1H, ArH), 7.10–6.95 (m, 6H, ArH), 
6.95–6.88 (m, 2H, ArH), 6.42 (dd, J = 7.6, 1.3 Hz, 1H, ArH), 3.84 (d, J = 13.9 Hz, 1H, 
1 × CH2), 3.61 (d, J = 13.9 Hz, 1H, 1 × CH2) ppm; 13C NMR (101 MHz, CDCl3): δ = 176.8 
(C=O), 153.0 (ArC–O), 151.1 (ddd, J = 250.1, 9.9, 4.1 Hz, 2 × ArC–F), 143.3 (ArC), 140.9 
(ArC), 139.5 (d, J = 253.2 Hz, ArC–F), 134.8–134.5 (m, ArC), 131.9 (ArC), 130.9 (ArC), 
129.8 (ArC), 129.7 (ArC), 128.2 (ArC), 127.6 (ArC), 127.4 (ArC), 127.2 (ArC), 126.8 
(ArC), 126.7 (ArC), 124.3 (ArC), 112.2–111.8 (m, 2 × ArC), 111.0 (ArC), 55.9 (C), 41.1 
(CH2) ppm; 19F NMR (376 MHz, CDCl3): δ = −132.7 (d, J = 20.7 Hz, 2F), −160.5 (t, J = 
20.7 Hz, 1F) ppm; IR (neat): ν = 3059w, 2926w, 1800s, 1618m, 1528s, 1462m, 1435, 
1232m, 1121m, 1045s, 750s, 704s cm−1; HRMS (ASAP): Exact mass calculated for 
C27H18F3O2 [M+H]+: 431.1259, found 431.1257.  
3-(2-Phenylbenzyl)-3-(pentafluorophenyl)benzofuran-2(3H)-one 185q:  
Performed according to General Procedure 19 on a 0.1 mmol scale 
of 184g and 0.1 mmol of 106d; 185q (24 mg, 0.052 mmol, 52% 
yield) was obtained after 24 hours at 50 °C as a colourless oil. 
1H NMR (500 MHz, CDCl3, 298 K) δ = 7.41–7.28 (m, 3H, ArH), 7.21 
(t, J = 7.7 Hz, 2H, ArH), 7.12 (t, J = 7.4 Hz, 1H, ArH), 7.07–6.97 (m, 4H, ArH), 6.90 (t, 
J = 7.6 Hz, 1H, ArH), 6.86 (d, J = 8.1 Hz, 1H, ArH), 6.57 (d, J = 7.5 Hz, 1H, ArH), 4.50 
(d, J = 13.4 Hz, 1H, 1 × CH2), 3.85 (d, J = 13.4 Hz, 1H, 1 × CH2) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 175.4 (C=O), 152.8 (ArC–O), 145.8 (d, J = 250.1 Hz, 2 × ArC–F), 143.6 
(ArC), 140.1 (ArC), 140.9 (d, J = 256.4 Hz, ArC–F), 138.1 (d, J = 254.3 Hz, 2 × ArC–F), 
131.0 (ArC), 131.0 (ArC), 130.3 (ArC), 130.0 (ArC), 129.7 (ArC), 128.4 (ArC), 128.2 
(ArC), 127.8 (ArC), 127.2 (ArC), 127.0 (ArC), 125.0 (ArC), 124.2 (ArC), 114.7–113.9 (m, 
ArC), 110.7 (ArC), 54.3 (C), 36.9 (t, J = 7.4 Hz, CH2) ppm; 19F NMR (376 MHz, CDCl3): 
δ = −136.0 (d, J = 19.6 Hz, 2F), −153.3 (t, J = 21.1 Hz, 1F), −160.5 (t, J = 21.0, 2F) ppm; 
IR (neat): ν = 3061w, 2924w, 2853w, 1809s, 1526s, 1487s, 1121s, 1063s, 968s, 746s, 
702s cm−1; HRMS (EI): Exact mass calculated for C27H16O2F5 [M+H]+: 467.1070, found 
467.1069. 
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3-Allyl-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185r: 
Performed according to General Procedure 19 on a 0.1 mmol scale 
of 184h and 0.1 mmol of 106e; 185r (17 mg, 0.057 mmol, 57% yield) 
was obtained after 24 hours at room temperature as a pale-yellow 
oil. 
1H NMR (500 MHz, CDCl3): δ = 7.42 (t, J = 7.6 Hz, 1H, ArH), 7.34–7.28 (m, 1H, ArH), 
7.26 (d, J = 9.0 Hz, 1H, ArH), 7.20 (d, J = 8.1 Hz, 1H, ArH), 7.08 (dd, J = 8.1, 6.7 Hz, 2H, 
ArH), 5.47–5.27 (m, 1H), 5.14–5.00 (m, 2H), 3.04–2.90 (m, 2H) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 176.4 (C=O), 153.2 (ArC–O), 151.4 (ddd, J = 251.0, 9.9, 4.1 Hz, 2 ×  
ArC–F), 139.5 (dt, J = 253.1, 15.2 Hz, ArC–F), 134.4 (td, J = 7.1, 4.5 Hz), 130.4, 130.1, 
128.0, 125.5, 124.8, 121.5, 112.0–111.6 (m, 2 × ArC), 111.6 (ArC), 54.8 (C), 43.5 (CH2) 
ppm; 19F NMR (376 MHz, CDCl3): δ = −132.6 (d, J = 20.1 Hz, 2F), −160.3 (t, J = 20.4 
Hz, 1F) ppm; IR (neat): ν = 3068w, 2954w, 1802s, 1529s, 1229s, 754s cm−1; HRMS 
(ES): Exact mass calculated for C17H10F3O2 [M−H]−: 303.0633, found 303.0644.  
3-Allyl-3-(pentafluorophenyl)benzofuran-2(3H)-one 185s: 
Performed according to General Procedure 19 on a 0.1 mmol scale 
of 184h and 0.1 mmol of 106d; 185s (20 mg, 0.060 mmol, 60% yield) 
was obtained after 24 hours at 50 °C as a pale-yellow oil. 
1H NMR (500 MHz, CDCl3): δ = 7.39–7.31 (m, 1H, ArH), 7.19–7.12 
(m, 3H, ArH), 5.51–5.39 (m, 1H, ArH), 5.14–5.07 (m, 2H), 3.28 (dd, J = 13.2, 6.2 Hz, 1H, 
1 × CH2), 3.20 (dd, J = 13.2, 8.0 Hz, 1H, 1 × CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 
175.2 (C=O), 152.9 (ArC–O), 145.9 (d, J = 250.2 Hz, 2 × ArC–F), 141.1 (d, J = 256.1 Hz, 
ArC–F), 138.2 (d, J = 254.0 Hz, 2 × ArC–F), 130.1 (ArC), 129.6 (ArC), 129.1 (ArC), 125.1 
(ArC), 123.5 (ArC), 122.2 (ArC), 114.2–112.6 (m, ArC), 111.2 (ArC), 52.6 (C), 40.8 (t, J = 
6.5 Hz, CH2) ppm; 19F NMR (376 MHz, CDCl3): δ = −136.7 (d, J = 19.7 Hz, 2F), −152.9 
(t, J = 20.9 Hz, 1F), −160.4 (t, J = 20.8 Hz, 2F) ppm; IR (neat): ν = 2922w, 1807s, 1524s, 
1487s, 1463s, 1291m, 1053s, 968s, 883s, 752s cm−1; HRMS (EI): Exact mass calculated 
for C17H9O2F5 [M]+: 340.0523, found 340.0522. 
3-Cinnamyl-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185t: 
Performed according to General Procedure 19 on a 0.1 mmol scale 
of 184i and 0.1 mmol of 106e; 185t (20 mg, 0.053 mmol, 53% yield) 
was obtained after 24 hours at room temperature as a colourless 
oil. 
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1H NMR (500 MHz, CDCl3): δ = 7.42 (t, J = 7.7 Hz, 1H, ArH), 7.33 (d, J = 7.4 Hz, 1H, 
ArH), 7.31–7.10 (m, 9H, ArH), 6.40 (d, J = 15.7 Hz, 1H, CH), 5.80–5.65 (m, 1H, CH), 
3.21–3.06 (m, 2H, CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 176.4 (C=O), 153.2  
(ArC–O), 151.4 (ddd, J = 251.0, 9.9, 4.1 Hz, 2 × ArC–F), 139.6 (dd, J = 254.1, 17.1 Hz, 
ArC–F), 136.5, 136.2, 134.7–134.0, 130.2, 128.7, 128.0, 128.0, 126.4, 125.6, 124.9, 
121.4, 112.0–111.8 (m, 2 × ArC), 111.6 (ArC), 55.1 (C), 42.9 (CH2) ppm; 19F NMR 
(376 MHz, CDCl3): δ = −132.5 (d, J = 20.8 Hz, 2F), −160.2 (t, J = 20.7 Hz) ppm; IR (neat): 
ν = 3030w, 1801s, 1618m, 1464s, 1232s, 1047s, 885m, 692s cm−1; HRMS (ES): Exact 
mass calculated for C23H14F3O2 [M−H]−: 379.0946, found 379.0953.  
3-Cinnamyl-3-(pentafluorophenyl)benzofuran-2(3H)-one 185u: 
Performed according to General Procedure 19 on a 0.1 mmol scale 
of 184i and 0.1 mmol of 106d; 185u (14 mg, 0.033 mmol, 33% 
yield) was obtained after 24 hours at 50 °C as a colourless solid, 
m.p.: 114–120 °C.  
1H NMR (500 MHz, CDCl3): δ = 7.35 (t, J = 7.3 Hz, 1H, ArH), 7.25–7.11 (m, 8H, ArH), 
6.39 (d, J = 15.7 Hz, 1H, Ph–CH), 5.80 (dt, J = 15.2, 7.4 Hz, 1H, CH2–CH), 3.47–3.30 
(m, 2H, CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 175.3 (C=O), 152.9 (ArC–O), 145.9 
(d, J = 248.0 Hz, 2 × ArC–F), 141.0 (d, J = 261.3 Hz, ArC–F), 138.14 (d, J = 249.1 Hz, 
2 × ArC–F), 136.8, 136.6, 130.2, 129.2, 128.6, 128.0, 126.5, 125.1, 123.8, 120.6, 113.1 
(ArC), 111.3 (ArC), 52.8 (C), 40.11 (t, J = 6.5 Hz, CH2) ppm; 19F NMR (376 MHz, CDCl3): 
δ = −136.6 (d, J = 19.2 Hz, 2F), −152.8 (t, J = 19.7 Hz, 1F), −160.3 (t, J = 20.7 Hz, 2F) 
ppm; IR (neat): ν = 2922m, 2852w, 1811s, 1526s, 1491s, 1122m, 1057m, 970m, 752m 
cm−1; HRMS (ES): Exact mass calculated for C23H13O2F5 [M−H]−: 415.0757, found 
415.0764. 
5-Bromo-3-(4-methylbenzyl)-3-(3,4,5-trifluorophenyl)benzofuran-2(3H)-one 185v: 
Performed according to General Procedure 19 on a 0.1 mmol 
scale of 184j and 0.1 mmol of 106e; 185v (37 mg, 0.082 mmol, 
82% yield) was obtained after 24 hours at room temperature as 
a colourless oil. 
1H NMR (400 MHz, CDCl3): δ = 7.45 (dd, J = 8.6, 2.1 Hz, 1H, ArH), 7.30 (d, J = 2.1 Hz, 
1H, ArH), 7.22–7.11 (m, 2H, ArH), 6.94 (d, J = 7.9 Hz, 2H, ArH), 6.88 (d, J = 8.6 Hz, 1H, 
ArH), 6.71 (d, J = 8.0 Hz, 2H, ArH), 3.56 (d, J = 13.2 Hz, 1H, 1 × CH2), 3.38 (d, J = 13.2 
Hz, 1H, 1 × CH2), 2.24 (s, 3H, CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 175.8 (C=O), 
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152.5 (ArC–O), 151.4 (ddd, J = 251.2, 9.9, 4.1 Hz, 2 × ArC–F), 139.7 (dt, J = 254.1, 15.2 
Hz, ArC–F), 137.6, 134.1 (td, J = 7.0, 4.6 Hz, ArC), 133.0 (ArC), 130.2 (ArC), 130.1 (ArC), 
130.0 (ArC), 129.9 (ArC), 129.2 (ArC), 128.9 (ArC), 117.0 (ArC), 113.0 (ArC), 112.4–
111.4 (m, 2 × ArC), 56.9 (C), 45.0 (CH2), 21.1 (CH3) ppm; 19F NMR (376 MHz, CDCl3): 
δ = −132.0 (d, J = 20.7 Hz, 2F), −159.6 (t, J = 20.7 Hz, 1F) ppm; IR (neat): ν = 2918w, 
1809s, 1618m, 1526m, 1462m, 1433m, 1132m, 1053s, 814s cm−1; HRMS (ES): Exact 
mass calculated for C22H13O2F3Br [M−H]−: 415.0757, found 415.0764. 
3-Benzyl-3-(3,4,5-trifluorophenyl)benzo[b]thiophen-2(3H)-one 225: 
Performed according to General Procedure 19 on a 0.083 mmol 
scale of 224 and 0.083 mmol of 106e; 225 (17 mg, 0.046 mmol, 
55% yield) was obtained after 72 hours at room temperature as a 
colorless solid, m.p.: 88–92 °C. 
1H NMR (500 MHz, CDCl3): δ = 7.36–7.29 (m, 2H, ArH), 7.25–7.20 (m, 1H, ArH), 7.20–
7.15 (m, 1H, ArH), 7.14–7.09 (m, 1H, ArH), 7.10–7.03 (m, 2H, ArH), 7.03–6.95 (m, 2H, 
ArH), 6.83–6.78 (m, 2H, ArH), 3.83 (d, J = 12.9 Hz, 1H, 1 × CH2), 3.36 (d, J = 12.9 Hz, 
1H, 1 × CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 206.2 (C=O), 152.3 (ArC–O), 151.3 
(ddd, J = 250.1, 9.8, 4.1 Hz, 2 × ArC–F), 139.3 (dt, J = 254.0, 15.4 Hz, ArC–F), 138.5 
(ArC), 136.7 (td, J = 6.9, 4.6 Hz, ArC), 138.4 (ArC), 138.4 (ArC), 136.7 (ArC), 136.7 
(ArC), 136.0 (ArC), 133.9 (ArC), 130.3 (ArC), 129.4 (ArC), 128.1 (ArC), 127.3 (ArC), 
126.9 (ArC), 126.7 (ArC), 123.4 (ArC), 112.3–111.9 (m, 2 × ArC), 67.7 (C), 44.8 (CH2) 
ppm; 19F NMR (376 MHz, CDCl3): δ = −132.9 (d, J = 20.8 Hz, 2F), −160.5 (t, J = 20.8 
Hz, 1F) ppm; IR (neat): ν = 3032w, 2926w, 1703s, 1618w, 1529s, 1435m, 1344w, 1244w, 
1051s cm−1; HRMS (ES): Exact mass calculated for C22H15O3F3 [M−H]−: 369.0561, found 
369.0565. 
5.3.4 Characterisation of Phenol Side Product 230 
Methyl 2-(2-hydroxyphenyl)-2-(perfluorophenyl)-3-phenylpropanoate 230b: 
Compound 230b was obtained as a side product after 
reaction of 184b (1 equiv.) and 106d (1 equiv.) at room 
temperature as a colorless oil (12 mg, 0.54 mmol, 52% 
yield). 
1H NMR (500 MHz, CDCl3): δ = 7.49 (dd, J = 8.1, 1.3 Hz, 
1H, ArH), 7.33 (d, J = 8.1 Hz, 2H, ArH), 7.28–7.22 (m, 1H, ArH), 7.03–6.99 (m, 1H, ArH), 
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6.99–6.95 (m, 3H, ArH + OH), 6.90 (dd, J = 8.1, 1.3 Hz, 1H, ArH), 4.30 (d, J = 13.4 Hz, 
1H, 1 × CH2), 3.80 (s, 3H, OCH3), 3.35 (d, J = 13.4 Hz, 1H, 1 × CH2) ppm; 13C NMR (126 
MHz, CDCl3): δ = 172.7 (C=O), 155.0 (ArC–O), 145.2 (d, J = 255.0 Hz, 2 × ArC–F), 140.4 
(d, J = 265.1 Hz, ArC–F), 139.6 (ArC), 137.5 (d, J = 246.0 Hz, 2 × ArC–F), 130.8 (ArC), 
130.1 (ArC), 129.7 (q, J = 32.6 Hz, ArC–CF3), 126.4 (ArC), 125.4 (ArC), 124.8 (q, J = 3.7 
Hz, 2 × ArC), 121.6 (ArC), 120.0 (ArC), 113.7 (ArC), 54.8 (C), 54.1 (OCH3), 40.8 (CH2) 
ppm; 19F not 1H-decoupled (471 MHz, CDCl3): δ = −62.7 (s, 3F), −134.9 (d, J = 15.4 Hz, 
2F), −153.7 (t, J = 21.3 Hz, 1F), −161.9 (td, J = 22.0, 6.6 Hz, 2F) ppm; IR (neat): ν = 
3333w, 1703m, 1489s, 1122s, 995s, 739s cm−1; HRMS (ES): Exact mass calculated for 
C23H14O3F8 [M+H]+: 490.0815, found 490.0811. 
Methyl 2-(2-hydroxyphenyl)-2-(perfluorophenyl)-3-phenylpropanoate 230c: 
Compound 230c was obtained as a side product after reaction 
of 184c (1 equiv.) and 106a (1 equiv.) as a colourless oil which 
was not stable during analysis and decomposing into 185i. 
1H NMR (500 MHz, CDCl3): δ = 7.53 (t, J = 7.7 Hz, 2H, ArH), 
7.41–7.14 (m, 7H, ArH), 7.01 (t, J = 7.6 Hz, 1H, ArH), 6.96 (d, J = 7.7 Hz, 2H, ArH), 6.86 
(dd, J = 8.0, 1.0 Hz, 1H, ArH), 6.77 (d, J = 8.6 Hz, 1H, ArH), 6.54 (d, J = 8.7 Hz, 1H, 
ArH), 6.51 (d, J = 8.7 Hz, 2H, ArH), 6.51 (d, J = 8.7 Hz, 2H, ArH), 6.27 (s, 1H, OH), 4.08 
(d, J = 12.9 Hz, 1H, 1 × CH2), 3.80 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 3.20 (d, J = 
12.9 Hz, 1H, 1 × CH2) ppm; IR (neat): ν = 3404m, 2951m, 2835m, 1800m, 1732s, 1705s, 
1610s, 1512s, 1462, 1454, 1246, 1034m, 1034, 754 cm−1; HRMS (ES): Exact mass 
calculated for C23H21O4 [M−H]−: 361.1440, found 361.1444. 
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5.4 Experimental Data for Chapter 4: 
Synthesis of N,O-acetals in a Flow Microreactor 
5.4.1 Synthesis of Starting Materials 
 [1,1’-Biphenyl]-2-carboxylic acid 287a: 
 
Grounded KOH (6 g, 110 mmol) was dispersed into 50 mL of xylene and the temperature 
was raised to 85 °C. A solution of 9-fluorenone 286 (10 g, 55 mmol) in 50 mL of xylene 
was added dropwise over 30 minutes and the reaction was stirred for a further 5 hours 
at 160 °C. Water was added, and the phases separated. The organic phase was further 
washed with 1 M KOH aqueous solution (50 mL). The combined aqueous layers were 
acidified with 1 M HCl aqueous solution until pH = 2. The desired product 287a (8 g, 
40 mmol, 72% yield) was afforded as a colourless solid after filtration and used for the 
next step without further purification; m.p.: 114–116 °C (Lit. 114.3 °C).34 
1H NMR (500 MHz, CDCl3): δ = 8.11–7.79 (m, 1H, ArH), 7.57 (td, J = 7.6, 1.4 Hz, 1H, 
ArH), 7.47–7.29 m, 7H, ArH) ppm; 13C NMR (126 MHz, CDCl3): δ = 173.5 (C=O), 143.5 
(ArC), 141.1 (ArC), 132.2 (ArC), 131.3 (ArC), 130.8 (ArC), 129.4 (ArC), 128.6 (2 × ArC), 
128.2 (2 × ArC), 127.5 (ArC), 127.3 (ArC) ppm. The spectroscopic data are in agreement 
with the literature.34 
General Procedure 20: 
 
The desired biphenylic acid 287 (2 mmol) was dissolved in 5 mL of dry toluene. Thionyl 
chloride (4 mmol) and 1 drop of DMF were added. The mixture was stirred for 6 hours at 
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60 °C under N2. Subsequently, the solvent and excess of thionyl chloride were removed 
under reduced pressure. The desired acyl chloride 288 was dissolved dry CH2Cl2 (1 mL) 
and added dropwise to an ice-cold solution of pyrrolidine 289 (2.2 mmol) and 
triethylamine (2.6 mmol) in dry CH2Cl2 (1 mL). The reaction was stirred at room 
temperature overnight then was diluted with CH2Cl2 and washed with 1 M HCl aqueous 
solution. The collected organic layers were washed with brine, dried over MgSO4 and 
concentrated under reduced pressure to afford the desired amides 293a–b which were 
used for the Shono oxidation35 without further purification. 
[1,1'-Biphenyl]-2-yl(pyrrolidin-1-yl)methanone 293a: 
Performed according to General Procedure 20 on a 5.8 mmol scale of 
288a; 293a (1.0 g, 4.0 mmol, 68% yield) was obtained as a colourless oil. 
1H NMR (500 MHz, CDCl3): δ = 7.57–7.42 (m, 2H, ArH), 7.42–7.23 (m, 
7H, ArH), 3.37 (br. s, 2H, CH2), 2.71 (br. s, 2H, CH2), 1.60 (br. s, 2H, CH2), 
1.42 (br. s, 2H, CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 169.8 (C=O), 
140.0 (ArC), 138.3 (ArC), 136.9 (ArC), 129.5 (ArC), 129.4 (ArC), 128.5 (2 × ArC), 128.4 
(2 × ArC), 127.7 (ArC), 127.6 (ArC), 127.2 (ArC), 47.5 (CH2), 45.4 (CH2), 25.6 (CH2), 
24.2 (CH2) ppm. The spectroscopic data are in agreement with the literature.36 
[1,1'-Biphenyl]-2-yl(pyrrolidin-1-yl)methanone 293b: 
Performed according to General Procedure 20 on a 2.0 mmol scale of 
288b; 293b (396 mg, 1.4 mmol, 71% yield) was obtained as a colourless 
oil. 
1H NMR (500 MHz, CDCl3): δ = 7.47–7.28 (m, 6H, ArH), 6.98 (td, J = 7.5, 
1.0 Hz, 1H, ArH), 6.94 (d, J = 8.2 Hz, 1H, ArH), 3.77 (s, 3H, OCH3), 3.36 
(t, J = 7.0 Hz, 2H, CH2), 2.98 (t, J = 6.7 Hz, 2H, CH2), 1.75–1.47 (m, 4H, 2 × CH2) ppm; 
13C NMR (126 MHz, CDCl3): δ = 169.7 (C=O), 156.3 (ArC–O), 137.9 (ArC), 135.5 (ArC), 
131.6 (ArC), 131.3 (ArC), 129.2 (ArC), 128.6 (ArC), 127.5 (ArC), 127.1 (ArC), 120.7 
(ArC), 110.8 (ArC), 55.6 (OCH3), 47.9 (CH2), 45.4 (CH2), 25.9 (CH2), 24.5 (CH2) ppm. 
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General Procedure 21: 
 
The carboxylic acid 287 (5 g, 17 mmol) was dissolved in 20 mL of dry toluene. Thionyl 
chloride (2.4 mL, 34 mmol) and 5 drops of DMF were added. The mixture was stirred for 
6 hours at 60 °C under N2 then the solvent and excess of thionyl chloride was removed 
under reduced pressure. The desired acyl chloride 288 was dissolved in dry THF (15 mL) 
and added dropwise to an ice-cold solution of L-amino acid (17 mmol) and KOH (2 g, 
34 mmol). The solution was stirred at room temperature overnight. Once the reaction 
was completed, THF was removed under reduced pressure and the residue was 
partitioned into NaHCO3 saturated aqueous solution (20 mL) and EtOAc (20 mL). The 
aqueous layer was acidified with HCl 1 M aqueous solution and the white precipitate was 
extracted with EtOAc (3 × 20 mL). The collected organic layers were washed with brine, 
dried over MgSO4 and concentrated under reduced pressure and recrystallised from 
Et2O and petroleum ether if needed. The products (S)-284a–f were isolated as colourless 
solids. 
([1,1'-Biphenyl]-2-carbonyl)-L-proline (S)-284a: 
Performed according to General Procedure 21 on a 8.5 mmol scale 
of 288a; (S)-284a (2.2 g, 7.5 mmol, 88% yield) was obtained as 
colourless crystals, m.p: 162–164 °C; [𝛼]𝐷20: −83.5° (c 0.93, MeOH). 
1H NMR (500 MHz, CDCl3): δ = 7.63–7.33 (m, 9H, ArH), 4.46 (s, 1H, 
N–CH), 2.88 (s, 2H, CH2), 2.34–2.10 (m, 1H, 1 × CH2), 1.75–1.51 (m, 
2H, CH2), 1.35 (s, 1H, 1 × CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 173.6 (C=O), 171.5 
(C=O), 139.4 (ArC), 134.4 (ArC), 130.6 (ArC), 129.8 (ArC), 128.9 (ArC), 128.5 (2 × ArC), 
128.3 (2 × ArC), 128.1 (ArC), 127.6 (ArC), 60.4 (N–CH), 49.0 (N–CH2), 27.3 (CH2), 24.3 
(CH2) ppm; The spectroscopic data are in agreement with the literature.37 
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(2'-Methoxy-[1,1'-biphenyl]-2-carbonyl)-L-proline (S)-284b: 
Performed according to General Procedure 21 on a 2.2 mmol scale 
of 288b; (S)-284b (672 mg, 2.1 mmol, 94% yield) was obtained as a 
colourless solid, m.p.: 68–70 °C; [α]D20: −78.0° (c 0.59, MeOH). 
1H NMR (500 MHz, CDCl3): δ = 7.54–7.48 (m, 1H, ArH), 7.48–7.38 
(m, 3H, ArH), 7.35 (ddd, J = 8.3, 7.5, 1.8 Hz, 1H, ArH), 7.31–7.17 (m, 
1H, ArH), 7.02 (td, J = 7.5, 1.0 Hz, 1H, ArH), 6.95 (d, J = 8.3 Hz, 1H, ArH), 4.51 (br. s, 
1H, N–CH), 3.74 (s, 3H, OCH3), 3.26 (br. s, 1H, 1 × CH2), 3.11 (br. s, 1H, 1 × CH2), 2.43 
(br. s, 1H, 1 × CH2), 1.92–1.68 (m, 2H, CH2), 1.56 (br. s, 1H, 1 × CH2) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 173.8 (C=O), 171.1 (C=O), 156.0 (ArC–O), 134.9 (ArC), 131.6 
(ArC), 131.3 (ArC), 130.2 (ArC), 129.9 (ArC), 128.2 (ArC), 127.5 (ArC), 127.0 (ArC), 
121.0 (ArC), 110.9 (ArC), 60.5 (N–CH), 55.5 (N–CH2), 49.6 (OCH3), 27.1 (CH2), 24.7 
(CH2) ppm; IR (neat): v = 3439w, 2949m, 1730s, 1591s, 1448s, 1421s, 1022s  
cm−1; HRMS (ES): Exact mass calculated for C19H20NO4 [M+H]+ 326.1392; found 
326.1404. 
([1,1'-Biphenyl]-2-carbonyl)-L-alanine (S)-284c: 
Performed according to General Procedure 21 on a 5.0 mmol scale 
of 288a; (S)-284c (1.3 g, 4.3 mmol, 86% yield) was obtained as a 
colourless solid, m.p.: 120–124 °C; [𝛼]𝐷20: −8.5 (c 1.4, MeOH). 
1H NMR (400 MHz, CDCl3): δ = 7.74 (dd, J = 7.6, 1.2 Hz, 1H, ArH), 
7.51 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.47–7.41 (m, 2H, ArH), 7.41–7.32 
(m, 5H, ArH), 5.72 (d, J = 6.7 Hz, 1H, NH), 4.49 (quin, J = 7.1 Hz, 1H, CH–CH3), 1.10 (d, 
J = 7.2 Hz, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 175.9 (C=O), 169.7 (C=O), 
140.2 (ArC), 140.1 (ArC), 134.3 (ArC), 130.9 (ArC), 130.5 (ArC), 129.2 (ArC), 128.9 
(2 × ArC), 128.8 (2 × ArC), 128.1 (ArC), 127.9 (ArC), 48.7 (NCH), 17.3 (CH3) ppm; IR 
(neat): v = 3271m, 3057m, 1718s, 1618s, 1518s, 1448s, 744s, 698s cm−1; HRMS (ES): 
Exact mass calculated for C16H15NO3Na [M+Na]+ 292.0950; found 292.0960. 
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([1,1'-Biphenyl]-2-carbonyl)-L-valine (S)-284d: 
Performed according to General Procedure 21 on a 5.0 mmol scale 
of 288a; (S)-284d (1.1 g, 3.7 mmol, 74% yield) was obtained as a 
colourless solid, m.p.: 160–164 °C; [𝛼]𝐷20: −6.0° (c 0.66, MeOH). 
1H NMR (400 MHz, CDCl3): δ = 7.75–7.69 (m, 1H, ArH), 7.49 (dt, J = 
7.5, 3.8 Hz, 1H, ArH), 7.45–7.30 (m, 7H, ArH), 5.84 (d, J = 8.2 Hz, 
1H, NH), 4.49 (dd, J = 8.3, 4.6 Hz, 1H, NCH), 2.07–1.93 (m, 1H, CH), 0.71 (d, J = 6.9 
Hz, 3H, CH3), 0.65 (d, J = 6.9 Hz, 3H, CH3) ppm; 13C NMR (101 MHz, CDCl3): δ = 175.9 
(C=O), 169.8 (C=O), 140.3 (ArC), 139.9 (ArC), 134.9 (ArC), 130.6 (ArC), 130.5 (ArC), 
129.1 (2 × ArC), 128.9 (2 × ArC), 128.6 (ArC), 128.1 (ArC), 127.8 (ArC), 57.8 (NCH), 
30.8 (CH), 18.8 (CH3), 17.5 (CH3) ppm. The spectroscopic data are in agreement with 
the literature.38 
([1,1'-Biphenyl]-2-carbonyl)-L-leucine (S)-284e: 
Performed according to General Procedure 21 on a 10 mmol scale of 
288a; (S)-284e (2.3 g, 7.4 mmol, 74% yield) was obtained as a 
colourless solid, m.p.: 90–9 4 °C; [𝛼]𝐷20: −17.7° (c 1.1, MeOH). 
1H NMR (400 MHz, CDCl3): δ = 7.74–7.71 (m, 1H, ArH), 7.49 (td, J = 
7.5, 1.5 Hz, 1H, ArH), 7.44–7.33 (m, 7H, ArH), 5.67 (d, J = 7.7 Hz, 
1H, NH), 4.50 (ddd, J = 9.2, 7.8, 5.2 Hz, 1H, NCH), 1.53–1.35 (m, 1H, 
CH), 1.35–1.06 (m, 2H, CH2), 0.79 (dd, J = 6.5, 4.1 Hz, 6H, 2 × CH3) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 176.5 (C=O), 169.9 (C=O), 140.3 (ArC), 140.0 (ArC), 134.6 (ArC), 
130.7 (ArC), 130.5 (ArC), 129.2 (ArC), 128.9 (ArC), 128.0 (4 × ArC), 127.8 (ArC), 51.3 
(NCH), 40.8, 24.5, 22.9, 21.9 ppm; IR (neat): v = 3306m, 2957m, 1705s, 1636s, 1510s, 
1244s cm−1; HRMS (ES): Exact mass calculated for C19H21NO3Na [M+Na]+ 334.1419; 
found 334.1430. 
([1,1'-Biphenyl]-2-carbonyl)-L-phenylalanine (S)-284f: 
Performed according to General Procedure 21 on a 8.5 mmol scale 
of 288a; (S)-284f (2.0 g, 5.8 mmol, 68% yield) was obtained as a 
colourless solid, m.p.: 134–136 °C; [𝛼]𝐷20: +1.8° (c 1.1, MeOH). 
1H NMR (500 MHz, CDCl3): δ = 7.61 (d, J = 7.6 Hz, 1H, ArH), 7.48 (t, 
J = 7.5 Hz, 1H, ArH), 7.42–7.30 (m, 7H, ArH), 7.24–7.15 (m, 3H, ArH), 
6.94–6.77 (m, 2H, ArH), 5.83 (d, J = 7.3 Hz, 1H, NH), 4.85 (q, J = 6.3 Hz, 1H, NCH), 
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3.17–2.74 (m, 2H, CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 175.1 (C=O), 169.8 (C=O), 
140.0 (ArC), 135.5 (ArC), 134.5 (ArC), 130.8 (ArC), 130.7 (ArC), 130.6 (ArC), 129.3 
(2 × ArC), 129.0 (2 × ArC), 128.9 (ArC), 128.8 (2 × ArC), 128.8 (2 × ArC), 128.1 (ArC), 
127.3 (ArC), 53.6 (NCH), 37.2 (CH2) ppm. The spectroscopic data are in agreement with 
the literature.37 
Benzoyl-L-proline (S)-259: 
Performed according to General Procedure 21 on a 10 mmol scale of 
benzoyl chloride; (S)-259 (1.8 g, 8.2 mmol, 82% yield) was obtained 
as a colourless solid, m.p.: 146–148 °C; [𝛼]𝐷20: −94.0° (c 1.0, MeOH).  
1H NMR (500 MHz, CDCl3): δ = 9.04 (s, 1H, CO2H), 7.57–7.52 (m, 
2H, ArH), 7.50–7.37 (m, 3H, ArH), 4.73 (dd, J = 7.7, 5.9 Hz, 1H, 1 × CH2), 3.63–3.49 (m, 
2H, CH2), 2.41–2.20 (m, 2H, CH2), 2.10–1.95 (m, 1H, 1 × CH2), 1.95–1.85 (m, 1H, 1 
× CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 174.7 (C=O), 171.2 (C=O), 135.5 (ArC), 
130.7 (ArC), 128.5 (2 × ArC), 127.4 (2 × ArC), 59.8 (NCH), 50.5 (NCH2), 28.8 (CH2), 25.3 
(CH2) ppm; The spectroscopic data are in agreement with the literature.37 
5.4.2 Synthesis of N,O-acetals  
5.4.2.1 Enantioselective Synthesis 
General Procedure 22: 
 
The amino acid derivative (S)-259 or (S)-284 was dissolved in methanol (0.012–0.05 M) 
and pumped through the Ion electrochemical microreactor at 0.2 mL•min−1. Platinum was 
used as the cathode, graphite or glassy carbon as the anode (spacer: 0.5 mm; working 
electrode surface: 12 cm2). The current was fixed at 16–32 mA (2 F•mol−1), and the 
temperature was maintained at −10 °C. The solution was collected over 90 minutes and 
the solvent was evaporated under reduced pressure. The desired N,O-acetals 260 or 
285 were obtained after column chromatography (n-hexane/ethyl acetate, 8:2) as 
colourless oil or solid depending on the substrate. 
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(2-Methoxypyrrolidin-1-yl)(phenyl)methanone 260: 
Performed according to General Procedure 22 on a 0.013 M methanol 
solution of (S)-259 using glassy carbon as anode; 260 (7.6 mg, 
3.2 mM, 25% yield, 0% ee) was afforded as a colourless oil as a 1:1.5 
mixture of rotamers. 
1H NMR (500 MHz, CDCl3): δ = 7.74–7.47 (m, 2H, ArH), 7.52–7.35 (m, 3H, ArH), 5.76 
(s, 0.4H, NCH), 4.73 (s, 0.6H, NCHI), 3.77–3.58 (m, 1.6H), 3.49 (s, 1.2H), 3.30 (s, 0.4H), 
3.06 (s, 1.8H), 2.27–1.64 (m, 4H) ppm; 13C NMR (126 MHz, CDCl3): δ = 171.5 (C=O), 
171.0 (CI=O), 136.7 (ArC), 130.1 (ArC), 128.2 (ArC), 127.4 (ArC), 127.2 (ArC), 90.1, 
87.5, 56.4, 54.1, 48.6, 45.5, 31.3, 30.6, 23.5, 21.0 ppm; HPLC analysis: 1D Varian 
Si-5 μm (250 × 4.6 mm) n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 254 nm, 
retention time 260 = 6.1 min; 2D DAICEL Chiralcel OB-H (250 × 4.6 mm, 5 μm), 
n-hexane/isopropanol 7:3 (v/v), 1.0 mL•min−1, λ = 254 nm, overall retention time major 
isomer = 12.4 min, retention time minor isomer = 14.0 min. The spectroscopic data are 
in agreement with the literature.39  
 
Peak # Time (min) 
1 6.066 
 
 
Peak # Time (min) Area (%) 
1 12.395 50.905 
2 13.981 49.095 
Figure 5.17: HPLC chromatograms for the enantiomers of 260. From the top: 1D dimension and 
2D for the racemic mixture. 
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(R)-[1,1'-Biphenyl]-2-yl(2-methoxypyrrolidin-1-yl)methanone (R)-285a: 
Performed according to General Procedure 22 on a 0.05 M methanol 
solution of (S)-284a using glassy carbon as anode; (R)-285a 
(102.8 mg, 0.026 M, 52% yield, 58% ee) was afforded as a colourless 
oil as a 1:2 mixture of rotamers; [𝛼]𝐷20: −16.3° (c 1.7, CH2Cl2).  
1H NMR (500 MHz, CDCl3): δ = 7.62–7.30 (m, 9H, ArH), 5.46 (br. s, 0.4H, NCH), 4.31 
(d, J = 4.1 Hz, 0.6H, NCHI), 3.52 (ddd, J = 11.9, 9.4, 2.5 Hz, 0.7H), 3.40–3.29 (m, 1.7H), 
2.78 (s, 2.2 H, OCHI3), 1.89–1.46 (m, 4H) ppm; 13C NMR (126 MHz): δ = 171.5 (C=O), 
170.6 (CI=O), 139.9 (ArC), 139.9 (ArC), 138.4 (ArC), 136.6 (ArC), 136.1 (ArC), 129.7 
(ArC), 129.6 (ArC), 129.3 (ArC), 129.2 (ArC), 128.7 (ArC), 128.6 (ArC), 128.6 (ArC), 
128.5 (ArC), 127.8 (ArC), 127.7 (ArC), 127.7 (ArC), 127.6 (ArC), 126.9 (ArC), 89.8 
(NCIH), 87.1 (NCIH), 56.6 (OCH3), 54.6 (OCIH3), 46.6 (NCH2), 44.4 (NCIH2), 31.2, 22.5, 
21.0 ppm; HPLC analysis (85:15 e.r.): 1D Varian Si-5 μm (250 × 4.6 mm) 
n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 254 nm, retention time 285a = 5.5 min; 
2D DAICEL Chiralcel OD-H (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 9:1 (v/v), 1.0 
mL•min−1, λ = 254 nm, retention time (R)-285a = 11.2 min, retention time (S)-285a = 13.1 
min. The spectroscopic data are in agreement with the literature.40 
 
Peak # Time (min) 
1 (Internal Standard) 3.668 
2 5.535 
Figure 5.18: 1D HPLC chromatograms for 285a. 
 
Peak # Time (min) Area (%) 
1 11.209 50.468 
2 13.053 49.532 
Figure 5.19: 2D HPLC chromatograms for the enantiomers of 285a (racemic). 
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Peak # Time (min) Area (%) 
1 11.794 85.105 
2 13.586 14.895 
Figure 5.20: 2D HPLC chromatograms for the enantiomers of 285a (70% ee). 
 
(R)-(2'-Methoxy-[1,1'-biphenyl]-2-yl)(2-methoxypyrrolidin-1-yl)methanone (R)-285b: 
Performed according to General Procedure 22 on a 0.013 M methanol 
solution of (S)-284b using glassy carbon as anode; (R)-285b 
(15.9 mg, 3.6 mM, 28% yield, 50% ee) was afforded as a colourless 
oil as a 1:1.5 mixture of rotamers; [𝜶]𝑫𝟐𝟎: −5.3° (c 0.38, CH2Cl2).  
1H NMR (500 MHz, CDCl3): δ = 7.60–7.23 (m, 6H, ArH), 7.02–6.86 (m, 
1H, 2H, ArH), 5.48 (d, J = 4.9 Hz, 0.4H, NCH), 4.54 (d, J = 4.4 Hz, 0.6H, NCHI), 3.85–
3.62 (m, 3H, OCH3), 3.56–3.05 (m, 3.2H), 2.85 (s, 1.8H), 1.99–1.47 (m, 4H) ppm; 
13C NMR (126 MHz, CDCl3): δ = 171.4 (C=O), 170.6 (CI=O), 156.2 (ArC–O), 156.2  
(ArC–O), 137.3 (ArC), 136.9 (ArC), 135.7 (ArC), 135.3 (ArC), 131.6 (ArC), 131.5 (ArC), 
131.4 (ArC), 131.1 (ArC), 129.4 (ArC), 129.3 (ArC), 128.8 (ArC), 128.8 (ArC), 128.7 
(ArC), 128.6 (ArC), 127.4 (ArC), 127.3 (ArC), 126.7 (ArC), 120.8 (ArC), 120.7 (ArC), 
110.9 (ArC), 110.8 (ArC), 89.8 (CIH), 86.9 (CH), 56.3, 55.5, 55.4, 54.8, 47.0, 44.5, 31.7, 
31.4, 22.9, 21.1 ppm; IR (neat): v = 3061w, 2926m, 2853w, 1632s, 1402s, 1254s, 1080s, 
908m, 750s, 729s cm−1; HRMS (ES): Exact mass calculated for C19H21NO3Na [M+Na]+ 
334.1419; found 334.1410; HPLC analysis (75:25 e.r.): 1D Varian Si-5 μm 
(250 × 4.6 mm) n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 254 nm, retention time 
285b = 6.3 min; 2D YMC Chiral Amylose-C (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 
85:15 (v/v), 1.0 mL•min−1, λ = 254 nm, overall retention time major isomer = 13.4 min, 
retention time minor isomer = 14.2 min. The HPLC chromatograms are reported in 
literature.41 
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(R)-[1,1'-Biphenyl]-2-yl(2-ethoxypyrrolidin-1-yl)methanone (R)-285c: 
Performed according to General Procedure 22 on a 0.013 M ethanol 
solution of (R)-284a using graphite as anode; (R)-285c (27.6 mg, 
6.9 mM, 53% yield, 23% ee) was afforded as a 1:2.3 mixture of 
rotamers; [𝛼]𝐷20: −7.6° (c 0.53, CH2Cl2).  
1H NMR (500 MHz, CDCl3): δ = 7.66–7.27 (m, 9H, ArH), 5.55 (br. s, 
0.3H, NCH), 4.40 (br. s, 0.7H, NCIH), 3.70–3.43 (m, 1.1H), 3.41–3.21 (m, 0.7H), 3.09–
2.90 (m, 1H), 2.87–2.68 (m, 1H), 1.98–1.35 (m, 4H), 1.10 (br. s, 0.9H), 0.84 (t, J = 7.0 Hz, 
2.1H, 3H) ppm; 13C NMR (126 MHz, CDCl3): δ = 171.4 (C=O), 170.6 (C=O), 140.0 (ArC), 
140.0 (ArC), 138.5 (ArC), 136.8 (ArC), 136.3 (ArC), 129.8 (ArC), 129.7 (ArC), 129.4 
(ArC), 129.2 (ArC), 128.8 (ArC), 128.7 (ArC), 128.7 (ArC), 128.5 (ArC), 127.8 (ArC), 
127.7 (ArC), 127.6 (ArC), 127.0 (ArC), 88.3 (NCIH), 85.7 (NCH), 64.4 (OCH2), 62.5 
(OCIH2), 46.6, 44.6, 31.9, 31.7, 22.6, 21.2, 15.5, 14.8 ppm; IR (neat): v = 3055w, 2974m, 
2882w, 1630s, 1402s, 1070s, 733s, 700s cm−1; HRMS (ES): Exact mass calculated for 
C19H21NO2Na [M+Na]+ 318.1470; found 318.1456; HPLC analysis (80:20 e.r.): 1D Varian 
Si-5 μm (250 × 4.6 mm) n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 254 nm, 
retention time 285c = 4.9 min; 2D DAICEL Chiralcel OD-H (250 × 4.6 mm, 5 μm), 
n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 254 nm, overall retention time major 
isomer = 9.9 min, retention time minor isomer = 11.3 min. The HPLC chromatograms are 
reported in literature.41 
(R)-[1,1'-Biphenyl]-2-yl(2-isopropoxypyrrolidin-1-yl)methanone (R)-285d: 
Performed according to General Procedure 22 on a 0.013 M propan-2-
ol solution of (S)-284a using graphite as anode; (R)-285d (22.6 mg, 
5.2 mM, 40% yield, 42% ee) was afforded as a colourless oil as a 1:2 
mixture of rotamers; [𝛼]𝐷20: −22.7° (c 0.26, CH2Cl2).  
1H NMR (500 MHz, CDCl3): δ = 7.61–7.30 (m, 9H, ArH), 5.62 (br. s, 
0.3H, NCH), 4.46 (br. s, 0.7H, NCHI), 3.97 (br. s, 0.3H), 3.66–3.50 (m, 0.7H), 3.27 (d, J = 
9.4 Hz, 0.7H), 3.07 (hept, J = 6.1 Hz, 0.7H), 2.93 (s, 0.2H), 2.87–2.70 (m, 0.3H), 1.97–
1.29 (m, 4H), 1.23–0.46 (m, 6H, 2 × CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 170.3 
(C=O), 139.9 (ArC), 36.3 (ArC), 129.6 (ArC), 129.2 (ArC), 128.7 (ArC), 128.6 (ArC), 
128.5 (ArC), 128.5 (ArC), 127.7 (ArC), 127.6 (ArC), 127.6 (ArC), 126.9 (ArC), 85.8 
(NCH), 67.6 (OCH), 46.4, 44.5, 32.3, 32.1, 23.4, 22.5, 22.1, 21.5, 21.0 ppm; IR (neat): 
v = 2970m, 1736s, 1616s, 1416s, 741s, 700s cm−1; HRMS (ES): Exact mass calculated 
for C20H23NO2Na [M+Na]+ 332.1626; found 332.1631; HPLC analysis (84:16 e.r.): 
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1D Varian Si-5 μm (250 × 4.6 mm) n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 
254 nm, retention time 285d = 4.7 min; 2D DAICEL Chiralcel OD-H (250 × 4.6 mm, 5 μm), 
n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 254 nm, overall retention time major 
isomer = 9.2 min, retention time minor isomer = 10.5 min. The HPLC chromatograms are 
reported in literature.41 
(R)-N-(1-Methoxyethyl)-[1,1'-biphenyl]-2-carboxamide (R)-285e: 
Performed according to General Procedure 22 on a 0.05 M methanol 
solution of (S)-284c using glassy carbon as anode; (R)-285e (39.1 mg, 
0.012 M, 23% yield, 8% ee) was afforded as a colourless solid, m.p.: 
82–84 °C; [𝜶]𝑫𝟐𝟎: +2.9° (c 0.69, CH2Cl2).  
1H NMR (500 MHz, CDCl3): δ = 7.73 (ddd, J = 7.6, 1.5, 0.4 Hz, 1H, 
ArH), 7.54–7.47 (m, 1H, ArH), 7.46–7.33 (m, 7H, ArH), 5.36 (d, J = 9.1 Hz, 1H NH), 5.18 
(dq, J = 9.5, 5.9 Hz, 1H, NCH), 3.19 (s, 3H, OCH3), 0.91 (d, J = 5.9 Hz, 3H, CH3) ppm; 
13C NMR (126 MHz, CDCl3): δ = 169.5 (C=O), 140.3 (ArC), 139.6 (ArC), 135.5 (ArC), 
130.5 (ArC), 130.4 (ArC), 129.0 (ArC), 128.9 (2 × ArC), 128.8 (2 × ArC), 128.1 (ArC), 
127.8 (ArC), 78.2 (NCH), 55.7 (OCH3), 21.0 (CH3) ppm; IR (neat): v = 3289m, 3059w, 
2984m, 2932m, 1647s, 1508s, 1088s, 910s, 729s, 698s cm−1; HRMS (EI): Exact mass 
calculated for C16H17NO2 [M]+ 255.1259; found 255.1252. HPLC analysis (55:43 e.r.): 
1D Varian Si-5 μm (250 × 4.6 mm) n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 
254 nm, retention time 267e = 5.0 min; 2D YMC Chiral Amylose-C (250 × 4.6 mm, 5 μm), 
n-hexane/isopropanol 85:15 (v/v), 1.0 mL•min−1, λ = 254 nm, overall retention time major 
isomer = 10.9 min, retention time minor isomer = 13.7 min. The HPLC chromatograms 
are reported in literature.41 
(R)-N-(1-Methoxy-2-methylpropyl)-[1,1'-biphenyl]-2-carboxamide (R)-285f: 
Performed according to General Procedure 22 on a 0.05 M methanol 
solution of (S)-284d using glassy carbon as anode; (R)-285f (70.2 mg, 
0.035 M, 69% yield, 7% ee) was afforded as a colourless solid, m.p.: 
98–100 °C; [𝛼]𝐷20: +23.5° (c 0.17, MeOH).  
1H NMR (500 MHz, CDCl3): δ = 7.72 (ddd, J = 7.6, 1.5, 0.5 Hz, 1H, 
ArH), 7.49 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.46–7.39 (m, 5H, ArH), 7.39–7.33 (m, 2H, ArH), 
5.48 (d, J = 9.7 Hz, 1H, NH), 4.89 (dd, J = 9.8, 5.1 Hz, 1H, NCH), 3.18 (s, 3H, OCH3), 
1.58–1.48 (m, 1H, CH) 0.66 (d, J = 6.9 Hz, 3H, CH3), 0.64 (d, J = 6.8 Hz, 3H, CH3) ppm; 
13C NMR (126 MHz, CDCl3): δ = 170.0 (C=O), 140.5 (ArC), 139.6 (ArC), 135.8 (ArC), 
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130.6 (ArC), 130.3 (ArC), 128.9 (2 × ArC), 128.9 (2 × ArC), 128.8 (ArC), 128.1 (ArC), 
127.8 (ArC), 85.3 (NCH), 56.3 (OCH3), 32.8(CH), 17.1 (CH3), 17.0 (CH3) ppm; IR (neat): 
v = 3280m, 3057w, 2958m, 2924m, 1647s, 1502s, 1146m, 1088s, 744s, 698s cm−1; 
HRMS (ES): Exact mass calculated for C18H21NO2Na [M+Na]+ 306.1470; found 
306.1472; HPLC analysis (53:46 e.r.): 1D Varian Si-5 μm (250 × 4.6 mm) 
n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 254 nm, retention time 285f = 4.0 min; 
2D YMC Chiral Amylose-C (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 85:15 (v/v), 
1.0 mL•min−1, λ = 254 nm, overall retention time major isomer = 9.6 min, retention time 
minor isomer = 11.6 min. The HPLC chromatograms are reported in literature.41 
(R)-N-(1-Methoxy-3-methylbutyl)-[1,1'-biphenyl]-2-carboxamide (R)-285g: 
Performed according to General Procedure 22 on a 0.05 M methanol 
solution of (S)-284e using glassy carbon as anode; (R)-285g (26.7 mg, 
6.9 mM, 14% yield, 14% ee) was afforded as a colourless solid, m.p.: 
86–88 °C; [𝛼]𝐷20: +4.0° (c 0.50, CH2Cl2).  
1H NMR (500 MHz, CDCl3): δ = 7.70 (ddd, J = 7.6, 1.5, 0.5 Hz, 1H, 
ArH), 7.49 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.45–7.40 (m, 5H, ArH), 7.39–
7.34 (m, 2H, ArH), 5.38 (d, J = 9.4 Hz, 1H, NH), 5.11 (ddd, J = 9.7, 7.1, 6.0 Hz, 1H, NCH), 
3.21 (s, 3H, OCH3), 1.38 (tq, J = 13.1, 6.5 Hz, 1H, 1 × CH2), 1.19 (dt, J = 14.1, 7.1 Hz, 
1H, 1 × CH2), 0.93 (ddd, J = 7.8, 6.9, 3.2 Hz, 1H, CH), 0.81 (dd, J = 6.6, 0.9 Hz, 6H, 2 × 
CH3) ppm; 13C NMR (126 MHz, CDCl3): δ = 169.8 (C=O), 140.4 (ArC), 139.6 (ArC), 135.7 
(ArC), 130.5 (ArC), 130.4 (ArC), 128.9 (2 × ArC), 128.9 (2 × ArC), 128.7 (ArC), 128.0 
(ArC), 127.8 (ArC), 80.2 (NCH), 56.0 (OCH3), 44.2, 24.3, 22.8, 22.5 ppm; IR (neat): v = 
3283m, 2955m, 1655s, 1508s, 1366m, 1148m 1095m, 1061m, 735s, 698s cm−1; 
HRMS (ES): Exact mass calculated for C19H23NO2Na [M+Na]+ 320.1626; found 
320.1629; HPLC analysis (57:43 e.r.): 1D Varian Si-5 μm (250 × 4.6 mm) 
n-hexane/isopropanol 9:1 (v/v), 1.0 mL•min−1, λ = 254 nm, retention time 285g = 4.0 min; 
2D YMC Chiral Amylose-C (250 × 4.6 mm, 5 μm), n-hexane/isopropanol 85:15 (v/v), 
1.0 mL•min−1, λ = 254 nm, overall retention time major isomer = 8.9 min, retention time 
minor isomer = 11.6 min. The HPLC chromatograms are reported in literature.41 
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(R)-N-(1-Methoxy-3-methylbutyl)-[1,1'-biphenyl]-2-carboxamide (R)-285h: 
Performed according to General Procedure 22 on a 0.05 M methanol 
solution of (S)-284f using glassy carbon as anode; (R)-285h (47.4 mg, 
0.033 M, 67% yield, 12% ee) was afforded as a colourless solid, m.p.: 
118–120 °C; [𝛼]𝐷20: +4.2° (c 0.95, CH2Cl2). 
1H NMR (500 MHz, CDCl3): δ = 7.58 (ddd, J = 7.6, 1.4, 0.4 Hz, 1H, 
ArH), 7.48 (td, J = 7.5, 1.4 Hz, 1H, ArH), 7.45–7.34 (m, 7H, ArH), 7.26–7.18 (m, 3H, ArH), 
7.01–6.94 (m, 2H, ArH), 5.50 (d, J = 9.5 Hz, 1H, NH), 5.36 (ddd, J = 9.6, 6.4, 4.5 Hz, 1H, 
NCH), 3.17 (s, 3H, OCH3), 2.65 (dd, J = 14.0, 4.4 Hz, 1H, 1 × CH2), 2.54 (dd, J = 14.0, 
6.3 Hz, 1H, 1 × CH2) ppm; 13C NMR (126 MHz, CDCl3): δ = 169.9 (C=O), 140.3 (ArC), 
139.5 (ArC), 135.9 (ArC), 135.7 (ArC), 130.5 (ArC), 130.4 (ArC), 129.8 (2 × ArC), 128.9 
(2 × ArC), 128.8 (2 × ArC), 128.7 (ArC), 128.4 (ArC), 128.1 (ArC), 127.7 (ArC), 126.8 
(ArC), 81.2 (NCH), 56.2 (OCH3), 41.2 (CH2) ppm; IR (neat): v = 3227m, 3055m, 3022m, 
2955m, 2928m, 1641s, 1530s, 1099s, 1067s, 862s, 742s, 696s cm−1; HRMS (ES): Exact 
mass calculated for C21H18NO [M−OMe+H]+ 300.1388; found 300.1377; HPLC analysis 
(55:44 e.r.): 1D Varian Si-5 μm (250 × 4.6 mm) n-hexane/isopropanol 9:1 (v/v), 
1.0 mL•min−1, λ = 254 nm, retention time 285h = 4.4 min; 2D YMC Chiral Amylose-C 
(250 × 4.6 mm, 5 μm), n-hexane/isopropanol 85:15 (v/v), 1.0 mL•min−1, λ = 254 nm, 
overall retention time major isomer = 11.7 min, retention time minor isomer = 14.8 min. 
The HPLC chromatograms are reported in literature.41 
6H-Benzo[c]chromen-6-one 294: 
Afforded as a side product. Colourless solid, m.p.: 84–86 °C. 
1H NMR (500 MHz, CDCl3): δ = 8.41 (ddd, J = 7.9, 1.4, 0.6 Hz, 1H, ArH), 
8.18–8.09 (m, 1H, ArH), 8.08 (dd, J = 7.9, 1.5 Hz, 1H, ArH), 7.84 (ddd, J = 
8.1, 7.3, 1.4 Hz, 1H, ArH), 7.66–7.50 (m, 1H, ArH), 7.52–7.44 (m, 1H, ArH), 
7.36 (dddd, J = 9.2, 8.0, 4.2, 0.8 Hz, 2H, ArH) ppm; 13C NMR (126 MHz, CDCl3): δ = 
161.4 (C=O), 151.4 (ArC–O), 135.0, 134.9, 130.7, 130.6, 129.0, 124.7, 122.9, 121.8, 
121.4, 118.2, 118.0 ppm. The spectroscopic data are in agreement with the literature.42 
5.4.2.2 Synthesis of Racemates: 
Rac-285a,b,c and d were synthesised via Shono oxidation from 293a–b following the 
procedure reported in literature.35  
Rac-285e–h were obtained via non-Kolbe reaction starting from achiral 284c–f.  
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5.4.3 DoE-assisted Optimisation 
For the electrochemical step, an Ion Electrochemical reactor design by Vapourtec was 
used combined to a R-Series modular system. The solution was pumped using a 
Chemyx Fusion 200 syringe pump and the reactor was powered up by an Aim-tti bench 
power supply (300 Watt). The offline or online analysis was performed using an Agilent 
1290 Infinity 2DLC system. The DoE was performed using Design Expert.9 
Table 5.3: 1D-HPLC calibration curve of the product 285a. 
 
 
Entry 266a (mg/mL) 
Int Stda 
(µg/mL) 
Area 266a 
(mAU) 
Area Int 
Std (mAU) 
Conc 𝟐𝟔𝟔𝐚Conc. Int Std Area 𝟐𝟔𝟔𝐚Area Int Std 
1 0.02 2.86 860.1 71.9 0.006993 0.0836 
2 0.1 2.86 828.7 306.8 0.034965 0.3702 
3 0.5 2.86 827.3 1707.45 0.1748252 2.0639 
4 1 2.86 851.8 3433.35 0.3496503 4.0307 
5 2 2.86 792 6872.5 0.6993007 8.6774 
General HPLC protocol: Varian Si 250 × 4.6 mm, 5 µm pore size, i-PrOH / n-hexane 1:9, 
1 mL•min−1, 20 °C, λ = 254 nm; aInt Std = internal standard (α,α,α-trifluorotoluene as 
internal standard). 
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Table 5.4: Real and coded values (+1 = higher level, −1 = lower level, 0 = central point) for the 
independent variables (k) and responses. 
Factor (k) Type Unit −1 0 +1 
A: (S)-284a Numeric mM 6.25 9.37 12.5 
B: Anode Categoric - graphite - glassy C 
C: Flow rate Numeric mL•min−1 0.1 0.15 0.2 
D: Charge Numeric F•mol−1 2 3 4 
E: Temperature Numeric °C −10 5 20 
Responses: 285a yield (%)a 285a ee (%)b 
aYield determined by 1H NMR by HPLC using α,α,α-trifluorotoluene as internal standard; 
bDetermined by chiral HPLC. 
Table 5.5: Experimental Matrix of the FFD 25-1 in coded values and factor generator E=A•B•C•D 
Std A B C D E = A•B•C•D 
1 −1 −1 −1 −1 +1 
2 +1 −1 −1 −1 −1 
3 −1 +1 −1 −1 −1 
4 +1 +1 −1 −1 +1 
5 −1 −1 +1 −1 −1 
6 +1 −1 +1 −1 +1 
7 −1 +1 +1 −1 +1 
8 +1 +1 +1 −1 −1 
9 −1 −1 −1 +1 −1 
10 +1 −1 −1 +1 +1 
11 −1 +1 −1 +1 +1 
12 +1 +1 −1 +1 −1 
13 −1 −1 +1 +1 +1 
14 +1 −1 +1 +1 −1 
15 −1 +1 +1 +1 −1 
16 +1 +1 +1 +1 +1 
17 0 level 1 0 0 0 - level 1 
18 0 level 2 0 0 0 - level 2 
 
Table 5.4 entries 1 and 3 gave lower yield and ee% than expected, that were very 
influential according to the Cook’s distance and other dagnostic plot, leading to a 
complex model with several significant terms and anomalous diagnostic plots. 
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Figure 5.21: Cook’s distance plot (yield). 
 
Figure 5.22: Residuals vs predicted diagnostic plot; “funnel” shape. 
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Figure 5.23: Half-normal plots for yield% and ee% considering all experiments. 
After several repeats of the experiments and a careful evaluation, it was decided to not 
include the two experiments (Table 5.4 entries 1 and 3) as they were leading into a less 
interesting part of the chemical space (low yield and low ee). The ANOVA is reported in 
literature.41 
ee% 
yield% 
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Figure 5.24: Half-normal plots for yield% and ee% without Std 1 and 3. 
 
 
 
 
a) 
b) 
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5.4.4 Cyclic Voltammetry  
 
 
 
 
 
Figure 5.25: Oxidative cyclic voltammograms of the model substrate 285a (5 mM) recorded in 
0.1 M n-Bu4NClO4/MeOH electrolyte at 20 mV/s scan rate (top) and solvent background (bottom). 
Working electrode: glassy carbon electrode tip (3 mm diameter); Counter electrode: platinum wire; 
Reference electrode: Ag/AgCl in 3 M NaCl. 
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Appendix A: Glossary of DoE Terminology 
Herein a glossary of terminologies and definitions regarding Design of Experiment is 
reported.1
 
2-Level Design: It is a set of experiments where all the factors are set at one of two levels 
(low = −1; high = +1). 
Alias (Aliasing): When the estimate of an effect also includes the influence of one or more 
other effects (e.g.: high order interactions), and they cannot be separated and 
assigned. The effects are said to be “aliased”. 
Analysis of Variance (ANOVA): A mathematical process that measures whether a factor 
contributes significantly to the variance of a response and which amount of 
variance is due to pure error. 
Axial Point: In a Central Composite Design (CCD) are those points that distance from 
the centre of a cube to a star portion of the design. The star portion of the design 
consists of an additional set of points arranged at equal distances from the 
centre of the cube on radii that pass through the centre point in the face of the 
cube. They afford an estimate of the experimental error variance to the entity of 
the curvature. 
Balanced Design: An experimental design where all points have the same number of 
observations. 
Blocking: It is achieved by restricting randomisation by blocking the experiments into 
homogenous groups. The reason for blocking is to isolate a systematic effect 
(nuisance) and prevent it from obscuring the main effects (e.g.: blocks can be 
created when it is necessary to include new batches of raw material, different 
laboratories, etc…). The runs must be randomised within the blocks. 
Central Composite Design (CCD): A 3-level design that starts with a 2-level factorial and 
some centre points. Used typically for quantitative factors and designed to 
estimate all the main effects plus the desired quadratics and two-factor 
interactions (2FI).  
Central Point: Are design points at which all the continuous factors are run halfway 
between their high and low levels. The centre points can be used to check for 
curvature in screening designs as well as to add additional runs to experiments 
(Repeats) to estimate pure error. 
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Coded Value: It is generated by transforming the scale of measurement for a factor so 
that the high value becomes +1 and the low value becomes −1. Coding is a 
simple linear transformation of the original measurement scale. The coded 
values are used for convenience of computation and comparison of effects 
between different factors. 
Confounding: Confusing two or more factors so their main effects cannot be separated 
(see Aliasing). Confounding designs naturally arise when full factorial designs 
have to be run in blocks and the block size is too small. They also occur 
whenever a fractional factorial design is chosen instead of a full factorial design.  
Contour Plot: A plot that represents a two-dimensional grid surface similar to a 
topographical map. In experimental design, the contours represent the 
estimated level of the response variable. 
Curvature: The degree of curving for a line or surface. 
Design:  A set of experimental runs which allows you to fit a particular model and 
estimate the desired effects.  
Design Matrix: It is a compact representation of the experiments to run, which shows the 
factors level combinations and associated response values in a table.  
Design of Experiment (DoE): It is a statistical technique that allows you to run the 
minimum number of experiments to optimise your product or process. It is 
defined by a list of experiments to run in order to fit the mathematical model. 
Design Points: An intended experimental run. 
Diagnostic Plot: is a scatterplot of the prediction errors (residuals) against the predicted 
values and is used to see if the predictions can be improved by fixing problems 
in your data. 
Effect:  It is the change in the average of the responses between two factor-level 
combinations or two experimental settings. For a factor A with two levels, scaled 
so that low = −1 and high = +1, the effect of A is estimated by subtracting the 
average response when A is −1 from the average response when A = +1 and 
dividing the result by 2. It gives an estimate of how changing the settings of a 
factor changes the response. The effect of a single factor is also called a Main 
Effect. 
Error:  Unexplained variation in a collection of observations. 
F-Ratio: A ratio of the variance explained by a factor to the unexplained variance. If 
there is no effect, the associated p-value is close to 1. 
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Factor:  It is a parameter (input) which is deliberately varied in an experiment in order to 
determine its effect on one or more responses (output). Some factors cannot be 
controlled by the experimenter but may affect the responses. If their effect is 
significant, these uncontrolled factors should be measured and used in the data 
analysis. The inputs can be: 
 Numerical: Are quantitative variables which can be: 
• Continuous: Are numerical variables in which infinite number of 
values between two given point are accepted. 
• Discrete: Are numerical variables that have a countable number of 
values within the limits. 
Categoric:  Are qualitative variables which contain a finite number of categories 
or distinct groups, which may not have a logical order (e.g. material 
types, solvent types). 
Face-Centered Design (FCD): A central composite design (CCD) with three levels and 
with axial points at the centre of the faces of the factorial cube instead of the 
curve. 
Factor Range: It is the range of values within the highest and the lowest levels. 
Factorial Generator: Equations that indicate the columns that must be multiplied to 
produce the last columns in a Fractional Factorial Design (FFD). 
Factorial Point: Are the points are the extremes, used to estimate the coefficients of the 
linear and the interaction terms. 
Fractional Factorial Design (FFD): Differs from a Full Factorial Design (FD) as the FFD 
does not specify all the combinations of the factors. Instead, the operator uses 
a subset of a FD (number of experiments = 2k-n, with k being the number of 
factor and n the number of Factorial Generator). 
Full Factorial (FD): A design that combines the levels for each factor with all the levels 
for every other factor (number of experiments = 2k, with k being the number of 
factors). 
Graphical Optimisation: It is used to simultaneously optimised multiple responses by 
overlapping the contour plots of every response. The area in which the optimal 
criteria for each response is satisfied (Sweet Spot) is usually highlighted. 
Half-Normal Plot: It is a graphical tool that uses ordered estimated effects to assess 
which factors are important (larger than the noise) and which are unimportant. 
Large effects appear on the right side of the plot.  
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Hard-to-Change (HTC): Are factor that are hard to change quickly and might restrict the 
randomisation. 
Interaction Effect: Occurs when a change in the response depends on the combination 
of multiple factors levels. An interaction involving two factors is known as a 
two-factor interaction (2FI), three factors as a three-factor interaction (etc). 
Lack of Fit Error: Error that occurs when the analysis omits one or more important terms 
or factors from the process model. 
Main Effect: A measure that estimates the influence of a single factor on a response 
when the factor is changed from one level to another. 
Model:  Mathematical relationship which relates changes in a measured response to 
changes in one or more factors. 
Noise:  Any unexplained or random variability in the response. 
Normal distribution: The “bell-shaped” curve distribution used to calculate probabilities 
of events that tend to occur around a mean value and trail off with decreasing 
likelihood (Gaussian Distribution). 
Normal Plot: It is a graphical tool that uses ordered estimated effects to assess which 
factors are important (larger than the noise) and which are unimportant. A 
default plot is shown in which it is assumed there are no significant parameters, 
hence all the points fall on a straight line. Any points that fall away from the line 
indicate real effects.  
Nuisance Variable: Factors that are not included or cannot be controlled in a design that 
will can distort the results, if not held constant or controlled through 
randomisation. 
One factor at a time (OFAT): A method where one factor is changed while all the others 
are kept constant. The method ignores the possibility of interactions. 
One variable at a time (OVAT): synonym of OFAT 
Orthogonality: A design where the correlation between factors is zero which means that 
all estimates can be obtained independently of one another. 
Outliner: It is a data point that does not fit the model. 
p-Value:The probability value or p-value is the probability of obtaining test results at least 
as extreme as the results actually observed during the test, assuming that the 
null hypothesis is correct (p-value > 0.05 are statistically insignificant; p-value < 
0.05 are statistically significant). 
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Pareto Chart: A graph that shows the amount of influence each factor has on the 
response in order of decreasing influence. 
Pure Error: The sums of squares from replicated environmental runs. Pure error provides 
an opportunity to test for lack-of-fit in the fitted model. 
Randomisation: A system of using random numbers to evenly spread the effects of 
factors not included in an experiment (nuisance variables). Randomisation is 
necessary for conclusions to be correct, unambiguous and defensible. 
Repeat: Performing the same treatment combination more than once. 
Replicate: Is a duplicate set of complete runs from the complete design.  
Resolution: Measure of the degree of confounding. Low-resolution designs are highly 
confounded and can only give limited information about the system under 
investigation. 
Response: It is the property of the system that is being measured (output). For example, 
yield, purity, ee%.   
Response Surface Methodology (RSM): A DoE that fully explores the process window 
and models the responses. Note: These designs are most effective when there 
are less than 5 factors. Quadratic models are used for response surface designs 
and at least three levels of every factor are needed in the design. 
Run: A set of experimental conditions in which each of the factors is held at a specific 
level. 
Screening Experiments: A screening experiment is used to identify the significant few 
factors that contribute the most to response variation. 
Sweet Spot: In a graphical optimisation is the area in which the optimal criteria for each 
response is satisfied. 
Treatment Combination: It is a set of factors and their levels; in other words, it is an 
entry of the design matrix. 
Variable: Synonym of Factor 
 
 
1  a) H. Tye, Drug Discov. Today 2004, 11, 485–491; b) J. A. Wass, J. Valid. Technol. 2010, 
49–57; c) Stat-Ease, Design of Expert v 10.01, Handbook for Experimenters, 2016; d) NIST-
SEMATECH, e-Handbook of Statistical Methods, http://www.itl.nist.gov/div898/handbook/, 
2013. 
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Appendix B: Kinetic Data Table for 185a Formation 
 
 
Entry Time (min) 226 (%) 227 (%) 228 (%) 185a (%) 
1 5 37 52 0,8 0 
2 10 29 56 0,9 0 
3 15 24 58 1 0 
4 20 20 61 11 5 
5 25 16 62 12 6 
6 30 14 65 13 7 
7 40 9 68 16 8 
8 50 8 68 17 15 
9 60 6 68 19 18 
10 120 0 60 29 23 
11 180 0 48 38 34 
12 240 0 39 53 46 
13 360 0 31 59 53 
14 480 0 24 66 57 
15 600 0 18 71 62 
16 720 0 14 76 68 
17 960 0 10 82 76 
18 1200 0 6 84 81 
19 1440 0 5 86 81 
20 1920 0 2 89 85 
21 2400 0 0 89 87 
22 2880 0 0 92 88 
Kinetic study for the formation of lactone 185a. The reaction between 184a (0.05 mmol) and 106e 
(0.05 mmol) was run and in situ 1H NMR (500 MHz, CDCl3) spectra were measured at different 
time intervals using mesitylene as the internal standard; Ar = 3,4,5-F3C6H2. 
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